Sentence,class,file
Sarcopenia and sarcopenic obesity www.kjim.org  https://doi.org/10.3904/kjim.2016.193 SARCOPENIC OBESITY Obesity is an important health threat that is a major risk  factor for metabolic and cardiovascular morbidity and  mortality.,Non-OADS,/arxiv_data1/oa_pdf/de/b4/kjim-2016-193.PMC5094937.pdf
        1058  www.kjim.org  https://doi.org/10.3904/kjim.2016.193 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/de/b4/kjim-2016-193.PMC5094937.pdf
Sarcopenia and sarcopenic obesity www.kjim.org  https://doi.org/10.3904/kjim.2016.193 16.,Non-OADS,/arxiv_data1/oa_pdf/de/b4/kjim-2016-193.PMC5094937.pdf
        1060  www.kjim.org  https://doi.org/10.3904/kjim.2016.193 The Korean Journal of Internal Medicine Vol.,Non-OADS,/arxiv_data1/oa_pdf/de/b4/kjim-2016-193.PMC5094937.pdf
"Copyright © 2016 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/3.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1226-3303 eISSN 2005-6648 http://www.kjim.org EDITORIALKorean J Intern Med 2016;31:1061-1063 https://doi.org/10.3904/kjim.2016.301  Lipoprotein(a): a not-so-well-known risk factor for  the development of cardiovascular disease in   patients with type 2 diabetes mellitus  Min Kyong Moon Department of Internal Medicine,  Seoul Metropolitan Government  Seoul National University  Boramae Medical Center, Seoul,  Korea Received : October 24, 2016 Accepted : October 26, 2016 Correspondence to Min Kyong Moon, M.D.",Non-OADS,/arxiv_data1/oa_pdf/6b/7b/kjim-2016-301.PMC5094938.pdf
"6, November 2016 https://doi.org/10.3904/kjim.2016.301to determine the level associated with CVD risk in Ko - reans.",OADS,/arxiv_data1/oa_pdf/6b/7b/kjim-2016-301.PMC5094938.pdf
Lipoprotein(a) and cardiovascular disease in T2DM https://doi.org/10.3904/kjim.2016.3014.,Non-OADS,/arxiv_data1/oa_pdf/6b/7b/kjim-2016-301.PMC5094938.pdf
http://www.iaso.org/iotf/obesity/.,Non-OADS,/arxiv_data1/oa_pdf/79/42/WIITM-11-28287.PMC5095275.pdf
"E-mail: mveterinario@yahoo.es Case Report DOI: http://dx.doi.org/10.4314/ovj.v6i3.4 Submitted: 03/05/2016 Accepted: 26/09/2016 Published: 15/10/201 6 Multiple endocrine neoplasia similar to human subtype 2A in a d og:  Medullary thyroid carcinoma, bilateral pheochromocytoma and  parathyroid adenoma E.A.",Non-OADS,/arxiv_data1/oa_pdf/30/5f/OpenVetJ-6-165.PMC5095500.pdf
http://www.openveterinaryjournal.com E.A.,Non-OADS,/arxiv_data1/oa_pdf/30/5f/OpenVetJ-6-165.PMC5095500.pdf
http://www.openveterinaryjournal.com E.A.,Non-OADS,/arxiv_data1/oa_pdf/30/5f/OpenVetJ-6-165.PMC5095500.pdf
http://www.openveterinaryjournal.com E.A.,Non-OADS,/arxiv_data1/oa_pdf/30/5f/OpenVetJ-6-165.PMC5095500.pdf
http://www.openveterinaryjournal.com E.A.,Non-OADS,/arxiv_data1/oa_pdf/30/5f/OpenVetJ-6-165.PMC5095500.pdf
http://www.openveterinaryjournal.com E.A.,Non-OADS,/arxiv_data1/oa_pdf/30/5f/OpenVetJ-6-165.PMC5095500.pdf
http://www.openveterinaryjournal.com E.A.,Non-OADS,/arxiv_data1/oa_pdf/30/5f/OpenVetJ-6-165.PMC5095500.pdf
E-mail: dlw33@cam.ac.ukOriginal Article DOI: http://dx.doi.org/10.4314/ovj.v6i3.5 Submitted: 17/04/2016 Accepted: 26/09/2016 Published: 22/10/201 6 Student attitudes regarding the educational value and welfare i mplications in  the use of model eyes and live dogs in teaching practical fundu s examination:  evaluation of responses from 40 students D.L.,Non-OADS,/arxiv_data1/oa_pdf/eb/0f/OpenVetJ-6-172.PMC5095501.pdf
http://www.openveterinaryjournal.com D.L.,Non-OADS,/arxiv_data1/oa_pdf/eb/0f/OpenVetJ-6-172.PMC5095501.pdf
http://www.openveterinaryjournal.com D.L.,Non-OADS,/arxiv_data1/oa_pdf/eb/0f/OpenVetJ-6-172.PMC5095501.pdf
http://www.openveterinaryjournal.com D.L.,Non-OADS,/arxiv_data1/oa_pdf/eb/0f/OpenVetJ-6-172.PMC5095501.pdf
http://www.openveterinaryjournal.com D.L.,Non-OADS,/arxiv_data1/oa_pdf/eb/0f/OpenVetJ-6-172.PMC5095501.pdf
http://www.openveterinaryjournal.com D.L.,Non-OADS,/arxiv_data1/oa_pdf/eb/0f/OpenVetJ-6-172.PMC5095501.pdf
"Available at: http://www.live.ac.uk/Media/LIVE/PDFs/LIVE%20TEACHING%20DEVELOPMENT%20TEAM%20PRIZE%202013%20Virtual%20stethoscope%20vlf%20(2).pdf Guest, G., Bunce, A., and Johnson, L. 2006.",Non-OADS,/arxiv_data1/oa_pdf/eb/0f/OpenVetJ-6-172.PMC5095501.pdf
"43(1), DOI: http://dx.doi.org/10.3138/jvme.0315-039R1.",Non-OADS,/arxiv_data1/oa_pdf/eb/0f/OpenVetJ-6-172.PMC5095501.pdf
"This is an Open Access article distributed under the terms of th e Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial u se, distribution, and reproduction in any medium, provided the original work is properly cited.CASE REPORTS IN PLASTIC SURGERY AND HAND SURGERY, 2016 VOL.",Non-OADS,/arxiv_data1/oa_pdf/48/b7/icrp-3-073.PMC5095519.pdf
"1, 73 –76 http://dx.doi.org/10.1080/23320885.2016.1247650",Non-OADS,/arxiv_data1/oa_pdf/48/b7/icrp-3-073.PMC5095519.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscriptREVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4292/wjgpt.v7.i4.469 469 November 6, 2016 |Volume 7 |Issue 4| WJGPT |www.wjgnet.comWorld J Gastrointest Pharmacol Ther  2016 November 6; 7(4): 469-476 ISSN 2150-5349 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/26/34/WJGPT-7-469.PMC5095566.pdf
wjgnet.com/ 2150-5349 /full/v7/i4/469.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/26/34/WJGPT-7-469.PMC5095566.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/26/34/WJGPT-7-469.PMC5095566.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Antonio Facciorusso, MD, Gastroenterology  Unit, Department of Medical and Surgical Sciences, University of  Foggia, Viale L. Pinto, 1, 71100 Foggia,  Italy.",Non-OADS,/arxiv_data1/oa_pdf/8c/31/WJGPT-7-477.PMC5095567.pdf
"antonio.facciorusso@virgilio.it Telephone: +39-0881-732154 Fax: +39-0881-732135  Received: May 22, 2016 Peer-review started:  May 23, 2016 First decision:  July 4, 2016 Revised: July 16, 2016 Accepted: August 17, 2016 Article in press: August 19, 2016REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4292/wjgpt.v7.i4.477 477 November 6, 2016 |Volume 7 |Issue 4| WJGPT |www.wjgnet.comWorld J Gastrointest Pharmacol Ther  2016 November 6; 7(4): 477-489 ISSN 2150-5349 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/8c/31/WJGPT-7-477.PMC5095567.pdf
"World J Gastrointest Pharmacol Ther 2016; 7(4): 477-489   Available from: URL:  http://www.wjgnet.com/ 2150-5349 /full/ v7/i4/477.htm  DOI: http://dx.doi.org/ 10.4292 /wjgpt.v7.i4.477 INTRODUCTION Hepatocellular carcinoma (HCC) represents a life- threatening condition and constitutes the main cause  of death among cirrhotic patients[1,2].",Non-OADS,/arxiv_data1/oa_pdf/8c/31/WJGPT-7-477.PMC5095567.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/8c/31/WJGPT-7-477.PMC5095567.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Sule Poturoglu, MD, Department of  Gastroenterology, Haseki Training and Research Hospital, 34096  Istanbul, Turkey.",Non-OADS,/arxiv_data1/oa_pdf/dc/c6/WJGPT-7-490.PMC5095568.pdf
"For this reason, pregnancy in patients with IBD is a REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4292/wjgpt.v7.i4.490 490 November 6, 2016 |Volume 7 |Issue 4| WJGPT |www.wjgnet.comWorld J Gastrointest Pharmacol Ther  2016 November 6; 7(4): 490-502 ISSN 2150-5349 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/dc/c6/WJGPT-7-490.PMC5095568.pdf
World  J Gastrointest Pharmacol Ther 2016; 7(4): 490-502  Available  from: URL:  http://www.wjgnet.com/ 2150-5349 /full/v7/i4/490.,Non-OADS,/arxiv_data1/oa_pdf/dc/c6/WJGPT-7-490.PMC5095568.pdf
"htm  DOI: http://dx.doi.org/ 10.4292 /wjgpt.v7.i4.490 INTRODUCTION Crohn’s disease (CD) and ulcerative colitis (UC) are  chronic, idiopathic diseases characterized by relapse and  remission periods, and they constitute a major portion  of the inflammatory bowel disease (IBD) spectrum.",Non-OADS,/arxiv_data1/oa_pdf/dc/c6/WJGPT-7-490.PMC5095568.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/dc/c6/WJGPT-7-490.PMC5095568.pdf
"World J Gastrointest Pharmacol  Ther 2016; 7(4): 503-512  Available from: URL:  http://www.Logical hypothesis: Low FODMAP diet to prevent  diverticulitis Yoshiharu Uno, Jennifer C van Velkinburgh Yoshiharu Uno, Office Uno Column (Medical Science Publisher),  Onoe-Cho, Hyogo 675-0025, Japan Jennifer C van Velkinburgh, van Velkinburgh Initiative for  Collaboratory Biomedical Research, Santa Fe, NM 87501, United  States Author contributions: Uno Y contributed to creation of theory,  reference collection, and creation of the table and figures; Uno Y  and van Velkinburgh JC contributed equally to the writing of the  manuscript.",Non-OADS,/arxiv_data1/oa_pdf/73/cd/WJGPT-7-503.PMC5095569.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Unsolicited manuscript Correspondence to: Yoshiharu Uno, MD, PhD, Office Uno  Column (Medical Science Publisher), Onoe-Cho, Yota 419-2,  Hyogo 675-0025, Japan.",Non-OADS,/arxiv_data1/oa_pdf/73/cd/WJGPT-7-503.PMC5095569.pdf
"yoshiharu333@hotmail.com Telephone:  +81-79-4394697 Fax: +81-79-4394697 Received: April 27, 2016 Peer-review started: April 28, 2016 First decision:  July 4, 2016 Revised: August 4, 2016 Accepted: August 15, 2016 Article in press:  August 17, 2016 Published online: November 6, 2016 REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4292/wjgpt.v7.i4.503 503 November 6, 2016 |Volume 7 |Issue 4| WJGPT |www.wjgnet.comWorld J Gastrointest Pharmacol Ther  2016 November 6; 7(4): 503-512 ISSN 2150-5349 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/73/cd/WJGPT-7-503.PMC5095569.pdf
wjgnet.com/ 2150-5349 /full/v7/i4/503.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/73/cd/WJGPT-7-503.PMC5095569.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/73/cd/WJGPT-7-503.PMC5095569.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Antoine Abou Rached, MD, MBAIP,  Division of Gastroenterology, Department of Internal Medicine,  School of Medicine, Lebanese University, Hadath, Campus, PO  Box #3, Hadath, Beirut 2903 1308,  Lebanon.",Non-OADS,/arxiv_data1/oa_pdf/dc/d6/WJGPT-7-513.PMC5095570.pdf
"abourachedantoine@gmail.co m  Telephone:  +961-5-451100 Fax: +961-5-455131 Received: December 5, 2015 Peer-review started:  December 7, 2015 First decision: February 15, 2016 Revised:  July 23, 2016 Accepted: August 15, 2016 Article in press:  August 17, 2016 Published online: November 6, 2016  Abstract Eosinophilic gastroenteritis (EGE) is a rare and benign REVIEWSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4292/wjgpt.v7.i4.513 513 November 6, 2016 |Volume 7 |Issue 4| WJGPT |www.wjgnet.comWorld J Gastrointest Pharmacol Ther  2016 November 6; 7(4): 513-523 ISSN 2150-5349 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/dc/d6/WJGPT-7-513.PMC5095570.pdf
World J Gastrointest  Pharmacol Ther 2016; 7(4): 513-523  Available from: URL:   http://www.wjgnet.com/ 2150-5349 /full/v7/i4/513.htm  DOI:  http://dx.doi.org/ 10.4292 /wjgpt.v7.i4.513 INTRODUCTION Eosinophilic gastroenteritis (EGE) is a rare inflammatory  disorder characterized by eosinophilic infiltration of  the intestinal wall.,Non-OADS,/arxiv_data1/oa_pdf/dc/d6/WJGPT-7-513.PMC5095570.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/dc/d6/WJGPT-7-513.PMC5095570.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript  source:  Invited  manuscript Correspondence to: Nanne KH de Boer, MD, PhD, Department  of Gastroenterology and Hepatology, VU University Medical  Center, PO Box 7057, 1007 MB, Amsterdam,  The Netherlands.",Non-OADS,/arxiv_data1/oa_pdf/02/3e/WJGPT-7-524.PMC5095571.pdf
"khn.deboer@vumc.n l Telephone:  +31-20-4440613 Fax: +31-20-4440554 Received:  July 21, 2016  Peer-review started: July 21, 2016  First decision:  September 5, 2016 Revised: September 12, 2016  Accepted: October 5, 2016 Article in press:  October 7, 2016 Published online: November  6, 2016  MINIREVIEWSSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4292/wjgpt.v7.i4.524 524 November 6, 2016 |Volume 7 |Issue 4| WJGPT |www.wjgnet.comWorld J Gastrointest Pharmacol Ther  2016 November 6; 7(4): 524-530 ISSN 2150-5349 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/02/3e/WJGPT-7-524.PMC5095571.pdf
World J Gastrointest Pharmacol Ther 2016; 7(4): 524-530   Available from: URL:  http://www.wjgnet.com/ 2150-5349 /full/ v7/i4/524.htm  DOI: http://dx.doi.org/ 10.4292 /wjgpt.v7.i4.524 INTRODUCTION Inflammatory bowel disease (IBD) is a chronic condition  of the gastrointestinal tract which is characterized by  episodes of remission and relapses and encompasses  both Crohn’s disease (CD) and ulcerative colitis (UC).,Non-OADS,/arxiv_data1/oa_pdf/02/3e/WJGPT-7-524.PMC5095571.pdf
"Available from: URL: http://www.rivm.nl/Documenten_ en_publicaties/Professioneel_Praktisch/Richtlijnen/Infectieziekten/ LCI_richtlijnen/LCI_richtlijn_Pfeiffer_ziekte_van 51 Biancone L , Onali S, Petruzziello C, Calabrese E, Pallone F. Cancer  and immunomodulators in inflammatory bowel diseases.",Non-OADS,/arxiv_data1/oa_pdf/02/3e/WJGPT-7-524.PMC5095571.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/02/3e/WJGPT-7-524.PMC5095571.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscript Correspondence to: Dr. Usha Krishnan, Department of  Paediatric Gastroenterology, Sydney Children’s Hospital, High  Street, Randwick NSW 2031,  Australia.",Non-OADS,/arxiv_data1/oa_pdf/15/da/WJGPT-7-531.PMC5095572.pdf
"usha.krishnan@sesiahs.health.nsw.gov.au Telephone: +61 ­ 2 ­ 93821752          Fax: +61 ­ 2 ­ 93821787 Received: April 6, 2016 Peer ­ review started: April 7, 2016 First decision:  June 6, 2016 Revised: July 16, 2016 Accepted:  August 6, 2016 Article in press:  August 8, 2016 Published online: November 6, 2016 MINIREVIEWSSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4292/wjgpt.v7.i4.531 531 November 6, 2016 |Volume 7 |Issue 4| WJGPT |www.wjgnet.comWorld J Gastrointest Pharmacol Ther  2016 November 6; 7(4): 531-539 ISSN 2150-5349 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/15/da/WJGPT-7-531.PMC5095572.pdf
wjgnet.com/ 2150 ­ 5349 /full/v7/i4/531.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/15/da/WJGPT-7-531.PMC5095572.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/15/da/WJGPT-7-531.PMC5095572.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Unsolicited manuscript Correspondence to: Ying Huang, MD, PhD, Department of  Gastroenterology, Children’s Hospital of Fudan University, No.",Non-OADS,/arxiv_data1/oa_pdf/c7/0f/WJGPT-7-540.PMC5095573.pdf
"yhuang815@163.com Telephone: +86-21-64931727 Fax: +86-21-64931901 Received: May 1, 2016ORIGINAL ARTICLESubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4292/wjgpt.v7.i4.540 540 November 6, 2016 |Volume 7 |Issue 4| WJGPT |www.wjgnet.comWorld J Gastrointest Pharmacol Ther  2016 November 6; 7(4): 540-549 ISSN 2150-5349 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/c7/0f/WJGPT-7-540.PMC5095573.pdf
World J  Gastrointest Pharmacol Ther 2016; 7(4): 540-549  Available  from: URL:  http://www.wjgnet.com/ 2150-5349 /full/v7/i4/540.,Non-OADS,/arxiv_data1/oa_pdf/c7/0f/WJGPT-7-540.PMC5095573.pdf
htm  DOI: http://dx.doi.org/ 10.4292 /wjgpt.v7.i4.540INTRODUCTION Inflammatory bowel disease (IBD) has been proposed  to be caused by an inappropriate inflammatory response  to normal components of the intestinal micro-biota in  genetically predisposed individuals[1-3].,Non-OADS,/arxiv_data1/oa_pdf/c7/0f/WJGPT-7-540.PMC5095573.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/c7/0f/WJGPT-7-540.PMC5095573.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Unsolicited manuscript Correspondence to: Dr .,Non-OADS,/arxiv_data1/oa_pdf/43/7c/WJGPT-7-550.PMC5095574.pdf
"syo335@koto.kpu-m.ac.j p  Telephone:  +81-75-5611121 Fax: +81-75-5616308ORIGINAL ARTICLESubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4292/wjgpt.v7.i4.550 550 November 6, 2016 |Volume 7 |Issue 4| WJGPT |www.wjgnet.comWorld J Gastrointest Pharmacol Ther  2016 November 6; 7(4): 550-555 ISSN 2150-5349 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/43/7c/WJGPT-7-550.PMC5095574.pdf
"World J  Gastrointest Pharmacol Ther 2016; 7(4): 550-555  Available from:  URL:  http://www.wjgnet.com/ 2150-5349 /full/v7/i4/550.htm  DOI:  http://dx.doi.org/ 10.4292 /wjgpt.v7.i4.550 INTRODUCTION Since Helicobacter pylori  (H. pylori ) eradication therapy  for chronic gastritis was approved for insurance cover  in February 2013 in Japan, the number of patients  undergoing eradication of H. pylori  has greatly increased.",Non-OADS,/arxiv_data1/oa_pdf/43/7c/WJGPT-7-550.PMC5095574.pdf
Available from: URL: http://www.takeda.,Non-OADS,/arxiv_data1/oa_pdf/43/7c/WJGPT-7-550.PMC5095574.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/43/7c/WJGPT-7-550.PMC5095574.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Susan Hutfless, PhD, Assistant Professor ,  Director, Department of Medicine, Division of Gastroenterology  and Hepatology, Johns Hopkins University, 600 N Wolfe Street,  Blalock 449, Baltimore, MD 21287,  United States.",Non-OADS,/arxiv_data1/oa_pdf/1e/88/WJGPT-7-556.PMC5095575.pdf
"shutfle1@jhmi.ed u Telephone:  +1-410-5020194 Received:  June 6, 2016 Peer-review started:  June 12, 2016 First decision:  July 20, 2016 Revised:  August 5, 2016 Accepted:  September 13, 2016Family history and disease outcomes in patients with Crohn’s  disease: A comparison between China and the United States Pei-Qi Wang, Jun Hu, Elie S Al Kazzi, Eboselume Akhuemonkhan, Min Zhi, Xiang Gao,  Raquel Holand de Paula Pessoa, Sami Ghazaleh, Tuhina Cornelius, Suhel Abbas Sabunwala,  Shadi Ghadermarzi, Kartikeya Tripathi, Mark Lazarev, Pin-Jin Hu, Susan Hutfless Pei-Qi Wang, Eboselume Akhuemonkhan, Shadi Ghadermarzi,  Mark Lazarev, Susan Hutfless, Department of Medicine, Division  of Gastroenterology and Hepatology, Johns Hopkins University,  Baltimore, MD 21287, United States Jun Hu, Guangdong provincial Key Laboratory of Colorectal  and Pelvic Floor Diseases, the Sixth Affiliated Hospital of Sun  Yat-sen University, Guangzhou 510655, Guangdong Province,  China Jun Hu, Min Zhi, Xiang Gao, Pin-Jin Hu, Department of  Gastroenterology, the Sixth Affiliated Hospital of Sun Yat-sen  University, Guangzhou 510655, Guangdong Province, China Elie S Al Kazzi, Department of Medicine, MedStar Health  Internal Medicine, Baltimore, MD 21287, United States Raquel Holand de Paula Pessoa, Department of Health and  Sport Sciences, Federal University of Acre, Rio Branco, Acre  69915-900, Brazil Sami Ghazaleh, Department of Medicine, Faculty of Medicine  and Health Sciences, An-Najah National University, Nablus  00972, Palestine Tuhina Cornelius, Suhel Abbas Sabunwala, Ravindra Nath  Tagore Medical College, Udaipur, Rajasthan 313001, India Kartikeya Tripathi, St Vincent Hospital, Worcester, MA 01608,  United States Susan Hutfless, Department of Epidemiology, Johns Hopkins  University Bloomberg School of Public Health, Baltimore, MD  21205, United States Author contributions: Wang PQ participated in study design,  analyzed and interpreted the data, and drafted the initial  manuscript; Hutfless S as the principle investigator, supervised  and advised the study; Hu J, Al Kazzi ES, Akhuemonkhan E,  Zhi M, Gao X, de Paula Pessoa RH, Ghazaleh S, Cornelius  T, Sabunwala SA, Ghadermarzi S and Tripathi K participated  in recruitment of study participants; all authors participated in ORIGINAL ARTICLESubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4292/wjgpt.v7.i4.556 556 November 6, 2016 |Volume 7 |Issue 4| WJGPT |www.wjgnet.comWorld J Gastrointest Pharmacol Ther  2016 November 6; 7(4): 556-563 ISSN 2150-5349 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/1e/88/WJGPT-7-556.PMC5095575.pdf
World J  Gastrointest Pharmacol Ther 2016; 7(4): 556-563  Available  from: URL:  http://www.wjgnet.com/ 2150-5349 /full/v7/i4/556.,Non-OADS,/arxiv_data1/oa_pdf/1e/88/WJGPT-7-556.PMC5095575.pdf
"htm  DOI: http://dx.doi.org/ 10.4292 /wjgpt.v7.i4.556 INTRODUCTION Crohn’s disease (CD) is a form of inflammatory bowel  disease (IBD), featured by chronic inflammation, most  frequently affecting the terminal ileum and colon, but  can also involve other portions of the gastrointestinal  (GI) tract from mouth to anus[1].",Non-OADS,/arxiv_data1/oa_pdf/1e/88/WJGPT-7-556.PMC5095575.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/1e/88/WJGPT-7-556.PMC5095575.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Invited manuscript Correspondence to: Rosario Cuomo, MD, Associate Professor , ORIGINAL ARTICLESubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4292/wjgpt.v7.i4.564 564 November 6, 2016 |Volume 7 |Issue 4| WJGPT |www.wjgnet.comWorld J Gastrointest Pharmacol Ther  2016 November 6; 7(4): 564-571 ISSN 2150-5349 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/c2/1d/WJGPT-7-564.PMC5095576.pdf
World J Gastrointest Pharmacol Ther 2016; 7(4): 564-571   Available from: URL:  http://www.wjgnet.com/ 2150-5349 /full/ v7/i4/564.htm  DOI: http://dx.doi.org/ 10.4292 /wjgpt.v7.i4.564 INTRODUCTION The Mediterranean diet (MD) is considered as a complex  set of eating habits adopted by peoples in countries  bordering the Mediterranean Sea.,Non-OADS,/arxiv_data1/oa_pdf/c2/1d/WJGPT-7-564.PMC5095576.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/c2/1d/WJGPT-7-564.PMC5095576.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source:  Invited manuscriptORIGINAL ARTICLESubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4292/wjgpt.v7.i4.572 572 November 6, 2016 |Volume 7 |Issue 4| WJGPT |www.wjgnet.comWorld J Gastrointest Pharmacol Ther  2016 November 6; 7(4): 572-578 ISSN 2150-5349 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/3a/67/WJGPT-7-572.PMC5095577.pdf
World J  Gastrointest Pharmacol Ther 2016; 7(4): 572-578  Available  from: URL:  http://www.wjgnet.com/ 2150-5349 /full/v7/i4/572.,Non-OADS,/arxiv_data1/oa_pdf/3a/67/WJGPT-7-572.PMC5095577.pdf
"htm  DOI: http://dx.doi.org/ 10.4292 /wjgpt.v7.i4.572 INTRODUCTION Image-enhanced gastroscopy, such as narrow-band  imaging and magnifying endoscopy, can detect subtle  early gastric cancer or precancerous lesions and this  technology is widely available in Singapore[1].",Non-OADS,/arxiv_data1/oa_pdf/3a/67/WJGPT-7-572.PMC5095577.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/3a/67/WJGPT-7-572.PMC5095577.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Unsolicited manuscript Correspondence to: Mara Barbosa, MD,  Department of  Gastroenterology, Hospital da Senhora da Oliveira, Creixomil,  4835-044 Guimarães, Portugal.",Non-OADS,/arxiv_data1/oa_pdf/59/34/WJGPT-7-579.PMC5095578.pdf
"maraisabelbarbosa@net.sapo.p t Telephone: +351-933-112632 Fax: +351-253-513592  Received: April 11, 2016 Peer-review started: April 13, 2016 First decision:  July 20, 2016 Revised: August 7, 2016 Accepted:  September 13, 2016 Article in press:  September 15, 2016 Published online: November 6, 2016 CASE REPORTSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4292/wjgpt.v7.i4.579 579 November 6, 2016 |Volume 7 |Issue 4| WJGPT |www.wjgnet.comWorld J Gastrointest Pharmacol Ther  2016 November 6; 7(4): 579-583 ISSN 2150-5349 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/59/34/WJGPT-7-579.PMC5095578.pdf
wjgnet.com/ 2150-5349 /full/v7/i4/579.htm  DOI: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/59/34/WJGPT-7-579.PMC5095578.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/59/34/WJGPT-7-579.PMC5095578.pdf
World J Gastrointest Pharmacol Ther 2016;  7(4): 584-586  Available from: URL:  http://www.wjgnet.,Non-OADS,/arxiv_data1/oa_pdf/2a/c6/WJGPT-7-584.PMC5095579.pdf
"com/ 2150-5349 /full/v7/i4/584.htm  DOI: http://dx.doi.org/ 10.4292 / wjgpt.v7.i4.584 TO THE EDITOR A Cinema is many times defined as the art of synthesis  and the art of dialectic composition of several other  artistic expressions like literature, painting or music.",Non-OADS,/arxiv_data1/oa_pdf/2a/c6/WJGPT-7-584.PMC5095579.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Manuscript source: Unsolicited manuscript Correspondence to: Guilherme Macedo, MD, PhD, WGO,  FACG, AGAF, FAASLD, Former President  of the Portuguese  Association For the Study of the Liver, Gastroenterology  Department, Centro Hospitalar São João, Faculty of Medicine of  the University of Porto, Alameda Professor Hernâni Monteiro,  4200-319 Porto, Portugal.",Non-OADS,/arxiv_data1/oa_pdf/2a/c6/WJGPT-7-584.PMC5095579.pdf
"This Project demonstrated how medical knowledge LETTERS TO THE EDITORSubmit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.4292/wjgpt.v7.i4.584 584 November 6, 2016 |Volume 7 |Issue 4| WJGPT |www.wjgnet.comWorld J Gastrointest Pharmacol Ther  2016 November 6; 7(4): 584-586 ISSN 2150-5349 (online) © 2016 Baishideng Publishing Group Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/2a/c6/WJGPT-7-584.PMC5095579.pdf
"All rights reserved.Published by Baishideng Publishing Group Inc 8226 Regency Drive, Pleasanton, CA 94588, USA Telephone: +1-925-223-8242 Fax: +1-925-223-8243 E-mail: bpgoffice@wjgnet.com Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx http://www.wjgnet.com",Non-OADS,/arxiv_data1/oa_pdf/2a/c6/WJGPT-7-584.PMC5095579.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016Plasmid DNA-encoded antibody inhibits tumor growth H Kim et al 347 Cancer Gene Therapy (2016), 341 –347",Non-OADS,/arxiv_data1/oa_pdf/b5/fc/cgt201637a.PMC5095588.pdf
e-mail: hurjin@jbnu.ac.kr ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/4c/70/jvms-78-1541.PMC5095622.pdf
e-mail: diego.sarotti@libero.it ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/65/dc/jvms-78-1549.PMC5095623.pdf
e-mail: ogawae@azabu-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/5a/10/jvms-78-1557.PMC5095624.pdf
e-mail: akiyo@mail.ecc.u-tokyo.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/c2/1f/jvms-78-1563.PMC5095625.pdf
e-mail: shira-m@vet.kagoshima-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/39/15/jvms-78-1569.PMC5095626.pdf
©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/d9/16/jvms-78-1577.PMC5095627.pdf
R package version  1.22. http://CRAN.R-project.org/package=DAAG.,Non-OADS,/arxiv_data1/oa_pdf/d9/16/jvms-78-1577.PMC5095627.pdf
URL http://www.R-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/d9/16/jvms-78-1577.PMC5095627.pdf
BMC  Bioinformatics 12: 77 http://www.biomedcentral.com/1471– 2105/12/77/.,Non-OADS,/arxiv_data1/oa_pdf/d9/16/jvms-78-1577.PMC5095627.pdf
e-mail: itoh@muses.tottori-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/30/1a/jvms-78-1583.PMC5095628.pdf
The transmembrane  region of HN protein was predicted by the SOSUI system (http://harrier.nagahama-i-bio.ac.jp/sosui/sosui_submit.html) [13].,OADS,/arxiv_data1/oa_pdf/30/1a/jvms-78-1583.PMC5095628.pdf
e-mail:	sshigeru@iwate-u.ac.jp ©2016	The	Japanese	Society	of	 Veterinary	Science This	is	an	open-access	 article	distributed 	under	the	terms	of	the	Creative	 Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/4a/20/jvms-78-1595.PMC5095629.pdf
e-mail: hjchoi@cnu.ac.kr ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/40/32/jvms-78-1601.PMC5095630.pdf
e-mail:	rieko@vet.ne.jp ©2016	The	Japanese	Society	of	 Veterinary	Science This	is	an	open-access	 article	distributed 	under	the	terms	of	the	Creative	 Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License	<http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/c8/e0/jvms-78-1607.PMC5095631.pdf
e-mail: okudamu@yamaguchi-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/10/dc/jvms-78-1611.PMC5095632.pdf
e-mail: ikadai@vmas.kitasato-u.ac.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/04/54/jvms-78-1615.PMC5095633.pdf
e-mail: okadahi@affrc.go.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/17/1c/jvms-78-1619.PMC5095634.pdf
e-mail: tjkim@chonnam.ac.kr ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/e5/c1/jvms-78-1625.PMC5095635.pdf
e-mail:	kanai@vmas.kitasato-u.ac.jp ©2016	The	Japanese	Society	of	 Veterinary	Science This	is	an	open-access	 article	distributed 	under	the	terms	of	the	Creative	 Commons Attribution Non-Commercial No Derivatives (by-nc-nd)  License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/a7/94/jvms-78-1631.PMC5095636.pdf
e-mail: yyu@affrc.go.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/5f/b2/jvms-78-1635.PMC5095637.pdf
e-mail: kameyama.mitsuhiro@pref.yamaguchi.lg.jp ©2016 The Japanese Society of Veterinary Science This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.,Non-OADS,/arxiv_data1/oa_pdf/d5/4b/jvms-78-1639.PMC5095638.pdf
GO analysis was performed using the GO  enrichment analysis at the Gene Ontology Consortium homepage (http://geneontology.org/).,OADS,/arxiv_data1/oa_pdf/4f/9d/mtna201664a.PMC5095680.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) (2016) Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/4f/9d/mtna201664a.PMC5095680.pdf
"To view a copy of this  license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ © The Author(s) (2016)",Non-OADS,/arxiv_data1/oa_pdf/7e/8c/mtna201676a.PMC5095681.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) (2016) Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/08/e2/mtna201680a.PMC5095684.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) (2016) Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/18/5c/mtna201682a.PMC5095685.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) (2016)",Non-OADS,/arxiv_data1/oa_pdf/eb/f7/mtna201683a.PMC5095686.pdf
Densitometric analysis was performed using ImageJ den- sitometry software (http://imagej.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/78/0d/mtna201688a.PMC5095687.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) (2016)",Non-OADS,/arxiv_data1/oa_pdf/78/0d/mtna201688a.PMC5095687.pdf
"Available at: https://www.gov.uk/government/ uploads/system/uploads/attachment_data/ﬁle/136551/Improving_outcomes_ second_annual_report.pdf (accessed May 30, 2014).",Non-OADS,/arxiv_data1/oa_pdf/00/b6/ECC-25-1056.PMC5095768.pdf
"Available at: http://www.worldcat.org/title/factors-affecting-recruitment-to-breast-cancer-clinical-trials-an- examination-of-the-british-association- of-surgical-oncology-ii-trial-and-the-international-breast-cancer-intervention- study/oclc/53571286 (accessed May 30, 2014).",Non-OADS,/arxiv_data1/oa_pdf/00/b6/ECC-25-1056.PMC5095768.pdf
"In this paper, we report our recent results on the [a]Departamento de Química Orgánica, University of Cádiz, Facultad de Ciencias,Polígono Río San Pedro s/n, 11510 Puerto Real, Cádiz, SpainE-mail: isidro.gonzalez@uca.eshttp://www.isidrogcollado.es/ [b]Department of Organic Chemistry, University of Sussex, Brighton, Sussex, BN1 9QJ, United Kingdom Supporting information and ORCID(s) from the author(s) for this article areavailable on the WWW under http://dx.doi.org/10.1002/ejoc.201600496.",Non-OADS,/arxiv_data1/oa_pdf/ca/55/EJOC-2016-3584.PMC5095770.pdf
http://www.cancer centrum.se/globalassets/cancerdiagnoser/brost/kvalitetsregister/nationell_rapport_2014-web.pdf [accessed 12 July2016].,Non-OADS,/arxiv_data1/oa_pdf/76/9b/BJS-103-1640.PMC5095775.pdf
Early and Locally Advanced Breast Cancer; Diagnosis and Treatment ; 2009. http://www.nice.org.uk/nicemedia/pdf/ cg80niceguideline.pdf [accessed 12 July 2016].,Non-OADS,/arxiv_data1/oa_pdf/76/9b/BJS-103-1640.PMC5095775.pdf
Statistikdatabasen ; 2016. http://www.statis tikdatabasen.scb.se/pxweb/sv/ssd/?rxid=21309244-35af- 401d-86fd-e3d3a965d82e [accessed 7 April 2016].,OADS,/arxiv_data1/oa_pdf/76/9b/BJS-103-1640.PMC5095775.pdf
2014; https://clinicaltrials.gov/ct2/show/study/NCT02149784?term 5NCT02149 784&rank 51.,Non-OADS,/arxiv_data1/oa_pdf/ba/3b/IJC-139-1927.PMC5095777.pdf
All sta-tistical analyses were performed using the R version 3.0.2 sta-tistical software (http://www.r-project.org/).,OADS,/arxiv_data1/oa_pdf/90/c1/IJC-139-2760.PMC5095781.pdf
"Aluminium salts, contained in antiperspirants at concentra- tions up to several molar units (http://www.fda.gov/RegulatoryInformation/Dockets/ucm130350.htm), have been hypothesizedto reach the mammary epithelium at signiﬁcant doses as a con-sequence of daily application to the skin of the underarm, thus Key words: aluminium, breast cancer, antiperspirants, carcinogen, mouse models of cancer, metastasis Abbreviations: HE: Hematoxylin/eosin; NK: natural killer; NMuMG: Normal murine mammary gland; NSG: NOD SCID gamma Additional Supporting Information may be found in the online version of this article.",Non-OADS,/arxiv_data1/oa_pdf/97/51/IJC-139-2781.PMC5095782.pdf
"The variants identiﬁed were ﬁltered through the “spin-off” tool speciﬁc for somatic cancer mutations, MuTect (https://www.broadinstitute.org/cancer/cga/mutect).",OADS,/arxiv_data1/oa_pdf/97/51/IJC-139-2781.PMC5095782.pdf
Direct sequencing on 18 such mutations was suc- cessful in 14 cases and conﬁrmed the mutation in 13 cases(92.8%; Supporting Information Table S1) consistent with thevery low false positive rate of MuTect (https://www.broadin-stitute.org/cancer/cga/mutect).,Non-OADS,/arxiv_data1/oa_pdf/97/51/IJC-139-2781.PMC5095782.pdf
"Y.Zhang Jiangsu Province Hi-TechKeyLabo ratory forBio-M edical Research Jiangsu Optoelec tronic Functiona lMaterial sand Engineer ingLabor atory ,Schoo lofChemis tryand Chemic alEngine ering,Sout heast University Nanjing 211189(P.R.Chin a) E-mail :Yuanjian .Zhang@s eu.edu.cn [b]Prof. Y.Shen Medical Schoo l,Southe astUniv ersity Nanjing 210009 (P.R.China) Suppo rting informa tion and theORCID identifica tion number(s) fortheau- thor(s) ofthisarticle canbefound under http://dx.do i.org/10 .1002/ chem.2 01602095 .",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/CHEM-22-12449.PMC5095786.pdf
"Available at: http://www.ncbi.nlm.nih.gov/books/NBK54103.Accessed January 10, 2016.",Non-OADS,/arxiv_data1/oa_pdf/c0/8b/LARY-126-2468.PMC5095791.pdf
Available at: https://www.miltenyibiotec.com/ /C24/media/Images/Products/Import/0002000/ IM0002014.ashx.,Non-OADS,/arxiv_data1/oa_pdf/c0/8b/LARY-126-2468.PMC5095791.pdf
http://www.neonatologyresearch.com/wp-content/ uploads/2012/04/CHD-Screening3.pdf 11.,Non-OADS,/arxiv_data1/oa_pdf/9f/7d/APA-105-e499.PMC5095792.pdf
"Studying a very common disorder, that affects around 50 million people worldwide (as determined by the WorldHealth Organization; http://www.who.int/mediacentre/fact- sheets/fs999/en/), the epilepsy research community is in dire ©2016 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/45/48/JNC-138-785.PMC5095804.pdf
"Lexical distances were estimated from lists of cognate words, amounting to over 6,000 roots (http://ielex.mpi.nl/); syntactic distances were measured over 56 parameters of nominal phrases (http://dx.doi.org/ 10.1075/jhl.3.1.07lon.additional).",OADS,/arxiv_data1/oa_pdf/de/e1/AJPA-157-630.PMC5095809.pdf
Available at: http://www.helsinki.ﬁ/~jolaakso/f-h-ety.html.,Non-OADS,/arxiv_data1/oa_pdf/de/e1/AJPA-157-630.PMC5095809.pdf
"Available at: http://www.peust.de/peustBasic- VocabularyList.pdf, accessed April 27, 2015.",Non-OADS,/arxiv_data1/oa_pdf/de/e1/AJPA-157-630.PMC5095809.pdf
These data are available at a spatial resolution of 2.5° from 1948 to present (http://www.esrl.noaa.gov/psd/).,OADS,/arxiv_data1/oa_pdf/51/5c/JGRD-121-9911.PMC5095811.pdf
"; and NSF AGSCAREER grant 0955283 and DOE Integrated Assessment Research Program grant DE-SC005171 to N.S.D.Gridded 2 m temperatures, geopoten-tial heights, meridional winds, and omega from the NCEP R1 and 2 m tem- peratures from the NCEP NorthAmerican Regional Reanalysis (NARR)are available at the NOAA ESRL website (http://www.esrl.noaa.gov/psd/data/ gridded/).",OADS,/arxiv_data1/oa_pdf/51/5c/JGRD-121-9911.PMC5095811.pdf
prism.oregonstate.edu/ and http://met-data.northwestknowledge.net/).,OADS,/arxiv_data1/oa_pdf/51/5c/JGRD-121-9911.PMC5095811.pdf
"PRISM (2015), PRISM Climate Group, Oregon State University, Available from: http://prism.oregonstate.edu (Accessed 1 March 2015).",OADS,/arxiv_data1/oa_pdf/51/5c/JGRD-121-9911.PMC5095811.pdf
https://clinicaltrials.gov/ ct2/show/NCT01019239?term=lapland&rank=1 [accessed 3 December 2015].,Non-OADS,/arxiv_data1/oa_pdf/25/bc/BJS-103-1539.PMC5095815.pdf
"V.Deigin, Dr.O.Ksenofont ova, Dr.A.Khrushc hev,Dr.O.Yatskin, Prof. V.Ivano v Institute ofBioo rganic Chemi stry,Russian Academy ofScienc es, Miklukho -Maklay a16/10,Moscow 117997 (Russia ) E-mail :vdeigi n@gm ail.com [b]Dr.A.Goryacheva TsybMedical Radiologi calResearch Center ,Ministry ofHealthofRussia, 249030 ,Kaluga regio n,Obninsk (Russ ia) Supp orting informa tionandtheORCIDidentification numb er(s) forthe autho r(s)ofthisarticle canbefoundunde rhttp://dx.doi.org/ 10.1002 / cmdc.20 1600157.",Non-OADS,/arxiv_data1/oa_pdf/7e/ef/CMDC-11-1974.PMC5095862.pdf
2011. http://www.pewforum.org/2011/01/27/the-future-of-the-global-muslim-population/.,Non-OADS,/arxiv_data1/oa_pdf/3f/4b/DOM-18-1025.PMC5095865.pdf
1996. http://www.ich.org/ ﬁleadmin/Public_Web_Site/ICH_Products/Guidelines/Ef ﬁcacy/E6/ E6_R1_Guideline.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3f/4b/DOM-18-1025.PMC5095865.pdf
2011. http://www.ema.europa.eu/docs/en_ GB/document_library/Scienti ﬁc_guideline/2012/06/WC500129256.,Non-OADS,/arxiv_data1/oa_pdf/3f/4b/DOM-18-1025.PMC5095865.pdf
SUPPORTING INFORMATION Additional Supporting Information may be found in the online version of this article at the publisher ’s web-site: http://onlinelibrary.wiley.,Non-OADS,/arxiv_data1/oa_pdf/3f/4b/DOM-18-1025.PMC5095865.pdf
"[Color ﬁgure can be seen in the online versionof this article, available at http://wileyonlinelibrary.com/journal/ajmga].2484 AMERICAN JOURNAL OF MEDICAL GENETICS PART A",Non-OADS,/arxiv_data1/oa_pdf/9b/a4/AJMG-170-2483.PMC5095869.pdf
2012; Available from: http://www.copenhagencon sensus.com/copenhagen-consensus-iii/outcome (Accessed 29 April 2016).,Non-OADS,/arxiv_data1/oa_pdf/80/48/MCN-12-940.PMC5095875.pdf
[cited 2015 5 December]; Available from: http://www.side.stat.iastate.edu/.,OADS,/arxiv_data1/oa_pdf/80/48/MCN-12-940.PMC5095875.pdf
[cited 2015 5 December]; Available from: http://www.who.int/healthinfo/global_burden_disease/tools_ national/en/.,Non-OADS,/arxiv_data1/oa_pdf/80/48/MCN-12-940.PMC5095875.pdf
[cited 2016 5 December]; Available from: http://www.who.int/choice/cost-effectiveness/methods/en/.,Non-OADS,/arxiv_data1/oa_pdf/80/48/MCN-12-940.PMC5095875.pdf
"Dr.L.I.Wiebe Depar tment ofOncology ,Cross Cancer Institut e, Universi tyofAlber ta,University Ave.,Edmo nton,AB,T6G1Z2(Canada ) E-mail :pkumar@ualberta .ca [b]Dr.H.R.H.Elsaidi Depar tment ofPhar maceutica lChemistry, Faculty ofPharm acy,Universit yofAlexan dria, ElSultan Hussein St.Azarita, Alexand ria(Egypt) [c]Dr.E.Laurens Clinica lImaging Resear chCent re, 14Medic alDrive, #B1-01, Singapore 117599 (Singapore) Supp orting informa tionandtheORCIDidentification numb er(s) forthe autho r(s)ofthisarticle canbefoundunde rhttp://dx.doi.org/ 10.1002 / cmdc.20 1600213.",Non-OADS,/arxiv_data1/oa_pdf/80/39/CMDC-11-1638.PMC5095876.pdf
"Wealso searched the following trial registers up to May 2015using the search terms ‘fumaric acid’, ‘fumarate’ and ‘fuma-derm’: the metaRegister of Controlled Trials (http://www.isrctn.com/page/mrct), The US National Institute of Health Ongoing Trials Register (www.clinicaltrials.gov), The Aus- tralian New Zealand Clinical Trials Registry (www.anzctr.or-g.au), The World Health Organization International ClinicalTrials Registry platform (www.who.int/trialsearch) and theEU Clinical Trials Register (https://www.clinicaltrialsregis-ter.eu/).",OADS,/arxiv_data1/oa_pdf/a5/03/BJD-175-873.PMC5095877.pdf
Available at: http://gdt.guidelinedevelopment.org/app/ handbook/handbook.html (last accessed 4 July 2016).,Non-OADS,/arxiv_data1/oa_pdf/a5/03/BJD-175-873.PMC5095877.pdf
Available at: http://handbook.cochrane.org/ (last accessed 4 July 2016).,OADS,/arxiv_data1/oa_pdf/a5/03/BJD-175-873.PMC5095877.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs311/en/.,Non-OADS,/arxiv_data1/oa_pdf/47/90/OBY-24-2101.PMC5095879.pdf
"[http://dx.doi.org/10.1371/journal.pone.0095763 ] [PMID: 24752677 ] [2] Ishii A, Tanaka M, Watanabe Y. Neural mechanisms of mental fatigue.",Non-OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
"[http://dx.doi.org/10.1016/j.brainresrev.2008.07.001 ] [PMID: 18652844 ] [4] Webb  HE,  Weldy  ML,  Fabianke-Kadue  EC,  Orndorff  GR,  Kamimori  GH,  Acevedo  EO.",OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
[http://dx.doi.org/10.1007/s00421-008-0852-1 ] [PMID: 18762969 ],Non-OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
[http://dx.doi.org/10.1016/j.nut.2008.07.010 ] [PMID: 18834718 ] [7] Dimsdale JE.,OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
"[http://dx.doi.org/10.1016/j.jacc.2007.12.024 ] [PMID: 18371552 ] [8] Besedovsky HO, del Rey A.",OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
"[http://dx.doi.org/10.1007/s003930070014 ] [PMID: 11155800 ] [9] Webb HE, Garten RS, McMinn DR, Beckman JL, Kamimori GH, Acevedo EO.",OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
"[http://dx.doi.org/10.1016/j.physbeh.2010.05.018 ] [PMID: 20570686 ] [11] Huang CJ, Webb HE, Garten RS, Kamimori GH, Evans RK, Acevedo EO.",OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
"[http://dx.doi.org/10.1016/j.ijpsycho.2009.12.013 ] [PMID: 20079388 ] [12] Huang CJ, Webb HE, Evans RK, et al.",OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
"[http://dx.doi.org/10.1258/ebm.2010.010176 ] [PMID: 21127346 ] [13] Webb HE, Garten RS, McMinn DR, Beckman JL, Kamimori GH, Acevedo EO.",OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
[http://dx.doi.org/10.1007/s11031-007-9066-9 ] [15] Wright RA.,Non-OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
"[http://dx.doi.org/10.1111/j.1751-9004.2008.00093.x ] [16] Acevedo EO, Webb HE, Weldy ML, Fabianke EC, Orndorff GR, Starks MA.",OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
"[http://dx.doi.org/10.1055/s-2006-923902 ] [PMID: 16612743 ] [17] Rousselle JG, Blascovich J, Kelsey RM.",OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
"[http://dx.doi.org/10.1016/0167-8760(95)00026-O ] [PMID: 8543484 ] [18] Hatfield BD, Spalding TW, Mahon AD, Slater BA, Brody EB, Vaccaro P. The effect of psychological strategies upon cardiorespiratory and muscular activity during treadmill running.",OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
"[http://dx.doi.org/10.1249/00005768-199202000-00010 ] [PMID: 1549011 ] [19] Marcora SM, Staiano W, Manning V. Mental fatigue impairs physical performance in humans.",Non-OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
"[http://dx.doi.org/10.1152/japplphysiol.91324.2008 ] [PMID: 19131473 ] [20] Pageaux B, Lepers R, Dietz KC, Marcora SM.",OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
"[http://dx.doi.org/10.1007/s00421-014-2838-5 ] [PMID: 24531591 ] [21] Brownsberger J, Edwards A, Crowther R, Cottrell D. Impact of mental fatigue on self-paced exercise.",OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
[http://dx.doi.org/10.1055/s-0033-1343402 ] [PMID: 23771830 ] [22] Lorist MM.,OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
"[http://dx.doi.org/10.1016/j.brainres.2008.07.053 ] [PMID: 18687317 ] [23] Tanaka M, Ishii A, Shigihara Y, et al.",OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
"[http://dx.doi.org/10.1016/j.bandc.2012.10.013 ] [PMID: 23262174 ] [25] van der Linden D, Frese M, Meijman TF.",OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
[http://dx.doi.org/10.1016/S0001-6918(02)00150-6 ] [PMID: 12679043 ] [26] Yeung RR.,OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
[http://dx.doi.org/10.1016/0022-3999(95)00554-4 ] [PMID: 8778396 ],OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
"[http://dx.doi.org/10.1016/S0028-3932(01)00226-3 ] [PMID: 11931927 ] [28] Bush G, Whalen PJ, Rosen BR, Jenike MA, McInerney SC, Rauch SL.",OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
"[http://dx.doi.org/10.1002/(SICI)1097-0193(1998)6:4<270::AID-HBM6>3.0.CO;2-0 ] [PMID: 9704265 ] [29] Williamson  JW,  McColl  R,  Mathews  D,  Mitchell  JH,  Raven  PB,  Morgan  WP.",OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
"[http://dx.doi.org/10.1152/japplphysiol.00939.2001 ] [PMID: 11842073 ] [31] Lovatt D, Xu Q, Liu W, et al.",OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
"[http://dx.doi.org/10.1152/ajpregu.00386.2002 ] [PMID: 12399249 ] [33] Mizuno K, Tanaka M, Nozaki S, et al.",OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
"[http://dx.doi.org/10.1007/s00702-006-0608-1 ] [PMID: 17160370 ] [34] Nozaki S, Tanaka M, Mizuno K, et al.",OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
[http://dx.doi.org/10.1016/j.nut.2008.07.010 ] [PMID: 18834718 ] [35] Gailliot MT.,OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
"[http://dx.doi.org/10.1111/j.1745-6924.2008.00077.x ] [PMID: 26158946 ] [36] Lorist MM, Tops M. Caffeine, fatigue, and cognition.",Non-OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
"[http://dx.doi.org/10.1016/S0278-2626(03)00206-9 ] [PMID: 14572506 ] [37] Pageaux B, Marcora SM, Lepers R. Prolonged mental exertion does not alter neuromuscular function of the knee extensors.",Non-OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
"[http://dx.doi.org/10.1249/MSS.0b013e31829b504a ] [PMID: 23698244 ] [38] Kato T, Murashita J, Shioiri T, Inubushi T, Kato N. Relationship of energy metabolism detected by 31P-MRS in the human brain with mental fatigue.",OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
"[http://dx.doi.org/10.1159/000026587 ] [PMID: 10343187 ] [39] Otto T, Zijlstra FR, Goebel R. Neural correlates of mental effort evaluationinvolvement of structures related to self-awareness.",OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
"[http://dx.doi.org/10.1093/scan/nss136 ] [PMID: 23202660 ] [40] Cook DB, OConnor PJ, Lange G, Steffener J. Functional neuroimaging correlates of mental fatigue induced by cognition among chronic fatigue syndrome patients and controls.",OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
"[http://dx.doi.org/10.1016/j.neuroimage.2007.02.033 ] [PMID: 17408973 ] [41] Ishii A, Tanaka M, Yamano E, Watanabe Y. Neural substrates activated by viewing others expressing fatigue: a magnetoencephalography study.",OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
"[http://dx.doi.org/10.1016/j.brainres.2012.03.031 ] [PMID: 22502975 ] [42] Pageaux B, Marcora SM, Lepers R. Prolonged mental exertion does not alter neuromuscular function of the knee extensors.",Non-OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
[http://dx.doi.org/10.1249/MSS.0b013e31829b504a ] [PMID: 23698244 ] [43] Smeets T. Autonomic and hypothalamic-pituitary-adrenal stress resilience: Impact of cardiac vagal tone.,Non-OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
"[http://dx.doi.org/10.1113/expphysiol.2005.032367 ] [PMID: 16282366 ] [45] Barbosa  DF,  Prada  FJ,  Glanner  MF,  Nóbrega  OdeT,  Córdova  CO.  Cardiovascular  response  to  Stroop  test:  comparison  between  the computerized and verbal tests.",OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
[http://dx.doi.org/10.1590/S0066-782X2010005000006 ] [PMID: 20209370 ] [46] Porges SW. Vagal tone: a physiologic marker of stress vulnerability.,Non-OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
"Acute Mental Exertion and Exercise Clinical Practice & Epidemiology in Mental Health, 2016, Volume 12    107 [http://dx.doi.org/10.1016/j.brainres.2014.03.009 ] [PMID: 24642273 ] [48] Tanaka M. Impaired selective attention caused by mental fatigue.",Non-OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
"[http://dx.doi.org/10.1139/H10-082 ] [PMID: 21326375 ] [50] Marcora SM, Staiano W. The limit to exercise tolerance in humans: mind over muscle?",Non-OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
"[http://dx.doi.org/10.1007/s00421-010-1418-6 ] [PMID: 20221773 ] [51] Bray SR, Graham JD, Martin Ginis KA, Hicks AL.",OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
[http://dx.doi.org/10.1111/j.1469-8986.2007.00625.x ] [PMID: 17995906 ] [53] Pageaux B.,OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
[http://dx.doi.org/10.1007/s40279-014-0198-2 ] [PMID: 24809249 ] © Silva-Júnior et al.,Non-OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
"; Licensee Bentham Open This is an open access articles licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/85/b7/CPEMH-12-94.PMC5095890.pdf
"[http://dx.doi.org/10.1136/hrt.2005.074187] [PMID: 16387829] [2] Owan TE, Redfield MM.",Non-OADS,/arxiv_data1/oa_pdf/1f/54/TOCMJ-10-212.PMC5095892.pdf
[http://dx.doi.org/10.1016/j.pcad.2005.02.010] [PMID: 16003647] [3] Hypertension in Diabetes Study (HDS): I.,Non-OADS,/arxiv_data1/oa_pdf/1f/54/TOCMJ-10-212.PMC5095892.pdf
"[http://dx.doi.org/10.1097/00004872-199303000-00012] [PMID: 8387089] [4] Reboldi G, Gentile G, Angeli F, Verdecchia P. Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials.",Non-OADS,/arxiv_data1/oa_pdf/1f/54/TOCMJ-10-212.PMC5095892.pdf
"[http://dx.doi.org/10.2147/VHRM.S4235] [PMID: 19475778] [5] Felício  JS,  Pacheco  JT,  Ferreira  SR,  et  al.",OADS,/arxiv_data1/oa_pdf/1f/54/TOCMJ-10-212.PMC5095892.pdf
"[http://dx.doi.org/10.1186/1475-2840-5-19] [PMID: 16968545] [6] Pieske B, Wachter R. Impact of diabetes and hypertension on the heart.",Non-OADS,/arxiv_data1/oa_pdf/1f/54/TOCMJ-10-212.PMC5095892.pdf
"[http://dx.doi.org/10.1097/HCO.0b013e3283031ab3] [PMID: 18520718] [7] Nichols GA, Hillier TA, Erbey JR, Brown JB.",OADS,/arxiv_data1/oa_pdf/1f/54/TOCMJ-10-212.PMC5095892.pdf
"[http://dx.doi.org/10.2337/diacare.24.9.1614] [PMID: 11522708] [8] Shahin Y, Khan JA, Samuel N, Chetter I. Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials.",Non-OADS,/arxiv_data1/oa_pdf/1f/54/TOCMJ-10-212.PMC5095892.pdf
"[http://dx.doi.org/10.1016/j.atherosclerosis.2011.02.044] [PMID: 21411098] [9] Çiftel M, Ertuğ H, Parlak M, Akçurin G, Kardelen F. Investigation of endothelial dysfunction and arterial stiffness in children with type 1 diabetes mellitus and the association with diastolic dysfunction.",Non-OADS,/arxiv_data1/oa_pdf/1f/54/TOCMJ-10-212.PMC5095892.pdf
"[http://dx.doi.org/10.1177/1479164113508564] [PMID: 24169808] [10] Tabit CE, Chung WB, Hamburg NM, Vita JA.",Non-OADS,/arxiv_data1/oa_pdf/1f/54/TOCMJ-10-212.PMC5095892.pdf
"[http://dx.doi.org/10.1007/s11154-010-9134-4] [PMID: 20186491] [11] Inaba Y, Chen JA, Bergmann SR.",Non-OADS,/arxiv_data1/oa_pdf/1f/54/TOCMJ-10-212.PMC5095892.pdf
"[http://dx.doi.org/10.1007/s10554-010-9616-1] [PMID: 20339920] [12] Sitia S, Tomasoni L, Atzeni F, et al.",OADS,/arxiv_data1/oa_pdf/1f/54/TOCMJ-10-212.PMC5095892.pdf
[http://dx.doi.org/10.1016/j.autrev.2010.07.016] [PMID: 20678595],OADS,/arxiv_data1/oa_pdf/1f/54/TOCMJ-10-212.PMC5095892.pdf
"[http://dx.doi.org/10.1161/01.CIR.0000112565.60887.1E] [PMID: 14769683] [14] Shivalkar B, Dhondt D, Goovaerts I, et al.",OADS,/arxiv_data1/oa_pdf/1f/54/TOCMJ-10-212.PMC5095892.pdf
"[http://dx.doi.org/10.1016/j.amjcard.2005.07.111] [PMID: 16377288] [15] Eltayeb AA, Ahmad FA, Sayed DM, Osama AM.",OADS,/arxiv_data1/oa_pdf/1f/54/TOCMJ-10-212.PMC5095892.pdf
"[http://dx.doi.org/10.1007/s00246-014-0883-9] [PMID: 24595824] [16] Ravikumar R, Deepa R, Shanthirani C, Mohan V. Comparison of carotid intima-media thickness, arterial stiffness, and brachial artery flow mediated dilatation in diabetic and nondiabetic subjects (The Chennai Urban Population Study [CUPS-9]).",Non-OADS,/arxiv_data1/oa_pdf/1f/54/TOCMJ-10-212.PMC5095892.pdf
"[http://dx.doi.org/10.1016/S0002-9149(02)02593-6] [PMID: 12356381] [17] Leung M, Phan V, Leung DY.",OADS,/arxiv_data1/oa_pdf/1f/54/TOCMJ-10-212.PMC5095892.pdf
"[http://dx.doi.org/10.1136/openhrt-2014-000113] [PMID: 25332819] [18] Nagueh SF, Appleton CP, Gillebert TC, et al.",OADS,/arxiv_data1/oa_pdf/1f/54/TOCMJ-10-212.PMC5095892.pdf
"[http://dx.doi.org/10.1016/j.echo.2008.11.023] [PMID: 19187853] [19] Tei C, Ling LH, Hodge DO, et al.",OADS,/arxiv_data1/oa_pdf/1f/54/TOCMJ-10-212.PMC5095892.pdf
"[http://dx.doi.org/10.1016/j.echo.2014.10.003] [PMID: 25559473] [21] Touboul PJ, Hennerici MG, Meairs S, et al.",OADS,/arxiv_data1/oa_pdf/1f/54/TOCMJ-10-212.PMC5095892.pdf
"[http://dx.doi.org/10.1159/000097034] [PMID: 17108679] [22] Corretti MC, Anderson TJ, Benjamin EJ, et al.",OADS,/arxiv_data1/oa_pdf/1f/54/TOCMJ-10-212.PMC5095892.pdf
"[http://dx.doi.org/10.1016/S0735-1097(01)01746-6] [PMID: 11788217] [23] Gismondi RA, Oigman W, Bedirian R, Pozzobon CR, Ladeira MC, Neves MF.",OADS,/arxiv_data1/oa_pdf/1f/54/TOCMJ-10-212.PMC5095892.pdf
"[http://dx.doi.org/10.1177/1470320315573681] [PMID: 25784709] [24] Flammer AJ, Hermann F, Wiesli P, et al.",OADS,/arxiv_data1/oa_pdf/1f/54/TOCMJ-10-212.PMC5095892.pdf
"[http://dx.doi.org/10.1097/HJH.0b013e3280287a72] [PMID: 17351370] [25] Rydén L, Standl E, Bartnik M, et al.",OADS,/arxiv_data1/oa_pdf/1f/54/TOCMJ-10-212.PMC5095892.pdf
"[http://dx.doi.org/10.2337/dc12-s011] [PMID: 22187469] [27] Ma LN, Zhao SP, Gao M, Zhou QC, Fan P. Endothelial dysfunction associated with left ventricular diastolic dysfunction in patients with coronary heart disease.",Non-OADS,/arxiv_data1/oa_pdf/1f/54/TOCMJ-10-212.PMC5095892.pdf
"[http://dx.doi.org/10.1016/S0167-5273(99)00203-X] [PMID: 10716138] [28] Uslu N, Eren M, Gorgulu S, et al.",OADS,/arxiv_data1/oa_pdf/1f/54/TOCMJ-10-212.PMC5095892.pdf
"[http://dx.doi.org/10.1016/j.amjcard.2006.01.041] [PMID: 16765135] [29] Elesber AA, Redfield MM, Rihal CS, et al.",OADS,/arxiv_data1/oa_pdf/1f/54/TOCMJ-10-212.PMC5095892.pdf
"[http://dx.doi.org/10.1016/j.ahj.2007.03.007] [PMID: 17540214] [30] Aksnes TA, Skårn SN, Kjeldsen SE.",OADS,/arxiv_data1/oa_pdf/1f/54/TOCMJ-10-212.PMC5095892.pdf
[http://dx.doi.org/10.1586/erc.12.59] [PMID: 22894629],Non-OADS,/arxiv_data1/oa_pdf/1f/54/TOCMJ-10-212.PMC5095892.pdf
"[http://dx.doi.org/10.1371/journal.pone.0090217] [PMID: 24595033] [32] Okoshi K, Guimarães JF, Di Muzio BP, Fernandes AA, Okoshi MP.",Non-OADS,/arxiv_data1/oa_pdf/1f/54/TOCMJ-10-212.PMC5095892.pdf
"[http://dx.doi.org/10.1590/S0004-27302007000200004] [PMID: 17505622] [33] Codinach Huix P, Freixa Pamias R. Diabetic cardiomyopathy: concept, heart function, and pathogenesis.",Non-OADS,/arxiv_data1/oa_pdf/1f/54/TOCMJ-10-212.PMC5095892.pdf
"[http://dx.doi.org/10.1161/01.HYP.37.4.1053] [PMID: 11304502] [35] Uusitupa MI, Mustonen JN, Airaksinen KE.",OADS,/arxiv_data1/oa_pdf/1f/54/TOCMJ-10-212.PMC5095892.pdf
[http://dx.doi.org/10.3109/07853899009147274] [PMID: 2076269] © Bedirian et al.,Non-OADS,/arxiv_data1/oa_pdf/1f/54/TOCMJ-10-212.PMC5095892.pdf
"; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/54/TOCMJ-10-212.PMC5095892.pdf
"[http://dx.doi.org/10.1111/jcpp.12293 ] [PMID: 25039570 ] [4] Doernberg E, Hollander E. Neurodevelopmental Disorders (ASD and ADHD): DSM-5, ICD-10, and ICD-11.",Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1017/S1092852916000262 ] [PMID: 27364515 ] [5] Takara K, Kondo T. Autism spectrum disorder among first-visit depressed adult patients: diagnostic clues from backgrounds and past history.",Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1016/j.genhosppsych.2014.08.004 ] [PMID: 25217491 ] [6] Dell'Osso L, Dalle Luche R, Maj M. Adult Autism Spectrum as a transnosographic dimension.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1017/S1092852900005836 ] [8] Cassano  GB,  Dell’Osso  L,  Frank  E,  et  al.",Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
[http://dx.doi.org/10.1016/S0165-0327(98)00158-X ] [PMID: 10467978 ] [9] Insel TR.,OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1038/nature09552 ] [PMID: 21068826 ] [10] Doherty JL, Owen MJ.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
[http://dx.doi.org/10.1186/gm546 ] [PMID: 24944580 ] [11] Asperger H. Die “autistischen Psychopathen” im kindesalter.,Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
[http://dx.doi.org/10.1007/BF01837709 ] [12] Kanner L. Autistic disturbances of affective contact.,Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1017/S0033291700053332 ] [PMID: 7208735 ] [15] Frith U, Morton J, Leslie AM.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
[http://dx.doi.org/10.1016/0166-2236(91)90041-R ] [PMID: 1722361 ] [16] Bleuler E. Dementia Praecox oder Gruppe der Schizophrenien.,OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
[http://dx.doi.org/10.1111/j.1469-8749.1973.tb04897.x ] [PMID: 4718692 ] [19] James I. Asperger's Syndrome and High Achievment: Some very remarkable people.,Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
[http://dx.doi.org/10.1177/1362361302006004010 ] [PMID: 12540134 ] [21] Fitzgerald M. Creativity Psychosis Autism and the Social Brain.,Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.5772/17439 ] [22] Baron-Cohen  S,  Wheelwright  S,  Skinner  R,  Martin  J,  Clubley  E.  The  autism-spectrum  quotient  (AQ):  evidence  from  Asperger syndrome/high-functioning  autism,  males  and  females,  scientists  and  mathematicians.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1023/A:1005653411471 ] [PMID: 11439754 ] [23] Fitzgerald K, Hyman M, Swift K. Autism spectrum disorders.",Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
[http://dx.doi.org/10.7453/gahmj.2012.1.4.010 ] [PMID: 24278834 ] [24] Frith U.,OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.3109/13682828909011952 ] [PMID: 2690916 ] [25] Baron-Cohen S, Richler J, Bisarya D, Gurunathan N, Wheelwright S. The systemizing quotient: an investigation of adults with Asperger syndrome or high-functioning autism, and normal sex differences.",Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1098/rstb.2002.1206 ] [PMID: 12639333 ] [26] Lyons V, Fitzgerald M. Early memory and autism.",Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1007/s10803-005-0012-y ] [PMID: 16175314 ] [27] Doobay AF, Foley-Nicpon M, Ali SR, Assouline SG.",Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1007/s10803-014-2082-1 ] [PMID: 24584434 ] [28] Schopler E, Mesibov G, Baker A.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1016/S0002-7138(09)60881-5 ] [PMID: 7096846 ] [29] Klin A, Volkmar FR, Sparrow SS.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1111/j.1469-7610.1992.tb01961.x ] [PMID: 1378847 ] [30] Eisenmajer R, Prior M, Leekam S, et al.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
[http://dx.doi.org/10.1023/A:1026004212375 ] [PMID: 9932239 ] [31] Gillberg C. Asperger syndrome and high-functioning autism.,Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1192/bjp.172.3.200 ] [PMID: 9614468 ] [32] Macintosh KE, Dissanayake C. Annotation: The similarities and differences between autistic disorder and Asperger’s disorder: a review of the empirical evidence.",Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1111/j.1469-7610.2004.00234.x ] [PMID: 15055363 ] [33] Klin A, Pauls D, Schultz R, Volkmar F. Three diagnostic approaches to Asperger syndrome: implications for research.",Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
[http://dx.doi.org/10.1007/s10803-004-2001-y ] [PMID: 15909408 ] [34] Sanders JL.,OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1007/s10803-009-0798-0 ] [PMID: 19548078 ] [35] Sharma S, Woolfson LM, Hunter SC.",Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1177/1362361311411935 ] [PMID: 21810909 ] [36] Nemeroff CB, Weinberger D, Rutter M, et al.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1186/1741-7015-11-202 ] [PMID: 24229007 ] [37] Mattila ML, Kielinen M, Linna SL, et al.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1016/j.jaac.2011.04.001 ] [PMID: 21621142 ] [38] Huerta M, Bishop SL, Duncan A, Hus V, Lord C. Application of DSM-5 criteria for autism spectrum disorder to three samples of children with DSM-IV diagnoses of pervasive developmental disorders.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1176/appi.ajp.2012.12020276 ] [PMID: 23032385 ] [39] Gibbs V, Aldridge F, Chandler F, Witzlsperger E, Smith K. Brief report: an exploratory study comparing diagnostic outcomes for autism spectrum disorders under DSM-IV-TR with the proposed DSM-5 revision.",Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1007/s10803-012-1560-6 ] [PMID: 22677932 ] [40] Helles A, Gillberg CI, Gillberg C, Billstedt E. Asperger syndrome in males over two decades: stability and predictors of diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1111/jcpp.12334 ] [PMID: 25283685 ] [41] Kim YS, Fombonne E, Koh YJ, Kim SJ, Cheon KA, Leventhal BL.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
[http://dx.doi.org/10.1016/j.jaac.2013.12.021 ] [PMID: 24745950 ] [42] Miller J. DSM-5 and autism spectrum disorders: the changes you haven’t heard about yet.,Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.4088/JCP.13l08933 ] [PMID: 25470101 ] [43] Lai MC, Lombardo MV, Chakrabarti B, Baron-Cohen S. Subgrouping the autism “spectrum”: reflections on DSM-5.",Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1371/journal.pbio.1001544 ] [PMID: 23630456 ] [44] Stewart ME, Barnard L, Pearson J, Hasan R, O’Brien G. Presentation of depression in autism and Asperger syndrome: a review.",Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1177/1362361306062013 ] [PMID: 16522713 ] [45] Skokauskas  N,  Gallagher  L.  Psychosis,  affective  disorders  and  anxiety  in  autistic  spectrum  disorder:  prevalence  and  nosological considerations.",Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1159/000255958 ] [PMID: 19893339 ] [46] Vannucchi G, Masi G, Toni C, Dell’Osso L, Marazziti D, Perugi G. Clinical features, developmental course, and psychiatric comorbidity of adult autism spectrum disorders.",Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1017/S1092852913000941 ] [PMID: 24352005 ] [47] Kato K, Mikami K, Akama F, et al.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1016/j.genhosppsych.2012.09.006 ] [PMID: 23141028 ] [48] Takara K, Kondo T. Comorbid atypical autistic traits as a potential risk factor for suicide attempts among adult depressed patients: a case- control study.",Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1186/s12991-014-0033-z ] [PMID: 25328535 ] [49] Le Couteur A, Bailey A, Goode S, et al.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1111/j.1469-7610.1996.tb01475.x ] [PMID: 8923222 ] [50] Duvall JA, Lu A, Cantor RM, Todd RD, Constantino JN, Geschwind DH.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1176/ajp.2007.164.4.656 ] [PMID: 17403980 ] [51] St Pourcain B, Wang K, Glessner JT, et al.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1176/appi.ajp.2010.09121789 ] [PMID: 20634369 ] [52] Constantino JN, Zhang Y, Frazier T, Abbacchi AM, Law P. Sibling recurrence and the genetic epidemiology of autism.",Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1176/appi.ajp.2010.09101470 ] [PMID: 20889652 ] [53] Levy Y, Bar-Yuda C. Language performance in siblings of nonverbal children with autism.",Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1177/1362361310386504 ] [PMID: 21363870 ] [54] Lundström S, Chang Z, Råstam M, et al.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1001/archgenpsychiatry.2011.144 ] [PMID: 22213788 ] [55] Piven J, Palmer P, Jacobi D, Childress D, Arndt S. Broader autism phenotype: evidence from a family history study of multiple-incidence autism families.",Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1176/ajp.154.2.185 ] [PMID: 9016266 ] [56] Constantino JN, Lajonchere C, Lutz M, et al.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1176/appi.ajp.163.2.294 ] [PMID: 16449484 ] [57] Scheeren AM, Stauder JE.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1007/s10803-007-0389-x ] [PMID: 17588199 ] [58] Losh M, Adolphs R, Poe MD, et al.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1001/archgenpsychiatry.2009.34 ] [PMID: 19414711 ] [59] Wheelwright S, Auyeung B, Allison C, Baron-Cohen S. Defining the broader, medium and narrow autism phenotype among parents using the Autism Spectrum Quotient (AQ).",Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1186/2040-2392-1-10 ] [PMID: 20678260 ] [60] Sucksmith E, Roth I, Hoekstra RA.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1007/s11065-011-9183-9 ] [PMID: 21989834 ] [61] Taylor LJ, Maybery MT, Wray J, Ravine D, Hunt A, Whitehouse AJ.",Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1007/s10803-013-1838-3 ] [PMID: 23619954 ] [62] De la Marche W, Noens I, Luts J, Scholte E, Van Huffel S, Steyaert J. Quantitative autism traits in first degree relatives: evidence for the broader autism phenotype in fathers, but not in mothers and siblings.",Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1177/1362361311421776 ] [PMID: 21949002 ] [63] Sucksmith E, Allison C, Baron-Cohen S, Chakrabarti B, Hoekstra RA.",Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1016/j.neuropsychologia.2012.11.013 ] [PMID: 23174401 ] [64] Berthoz S, Lalanne C, Crane L, Hill EL.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1016/j.psychres.2013.05.014 ] [PMID: 23747233 ] [65] Levin-Decanini T, Maltman N, Francis SM, et al.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1002/aur.1322 ] [PMID: 23956104 ] [66] Ozonoff  S,  Young  GS,  Belding  A,  et  al.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1016/j.jaac.2013.12.020 ] [PMID: 24655649 ] [67] Cooper SA, Smiley E, Morrison J, et al.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1007/s00127-007-0197-9 ] [PMID: 17502974 ] [68] Hutton J, Goode S, Murphy M, Le Couteur A, Rutter M. New-onset psychiatric disorders in individuals with autism.",Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1177/1362361308091650 ] [PMID: 18579645 ] [69] Mouridsen SE, Rich B, Isager T. Psychiatric disorders in adults diagnosed as children with atypical autism.",Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
[http://dx.doi.org/10.1007/s00702-007-0798-1 ] [PMID: 17768593 ],Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
[http://dx.doi.org/10.1111/j.1365-2788.2011.01418.x ] [PMID: 21492292 ] [71] Nylander I.,OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1192/bjp.186.3.182 ] [PMID: 15738496 ] [73] Dell’Osso L, Pini S. What did we learn from research on comorbidity in psychiatry?",Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.2174/1745017901208010180 ] [PMID: 23304235 ] [74] Diagnostic and Statistical Manual of Mental Disorders, DSM-III.",Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
[http://dx.doi.org/10.1016/j.wpsyc.2012.05.001 ] [PMID: 22654929 ] [76] Minkowski E. La Schizophrenie: psychopathologie des schizoides et des schizophrenes.,OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
[http://dx.doi.org/10.1016/0010-440X(91)90065-K ] [PMID: 2001623 ] [79] Parnas J.,OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
[http://dx.doi.org/10.1093/schbul/sbr081 ] [PMID: 21771902 ] [80] Gross G. The onset of schizophrenia.,Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
[http://dx.doi.org/10.1016/S0920-9964(97)00118-7 ] [PMID: 9468353 ] [81] Dalle Luche R. Psychotic and hysterical dissociative syndromes.,Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1002/mpr.58 ] [84] Shear MK, Frank E, Rucci P, et al.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1016/S0022-3956(01)00002-4 ] [PMID: 11287057 ] [85] Sbrana A, Dell’Osso L, Benvenuti A, et al.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1016/j.schres.2004.09.016 ] [PMID: 15885528 ] [86] Dell’Osso L, Armani A, Rucci P, et al.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1053/comp.2002.29852 ] [PMID: 11788923 ] [87] Dell’Osso L, Rucci P, Cassano GB, et al.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1053/comp.2002.30795 ] [PMID: 11893984 ] [88] Dell’Osso L, Shear MK, Carmassi C, et al.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1186/1745-0179-4-2 ] [PMID: 18226228 ] [89] Cassano  GB,  Banti  S,  Mauri  M,  et  al.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1002/mpr.64 ] [90] Dell’Osso L, Carmassi C, Rucci P, et al.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1016/j.comppsych.2008.11.006 ] [PMID: 19683620 ] [91] Dell’Osso L, Gesi C, Massimetti E, et al.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1080/10720160490900614 ] [94] Dell'Osso L, Dalle Luche R, Cerliani C, et al.",Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1016/j.comppsych.2015.04.003 ] [PMID: 26031384 ] [95] Dougherty CC, Evans DW, Myers SM, Moore GJ, Michael AM.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1007/s11065-015-9300-2 ] [PMID: 26482248 ] [96] Grove R, Baillie A, Allison C, Baron-Cohen S, Hoekstra RA.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1037/a0031919 ] [PMID: 23713510 ] [97] Hofvander  B,  Delorme  R,  Chaste  P,  et  al.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1186/1471-244X-9-35 ] [PMID: 19515234 ] [98] Lugnegård T, Hallerbäck MU, Gillberg C. Psychiatric comorbidity in young adults with a clinical diagnosis of Asperger syndrome.",Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1016/j.ridd.2011.03.025 ] [PMID: 21515028 ] [99] Oldershaw A, Treasure J, Hambrook D, Tchanturia K, Schmidt U.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1002/erv.1069 ] [PMID: 21280165 ] [100] Dell’Osso L, Abelli M, Carpita B, et al.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.2147/ntd.s 108912 ] [101] Kamio Y, Moriwaki A, Takei R, et al.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1155/2014/459524 ] [103] Dell’Osso L, Dalle Luche R, Carmassi C. A new perspective in post-traumatic stress disorder: which role for unrecognized autism spectrum?",Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
[http://dx.doi.org/10.1080/08039480500504685 ] [PMID: 16500795 ] [105] King R. Complex Post-Traumatic Stress Disorder: implications for individuals with Autism Spectrum Disorders- Part 1.,Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1093/bmb/ldp006 ] [PMID: 19240041 ] [107] Gesi C, Carmassi C, Miniati M, et al.",OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.1186/s12991-016-0101-7 ] [108] Billeci L, Calderoni S, Conti E, et al.",Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"[http://dx.doi.org/10.3389/FNINS.2016.00346 ] [109] Dell’Osso L, Gesi C, Carmassi C. Suicide and autism spectrum disorders: The role of trauma J Psychopatol 2016; 107-9.",Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
"; Licensee Bentham Open This is an open access articles licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9e/e9/CPEMH-12-120.PMC5095893.pdf
Available  from:  http://files.unaids.org/en/media/unaids/contentassets/ documents/factsheet/2014/20140716_FactSheet_en.pdf [3] Rapport Préliminaire sur la Prévalence du VIH.,Non-OADS,/arxiv_data1/oa_pdf/39/6e/TOAIDJ-10-199.PMC5095895.pdf
"[http://dx.doi.org/10.1007/978-1-4419-1712-6_2 ] [6] Joshi D, OGrady J, Dieterich D, Gazzard B, Agarwal K. Increasing burden of liver disease in patients with HIV infection.",Non-OADS,/arxiv_data1/oa_pdf/39/6e/TOAIDJ-10-199.PMC5095895.pdf
"[http://dx.doi.org/10.1016/S0140-6736(10)62001-6 ] [PMID: 21459211 ] [7] Barth RE, Huijgen Q, Taljaard J, Hoepelman AI.",OADS,/arxiv_data1/oa_pdf/39/6e/TOAIDJ-10-199.PMC5095895.pdf
"[http://dx.doi.org/10.1016/j.ijid.2010.06.013 ] [PMID: 20870439 ] [8] Badridze N, Chkhartishvili N, Abutidze A, Gatserelia L, Sharvadze L. Prevalence of hepatitis B and C among HIV positive patients in Georgia and its associated risk factors.",Non-OADS,/arxiv_data1/oa_pdf/39/6e/TOAIDJ-10-199.PMC5095895.pdf
"[http://dx.doi.org/10.1128/JVI.00191-09 ] [PMID: 19420073 ] [11] Milazzo L, Antinori S. Hepatitis virus and HIV interactions.",Non-OADS,/arxiv_data1/oa_pdf/39/6e/TOAIDJ-10-199.PMC5095895.pdf
[http://dx.doi.org/10.1016/S1473-3099(14)70853-9 ] [PMID: 25303842 ],OADS,/arxiv_data1/oa_pdf/39/6e/TOAIDJ-10-199.PMC5095895.pdf
"[http://dx.doi.org/10.7448/IAS.19.1.20659 ] [PMID: 26979535 ] [13] Matthews PC, Beloukas A, Malik A, et al.",OADS,/arxiv_data1/oa_pdf/39/6e/TOAIDJ-10-199.PMC5095895.pdf
"[http://dx.doi.org/10.1371/journal.pone.0134037 ] [PMID: 26218239 ] [14] Laurent C, Bourgeois A, Mpoudi-Ngolé E, et al.",Non-OADS,/arxiv_data1/oa_pdf/39/6e/TOAIDJ-10-199.PMC5095895.pdf
"[http://dx.doi.org/10.1111/j.1468-1293.2009.00742.x ] [PMID: 19659944 ] [15] Ottop FM, Atashili J, Ndumbe PM.",Non-OADS,/arxiv_data1/oa_pdf/39/6e/TOAIDJ-10-199.PMC5095895.pdf
"[http://dx.doi.org/10.1177/1545109712447199 ] [PMID: 22699715 ] [16] Agyeman AA, Ofori-Asenso R. Prevalence of HIV and hepatitis B coinfection in Ghana: a systematic review and meta-analysis.",Non-OADS,/arxiv_data1/oa_pdf/39/6e/TOAIDJ-10-199.PMC5095895.pdf
[http://dx.doi.org/10.1186/s12981-016-0107-x ] [PMID: 27190544 ] [17] Centers for Disease Control and Prevention (CDC).,Non-OADS,/arxiv_data1/oa_pdf/39/6e/TOAIDJ-10-199.PMC5095895.pdf
"[http://dx.doi.org/10.1086/593104 ] [PMID: 18937580 ] [19] Franzeck FC, Ngwale R, Msongole B, et al.",Non-OADS,/arxiv_data1/oa_pdf/39/6e/TOAIDJ-10-199.PMC5095895.pdf
"[http://dx.doi.org/10.1371/journal.pone.0058468 ] [PMID: 23469281 ] [20] Soriano V, Barreiro P, Sherman KE.",Non-OADS,/arxiv_data1/oa_pdf/39/6e/TOAIDJ-10-199.PMC5095895.pdf
"[http://dx.doi.org/10.1097/QAD.0b013e32830162a8 ] [PMID: 18525268 ] [22] Muriuki BM, Gicheru MM, Wachira D, Nyamache AK, Khamadi SA.",Non-OADS,/arxiv_data1/oa_pdf/39/6e/TOAIDJ-10-199.PMC5095895.pdf
"[http://dx.doi.org/10.1186/1756-0500-6-363 ] [PMID: 24016453 ] [23] Wondimeneh Y, Alem M, Asfaw F, Belyhun Y. HBV and HCV seroprevalence and their correlation with CD4 cells and liver enzymes among HIV positive individuals at University of Gondar Teaching Hospital, Northwest Ethiopia.",Non-OADS,/arxiv_data1/oa_pdf/39/6e/TOAIDJ-10-199.PMC5095895.pdf
"[http://dx.doi.org/10.1186/1743-422X-10-171 ] [PMID: 23721493 ] [24] Otegbayo JA, Taiwo BO, Akingbola TS, et al.",Non-OADS,/arxiv_data1/oa_pdf/39/6e/TOAIDJ-10-199.PMC5095895.pdf
"[http://dx.doi.org/10.3855/jidc.245 ] [PMID: 19759507 ] [26] Nyirenda M, Beadsworth MB, Stephany P, et al.",OADS,/arxiv_data1/oa_pdf/39/6e/TOAIDJ-10-199.PMC5095895.pdf
"[http://dx.doi.org/10.1016/j.jinf.2008.05.004 ] [PMID: 18555534 ] [27] Diop-Ndiaye H, Touré-Kane C, Etard JF, et al.",OADS,/arxiv_data1/oa_pdf/39/6e/TOAIDJ-10-199.PMC5095895.pdf
"[http://dx.doi.org/10.1002/jmv.21236 ] [PMID: 18551596 ] [28] Mbanya DN, Takam D, Ndumbe PM.",Non-OADS,/arxiv_data1/oa_pdf/39/6e/TOAIDJ-10-199.PMC5095895.pdf
"[http://dx.doi.org/10.1046/j.1365-3148.2003.00453.x ] [PMID: 14617337 ] [29] Madhava V, Burgess C, Drucker E. Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa.",Non-OADS,/arxiv_data1/oa_pdf/39/6e/TOAIDJ-10-199.PMC5095895.pdf
"[http://dx.doi.org/10.1016/S1473-3099(02)00264-5 ] [PMID: 12062995 ] [30] Pirillo MF, Bassani L, Germinario EA, et al.",OADS,/arxiv_data1/oa_pdf/39/6e/TOAIDJ-10-199.PMC5095895.pdf
"[http://dx.doi.org/10.1002/jmv.21007 ] [PMID: 17935164 ] [31] Msuya SE, Mbizvo EM, Hussain A, Sam NE, Stray-Pedersen B. Seroprevalence of hepatitis B and C viruses among women of childbearing age in Moshi Urban, Tanzania.",Non-OADS,/arxiv_data1/oa_pdf/39/6e/TOAIDJ-10-199.PMC5095895.pdf
"[http://dx.doi.org/10.4314/eamj.v83i2.9394 ] [PMID: 16708880 ] [32] Rao VB, Johari N, du Cros P, Messina J, Ford N, Cooke GS.",OADS,/arxiv_data1/oa_pdf/39/6e/TOAIDJ-10-199.PMC5095895.pdf
"[http://dx.doi.org/10.1016/S1473-3099(15)00006-7 ] [PMID: 25957078 ] [33] Biwole-Sida M, Noah D, Eloumou AF, Dang I, Talla P. Carriage prevalence of HCV markers in the working environment (Cameroun).",Non-OADS,/arxiv_data1/oa_pdf/39/6e/TOAIDJ-10-199.PMC5095895.pdf
"[http://dx.doi.org/10.1007/s12157-014-0581-5 ] [34] Njouom RT, Texier G, Fontanet A.",Non-OADS,/arxiv_data1/oa_pdf/39/6e/TOAIDJ-10-199.PMC5095895.pdf
"[http://dx.doi.org/10.1111/jvh.01_12424 ] [35] Kerubo G, Khamadi S, Okoth V, et al.",Non-OADS,/arxiv_data1/oa_pdf/39/6e/TOAIDJ-10-199.PMC5095895.pdf
"[http://dx.doi.org/10.1371/journal.pone.0129247 ] [PMID: 26068212 ] [36] Mboto CI, Davies A, Fielder M, Jewell AP.",Non-OADS,/arxiv_data1/oa_pdf/39/6e/TOAIDJ-10-199.PMC5095895.pdf
"[http://dx.doi.org/10.1080/09674845.2006.11732716 ] [PMID: 16613141 ] [37] Brandão NA, Pfrimer IA, Martelli CM, Turchi MD.",OADS,/arxiv_data1/oa_pdf/39/6e/TOAIDJ-10-199.PMC5095895.pdf
"[http://dx.doi.org/10.1016/j.bjid.2015.02.001 ] [PMID: 25766773 ] [38] Weldemhret  L,  Asmelash  T,  Belodu  R,  Gebreegziabiher  D.  Sero-prevalence  of  HBV  and  associated  risk  factors  among  HIV  positive individuals attending ART clinic at Mekelle hospital, Tigray, Northern Ethiopia.",Non-OADS,/arxiv_data1/oa_pdf/39/6e/TOAIDJ-10-199.PMC5095895.pdf
[http://dx.doi.org/10.1186/s12981-016-0090-2 ] [PMID: 26855663 ] © Luma et al.,OADS,/arxiv_data1/oa_pdf/39/6e/TOAIDJ-10-199.PMC5095895.pdf
"; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/39/6e/TOAIDJ-10-199.PMC5095895.pdf
"Seishin iyuou hoken fukushi no kaikaku bizyon [Visions in reform of mental health and medical welfare] 2004 Available at: http://www.mhlw.go.jp/topics/2004/09/dl/tp0902-1a.pdf [3] The Ministry of Health, Labour and Welfare and War Victims’ Relief Bureau of the Ministry of Health, Labour, and Welfare.",Non-OADS,/arxiv_data1/oa_pdf/14/25/CPEMH-12-87.PMC5095896.pdf
"Seishin hoken iryou no saranaru kaikaku ni mukete [Investigative commission on the approach to further mental health and medical welfare system] 2009 Available at: http://www.mhlw.gp.jfukuship/shingi/2009/09/dl/tp0902-1a.pdf [4] The Ministry of Health, Labour and Welfare.",Non-OADS,/arxiv_data1/oa_pdf/14/25/CPEMH-12-87.PMC5095896.pdf
Available from: http://www.mhlw.go.jp/wamappl/bbb15GS60.nsf/vAdmPBigcategory/50/2A.,Non-OADS,/arxiv_data1/oa_pdf/14/25/CPEMH-12-87.PMC5095896.pdf
"[http://dx.doi.org/10.1186/1471-2458-9-306] [PMID: 19698136] [12] Anzai N, Yoneda S, Kumagai N, Nakamura Y, Ikebuchi E, Liberman RP.",OADS,/arxiv_data1/oa_pdf/14/25/CPEMH-12-87.PMC5095896.pdf
"[http://dx.doi.org/10.1176/appi.ps.53.5.545] [PMID: 11986501] [13] Moriyama M, Iwamoto S, Hobara T. Kourei sya no syakai teki nyuiin wo hathusei saseru youin no kentou.",OADS,/arxiv_data1/oa_pdf/14/25/CPEMH-12-87.PMC5095896.pdf
"[http://dx.doi.org/10.1590/S0034-89102006000500021] [PMID: 17063248] [18] Kondo K, Adachi M. Nousoxtutyu rihabirite-syon kanjya no taiin saki ni eikyou suru inshi no kenkyu: tajyu rojisutixtuku moderu niyoru kaiseki.",OADS,/arxiv_data1/oa_pdf/14/25/CPEMH-12-87.PMC5095896.pdf
"[http://dx.doi.org/10.1111/j.1600-0447.1999.tb10849.x] [PMID: 10493089] [22] Thornicroft G, Bebbington P, Leff J. Outcomes for long-term patients one year after discharge from a psychiatric hospital.",Non-OADS,/arxiv_data1/oa_pdf/14/25/CPEMH-12-87.PMC5095896.pdf
"[http://dx.doi.org/10.1176/appi.ps.56.11.1416] [PMID: 16282261] [23] Nakanishi M, Niimura J, Tanoue M, Yamamura M, Hirata T, Asukai N. Association between length of hospital stay and implementation of discharge planning in acute psychiatric inpatients in Japan.",OADS,/arxiv_data1/oa_pdf/14/25/CPEMH-12-87.PMC5095896.pdf
[http://dx.doi.org/10.1186/s13033-015-0015-9] [PMID: 26029254] © Yoneyama et al.,OADS,/arxiv_data1/oa_pdf/14/25/CPEMH-12-87.PMC5095896.pdf
"; Licensee Bentham Open This is an open access articles licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/25/CPEMH-12-87.PMC5095896.pdf
"[http://dx.doi.org/10.1017/CBO9780511820724 ] [2] Petruzzello SJ, Landers DM.",Non-OADS,/arxiv_data1/oa_pdf/bc/3e/CPEMH-12-108.PMC5095897.pdf
"[http://dx.doi.org/10.1249/00005768-199408000-00015 ] [PMID: 7968420 ] [3] Petruzzello SJ, Landers DM, Hatfield BD, Kubitz KA, Salazar W. A meta-analysis on the anxiety-reducing effects of acute and chronic exercise.",OADS,/arxiv_data1/oa_pdf/bc/3e/CPEMH-12-108.PMC5095897.pdf
"[http://dx.doi.org/10.2165/00007256-199111030-00002 ] [PMID: 1828608 ] [4] Ekkekakis P, Petruzzello SJ.",Non-OADS,/arxiv_data1/oa_pdf/bc/3e/CPEMH-12-108.PMC5095897.pdf
"[http://dx.doi.org/10.2165/00007256-199928050-00005 ] [PMID: 10593646 ] [5] Reed J, Ones DS.",OADS,/arxiv_data1/oa_pdf/bc/3e/CPEMH-12-108.PMC5095897.pdf
[http://dx.doi.org/10.1016/j.psychsport.2005.11.003 ] [6] Ekkekakis P. Let them roam free?,Non-OADS,/arxiv_data1/oa_pdf/bc/3e/CPEMH-12-108.PMC5095897.pdf
"[http://dx.doi.org/10.2165/11315210-000000000-00000 ] [PMID: 19757863 ] [7] Ekkekakis P, Parfitt G, Petruzzello SJ.",OADS,/arxiv_data1/oa_pdf/bc/3e/CPEMH-12-108.PMC5095897.pdf
"[http://dx.doi.org/10.2165/11590680-000000000-00000 ] [PMID: 21780850 ] [8] Hall EE, Ekkekakis P, Petruzzello SJ.",OADS,/arxiv_data1/oa_pdf/bc/3e/CPEMH-12-108.PMC5095897.pdf
"[http://dx.doi.org/10.1080/02701367.2000.10608883 ] [PMID: 10763524 ] [11] Davidson RJ, Ekman P, Saron CD, Senulis JA, Friesen WV.",OADS,/arxiv_data1/oa_pdf/bc/3e/CPEMH-12-108.PMC5095897.pdf
"[http://dx.doi.org/10.1037/0022-3514.58.2.330 ] [PMID: 2319445 ] [12] Oakes TR, Pizzagalli DA, Hendrick AM, et al.",OADS,/arxiv_data1/oa_pdf/bc/3e/CPEMH-12-108.PMC5095897.pdf
"[http://dx.doi.org/10.1002/hbm.20004 ] [PMID: 15038007 ] [13] Petruzzello SJ, Hall EE, Ekkekakis P. Regional brain activation as a biological marker of affective responsivity to acute exercise: influence of fitness.",OADS,/arxiv_data1/oa_pdf/bc/3e/CPEMH-12-108.PMC5095897.pdf
"[http://dx.doi.org/10.1111/1469-8986.3810099 ] [PMID: 11321625 ] [14] Petruzzello  SJ,  Tate  AK.",Non-OADS,/arxiv_data1/oa_pdf/bc/3e/CPEMH-12-108.PMC5095897.pdf
"[http://dx.doi.org/10.1111/j.1469-8986.1997.tb01739.x ] [PMID: 9299907 ] [15] Woo M, Kim S, Kim J, Petruzzello SJ, Hatfield BD.",OADS,/arxiv_data1/oa_pdf/bc/3e/CPEMH-12-108.PMC5095897.pdf
"[http://dx.doi.org/10.1080/02701367.2010.10599683 ] [PMID: 20949855 ] [16] Schneider S, Askew CD, Diehl J, et al.",OADS,/arxiv_data1/oa_pdf/bc/3e/CPEMH-12-108.PMC5095897.pdf
"[http://dx.doi.org/10.1016/j.physbeh.2009.01.007 ] [PMID: 19385025 ] [17] Parfitt G, Rose EA, Burgess WM.",OADS,/arxiv_data1/oa_pdf/bc/3e/CPEMH-12-108.PMC5095897.pdf
"[http://dx.doi.org/10.1348/135910705X43606 ] [PMID: 16480554 ] [18] Rose EA, Parfitt G. A quantitative analysis and qualitative explanation of the individual differences in affective responses to prescribed and self-selected exercise intensities.",Non-OADS,/arxiv_data1/oa_pdf/bc/3e/CPEMH-12-108.PMC5095897.pdf
"[http://dx.doi.org/10.1123/jsep.29.3.281 ] [PMID: 17876968 ] [19] Lind E, Ekkekakis P, Vazou S. The affective impact of exercise intensity that slightly exceeds the preferred level: pain for no additional gain.",Non-OADS,/arxiv_data1/oa_pdf/bc/3e/CPEMH-12-108.PMC5095897.pdf
[http://dx.doi.org/10.1177/1359105308088517 ] [PMID: 18420754 ] [20] Medicine ACoS.,Non-OADS,/arxiv_data1/oa_pdf/bc/3e/CPEMH-12-108.PMC5095897.pdf
"[http://dx.doi.org/10.1249/01.MSS.0000135774.28494.19 ] [PMID: 15292752 ] [22] Norton K, Olds T. Anthropometrica: a textbook of body measurement for sports and health courses.",Non-OADS,/arxiv_data1/oa_pdf/bc/3e/CPEMH-12-108.PMC5095897.pdf
[http://dx.doi.org/10.1079/BJN19780152 ] [PMID: 718832 ] [24] Siri WE.,Non-OADS,/arxiv_data1/oa_pdf/bc/3e/CPEMH-12-108.PMC5095897.pdf
"[http://dx.doi.org/10.1016/S1469-0292(01)00028-0 ] [27] Hardy CJ, Rejeski WJ.",OADS,/arxiv_data1/oa_pdf/bc/3e/CPEMH-12-108.PMC5095897.pdf
"[http://dx.doi.org/10.1123/jsep.11.3.304 ] [28] Svebak S, Murgatroyd S. Metamotivational dominance: a multimethod validation of reversal theory constructs.",OADS,/arxiv_data1/oa_pdf/bc/3e/CPEMH-12-108.PMC5095897.pdf
[http://dx.doi.org/10.1037/0022-3514.48.1.107 ] [29] Jasper H. Progress and problems in brain research.,Non-OADS,/arxiv_data1/oa_pdf/bc/3e/CPEMH-12-108.PMC5095897.pdf
"[http://dx.doi.org/10.1007/s00421-013-2604-0 ] [PMID: 23412542 ] [31] Oliveira BR, Deslandes AC, Nakamura FY, Viana BF, Santos TM.",Non-OADS,/arxiv_data1/oa_pdf/bc/3e/CPEMH-12-108.PMC5095897.pdf
"[http://dx.doi.org/10.1080/02640414.2014.968191 ] [PMID: 25356844 ] [32] Williams DM, Raynor HA.",OADS,/arxiv_data1/oa_pdf/bc/3e/CPEMH-12-108.PMC5095897.pdf
"[http://dx.doi.org/10.1016/j.psychsport.2013.04.001 ] [33] Oliveira BR, Deslandes AC, Santos TM.",Non-OADS,/arxiv_data1/oa_pdf/bc/3e/CPEMH-12-108.PMC5095897.pdf
"[http://dx.doi.org/10.3389/fpsyg.2015.01105 ] [PMID: 26300805 ] [34] Stych K, Parfitt G. Exploring affective responses to different exercise intensities in low-active young adolescents.",Non-OADS,/arxiv_data1/oa_pdf/bc/3e/CPEMH-12-108.PMC5095897.pdf
"Self-selected Exercise and Affective Response Clinical Practice & Epidemiology in Mental Health, 2016, Volume 12    119 [http://dx.doi.org/10.1123/jsep.33.4.548 ] [PMID: 21808079 ] [35] Coan JA, Allen JJ.",Non-OADS,/arxiv_data1/oa_pdf/bc/3e/CPEMH-12-108.PMC5095897.pdf
[http://dx.doi.org/10.1080/02640414.2010.545427 ] [PMID: 21360405 ] © Lattari et al.,Non-OADS,/arxiv_data1/oa_pdf/bc/3e/CPEMH-12-108.PMC5095897.pdf
"; Licensee Bentham Open This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) ( https://creativecommons.org/licenses/by-nc/4.0/legalcode ), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bc/3e/CPEMH-12-108.PMC5095897.pdf
"IIhttp://hdl.handle.net/2268/160189 46 Strnad, P. and Gönczy, P. (2008) Mechanisms of procentriole formation.",OADS,/arxiv_data1/oa_pdf/75/0c/BST-2016-0116.PMC5095913.pdf
Assays were set up in black 96-well plates with pre-incubation in 1 mM and 25 mM glucose media carried out for 16 h. Oxygen and glycolysis sensing probes: MitoXpress xtra and pH xtra from Luxcel Biosciences were used to determine OCR and ECAR (http://luxcel.com/).,Non-OADS,/arxiv_data1/oa_pdf/2a/70/BST-2016-0094.PMC5095922.pdf
Funding Michelle Potter and Emma Newport were supported by Williams fund (http://www.williamsfund.co.uk/).,Non-OADS,/arxiv_data1/oa_pdf/2a/70/BST-2016-0094.PMC5095922.pdf
Available at: https://idsa.con-fex.com/idsa/2013/webprogram/Paper41627.html.Accessed 10 November 2015.,Non-OADS,/arxiv_data1/oa_pdf/dc/58/ofw091.PMC5095935.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e6/5a/omw034.PMC5095978.pdf
Physiol Behav 2016. http://dx.doi.org/10.1016/j.physbeh.2016.03.038.,OADS,/arxiv_data1/oa_pdf/b0/62/OBY-24-2126.PMC5096006.pdf
http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm071624.pdf Accessed June 2016.,Non-OADS,/arxiv_data1/oa_pdf/14/68/DOM-18-1081.PMC5096008.pdf
"Guidance for industry: patient-reported outcome measures: use inmedical product development to support labeling claims: statistical con-siderations for using multiple endpoints, 2009. http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm193282.",Non-OADS,/arxiv_data1/oa_pdf/14/68/DOM-18-1081.PMC5096008.pdf
"Guidanceforindustry:drug-inducedliverinjury:premarketingclinicalevalua-tion, 2009. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM174090.pdfAccessedJune2016.",Non-OADS,/arxiv_data1/oa_pdf/14/68/DOM-18-1081.PMC5096008.pdf
"Publically available protein modiﬁcation databases comprising large sets of ex- perimentally veriﬁed phosphorylation sites of diverse species include PhosphoSitePlus (www.phosphosite.org [108]), PHOSIDA (www.phosida.com [109] and Phospho.ELM (http://phospho.elm.eu.org [110]).",OADS,/arxiv_data1/oa_pdf/a0/e2/PRCA-10-994.PMC5096009.pdf
"PhosphoSitePlus also allows the user to search for experimentally veriﬁed upstream kinases for spe- ciﬁc substrate phosphosites; these sites can also be predicted by tools, such as NetPhorest (http://netphorest.info [111]),KinasePhos (http://kinasephos.mbc.nctu.edu.tw [112]) and GPS (http://gps.biocuckoo.org [113]).",OADS,/arxiv_data1/oa_pdf/a0/e2/PRCA-10-994.PMC5096009.pdf
"[a]M.Quan t,Dr.A.Lenna rtson, A.Dreos, K.Bçrjess on,Dr.K.Moth-Poul sen Depar tment ofChem istry and Chem icalEngine ering Chalmer sUniversit yofTechno logy,Kemig/C229rden 4 41296Gothe nburg (Sweden) E-mail :kasper .moth-poulsen@ chalmers.se [b]M.Kuisma ,P.Erhart Depar tment ofPhysic s Chalmer sUniversit yofTechno logy (Sweden) [c]K.Bçrjesson Depar tment ofChem istry and Molec ular Biolog y Universi tyofGothenburg (Sweden) Suppo rting informa tion and theORCID identifica tion numbers forthe autho rsofthisarticle canbefound under http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/d5/18/CHEM-22-13265.PMC5096010.pdf
"Based on these deﬁciencies, we make the follow- ing recommendations: (1) The toxicological effects of tear gas agents should be reassessed using state-of-the-art toxicological techniques utilizing toxicology in the 21st century (T ox21) collaboration approaches (https://www.epa.gov/chemical- research/toxicology-testing-21st-century- tox21) and animal models of respiratory, cutaneous, and cardiovascular morbidities, taking into account age and sex differences.",Non-OADS,/arxiv_data1/oa_pdf/2c/a3/NYAS-1378-96.PMC5096012.pdf
"Accessed May 11, 2016. https://fr.news.yahoo.com/ video/turkey-violence-ﬂares-police-storm-191500809.html.",Non-OADS,/arxiv_data1/oa_pdf/2c/a3/NYAS-1378-96.PMC5096012.pdf
"Accessed May 20, 2016. http://www.washingtonpost.com/news/post-nation/wp/ 2014/08/12/police-use-tear-gas-on-crowd/.",Non-OADS,/arxiv_data1/oa_pdf/2c/a3/NYAS-1378-96.PMC5096012.pdf
"Accessed May 12, 2016. http://www.reuters.com/article/us- hongkong-china-idUSKCN0HN03Q20140928.",Non-OADS,/arxiv_data1/oa_pdf/2c/a3/NYAS-1378-96.PMC5096012.pdf
"Accessed May 20, 2016. http://www.nytimes.",Non-OADS,/arxiv_data1/oa_pdf/2c/a3/NYAS-1378-96.PMC5096012.pdf
"Accessed May 12, 2016. http://www.cbsnews.",Non-OADS,/arxiv_data1/oa_pdf/2c/a3/NYAS-1378-96.PMC5096012.pdf
"Accessed May 20, 2016. http://www.bbc.com/news/ world-middle-east-19078659.",Non-OADS,/arxiv_data1/oa_pdf/2c/a3/NYAS-1378-96.PMC5096012.pdf
"Accessed May 20, 2016. http://www.theatlantic.com/international/ archive/2014/08/100-years-of-tear-gas/378632/?single_page =true.",Non-OADS,/arxiv_data1/oa_pdf/2c/a3/NYAS-1378-96.PMC5096012.pdf
"Accessed May 03, 2016. http://www.cdc.gov/niosh/npg/npgd0326.html.",OADS,/arxiv_data1/oa_pdf/2c/a3/NYAS-1378-96.PMC5096012.pdf
"Accessed May 20, 2016. http://www.atsjournals.org/doi/pdf/ 10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.",OADS,/arxiv_data1/oa_pdf/2c/a3/NYAS-1378-96.PMC5096012.pdf
"Accessed March 30, 2016. http://www.bbc.com/ news/world-middle-east-26626367.",Non-OADS,/arxiv_data1/oa_pdf/2c/a3/NYAS-1378-96.PMC5096012.pdf
"Accessed June 11, 2016. https://www.hrw.org/news/2011/02/08/egypt-documented- death-toll-protests-tops-300.",Non-OADS,/arxiv_data1/oa_pdf/2c/a3/NYAS-1378-96.PMC5096012.pdf
Heart J. http://dx.doi.org/10.1093/eurheartj/ehw151.,Non-OADS,/arxiv_data1/oa_pdf/2c/a3/NYAS-1378-96.PMC5096012.pdf
"Accessed June 11, 2016. http://www.guidetopharmacology.org/GRAC/ObjectDisplay Forward?objectId =485.",OADS,/arxiv_data1/oa_pdf/2c/a3/NYAS-1378-96.PMC5096012.pdf
https://clinicaltrials.gov/ ct2/show/NCT00505687?term=NCT00505687&rank=1.,Non-OADS,/arxiv_data1/oa_pdf/51/19/ENE-23-1556.PMC5096013.pdf
2009:28. http://www.fda.gov/downloads/Drugs/ …/Guidances/UCM193282.pdf.,Non-OADS,/arxiv_data1/oa_pdf/56/1f/DOM-18-1055.PMC5096014.pdf
2009:8. http://www.fda.gov/downloads/Drugs/ …/Guidances/UCM174090.pdf.,Non-OADS,/arxiv_data1/oa_pdf/56/1f/DOM-18-1055.PMC5096014.pdf
SUPPORTING INFORMATION Additional Supporting Information may be found in the online version of this article at the publisher ’s web-site: http://onlinelibrary.wiley.,Non-OADS,/arxiv_data1/oa_pdf/56/1f/DOM-18-1055.PMC5096014.pdf
2015. http://bidocs.boehringer-ingelheim.com/ BIWebAccess/ViewServlet.ser?docBase=renetnt&folderPath=/ Prescribing+Information/PIs/Jardiance/jardiance.pdf.,Non-OADS,/arxiv_data1/oa_pdf/cd/fc/DOM-18-1034.PMC5096016.pdf
2015. http://www.ema.europa.eu/ema/index.jsp?,Non-OADS,/arxiv_data1/oa_pdf/cd/fc/DOM-18-1034.PMC5096016.pdf
SUPPORTING INFORMATION Additional Supporting Information may be found in the online version of this article at the publisher ’s web-site: http://onlinelibrary.wiley.,Non-OADS,/arxiv_data1/oa_pdf/cd/fc/DOM-18-1034.PMC5096016.pdf
"Center for Diseases Control (2014) Breastfeeding Report Card United States 2014 [document on the Internet] http://www.cdc.gov/breastfeeding/pdf/2014breastfeedingreportcard.pdf Chamberlain L.B., McMahon M., Philipp B.L.",Non-OADS,/arxiv_data1/oa_pdf/de/ac/MCN-12-726.PMC5096021.pdf
"Protocolversion 2 http://www.nets.nihr.ac.uk/__data/assets/pdf_ ﬁle/ 0020/55370/PRO-10-31-02.pdf Hoddinott P., Britten J., McInnes R., Craig L. & Darwent K. (2012) Signi ﬁcant others, situations and their in ﬂ uence on infant feeding.",Non-OADS,/arxiv_data1/oa_pdf/de/ac/MCN-12-726.PMC5096021.pdf
Haplotypes were constructed for 75 gene variants using the HaploView program (https://www.broadinstitute.org/scientiﬁc-community/science/programs/medical-and-population-genetics/haploview/haploview).,OADS,/arxiv_data1/oa_pdf/9e/30/AJMG-170-2788.PMC5096035.pdf
Royal College of Psychiatrists (2012) Second round of the National Audit of Dementia (carein general hospitals) guidance document https://www.rcpsych.ac.uk/pdf/Core%20Audit% 20Guidance%20-%202nd%20round.pdf [Last Accessed: April 2015] 31.,Non-OADS,/arxiv_data1/oa_pdf/4d/77/PON-25-19.PMC5096051.pdf
Supportin ginform ationand ORCID(s )from theautho r(s)forthisarticle can befound under http://dx.doi.or g/10.1002/c bic.20160 0362.,OADS,/arxiv_data1/oa_pdf/b2/00/CBIC-17-1915.PMC5096054.pdf
2013.Available from: https://www.youtube.com/user/ DrAMBHeardAirway.,Non-OADS,/arxiv_data1/oa_pdf/5b/1c/ACEM-23-1074.PMC5096061.pdf
Availablefrom http://www.ema.europa.eu/docs/en_GB/document_ 427Antidepressant use in adolescents,Non-OADS,/arxiv_data1/oa_pdf/75/23/ACPS-134-420.PMC5096062.pdf
Avail- able from http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2004/ucm108363.htm (accessed 18March 2015).,Non-OADS,/arxiv_data1/oa_pdf/75/23/ACPS-134-420.PMC5096062.pdf
Available from http://legeforeningen.no/Fagmed/Norsk-barne–og-ungdomspsy-kiatrisk-forening/Faglig-veileder-for-barne-og-ungdomss- psykiatri/forord-til-3-utgave-av-faglig-veileder-for-barne-og -ungdomspsykiatri/ (accessed 17 June 2015).,OADS,/arxiv_data1/oa_pdf/75/23/ACPS-134-420.PMC5096062.pdf
Available from https://www.nice.org.uk/guidance/cg31/(accessed 1 March 2016).,Non-OADS,/arxiv_data1/oa_pdf/75/23/ACPS-134-420.PMC5096062.pdf
"Available from http://www.fhi.no/eway/ default.aspx?pid=233&trg=MainArea_5661&MainArea_5661=5565:0:15,3791:1:0:0:::0:0&MainLeft_5565=5544:50553::1:5569:10:::0:0 (accessed 15 June 2015).",Non-OADS,/arxiv_data1/oa_pdf/75/23/ACPS-134-420.PMC5096062.pdf
Available from http://www.hedmark.org/Hedmark-fylkeskommune/ Om-fylkeskommunen/Fag-stab- og-serviceenheter/Strate- gisk-stab/Folkehelse/Statist ikk-og-fakta-folkehelse/Ung- domsundersoekelsen-2009 (accessed 8 March 2015).,OADS,/arxiv_data1/oa_pdf/75/23/ACPS-134-420.PMC5096062.pdf
Available from http://www.fda.gov/ Drugs/DrugSafety/ucm297391.htm (accessed 19 March2015).,Non-OADS,/arxiv_data1/oa_pdf/75/23/ACPS-134-420.PMC5096062.pdf
http://data.gov.uk/publisher/nhs-reference-costs-2012-to- 2013 (accessed 06/08/2015) 9.,Non-OADS,/arxiv_data1/oa_pdf/d3/95/ENE-23-1588.PMC5096063.pdf
"National Health Service: Prescription Cost Analysis /C0 England, 2013. http://www.hscic.gov.uk/catalogue/ PUB13887 (accessed 25/08/2015) 10.",Non-OADS,/arxiv_data1/oa_pdf/d3/95/ENE-23-1588.PMC5096063.pdf
"WHO International Standard, OXYTOCIN 4th International Stan- dard, 2013. http://www.nibsc.org/documents/ifu/76-575.pdf.",Non-OADS,/arxiv_data1/oa_pdf/12/b3/JNE-28-0.PMC5096068.pdf
"WHO International Standard, ARGININE VASOPRESSIN (AVP) 1st International Standard, 2013. http://www.nibsc.org/documents/ifu/77- 501.pdf.",Non-OADS,/arxiv_data1/oa_pdf/12/b3/JNE-28-0.PMC5096068.pdf
Available at: http://www.enzolifesciences.com/ﬁleadmin/ redacteur/pdf/adi/ADI-900-153.pdf.,Non-OADS,/arxiv_data1/oa_pdf/12/b3/JNE-28-0.PMC5096068.pdf
"These new agents include the immunomodulatory drugs thalidomide, lenalidomide and pomalidomide, and the proteasome inhibitors bortezomib and carﬁlzomib (http://www.ema.europa.eu/docs/en_GB/doc- ument_library/EPAR_-_Product_Information/human/003790/ WC500197692.pdf, Richardson et al, 2015; Torimoto et al, 2015).",Non-OADS,/arxiv_data1/oa_pdf/8b/8e/BJH-175-252.PMC5096152.pdf
"Alternatively, treatmentdiscontinuation could be due to the use of bortezomib- orthalidomide-containing regimens, for which the prescribinginstructions recommend a ﬁxed number of cycles (http:// www.ema.europa.eu/docs/en_ GB/document_library/EPAR_- _Product_Information/human/000823/WC500037050.pdf,http://www.ema.europa.eu/do cs/en_GB/document_library/ EPAR_-_Product_Information/human/000539/WC500048471.pdf).",Non-OADS,/arxiv_data1/oa_pdf/8b/8e/BJH-175-252.PMC5096152.pdf
"Surprisingly, patients receiving lenalidomide frequentlydiscontinued before progression, illustrating how real-worldpractice can deviate from the summary of product charac-teristics http://www.ema.europa.eu/docs/en_GB/document_li- brary/EPAR_-_Product_Information/human/000717/WC5000 56018.pdf).",Non-OADS,/arxiv_data1/oa_pdf/8b/8e/BJH-175-252.PMC5096152.pdf
"Although Chinese professionals have been required to promise ethically Table 1: Potential unethical organ sources in abstracts accepted for The Transplantation Society 2016 Congress in Hong Kong Abstract title Abstract URL Ethical concerns about organ sources Conversion from mycophenolate mofetil to mizoribine and its therapeutic exposure in Chinese renal transplantrecipients with leucopeniahttps://confman.tts2016.org/mobis/ lecture/2019Study uses transplant cases from 2006 to 2007, when no organ donation system was used and organs were procuredfrom prisoners (executed/of conscience) Outcomes of kidney transplantation from DBD, DCD or DBCD donors: Asingle center experience from Chinahttps://confman.tts2016.org/mobis/ lecture/1902Study uses transplant cases from 2011 to 2014 and states use of DBD, but Chinadoes not have a DBD regulation Hemodynamics in transplant renal artery investigated by computational ﬂuid dynamicshttps://confman.tts2016.org/mobis/ lecture/1636No information on study year, so cannot rule out use of prisoners’ organs Pathological analysis of 544 cases of indicated renal allograft biopsieshttps://confman.tts2016.org/mobis/ lecture/1942The study years (2010 –2015) partially overlap prevoluntary donor system, so cannot rule out use of prisoners’ organs Comparison of kidney transplantation from living and deceased donation: A consecutive data analysis since implement of donation after citizen’sdeath in Chinahttps://confman.tts2016.org/mobis/ lecture/1973Study (2010 –2015) compares 389 living- related kidney donations to 269 cases from Chinese donation after citizen’s death (CDCD); how was this veriﬁed?",Non-OADS,/arxiv_data1/oa_pdf/0c/4d/AJT-16-3115.PMC5096240.pdf
"Effect of machine perfusion and urokinase on the kidney transplants with glomerular thrombosishttps://confman.tts2016.org/mobis/ lecture/1291No information on study year, so cannot rule out use of prisoners’ organs Kidney transplantation from donors with rhabdomyolysis and acute renal failure: A report of 16 caseshttps://confman.tts2016.org/mobis/ lecture/1469The study years (2012 –2015) partially overlap prevoluntary donor system, so cannot rule out use of prisoners’ organs BK polyomavirus prophylaxis with ciproﬂoxacin in kidney transplant recipients: A prospective studyhttps://confman.tts2016.org/mobis/ lecture/1911Study time (2013 –2014) falls into the early phase of the organ donation program; still overlapping with organ procurement from prisoners, so cannot rule out use ofprisoners’ organs Inﬂuencing factors of fatigue in liver transplant recipientshttps://confman.tts2016.org/mobis/ lecture/1318No information on study year, so cannot rule out use of prisoners’ organs Health-related quality of life and its inﬂuencing factors in Chinese renaltransplant recipientshttps://confman.tts2016.org/mobis/ lecture/1749No information on study year, so cannot rule out use of prisoners’ organs DBD, donation after brain death; DCD, donation after circulatory death; DBCD, donation after circulatory and brain death.",Non-OADS,/arxiv_data1/oa_pdf/0c/4d/AJT-16-3115.PMC5096240.pdf
Available from: http://endorganpillaging.org/wp-content/uploads/2016/06/Bloody_Harvest-The_Slaughter-June-23-V2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0c/4d/AJT-16-3115.PMC5096240.pdf
Available from: https://news.vice.com/article/china- makes-a-new-years-resolution-to-stop-harvesting-the-organs-of- executed-prisoners.,Non-OADS,/arxiv_data1/oa_pdf/0c/4d/AJT-16-3115.PMC5096240.pdf
Available from: http://organharvestinvestigation.net.,Non-OADS,/arxiv_data1/oa_pdf/0c/4d/AJT-16-3115.PMC5096240.pdf
Available from: https://catalog.hathitrust.org/Record/008519262.,Non-OADS,/arxiv_data1/oa_pdf/0c/4d/AJT-16-3115.PMC5096240.pdf
Available from: http://www.nytimes.com/2015/11/26/world/ asia/china-organ-transplants-prisoner-donations-huang-jiefu.html.,Non-OADS,/arxiv_data1/oa_pdf/0c/4d/AJT-16-3115.PMC5096240.pdf
Available from: http://www.yzjjh.org/index.php?m=content&c=index&a=show&catid=26&id=238.,Non-OADS,/arxiv_data1/oa_pdf/0c/4d/AJT-16-3115.PMC5096240.pdf
Available from: http://endorganpillaging.org/ transparency-of-organ-donations-the-case-of-china/.,Non-OADS,/arxiv_data1/oa_pdf/0c/4d/AJT-16-3115.PMC5096240.pdf
Available from: http://usa.chinadaily.com.cn/ china/2013-06/13/content_16612435_2.htm.,Non-OADS,/arxiv_data1/oa_pdf/0c/4d/AJT-16-3115.PMC5096240.pdf
Available from: http://www.theepochtimes.com/n3/1958171-china-hospital- builtformurder/4/.,Non-OADS,/arxiv_data1/oa_pdf/0c/4d/AJT-16-3115.PMC5096240.pdf
Available from: http://www.china-organdonation.org/ (Chinese).,Non-OADS,/arxiv_data1/oa_pdf/0c/4d/AJT-16-3115.PMC5096240.pdf
Available from: http://news.xinhuanet.com/english/2016-04/01/c_135243312.htm.,Non-OADS,/arxiv_data1/oa_pdf/0c/4d/AJT-16-3115.PMC5096240.pdf
Available from: http://www.bbc.com/news/ world-asia-china-30324440.,Non-OADS,/arxiv_data1/oa_pdf/0c/4d/AJT-16-3115.PMC5096240.pdf
Available from: http://www.theepochtimes.com/n3/46985-china-tries-paying-for-organs/.,Non-OADS,/arxiv_data1/oa_pdf/0c/4d/AJT-16-3115.PMC5096240.pdf
Available from:http://www.declarationoﬁstanbul.org/resources/policy-documents/ 675-dicg-statement-regarding- payments-to-fa milies- of-deceased- organ-donors.,Non-OADS,/arxiv_data1/oa_pdf/0c/4d/AJT-16-3115.PMC5096240.pdf
Available from: http://www.theepochtimes.com/n3/ 2130297-a-transplant-conference-plays-host-to-china-and-its-surgeons-accused-of-killing/.,Non-OADS,/arxiv_data1/oa_pdf/0c/4d/AJT-16-3115.PMC5096240.pdf
Avail- able from: http://www.ishlt.org/ContentDocuments/ISHLT_Call4Abstracts_2017.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0c/4d/AJT-16-3115.PMC5096240.pdf
Available from:https://www.congress.gov/bill/114th-congress/house-resolution/343.,Non-OADS,/arxiv_data1/oa_pdf/0c/4d/AJT-16-3115.PMC5096240.pdf
Available from:http://m.chinapost.com.tw/taiwan/2015/06/15/438466/Taiwan- to.htm.,Non-OADS,/arxiv_data1/oa_pdf/0c/4d/AJT-16-3115.PMC5096240.pdf
Available from: http://www.theepochtimes.com/n3/1276265-italy-censures-china-organ- harvest-with-senate-bill/print/.,Non-OADS,/arxiv_data1/oa_pdf/0c/4d/AJT-16-3115.PMC5096240.pdf
Available from: http://www.parl.gc.ca/HousePublications/ Publication.aspx?DocId=6769309&Language=E&Mode=1.,Non-OADS,/arxiv_data1/oa_pdf/0c/4d/AJT-16-3115.PMC5096240.pdf
Available from: http://www.europarl.,Non-OADS,/arxiv_data1/oa_pdf/0c/4d/AJT-16-3115.PMC5096240.pdf
Available from: http://www.dafoh.org/1-5-million-people-worldwide-sign-petition-to-un-high-commissioner-for-human- rights/.,Non-OADS,/arxiv_data1/oa_pdf/0c/4d/AJT-16-3115.PMC5096240.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/0c/4d/AJT-16-3115.PMC5096240.pdf
Available from: http://www.dyyy.xjtu.edu.cn/info/ 1779/13602.htm (Chinese).,Non-OADS,/arxiv_data1/oa_pdf/0c/4d/AJT-16-3115.PMC5096240.pdf
To view these visit http://dx.doi.org/ 10.1111/1471-0528.14031.,Non-OADS,/arxiv_data1/oa_pdf/db/63/BJO-123-1973.PMC5096244.pdf
[http://apps.who.int/ bmi/index.jsp?introPage=intro_3.html] Accessed 30 March 2015.,Non-OADS,/arxiv_data1/oa_pdf/db/63/BJO-123-1973.PMC5096244.pdf
To view this article visit http://dx.doi.org/10.1111/1471-0528.13891.,Non-OADS,/arxiv_data1/oa_pdf/db/63/BJO-123-1973.PMC5096244.pdf
"It can be accessed freely at http://projects.biotec.tu- dresden.de/msVolcano/ Keywords: Bioinformatics / Data visualization / Interaction proteomics / Label free quantiﬁcation / Web Application The analysis of protein–protein interactions and complex net- works using afﬁnity puriﬁcation or afﬁnity enrichment cou- pled to mass spectrometry (AP/MS, AE/MS) is a commonly used technique in proteomics.",OADS,/arxiv_data1/oa_pdf/5a/57/PMIC-16-2491.PMC5096246.pdf
(http://www.sprc.org/sites/ sprc.org/ﬁles/library/glossary.pdf) 27.,Non-OADS,/arxiv_data1/oa_pdf/b4/56/CNS-22-915.PMC5096249.pdf
http://www.stat.go.jp/english/ data/jinsui/tsuki/index.htm.,OADS,/arxiv_data1/oa_pdf/57/d3/EHF2-3-145.PMC5096253.pdf
"[a]X.Li,Dr.J.vandeStreek Depar tment ofPhar macy Universi tyofCopenha gen Universi tetspar ken2 DK-21 00Copenha gen (Den mark) E-mail :jaccov andestreek@y ahoo.co .uk [b]L.Tapmeye r,Dr.M.Bolte Institute forInorganic and Analytical Chemistr y Goeth eUniversity Max-vo n-Laue-St rasse7 D-6043 8Frankfurt amMain (Germany ) Supp orting Infor mati onand theORCID identificati onnumber (s)forthe autho r(s)ofthis article canbefoundunde rhttp://dx.doi.org/ 10.1002 / cphc.2 01600398.",Non-OADS,/arxiv_data1/oa_pdf/33/80/CPHC-17-2496.PMC5096255.pdf
"https://www.gov.uk/government/publications/alteplase- for-treatment-of-acute-ischaemic-stroke-inde- pendent-review Mehta, R. & Shapiro, A.D. (2008) Plasminogen activator inhibitor type 1 deﬁciency.",Non-OADS,/arxiv_data1/oa_pdf/8c/18/BJH-175-12.PMC5096260.pdf
Available from: http://www.prota4u.org/search.asp.,Non-OADS,/arxiv_data1/oa_pdf/34/48/PM-12-253.PMC5096269.pdf
Available from http://www.theplantlist.org/.,Non-OADS,/arxiv_data1/oa_pdf/7c/1f/PM-12-288.PMC5096275.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d2/7d/main.PMC5096381.pdf
Contents lists available at ScienceDirect Contemporary Clinical Trials Communications journal homepage: www.elsevier.com /locate/conctc http://dx.doi.org/10.1016/j.conctc.2016.03.002 2451-8654/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d2/7d/main.PMC5096381.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Contemporary Clinical Trials Communications 3 (2016) 74 e79,Non-OADS,/arxiv_data1/oa_pdf/d2/7d/main.PMC5096381.pdf
"Doxy.me platform Teleconsent was built as an ‘extension ’to the Doxy.me tele- medicine platform ( https://doxy.me ), a free web-based telemedi- cine solution that utilizes the open-source web real-time communication (webRTC) technology for peer-to-peer audio-video telecommunication and data exchange [25].",OADS,/arxiv_data1/oa_pdf/d2/7d/main.PMC5096381.pdf
"Remote study sites would just need to access the designated telemedicine room (e.g., https://musc.doxy.me/MultisiteStudyX ) for the patient for the consent to take place.",Non-OADS,/arxiv_data1/oa_pdf/d2/7d/main.PMC5096381.pdf
"[9] J. Sullivan, Subject Recruitment and Retention: Barriers to Success, 2004 at, http://www.appliedclinicaltrialsonline.com/subject-recruitment-and- retention-barriers-success .",Non-OADS,/arxiv_data1/oa_pdf/d2/7d/main.PMC5096381.pdf
At <http://www.americantelemed.org/about-telemedicine/what-is-telemedicine#.VW3_RM9VhBc >.,Non-OADS,/arxiv_data1/oa_pdf/d2/7d/main.PMC5096381.pdf
Modern Healthcare at <http://www.modernhealthcare.com/article/ 20140308/MAGAZINE/303089979 >.,Non-OADS,/arxiv_data1/oa_pdf/d2/7d/main.PMC5096381.pdf
Apple Inc at <http://www.apple.com/researchkit/ >.,Non-OADS,/arxiv_data1/oa_pdf/d2/7d/main.PMC5096381.pdf
Research Electronic Data Capture at <http://project-redcap.org/ >.,Non-OADS,/arxiv_data1/oa_pdf/d2/7d/main.PMC5096381.pdf
At <https://www.researchmatch.org/ >.,Non-OADS,/arxiv_data1/oa_pdf/d2/7d/main.PMC5096381.pdf
"[40] J.B. Horrigan, M. Duggan, Home Broadband 2015, Pew Research Center: Internet, Science &Tech, 2015 at, http://www.pewinternet.org/2015/12/21/ home-broadband-2015/ .",Non-OADS,/arxiv_data1/oa_pdf/d2/7d/main.PMC5096381.pdf
"Smith, Smartphone Use in 2015, Pew Research Center: Internet, Science &Tech, 2015 at, http://www.pewinternet.org/2015/04/01/us-smartphone- use-in-2015/ .B.M.",Non-OADS,/arxiv_data1/oa_pdf/d2/7d/main.PMC5096381.pdf
"Lymphatic Vessel and Valve Quantiﬁcation The analysis was performed as reported previously.9,11–14 Brieﬂy, for LG evaluation, LYVE-1þvascular structures were analyzed by ImageJ software (http://imagej.nih.gov/ij/; provid-ed in the public domain by the National Institutes of Health,Bethesda, MD, USA).",OADS,/arxiv_data1/oa_pdf/78/c2/i1552-5783-57-14-5935.PMC5096415.pdf
"FPIR is an index of the βcell re- sponse to intravenous glucose (insulinogenic index) and was calculated using the IV GTT by FPIR = (AUC insulin t0-10 minutes)/(Glucose t0minutes −(Av(t-10 minutes and t-1 minutes)) as previously described.23Insulin resis- tance was determined using paired insulin and glucose re- sults obtained from IV GTT, which were then applied to the homeostatic model assessment 2 (HOMA2) calculator, available from https://www.dtu.ox.ac.uk/homacalculator/ download.php.",OADS,/arxiv_data1/oa_pdf/65/8c/txd-2-e107.PMC5096434.pdf
2013 available at http://apps.who.int/iris/bitstream/10665/85975/1/WHO_NMH_MND_13.2_eng.pdf 40.,OADS,/arxiv_data1/oa_pdf/65/8c/txd-2-e107.PMC5096434.pdf
"To better categorize epitopes tha t have been experimentally con- firmed, a Web-based epitope regi ster was recently established (http://www.epregistry.com.br).12Although a few eplets have been shown to recognize the amino acid sequence that pur- portedly defines the epitope,13most remain theoretical.14 Solid-phase single-antigen beads assay performed on Luminex (referred to as Lumi nex Single-Antigen beads assay or LSA by One Lambda) is very sensitive and spe- cific to detect preformed or de novo formed antibodies.",Non-OADS,/arxiv_data1/oa_pdf/9b/dc/txd-2-e109.PMC5096436.pdf
"Ad- ditional methods are in Materials and Methods, SDC, http://links.lww.com/TXD/A29.",Non-OADS,/arxiv_data1/oa_pdf/9b/dc/txd-2-e109.PMC5096436.pdf
"When this occurred, we kept only 1 copy of identical sequences for the synthesis ofa non-redundant set of 420 DQ peptides ( Table S2, SDC, http://links.lww.com/TXD/A29) in an array format (herein- after individual peptides are referred to by their x-a n d y- axis coordinates on the array).",OADS,/arxiv_data1/oa_pdf/9b/dc/txd-2-e109.PMC5096436.pdf
"Each individual serum produced drastically differing antigen patterns from the others (Figure 2 and Figure S1, SDC, http://links.lww.com/ TXD/A29), demonstrating that the method can capture dis- tinct antibody specificity.",Non-OADS,/arxiv_data1/oa_pdf/9b/dc/txd-2-e109.PMC5096436.pdf
"Patient 1 had his strongest antibody sig- nals at spots b14 and g10 from the donor's DQA1 alleles of *01:02 and *05:01, respectively (highlighted in red inFigure 2; marked in Table S2, SDC, http://links.lww.com/ TXD/A29, and Table 1).",Non-OADS,/arxiv_data1/oa_pdf/9b/dc/txd-2-e109.PMC5096436.pdf
"A standard array was assembled with a nonredundant set of 420 peptides derived from 27 HLA-DQ sequences (peptide sequences in Table S2, SDC, http://links.lww.com/TXD/ A29).",OADS,/arxiv_data1/oa_pdf/9b/dc/txd-2-e109.PMC5096436.pdf
"There was a total of 16 peptides on the array that contained these soft- ware-identified eplets; however, none of them showed a positive signal from the patients ’sera ( Table S2, SDC, http://links.lww.com/TXD/A29: eplet-containing peptides shaded in grey; and Figure S2A, SDC, http://links.lww.",OADS,/arxiv_data1/oa_pdf/9b/dc/txd-2-e109.PMC5096436.pdf
"However, nei- ther of the 10 peptides on the array that contain this P52LG motif, such as in spots k20 –k22, l18 –l20, l27, and m5 –m7, were reactive to the patient 3 antiserum (Figure 2, PTN3; and in Figure S2B and Table S2, SDC, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/9b/dc/txd-2-e109.PMC5096436.pdf
"For patient 1, we se- lected HLA-A11 as the donor template for the peptide array (Table S4, SDC, http://links.lww.com/TXD/A29).",Non-OADS,/arxiv_data1/oa_pdf/9b/dc/txd-2-e109.PMC5096436.pdf
"Similarly, for patient 3 we selected HLA-DR4 to as semble the peptide array (Table S3, SDC, http://links.lww.com/TXD/A29).",Non-OADS,/arxiv_data1/oa_pdf/9b/dc/txd-2-e109.PMC5096436.pdf
"To do that, we performed a sequence alignment of donor vs. recipient HLA sequences to locate mismatches (highlighted in Figure S3, SDC, http://links.lww.com/ TXD/A29), and generated templates for the synthesis of donor-derived peptides that encompassed all mismatched residues.",OADS,/arxiv_data1/oa_pdf/9b/dc/txd-2-e109.PMC5096436.pdf
"In each array, serial peptides were derived to cover the template allele (peptide sequences in Table S1, SDC, http://links.lww.com/TXD/A29).",OADS,/arxiv_data1/oa_pdf/9b/dc/txd-2-e109.PMC5096436.pdf
"Among the preexisting intensities, while a8, a24, 25, and g1 signals were reduced in the posttransplant probing round (Figure 4 and Figure S3, SDC, http://links.lww.com/TXD/A29) possibly due to the effects of immuno- suppressants, b26, 27 signals were greatly elevated in the posttransplant serum.",Non-OADS,/arxiv_data1/oa_pdf/9b/dc/txd-2-e109.PMC5096436.pdf
"Serial peptides were derived from the donor ’s sequences to cover mismatched residues (peptide layout in Table S5, SDC, http://links.lww.com/TXD/A29).",Non-OADS,/arxiv_data1/oa_pdf/9b/dc/txd-2-e109.PMC5096436.pdf
"in Figure 5: table below, and highlighted in Figure S4 and Table S6, SDC, http://links.lww.com/TXD/A29).",Non-OADS,/arxiv_data1/oa_pdf/9b/dc/txd-2-e109.PMC5096436.pdf
"Cocrystal structure of HLA-DQ8 was used as a template (see details in Methods, SDC, http://links.lww.com/TXD/A29).",OADS,/arxiv_data1/oa_pdf/9b/dc/txd-2-e109.PMC5096436.pdf
"First, we have experienced 1 example of an LSA-positive allele (rated as moderate) not having any antibody-reactivepeptide ( Figure S6, SDC, http://links.lww.com/TXD/A29).",Non-OADS,/arxiv_data1/oa_pdf/9b/dc/txd-2-e109.PMC5096436.pdf
Available from: http://www.aihw.gov.au/publication-detail/?id=60129546922.,Non-OADS,/arxiv_data1/oa_pdf/ec/b3/txd-2-e112.PMC5096439.pdf
"Oslo, Norway: 2014.Available from: http://www.nephro.no/nnr.html.",Non-OADS,/arxiv_data1/oa_pdf/ec/b3/txd-2-e112.PMC5096439.pdf
Available from: http://trasplantaments.gencat.cat/web/.content/minisite/trasplantament/registres_activitat/registre_de_malalts_renals/arxius/informe-2013_FINAL.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ec/b3/txd-2-e112.PMC5096439.pdf
Available from: https://www.usrds.org/2015/view/v2_07.aspx.,Non-OADS,/arxiv_data1/oa_pdf/ec/b3/txd-2-e112.PMC5096439.pdf
Available from: http://www.odt.nhs.uk/pdf/organ_specific_report_kidney_2014.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ec/b3/txd-2-e112.PMC5096439.pdf
Available from: http://www.anzdata.org.au/anzod/v1/reports.html.6 Transplantation DIRECT ■2016 www.transplantationdirect.com,Non-OADS,/arxiv_data1/oa_pdf/ec/b3/txd-2-e112.PMC5096439.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5c/b5/main.PMC5096444.pdf
Contents lists available at ScienceDirect Contemporary Clinical Trials Communications journal homepage: www.elsevier.com/locate/conctc http://dx.doi.org/10.1016/j.conctc.2016.05.006 2451-8654/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5c/b5/main.PMC5096444.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Contemporary Clinical Trials Communications 3 (2016) 139 e141,Non-OADS,/arxiv_data1/oa_pdf/5c/b5/main.PMC5096444.pdf
"de Carle, R. Kohn, Electro-convulsive therapy and falls in the elderly, J. ECT 16 (2000) 252 e257, http://dx.doi.org/10.1097/00124509-200009000-00005 .",Non-OADS,/arxiv_data1/oa_pdf/5c/b5/main.PMC5096444.pdf
"53 (2005) 1618 e1622, http://dx.doi.org/ 10.1111/j.1532-5415.2005.53455.x .",Non-OADS,/arxiv_data1/oa_pdf/5c/b5/main.PMC5096444.pdf
"Looney, K. Van Haitsma, L. Teri, BE-ACTIV: a staff-assisted, behavioral intervention for depression in nursing homes, Gerontologist 48(2008) 105 e114, http://dx.doi.org/10.1093/geront/48.1.105 .",Non-OADS,/arxiv_data1/oa_pdf/5c/b5/main.PMC5096444.pdf
"70 (1) (2015) 13 e23, http://dx.doi.org/10.1093/geronb/gbu026 .",Non-OADS,/arxiv_data1/oa_pdf/5c/b5/main.PMC5096444.pdf
"121 (1994) 442 e451, http://dx.doi.org/10.7326/0003-4819-121-6- 199409150-00009 .",Non-OADS,/arxiv_data1/oa_pdf/5c/b5/main.PMC5096444.pdf
"169 (2009) 1952 e1960, http://dx.doi.org/ 10.1001/archinternmed.2009.357 .S.",Non-OADS,/arxiv_data1/oa_pdf/5c/b5/main.PMC5096444.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/9e/main.PMC5096461.pdf
Contents lists available at ScienceDirect Contemporary Clinical Trials Communications journal homepage: www.elsevier.com/locate/conctc http://dx.doi.org/10.1016/j.conctc.2016.05.004 2451-8654/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/1c/9e/main.PMC5096461.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Contemporary Clinical Trials Communications 3 (2016) 111 e116,Non-OADS,/arxiv_data1/oa_pdf/1c/9e/main.PMC5096461.pdf
"Robinson, Antenatal interventions for overweight or obese pregnant women: a systematic review of randomised trials, BJOG 117 (11) (2010) 1316 e1326, http://dx.doi.org/10.1111/j.1471- 0528.2010.02540.x .",Non-OADS,/arxiv_data1/oa_pdf/1c/9e/main.PMC5096461.pdf
"56 (6) (2013) 372 e378, http://dx.doi.org/10.1016/ j.ypmed.2013.02.015 .",OADS,/arxiv_data1/oa_pdf/1c/9e/main.PMC5096461.pdf
"(Silver Spring) (2015), http://dx.doi.org/10.1002/oby.21330 [Epub ahead of print].",Non-OADS,/arxiv_data1/oa_pdf/1c/9e/main.PMC5096461.pdf
"FL: Health- Smart Behavior Program, 2014. http://ufhealthdisparities.med.u ﬂ.edu/ research/health-smart-behavior-program-tools/ .",Non-OADS,/arxiv_data1/oa_pdf/1c/9e/main.PMC5096461.pdf
"(2016), http://dx.doi.org/10.1177/1559827615623773 .",Non-OADS,/arxiv_data1/oa_pdf/1c/9e/main.PMC5096461.pdf
"(Lond) 32 (3) (2008) 495e501, http://dx.doi.org/10.1038/sj.ijo.0803710 .",Non-OADS,/arxiv_data1/oa_pdf/1c/9e/main.PMC5096461.pdf
Contents lists available at ScienceDirect Contemporary Clinical Trials Communications journal homepage: www.elsevier.com /locate/conctc http://dx.doi.org/10.1016/j.conctc.2016.04.006 2451-8654/Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/da/67/main.PMC5096463.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Contemporary Clinical Trials Communications 3 (2016) 122 e130,Non-OADS,/arxiv_data1/oa_pdf/da/67/main.PMC5096463.pdf
Available at http://www.icmje.org/icmje- recommendations.pdf ; (accessed 01.12.15).,Non-OADS,/arxiv_data1/oa_pdf/da/67/main.PMC5096463.pdf
Available at http://www.gpo.gov/fdsys/pkg/PLAW- 110publ85/pdf/PLAW-110publ85.pdf ; (accessed 01.12.15).,Non-OADS,/arxiv_data1/oa_pdf/da/67/main.PMC5096463.pdf
Avail- able at https://prsinfo.clinicaltrials.gov/de ﬁnitions.html ; (accessed 01.12.15).,Non-OADS,/arxiv_data1/oa_pdf/da/67/main.PMC5096463.pdf
"[26] Congressional Research Service, Fischer H: A Guide to U.S. Military Casualty Statistics: Operation Freedom's Sentinel, Operation Inherent Resolve, Opera- tion New Dawn, Operation Iraqi Freedom, and Operation Enduring Freedom.Available at http://fas.org/sgp/crs/natsec/RS22452.pdf ; (accessed 01.12.15).",Non-OADS,/arxiv_data1/oa_pdf/da/67/main.PMC5096463.pdf
Available at http://www.whitehouse.gov/the-press- ofﬁce/2012/08/31/executive-order-improving-access-mental-health- services-veterans-service ; (accessed 01.12.15).,Non-OADS,/arxiv_data1/oa_pdf/da/67/main.PMC5096463.pdf
"Available at, http://www.whitehouse.gov/sites/default/ ﬁles/uploads/ nrap_for_eo_on_mental_health_august_2013.pdf (accessed 01.12.15).",Non-OADS,/arxiv_data1/oa_pdf/da/67/main.PMC5096463.pdf
"PRP	Preparation PRP was prepared from a small volume of blood  (18 ml) according to the method of the Cascade-Selphyl- Esforax procedure (Aesthetic Factors, LLC; Wayne, N.J.,  http://www.selphyl.com), with modifications, and from  60 ml of blood according to the P.R.L.",Non-OADS,/arxiv_data1/oa_pdf/e4/de/gox-4-e1027.PMC5096517.pdf
"Coop; San Giuliano Milanese, Italy, http://www.corios.it), with modifications, using PRP alone (C-Punt, Biomed Device; Modena, Italy,  http://www.",Non-OADS,/arxiv_data1/oa_pdf/e4/de/gox-4-e1027.PMC5096517.pdf
https://www.osac.gov/pages/ContentReportDetails.aspx?cid=16263.,OADS,/arxiv_data1/oa_pdf/1e/98/gox-4-e1034.PMC5096519.pdf
7. http://data.worldbank.org/country/trinidad-and-tobago  8.,Non-OADS,/arxiv_data1/oa_pdf/1e/98/gox-4-e1034.PMC5096519.pdf
"After tumor extirpation,  a circular defect of 11 cm × 12 cm, covering almost 50% of  the unilateral buttock, required reconstruction (see	 fig- ure,	Supplemental	 Digital	 Content	 1, which illustrates the  flap technique; http://links.lww.com/PRSGO/A256).",Non-OADS,/arxiv_data1/oa_pdf/83/ba/gox-4-e1039.PMC5096521.pdf
"Higher magnification (20×) images clearly demon- strated the consistent open, interconnected network of  HR-ADM compared with the asymmetrical papillary der - mis (See	 PDF, Supplemental	 Digital	 Content	 1, which re- veals distinct structural differences between papillary and  reticular dermal structures, http://links.lww.com/PRSGO/ A274).",Non-OADS,/arxiv_data1/oa_pdf/92/fc/gox-4-e1065.PMC5096524.pdf
"Immunohistochemistry analysis confirmed fibroblasts secreted an abundance of collagen IV in a multilayered network on top and within the open HR-ADM network as early as day 7 (See	 PDF,  Supplemental	 Digital	 Content	 3, which displays fibro- nectin secretion and day 14 images, http://links.lww.com/ PRSGO/A276).",Non-OADS,/arxiv_data1/oa_pdf/92/fc/gox-4-e1065.PMC5096524.pdf
"2) (See	figure,	 Supplemental	 Digital	 Content	 1, which displays a clinical  exam of mastectomy flaps, http://links.lww.com/PRSGO/ A277).",Non-OADS,/arxiv_data1/oa_pdf/57/fa/gox-4-e1075.PMC5096527.pdf
"1–4 Topical nitroglycerin can sal- vage tissue with threatened vascularity; however, it is not  without side effects (See	 figures,	 Supplemental	 Digital 	 Content	 2	and	 3, which demonstrate 1- and 4-week  postop photos, http://links.lww.com/PRSGO/A278 and  http://links.lww.com/PRSGO/A279).",Non-OADS,/arxiv_data1/oa_pdf/57/fa/gox-4-e1075.PMC5096527.pdf
This video is available in the “Related Videos” section of  the full-text article on PRSGlobalOpen.com or available at  http://links.lww.com/PRSGO/A280).,Non-OADS,/arxiv_data1/oa_pdf/a9/49/gox-4-e1083.PMC5096532.pdf
this video is available in the “re - lated videos” section of the full-text article on pRsGlobalopen.com or available at http://links.lww.com/PRSGO/A280.,Non-OADS,/arxiv_data1/oa_pdf/a9/49/gox-4-e1083.PMC5096532.pdf
"Data were collected from social  network groups within the social media site, Facebook  (http://www.facebook.com).",OADS,/arxiv_data1/oa_pdf/30/bd/gox-4-e1084.PMC5096533.pdf
Available at: http://iqsresearch.com/social-media-as-a-research-tool-the-danger-of-selection-bias/.,Non-OADS,/arxiv_data1/oa_pdf/30/bd/gox-4-e1084.PMC5096533.pdf
http://www.aqualyx.com.,Non-OADS,/arxiv_data1/oa_pdf/88/6c/gox-4-e1085.PMC5096534.pdf
Available at: http://www.ibcmt.com/2013-04-14-Lipostabil-Phos- phatidylcholine-Essentiale303.pdf.,Non-OADS,/arxiv_data1/oa_pdf/88/6c/gox-4-e1085.PMC5096534.pdf
Available at: http://www.accessdata.fda.gov/drugsatfda_docs/ label/2015/206333Orig1s000lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/88/6c/gox-4-e1085.PMC5096534.pdf
Available at: http://globocan.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/2d/a8/gox-4-e1086.PMC5096535.pdf
Available at: http://seer.cancer.gov/csr/1975_2012/.,Non-OADS,/arxiv_data1/oa_pdf/2d/a8/gox-4-e1086.PMC5096535.pdf
Available at: http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2d/a8/gox-4-e1086.PMC5096535.pdf
Available at: http://www.cancer.org/cancer/breastcancer/de-tailedguide/breast-cancer-survival-by-stage.,Non-OADS,/arxiv_data1/oa_pdf/2d/a8/gox-4-e1086.PMC5096535.pdf
Available at: http://www.cancer.org/cancer/prostatecancer/detailedguide/prostate-cancer-survival-rates.,Non-OADS,/arxiv_data1/oa_pdf/2d/a8/gox-4-e1086.PMC5096535.pdf
Available at: http://www.stopbullying.gov/what-is-bullying/index.,Non-OADS,/arxiv_data1/oa_pdf/2d/98/gox-4-e1087.PMC5096536.pdf
Available at: http://www.uptodate.com (captured 04/12/16).,Non-OADS,/arxiv_data1/oa_pdf/2d/98/gox-4-e1087.PMC5096536.pdf
Available at: https://www.jointcommission.org/jc_physician_blog/revisiting_disruptive_and_inappropriate_behavior (cap-tured 06/09/16).,Non-OADS,/arxiv_data1/oa_pdf/2d/98/gox-4-e1087.PMC5096536.pdf
"Available at: http://www.nmms.org/sites/default/files/ images/2013_9_23_ama_survey_prp-physician-practice-arrangements.pdf Accessed April 12, 2016.",Non-OADS,/arxiv_data1/oa_pdf/2d/98/gox-4-e1087.PMC5096536.pdf
Available at: https://www.cms.gov/medicare/fraud-and-abuse/physicianselfreferral/index.html (captured 05/28/16).,Non-OADS,/arxiv_data1/oa_pdf/2d/98/gox-4-e1087.PMC5096536.pdf
Available at: http://www.modernhealthcare.com/article/20150919/ MAGAZINE/309199979 (captured 05/26/16).,Non-OADS,/arxiv_data1/oa_pdf/2d/98/gox-4-e1087.PMC5096536.pdf
Available at: https://coe.uga.edu/news/archive/mullendore-cell-phone-is-umbilical-cord-for-helicopter-parents (captured 04/12/16).,Non-OADS,/arxiv_data1/oa_pdf/2d/98/gox-4-e1087.PMC5096536.pdf
Available at: http://www.acgme.org/What-We-Do/Accreditation/Duty-Hours (captured 04/12/16).,Non-OADS,/arxiv_data1/oa_pdf/2d/98/gox-4-e1087.PMC5096536.pdf
"Available at: https://www.acgme.org/Portals/0/PDFs/Resident_Duty_Hours_and_Related_Topics[1].pdf (captured 08/08/16, page 10).",Non-OADS,/arxiv_data1/oa_pdf/2d/98/gox-4-e1087.PMC5096536.pdf
"After the platelets were resuspended,  0.6 mL of PFC and 0.4 mL of non–cross-linked HA (Artz,  Seikagaku Corporation; Tokyo, Japan) were mixed and injected into the surface of the ulcer of the medial re- gion through a 30-gauge needle once a week (see	 video, 	 Supplemental	 Digital	 Content	 1, which displays the in- jection technique, http://links.lww.com/PRSGO/A281).",Non-OADS,/arxiv_data1/oa_pdf/f2/bc/gox-4-e1089.PMC5096537.pdf
"this is performed once a week,  http://links.lww.com/PRSGO/A281.",Non-OADS,/arxiv_data1/oa_pdf/f2/bc/gox-4-e1089.PMC5096537.pdf
Available at: http://www.cdc.gov/diabetes/pubs/ statsre- port14/national-diabetes-report-web.pdf.,Non-OADS,/arxiv_data1/oa_pdf/48/44/gox-4-e1090.PMC5096538.pdf
https://www.natrelle.com/warranty.,Non-OADS,/arxiv_data1/oa_pdf/e6/c6/gox-4-e1096.PMC5096543.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8c/a4/main.PMC5096590.pdf
Contents lists available at ScienceDirect Contemporary Clinical Trials Communications journal homepage: www.elsevier.com /locate/conctc http://dx.doi.org/10.1016/j.conctc.2016.04.002 2451-8654/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/8c/a4/main.PMC5096590.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Contemporary Clinical Trials Communications 3 (2016) 70 e73,Non-OADS,/arxiv_data1/oa_pdf/8c/a4/main.PMC5096590.pdf
"References [1] U.S. Renal Data System, USRDS, Annual Data Report: Atlas of Chronic Kidney Disease and End-stage Renal Disease in the United States, National Institutes of health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda MD, 2014, http://dx.doi.org/10.1053/j.ajkd.2015.04.026 , 2014.",Non-OADS,/arxiv_data1/oa_pdf/8c/a4/main.PMC5096590.pdf
"20 (2011) 331 e340, http://dx.doi.org/10.1111/j.1365- 2702.2010.03348.x .",Non-OADS,/arxiv_data1/oa_pdf/8c/a4/main.PMC5096590.pdf
"Gabbai, M. Pahl, et al., A randomized control trial of continuous versus intermittent dialysis for acute renal failure, Kidney Int.60 (2001) 1154 e1163, http://dx.doi.org/10.1046/j.1523- 1755.2001.0600031154.x .",Non-OADS,/arxiv_data1/oa_pdf/8c/a4/main.PMC5096590.pdf
"2 (2002) 339 e345, http://dx.doi.org/10.1046/j.1523- 1755.2002.00437.x .",Non-OADS,/arxiv_data1/oa_pdf/8c/a4/main.PMC5096590.pdf
"11 (1) (2007) 25 e32,http://dx.doi.org/ 10.1111/j.1525-139x.1998.tb00206.x .",Non-OADS,/arxiv_data1/oa_pdf/8c/a4/main.PMC5096590.pdf
"14 (5) (2001) 337 e347, http://dx.doi.org/10.1046/j.1525-139x.2001.00086.x .",Non-OADS,/arxiv_data1/oa_pdf/8c/a4/main.PMC5096590.pdf
"10 (2014) 1277 e1284, http://dx.doi.org/10.1093/ajh/ hpt294 .",Non-OADS,/arxiv_data1/oa_pdf/8c/a4/main.PMC5096590.pdf
"21 (2002) 393 e397, http://dx.doi.org/10.1037//0278-6133.21.4.393 .",Non-OADS,/arxiv_data1/oa_pdf/8c/a4/main.PMC5096590.pdf
"Psychiatry 12 (1981) 63e67,http://dx.doi.org/10.1016/0005-7916(81)90031-8 .",Non-OADS,/arxiv_data1/oa_pdf/8c/a4/main.PMC5096590.pdf
"11 (1992) 324 e330, http://dx.doi.org/10.1037/ 0278-6133.11.5.324 .",Non-OADS,/arxiv_data1/oa_pdf/8c/a4/main.PMC5096590.pdf
"39 (2002) 695 e704, http://dx.doi.org/10.1016/ s0020-7489(02)00007-x .",Non-OADS,/arxiv_data1/oa_pdf/8c/a4/main.PMC5096590.pdf
"28 (4) (2013) 384 e391, http://dx.doi.org/10.1097/ 01.TIN.0000437407.76867.65 .",Non-OADS,/arxiv_data1/oa_pdf/8c/a4/main.PMC5096590.pdf
"104 (2004) 35 e41,http://dx.doi.org/10.1016/j.jada.2003.10.016 .",OADS,/arxiv_data1/oa_pdf/8c/a4/main.PMC5096590.pdf
"37 (2005) 25e29,http://dx.doi.org/10.1111/j.1547-5069.2005.00009.x .",Non-OADS,/arxiv_data1/oa_pdf/8c/a4/main.PMC5096590.pdf
"170 (8) (2010) 732 e734, http://dx.doi.org/10.1001/ archinternmed.2010.72 .",Non-OADS,/arxiv_data1/oa_pdf/8c/a4/main.PMC5096590.pdf
"45 (2005) 223 e232, http://dx.doi.org/10.1053/j.ajkd.2004.09.022 .",Non-OADS,/arxiv_data1/oa_pdf/8c/a4/main.PMC5096590.pdf
"25 (2010) 545 e551, http://dx.doi.org/10.1093/ndt/gfp517 .",Non-OADS,/arxiv_data1/oa_pdf/8c/a4/main.PMC5096590.pdf
"31 (2011)574e582, http://dx.doi.org/10.3747/pdi.2009.00140 .",Non-OADS,/arxiv_data1/oa_pdf/8c/a4/main.PMC5096590.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/53/main.PMC5096594.pdf
Contents lists available at ScienceDirect Annals of Medicine and Surgery journal homepage: www.annalsjournal.com http://dx.doi.org/10.1016/j.amsu.2016.10.005 2049-0801/ ©2016 The Author(s).,Non-OADS,/arxiv_data1/oa_pdf/7b/53/main.PMC5096594.pdf
"62 (9) (September 2010) 1312 e1318, http://dx.doi.org/10.1002/acr.20215 .",Non-OADS,/arxiv_data1/oa_pdf/7b/53/main.PMC5096594.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d5/29/main.PMC5096596.pdf
Contents lists available at ScienceDirect International Journal for Parasitology: Parasites and Wildlife journal homepage: www.elsevier.com/locate/ijppaw http://dx.doi.org/10.1016/j.ijppaw.2016.10.002 2213-2244/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/d5/29/main.PMC5096596.pdf
"By the end of July 2014, California was entering a third year of drought and over 58% of the state was classi ﬁed as being in exceptional drought according to the National Drought Mitigation Center ( http://droughtmonitor.unl.edu ).",Non-OADS,/arxiv_data1/oa_pdf/d5/29/main.PMC5096596.pdf
Parasitology 1e12.http://dx.doi.org/10.1017/S0031182013000930 .,Non-OADS,/arxiv_data1/oa_pdf/d5/29/main.PMC5096596.pdf
http://bna.birds.cornell/bna/species/179 .,Non-OADS,/arxiv_data1/oa_pdf/d5/29/main.PMC5096596.pdf
http://bna.birds.cornell.edu/bna/species/530 .,Non-OADS,/arxiv_data1/oa_pdf/d5/29/main.PMC5096596.pdf
"Sao Paulo 2016;58:74 http://dx.doi.org/10.1590/S1678-9946201658074 ORIGINAL ARTICLE FIRST MOLECULAR DETECTION AND VP7 (G) GENOTYPING OF GROUP A ROTAVIRUS BY  SEMI‑NESTED RT ‑PCR FROM SEWAGE IN NIGERIA Babatunde Olanrewaju MOTAYO(1), Adekunle Johnson ADENIJI(1,2) & Adedayo Omotayo FANEYE(1) SUMMARY Rotavirus is the leading cause of viral gastroenteritis worldwide, and sewage is a major source of the virus dissemination in the  environment.",Non-OADS,/arxiv_data1/oa_pdf/b4/3d/0036-4665-rimtsp-58-00074.PMC5096628.pdf
Strains were determined by  BLAST (Basic Local Alignment Search Tool) http://blast.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/b4/3d/0036-4665-rimtsp-58-00074.PMC5096628.pdf
"Sao Paulo 2016;58:75 http://dx.doi.org/10.1590/S1678-9946201658075 ORIGINAL ARTICLE Leishmania infantum  INFECTION IN DOGS FROM THE SOUTHERN REGION OF   MINAS GERAIS  STATE, BRAZIL Juliana Barbosa NUNES(1), Márcia Dalastra LAURENTI(2), Herminia Yohko KANAMURA(1), Alessandro Antônio Costa PEREIRA(1),   Fabio Antonio COLOMBO(1) & Marcos José MARQUES(1) SUMMARY Visceral leishmaniasis is a systemic and chronic disease and dogs are the main reservoir of the etiologic agent, Leishmania  infantum ( syn L. chagasi) .",Non-OADS,/arxiv_data1/oa_pdf/7f/79/0036-4665-rimtsp-58-00075.PMC5096629.pdf
BioEdit Sequence Alignment Editor version 8.1  (available from: http://bioedit.software.informer.com/) was used for the  analysis and manual editing of the genetic sequences.,OADS,/arxiv_data1/oa_pdf/7f/79/0036-4665-rimtsp-58-00075.PMC5096629.pdf
This sequence was compared with the one  deposited in GenBank by means of BLAST (http://blast.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/7f/79/0036-4665-rimtsp-58-00075.PMC5096629.pdf
"Sao Paulo 2016;58:76 http://dx.doi.org/10.1590/S1678-9946201658076 ORIGINAL ARTICLE DENTISTS’ KNOWLEDGE AND EXPERIENCE REGARDING LEPROSY IN AN   ENDEMIC AREA IN BRAZIL Ronald Jefferson MARTINS, Maria Emília Oliveira Gomes CARLONI, Suzely Adas Saliba MOIMAZ, Cléa Adas Saliba GARBIN & Artênio José Ísper GARBIN SUMMARY This study aims to analyze the dental surgeons’ knowledge about leprosy and its ways of transmission, clinical characteristics and  treatment, besides analyzing their experience with respect to diagnostic suspicion and case referrals.",Non-OADS,/arxiv_data1/oa_pdf/aa/32/0036-4665-rimtsp-58-00076.PMC5096630.pdf
Available from: http://bvsms.saude.gov.br/bvs/publicacoes/ saude_brasil_2010.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/aa/32/0036-4665-rimtsp-58-00076.PMC5096630.pdf
Available from: http://bvsms.saude.gov.br/bvs/publicacoes/cab_n21_vigilancia_ saude_2ed_p1.pdf  3.,Non-OADS,/arxiv_data1/oa_pdf/aa/32/0036-4665-rimtsp-58-00076.PMC5096630.pdf
Available from: http://cidades.ibge.gov.br/xtras/perfil.,OADS,/arxiv_data1/oa_pdf/aa/32/0036-4665-rimtsp-58-00076.PMC5096630.pdf
Available from: http://bvsms.saude.gov.br/bvs/saudelegis/gm/2010/ prt3125_07_10_2010.html  21.,OADS,/arxiv_data1/oa_pdf/aa/32/0036-4665-rimtsp-58-00076.PMC5096630.pdf
"Sao Paulo 2016;58:77 http://dx.doi.org/10.1590/S1678-9946201658077 ORIGINAL ARTICLE A DECADE TREND OF MULTIDRUG RESISTANT TUBERCULOSIS IN SÃO PAULO  STATE, BRAZIL Valdes Roberto BOLLELA(1), Fernanda Guioti PUGA(1), Maria Janete MOYA(1), Mauro ANDREA(2) & Maria de Lourdes Viude OLIVEIRA(3) SUMMARY The aim of this retrospective study was to review all the notified cases of multidrug-resistant tuberculosis (MDR-TB) in São Paulo   State (Brazil), as well as to describe and discuss the clinical, microbiological and radiologic aspects in a single reference center, within  the same state, from 2000 to 2012.",Non-OADS,/arxiv_data1/oa_pdf/36/b0/0036-4665-rimtsp-58-00077.PMC5096631.pdf
Data source   The SITE-TB website (http://sitetb.org/) was the basic source of  information.,OADS,/arxiv_data1/oa_pdf/36/b0/0036-4665-rimtsp-58-00077.PMC5096631.pdf
"Sao Paulo 2016;58:78 http://dx.doi.org/10.1590/S1678-9946201658078 ORIGINAL ARTICLE A DESCRIPTIVE STUDY OF PANDEMIC INFLUENZA A(H1N1)PDM09 IN BRAZIL, 2009 – 2010 Erika Valeska ROSSETTO & Expedito José de Albuquerque LUNA SUMMARY Influenza A viruses undergo frequent antigenic mutations and may thus cause seasonal epidemics and pandemics.",Non-OADS,/arxiv_data1/oa_pdf/4d/3b/0036-4665-rimtsp-58-00078.PMC5096632.pdf
"Subsequently, the  databases were submitted to the duplicity verification process by using  the software RecLink III® (http://reclink.sourceforge.net/).",OADS,/arxiv_data1/oa_pdf/4d/3b/0036-4665-rimtsp-58-00078.PMC5096632.pdf
Available from: http://www2.camara.leg.br/legin/fed/decleg/2009/decretolegislativo- 395-9-julho-2009-589324-publicacaooriginal-114307-pl.html   5.,Non-OADS,/arxiv_data1/oa_pdf/4d/3b/0036-4665-rimtsp-58-00078.PMC5096632.pdf
Available from: http://www2.datasus.gov.br/ DATASUS/index.php?area=0206&VObj=http://tabnet.datasus.gov.br/cgi/deftohtm.,OADS,/arxiv_data1/oa_pdf/4d/3b/0036-4665-rimtsp-58-00078.PMC5096632.pdf
Available from: http://bvsms.saude.gov.br/bvs/saudelegis/sas/2011/ prt0650_05_10_2011.html   13.,OADS,/arxiv_data1/oa_pdf/4d/3b/0036-4665-rimtsp-58-00078.PMC5096632.pdf
Available  from: http://tabnet.datasus.gov.br/cgi/deftohtm.exe?sinasc/cnv/nvuf.def  14.,OADS,/arxiv_data1/oa_pdf/4d/3b/0036-4665-rimtsp-58-00078.PMC5096632.pdf
Available from: http://www.planalto.gov.br/ccivil_03/_ato2011- 2014/2011/lei/l12527.htm   15.,Non-OADS,/arxiv_data1/oa_pdf/4d/3b/0036-4665-rimtsp-58-00078.PMC5096632.pdf
Available from: http://bvsms.saude.gov.br/bvs/saudelegis/gm/2012/ prt1583_19_07_2012.html   16.,Non-OADS,/arxiv_data1/oa_pdf/4d/3b/0036-4665-rimtsp-58-00078.PMC5096632.pdf
Available from: http://bvsms.saude.gov.br/bvs/periodicos/boletim_eletronico_epi_ ano04_n01.pdf  17.,OADS,/arxiv_data1/oa_pdf/4d/3b/0036-4665-rimtsp-58-00078.PMC5096632.pdf
Available from: ftp://ftp.cve.saude.sp.gov.,OADS,/arxiv_data1/oa_pdf/4d/3b/0036-4665-rimtsp-58-00078.PMC5096632.pdf
Available from: http://www.ibge.gov.br/home/estatistica/populacao/censo2010/ caracteristicas_religiao_deficiencia/default_caracteristicas_religiao_deficiencia.shtm.,Non-OADS,/arxiv_data1/oa_pdf/4d/3b/0036-4665-rimtsp-58-00078.PMC5096632.pdf
Available from: http://pni.datasus.gov.br/consulta_h1n1_10_selecao.,OADS,/arxiv_data1/oa_pdf/4d/3b/0036-4665-rimtsp-58-00078.PMC5096632.pdf
Available from: http://www.cdc.gov/flu/swineflu/ variant.htm  34.,Non-OADS,/arxiv_data1/oa_pdf/4d/3b/0036-4665-rimtsp-58-00078.PMC5096632.pdf
Available from: http://www.paho.org/hq/index.,Non-OADS,/arxiv_data1/oa_pdf/4d/3b/0036-4665-rimtsp-58-00078.PMC5096632.pdf
"Sao Paulo 2016;58:79 http://dx.doi.org/10.1590/S1678-9946201658079 ORIGINAL ARTICLE PREVALENCE OF AMERICAN TRYPANOSOMIASIS AND LEISHMANIASES IN DOMESTIC DOGS IN A  RURAL AREA OF THE MUNICIPALITY OF SÃO JOÃO DO PIAUÍ, PIAUÍ  STATE, BRAZIL Taliha Dias PEREZ(1), Fabiano Borges FIGUEIREDO(2), Artur Augusto Mendes VELHO JUNIOR(2), Valmir Laurentino SILV A(3),   Maria de Fátima MADEIRA(4), Reginaldo Peçanha BRAZIL(1) & José Rodrigues COURA(1) SUMMARY Chagas disease and the leishmaniases are endemic zoonoses of great importance to public health in the state of Piauí,  Brazil.",Non-OADS,/arxiv_data1/oa_pdf/de/ca/0036-4665-rimtsp-58-00079.PMC5096633.pdf
Available from: http://www.paho.org/hq/ index.php?option=com_content&view=article&id=9438&Itemid=1926&lang=en  2.,Non-OADS,/arxiv_data1/oa_pdf/de/ca/0036-4665-rimtsp-58-00079.PMC5096633.pdf
Available  from: http://www.ibge.gov.br/home/estatistica/populacao/censo2010/default.shtm  18.,Non-OADS,/arxiv_data1/oa_pdf/de/ca/0036-4665-rimtsp-58-00079.PMC5096633.pdf
Available  from: http://brasil.campusvirtualsp.org/node/198026  20.,Non-OADS,/arxiv_data1/oa_pdf/de/ca/0036-4665-rimtsp-58-00079.PMC5096633.pdf
"Sao Paulo 2016;58:80 http://dx.doi.org/10.1590/S1678-9946201658080 ORIGINAL ARTICLE SEROPREVALENCE OF HTLV IN A POPULATION OF HIV1-INFECTED PATIENTS IN   MIDWESTERN BRAZIL Aline Garcia KOZLOWSKI(1), Márcia Alves Dias de MATOS(1), Megmar Aparecida dos Santos CARNEIRO(1), Carmen Luci Rodrigues LOPES(2),   Sheila Araújo TELES(2), Carolina Paulo VICENTE(3) & Regina Maria Bringel MARTINS(1) SUMMARY Human T-cell lymphotropic virus (HTLV) may affect the clinical course of human immunodeficiency virus 1 (HIV1).",Non-OADS,/arxiv_data1/oa_pdf/77/c1/0036-4665-rimtsp-58-00080.PMC5096634.pdf
Available from: http://www.aids.gov.br/sites/default/files/anexos/ publicacao/2014/56677/boletim_2014_final_pdf_15565.pdf  23.,Non-OADS,/arxiv_data1/oa_pdf/77/c1/0036-4665-rimtsp-58-00080.PMC5096634.pdf
Available from:http://www.aids.gov.br/sites/default/files/anexos/ publicacao/2013/55308/protocolofinal_31_7_2015_pdf_31327.pdf   27.,OADS,/arxiv_data1/oa_pdf/77/c1/0036-4665-rimtsp-58-00080.PMC5096634.pdf
"Sao Paulo 2016;58:81 http://dx.doi.org/10.1590/S1678-9946201658081 ORIGINAL ARTICLE SAPOVIRUSES IN CHILDREN WITH ACUTE GASTROENTERITIS FROM MANAUS ,   AMAZON REGION, BRAZIL, 2010-2011 Tammy Kathlyn Amaral REYMÃO(1), Juliana das Merces HERNANDEZ(1), Samya Thalita Picanço da COSTA(2), Maísa Silva de SOUSA(3),   Darleise de Souza OLIVEIRA(4), Luciana Damascena da SILV A(4), Renato da Silva BANDEIRA(4), Ian Carlos Gomes de LIMA(4),   Luana da Silva SOARES(4), Joana Darc Pereira MASCARENHAS(4) & Yvone Benchimol GABBAY(4) SUMMARY Sapoviruses (SaVs) are responsible for acute gastroenteritis in humans, especially children and the elderly.",Non-OADS,/arxiv_data1/oa_pdf/ba/cb/0036-4665-rimtsp-58-00081.PMC5096635.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs330/en/  3.,Non-OADS,/arxiv_data1/oa_pdf/ba/cb/0036-4665-rimtsp-58-00081.PMC5096635.pdf
"Sao Paulo 2016;58:82 http://dx.doi.org/10.1590/S1678-9946201658082 ORIGINAL ARTICLE ADHERENCE TO INFLUENZA VACCINATION AMONG MEDICAL STUDENTS DURING AND AFTER  INFLUENZA A (H1N1) PANDEMIC Stéfano Ivani de PAULA, Gustavo Ivani de PAULA, Kelly Simone Almeida CUNEGUNDES & Maria Isabel de MORAES-PINTO SUMMARY This study evaluated the adherence to influenza vaccination among medical students in 2010 and 2011.",Non-OADS,/arxiv_data1/oa_pdf/2b/06/0036-4665-rimtsp-58-00082.PMC5096636.pdf
Available from: http://pni.datasus.gov.br/consulta_h1n1_10_selecao.,OADS,/arxiv_data1/oa_pdf/2b/06/0036-4665-rimtsp-58-00082.PMC5096636.pdf
"Sao Paulo 2016;58:83 http://dx.doi.org/10.1590/S1678-9946201658083 ORIGINAL ARTICLE ANTIMICROBIAL SUSCEPTIBILITY OF Streptococcus agalactiae ISOLATED   FROM PREGNANT WOMEN Simone Cristina Castanho Sabaini de MELO(1), Nathally Claudiane de Souza SANTOS(2), Marcia de OLIVEIRA(2),   Regiane Bertin de Lima SCODRO(2), Rosilene Fressatti CARDOSO(2), Rúbia Andreia Falleiros PÁDUA(2),   Flavia Teixeira Ribeiro SILV A(3), Aline Balandis COSTA(3), Maria Dalva de Barros CARV ALHO(1) & Sandra Marisa PELLOSO(1) SUMMARY Introduction : Group B streptococcus (GBS) or Streptococcus agalactiae  can colonize the gastrointestinal and genitourinary tracts  and has been considered one of the most important risk factors for the development of neonatal disease.",Non-OADS,/arxiv_data1/oa_pdf/5e/42/0036-4665-rimtsp-58-00083.PMC5096637.pdf
"Sao Paulo 2016;58:84 http://dx.doi.org/10.1590/S1678-9946201658084 ORIGINAL ARTICLE CLINICAL MANAGEMENT OF LOCALIZED BCG ADVERSE EVENTS IN CHILDREN Thais das Neves Fraga MOREIRA(1), Maria Isabel de MORAES-PINTO(2), Beatriz Tavares COSTA-CARV ALHO(2),   Anete Sevciovic GRUMACH(3) & Lily Yin WECKX(1) SUMMARY BCG adverse events (BCG-AE) are rare conditions with no well-established treatment.",Non-OADS,/arxiv_data1/oa_pdf/e5/51/0036-4665-rimtsp-58-00084.PMC5096638.pdf
Available from: http://www.who.int/ vaccine_safety/initiative/tools/vaccinfosheets/en/index.html  5.,Non-OADS,/arxiv_data1/oa_pdf/e5/51/0036-4665-rimtsp-58-00084.PMC5096638.pdf
Available  from: http://portalsaude.saude.gov.br/index.php/o-ministerio/principal/leia-mais-o- ministerio/197-secretaria-svs/13600-calendario-nacional-de-vacinacao.,Non-OADS,/arxiv_data1/oa_pdf/e5/51/0036-4665-rimtsp-58-00084.PMC5096638.pdf
Available from: http://tabnet.datasus.gov.br/cgi/tabcgi.exe?pni/cnv/dpniuf.,OADS,/arxiv_data1/oa_pdf/e5/51/0036-4665-rimtsp-58-00084.PMC5096638.pdf
Available from: http://www.who.int/pmnch/ media/news/2012/preterm_birth_report/en/   20.,Non-OADS,/arxiv_data1/oa_pdf/e5/51/0036-4665-rimtsp-58-00084.PMC5096638.pdf
Available from: http://www.aids.gov.br/ publicacao/2013/boletim-epidemiologico-aids-e-dst-2013 24.,Non-OADS,/arxiv_data1/oa_pdf/e5/51/0036-4665-rimtsp-58-00084.PMC5096638.pdf
Available  from: http://www.lasid.org/index.php?option=com_content&view=article&id=91& Itemid=72&lang=en  25.,OADS,/arxiv_data1/oa_pdf/e5/51/0036-4665-rimtsp-58-00084.PMC5096638.pdf
"Sao Paulo 2016;58:85 http://dx.doi.org/10.1590/S1678-9946201658085 LETTER TO THE EDITOR OCULAR COMPLICATIONS CAUSED BY Cryptococcus gattii  AFLP4/VGI MENINGITIS IN AN  IMMUNOCOMPETENT HOST Changhua, June 15, 2016 Dear Editor The Cryptococcus gattii complex  has been recognized as an endemic pathogen since the 1990s and has caused multiple outbreaks since then1.",Non-OADS,/arxiv_data1/oa_pdf/60/d9/0036-4665-rimtsp-58-00085.PMC5096639.pdf
"dovepress.com/terms.ph p and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e3/6b/clep-8-521.PMC5096723.pdf
"For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Epidemiology Clinical Epidemiology 2016:8 521–524 (Thematic series on clinical quality databases in Denmark) Dove press submit your manuscript | www.dovepress.co m Dove press  REviEwopen access to scientific and medical research Open Access Full T ext Article 521 http: //dx.doi.org/10.2147/CLEP .S9951 2The Danish inguinal Hernia database Hans Friis-Andersen1,2 Thue Bisgaard2,3 1Surgical Department, Horsens  Regional Hospital, Horsens,   Denmark; 2Steering Committee,   Danish Hernia Database, 3Surgical  Gastroenterological Department  235, Copenhagen University Hospital,   Hvidovre, Denmark Correspondence: Hans Friis-Andersen   Surgical Department, Horsens Regional  Hospital, Sundvej 30, DK-8700 Horsens,  Denmark   T el +45 7842 6222   Fax +45 7842 6399   Email hanfri@rm.d kAim of database:  To monitor and improve nation-wide surgical outcome after groin hernia  repair based on scientific evidence-based surgical strategies for the national and international  surgical community.",Non-OADS,/arxiv_data1/oa_pdf/e3/6b/clep-8-521.PMC5096723.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/e3/6b/clep-8-521.PMC5096723.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/41/ee/ijnrd-9-257.PMC5096724.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/41/ee/ijnrd-9-257.PMC5096724.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of Nephrology and Renovascular Disease 2016:9 257–262International Journal of Nephrology and Renovascular Disease Dovepress submit your manuscript | www.dovepress.com Dovepress 257 ORIGINAL RESEARCH   open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJNRD.S113389 Acute kidney injury adjusted to volume status  in critically ill patients: recognition of delayed  diagnosis, restaging, and associated outcomes Harout Yacoub1 Leen Khoury1 Y oussef El Douaihy1 Chadi Salmane1 Jeanne Kamal1 Marc Saad2 Patricia Nasr1 Jared Radbel3 Elie El-Charabaty1 Suzanne El-Sayegh1 1Department of Medicine, Staten  Island University Hospital, Staten  Island, NY, USA; 2Division of Renal  Medicine, Emory University, Atlanta,  GA, USA;  3Department of Pulmonary  and Critical Care Medicine, Rutgers Robert Wood Johnson Medical School,  New Brunswick, NJ, USA Abstract:  Critically ill patients receive a significant amount of fluids leading to a positive fluid  balance; this dilutes serum creatinine resulting in an overestimated glomerular filtration rate.",Non-OADS,/arxiv_data1/oa_pdf/41/ee/ijnrd-9-257.PMC5096724.pdf
"3 This is of particular importance in the critical care setting.Correspondence: Harout Yacoub Department of Medicine, Staten Island University Hospital, 475 Seaview Avenue, Staten Island, NY 10305, USA Email hyacoub@norwell.eduJournal name: International Journal of Nephrology and Renovascular Disease Article Designation: ORIGINAL RESEARCH Y ear: 2016V olume: 9Running head verso: Y acoub et alRunning head recto: Recognition of delayed diagnosis, restaging, and associated outcomes for AKIDOI: http://dx.doi.org/10.2147/IJNRD.S113389",Non-OADS,/arxiv_data1/oa_pdf/41/ee/ijnrd-9-257.PMC5096724.pdf
"International Journal of Nephrology and Renovascular Disease 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journalThe International Journal of Nephrology and Renovascular Disease is   an international, peer-reviewed open access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/41/ee/ijnrd-9-257.PMC5096724.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published   authors.Dovepress 262 Yacoub et al,Non-OADS,/arxiv_data1/oa_pdf/41/ee/ijnrd-9-257.PMC5096724.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/61/8c/ppa-10-2209.PMC5096725.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 2209–2215Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  2209OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10994 1 Time to lack of persistence with pharmacological  treatment among patients with current depressive  episodes: a natural study with 1-year follow-up Kanglai li1,* Qinling Wei2,* guanying li2 Xiangjun he2 Yingtao liao2 Zhaoyu gan2 1Very important Patient Department,   2Department of Psychiatry, The  Third Affiliated hospital of sun  Yat-sen University, Tianhe District,   guangzhou, guangdong, People’s  republic of china *These authors contributed equally  to this workIntroduction:  Medication nonadherence remains a big challenge for depressive patients.",Non-OADS,/arxiv_data1/oa_pdf/61/8c/ppa-10-2209.PMC5096725.pdf
"However, the epidemiology of  persistence with pharmacological treatment in patients with UD or BD shows that correspondence: Zhaoyu gan Department of Psychiatry, The Third  Affiliated Hospital of Sun Yat-sen  University, no 600, Tianhe road, Tianhe  District, guangzhou, guangdong 510630,  People’s republic of china Tel +86 20 8525 3423 email moyanchou@163.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Li et al Running head recto: Time to lack of persistence with pharmacological treatment DOI: http://dx.doi.org/10.2147/PPA.S109941",Non-OADS,/arxiv_data1/oa_pdf/61/8c/ppa-10-2209.PMC5096725.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/61/8c/ppa-10-2209.PMC5096725.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/2c/f4/clep-8-589.PMC5096726.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/2c/f4/clep-8-589.PMC5096726.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Epidemiology 2016:8 589–594 (Thematic series on clinical quality databases in Denmark)Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  589REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S9951 3The Danish National Penile Cancer Quality  database Jakob Kristian Jakobsen1 Buket Öztürk2 Mette Søgaard2 1Department of Urology, 2Department  of Clinical Epidemiology, Aarhus  University Hospital, Aarhus Nord,   Denmark Correspondence: Jakob Kristian Jakobsen   Department of Urology, Aarhus  University Hospital, Palle Juul-Jensens  Boulevard 99, 8200 Aarhus Nord,  Denmark   T el +45 2624 8583   Fax +45 7845 2630   Email jkjakobsen@gmail.co mAim of database:  The Danish National Penile Cancer Quality database (DaPeCa-data) aims  to improve the quality of cancer care and monitor the diagnosis, staging, and treatment of all  incident penile cancer cases in Denmark.",Non-OADS,/arxiv_data1/oa_pdf/2c/f4/clep-8-589.PMC5096726.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/2c/f4/clep-8-589.PMC5096726.pdf
Updated information on DaPeCa-data is available  at the DaPeCa-group Internet homepage: http://ducg.dk/ dapeca-peniscancer /.,OADS,/arxiv_data1/oa_pdf/2c/f4/clep-8-589.PMC5096726.pdf
Available from: http://ducg.dk/dapeca-peniscancer / kliniske-retningslinjer/.,Non-OADS,/arxiv_data1/oa_pdf/2c/f4/clep-8-589.PMC5096726.pdf
Available from: http://www.nopho.,Non-OADS,/arxiv_data1/oa_pdf/2c/f4/clep-8-589.PMC5096726.pdf
Available from: http://www.patobank.dk /.,Non-OADS,/arxiv_data1/oa_pdf/2c/f4/clep-8-589.PMC5096726.pdf
Available from: http://rkkp.dk /.,Non-OADS,/arxiv_data1/oa_pdf/2c/f4/clep-8-589.PMC5096726.pdf
Available from: http://www.kcks-vest.,Non-OADS,/arxiv_data1/oa_pdf/2c/f4/clep-8-589.PMC5096726.pdf
Available from:  http://www.kea.au.dk/en/ClinicalQuality/CentreClinEpiBiostatNorth.,Non-OADS,/arxiv_data1/oa_pdf/2c/f4/clep-8-589.PMC5096726.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/1a/1f/dmso-9-337.PMC5096728.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/1a/1f/dmso-9-337.PMC5096728.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016:9 337–345Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 337 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S116243 Changes in HbA1c, body weight, and systolic  blood pressure in type 2 diabetes patients  initiating dapagliflozin therapy: a primary care  database study Markus F Scheerer1 Roland Rist1 Orm Proske1 Annika Meng2 Karel Kostev2 1Medical Department, AstraZeneca  GmbH, Wedel, Germany; 2IMS Health  GmbH & Co. OHG, Frankfurt am  Main, GermanyAims: To investigate changes in glycated hemoglobin (HbA1c), body weight (BW), and systolic  blood pressure (SBP) in type 2 diabetes (T2D) primary care patients initiating dapagliflozin treatment.",Non-OADS,/arxiv_data1/oa_pdf/1a/1f/dmso-9-337.PMC5096728.pdf
"In 2015, the Correspondence: Karel Kostev Epidemiology & Evidence-Based Medicine, Real-World Evidence Solutions, IMS Health GmbH & Co. OHG, Darmstädter Landstraße 108, 60598 Frankfurt am Main, GermanyTel +49 69 6604 4878Email kkostev@de.imshealth.comJournal name: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Scheerer et alRunning head recto: Dapagliflozin effects on HbA1c, weight, and blood pressureDOI: http://dx.doi.org/10.2147/DMSO.S116243",Non-OADS,/arxiv_data1/oa_pdf/1a/1f/dmso-9-337.PMC5096728.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journal Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to   the rapid publication of the latest laboratory and clinical findings   in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/1a/1f/dmso-9-337.PMC5096728.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 345 Dapagliflozin effects on HbA1c, weight, and blood pressure Supplementary materials Table S1 Three-month changes (after the ID) in HbA1c, body weight, and systolic blood pressure in type 2 diabetes patients initiating  dapagliflozin therapy in primary care practices in Germany Variables N Baseline £6 months   before ID3 months after ID Difference P-value Dapagliflozin monotherapy HbA1c (%) 72 8.1 (1.7) 7.7 (1.4) −0.4 (1.2) 0.010 Body weight (kg) 24 110.0 (27.6) 105.3 (25.7) −4.7 (7.5) <0.001 Systolic blood pressure (mmHg) 45 137.1 (15.3) 136.0 (18.6) −1.1 (17.6) 0.499 Dapagliflozin + metforminHbA1c (%) 73 8.3 (1.6) 7.7 (1.2) −0.6 (1.5) <0.001 Body weight (kg) 17 99.9 (21.4) 96.7 (22.3) −3.2 (3.7) 0.002 Systolic blood pressure (mmHg) 37 135.4 (18.1) 134.5 (14.8) −0.9 (20.3) 0.964 Dapagliflozin + insulinHbA1c (%) 305 8.7 (1.5) 8.0 (1.2) −0.8 (1.4) <0.001 Body weight (kg) 133 105.7 (22.8) 103.8 (22.5) −1.9 (5.0) <0.001 Systolic blood pressure (mmHg) 223 137.0 (17.8) 135.4 (18.1) −1.6 (18.1) 0.070 Dapagliflozin + DPP-4 inhibitorsHbA1c (%) 298 8.5 (1.5) 7.6 (1.1) −0.9 (1.4) <0.001 Body weight (kg) 68 96.9 (18.1) 94.7 (17.0) −2.1 (3.6) <0.001 Systolic blood pressure (mmHg) 128 139.0 (18.1) 135.4 (17.2) −3.6 (17.0) 0.018 Note: Data are presented as mean (SD).",Non-OADS,/arxiv_data1/oa_pdf/1a/1f/dmso-9-337.PMC5096728.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/1a/e5/jmdh-9-565.PMC5096738.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/1a/e5/jmdh-9-565.PMC5096738.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Multidisciplinary Healthcare 2016:9 565–573Journal of Multidisciplinary Healthcare Dovepress submit your manuscript | www.dovepress.com Dovepress 565 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JMDH.S116340Roles and challenges of the multidisciplinary team  involved in prosthetic rehabilitation, in a rural  district in South Africa Liezel Ennion   Anthea Rhoda Department of Physiotherapy, Faculty  of Community and Health Sciences,  University of the Western Cape, Cape T own, South AfricaBackground: Major lower limb amputations result in a significant sense of loss, psychological  stress, and decrease in function and overall quality of life for the amputee.",Non-OADS,/arxiv_data1/oa_pdf/1a/e5/jmdh-9-565.PMC5096738.pdf
"2 Different health care  professionals are involved in the rehabilitation of any person with a disability, but most often physiotherapists are in charge of the physical rehabilitation process in developing Correspondence: Liezel Ennion  Department of Physiotherapy, Faculty of Community and Health Sciences, University of the Western Cape, Robert Sobukwe Road, Bellville 7535, Cape Town, South AfricaTel +27 21 959 2542Email liezel.ennion@gmail.comJournal name: Journal of Multidisciplinary Healthcare Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Ennion and RhodaRunning head recto: Roles and challenges of the rural multidisciplinary prosthetic teamDOI: http://dx.doi.org/10.2147/JMDH.S116340",Non-OADS,/arxiv_data1/oa_pdf/1a/e5/jmdh-9-565.PMC5096738.pdf
Available from:  http://www.oandp.org/publications/resident/pdf/DevelopingCountries.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1a/e5/jmdh-9-565.PMC5096738.pdf
"Journal of Multidisciplinary Healthcare 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-multidisciplinary-healthcare-journalThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/1a/e5/jmdh-9-565.PMC5096738.pdf
Visit http://www.dovepress.com/   testimonials.php to read real quotes from published authors.Dovepress 573 Roles and challenges of the rural multidisciplinary prosthetic team  9.,Non-OADS,/arxiv_data1/oa_pdf/1a/e5/jmdh-9-565.PMC5096738.pdf
Available from: http://www.gov.za/sites/www.gov.za/files/hrh_strategy_0.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1a/e5/jmdh-9-565.PMC5096738.pdf
DOI: http://dx.doi.org/10.4135/9781849208574 Online ISBN: 9781849208574.,Non-OADS,/arxiv_data1/oa_pdf/1a/e5/jmdh-9-565.PMC5096738.pdf
Available from: http://www.broadreachhealthcare.com/gh/wp-content/uploads/2014/04/Article_Official-visits-in-Ugu.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1a/e5/jmdh-9-565.PMC5096738.pdf
Available from:  http://www.kznhealth.gov.za/Mosvold/history.htm.,Non-OADS,/arxiv_data1/oa_pdf/1a/e5/jmdh-9-565.PMC5096738.pdf
Available from: http://www.rhap.org.za/wp-content/uploads/2015/02/2015-01-13-RHAP-Rural-Proofing-Guideline-A4-Email-1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/1a/e5/jmdh-9-565.PMC5096738.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9a/3c/ndt-12-2797.PMC5096739.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/9a/3c/ndt-12-2797.PMC5096739.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9a/3c/ndt-12-2797.PMC5096739.pdf
This article was found to have plagiarized the content of: Low-energy extracorporeal shock wave therapy promotes  vascular endothelial growth factor expression and improves Journal name: Neuropsychiatric Disease and Treatment Article Designation: Retraction Y ear: 2016 Volume: 12 Running head verso: Dove Medical Press Running head recto: Effect of low-energy extracorporeal shock wave on vascular regeneration  DOI: http://dx.doi.org/10.2147/NDT.S124094 locomotor recovery after spinal cord injury published in  the Journal of Neurosurgery in 2014 ( J Neurosurg .,Non-OADS,/arxiv_data1/oa_pdf/9a/3c/ndt-12-2797.PMC5096739.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/04/64/mder-9-377.PMC5096743.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/04/64/mder-9-377.PMC5096743.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Medical Devices: Evidence and Research 2016:9 377–382Medical Devices: Evidence and Research Dovepress submit your manuscript | www.dovepress.com Dovepress 377 ORiginal REsEaRch open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S116525 instrumental tactile diagnostics in   robot-assisted surgery Rozalia F solodova1,2 Vladimir V galatenko1,2 Eldar R nakashidze3 igor l andreytsev3 alexey V galatenko1 Dmitriy K senchik2 Vladimir M staroverov1 Vladimir E Podolskii1,2 Mikhail E sokolov1,2 Victor a sadovnichy1,2 1Faculty of Mechanics and  Mathematics, 2institute of  Mathematical studies of complex  systems, lomonosov Moscow state  University, 31st surgery Department,   clinical hospital 31, Moscow, RussiaBackground: Robotic surgery has gained wide acceptance due to minimizing trauma in patients.",Non-OADS,/arxiv_data1/oa_pdf/04/64/mder-9-377.PMC5096743.pdf
"A kinesthetic feedback is transmitted through instruments and related to force and positions of muscles and joints, while a tactile (or cutaneous) feedback is sensed by hands (in particular, fingers) and related to skin.correspondence: Rozalia F solodova 1-46 Leninskiye Gory, Office 145, GSP-1, Moscow 119991, RussiaTel +7 919 966 6152Fax +7 495 939 4536Email rozaliya@solodov.orgJournal name: Medical Devices: Evidence and Research Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Solodova et alRunning head recto: Instrumental tactile diagnostics in robot-assisted surgeryDOI: http://dx.doi.org/10.2147/MDER.S116525",Non-OADS,/arxiv_data1/oa_pdf/04/64/mder-9-377.PMC5096743.pdf
"Medical Devices: Evidence and Research 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/medical-devices-evidence-and-research-journalMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology, research, and expert opinion supporting the use and application of   medical devices in the diagnosis, monitoring, treatment and management of clinical conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/04/64/mder-9-377.PMC5096743.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8d/33/ott-9-6751.PMC5096744.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6751–6762OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6751Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11210 5 Minimally invasive esophagectomy versus  open esophagectomy for esophageal cancer:  a meta-analysis lu lv Weidong hu Yanchen ren Xiaoxuan Wei hubei Key laboratory of Tumor  Biological Behaviors, Department of  Thoracic Oncology, hubei cancer  clinical study center, Zhongnan  hospital of Wuhan University, Wuhan,   hubei, People’s republic of chinaBackground and objectives:  The safety and effectiveness of minimally invasive esophagec - tomy (MIE) in comparison with the open esophagectomy (OE) remain uncertain in esophageal  cancer treatment.",Non-OADS,/arxiv_data1/oa_pdf/8d/33/ott-9-6751.PMC5096744.pdf
"Guo et al4 had conducted a prospective randomized  study and their results indicated that MIE had some short-term benefits such as less  hemorrhage, better recovery, and fewer complications but no difference in long-term correspondence: Weidong hu hubei Key laboratory of Tumor  Biological Behaviors, Department  of Thoracic Oncology, Zhongnan  hospital of Wuhan University, 169  Donghu road, Wuhan 430071, hubei,  People’s republic of china Tel/fax +86 27 6781 2860 email wb0013340@whu.edu.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Lv et al Running head recto: MIE versus open esophagectomy DOI: http://dx.doi.org/10.2147/OTT.S112105",OADS,/arxiv_data1/oa_pdf/8d/33/ott-9-6751.PMC5096744.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/8d/33/ott-9-6751.PMC5096744.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/33/ott-9-6751.PMC5096744.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d6/db/ndt-12-2807.PMC5096745.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2807–2818Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2807Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S11154 3 Beliefs and perception about mental health issues:  a meta-synthesis Fahad Riaz Choudhry1 vasudevan Mani2 Long Chiau Ming3,4 Tahir Mehmood Khan5 1Psychology Department, Jeffrey  Cheah School of Medicine and  Health Sciences, Monash University  Malaysia, Sunway City, Selangor,   Malaysia; 2College of Pharmacy,   Qassim University, Buraidah,   Al-Qassim, Kingdom of Saudi Arabia;   3vector-borne Diseases Research  Group ( veRDi), Pharmaceutical  and Life Sciences CoRe, Universiti  T eknologi MARA, Shah Alam; 4Brain  Degeneration and Therapeutics  Group, Faculty of Pharmacy,   Universiti T eknologi MARA, Puncak  Alam, 5School of Pharmacy, Monash  University Malaysia, Sunway City,   Selangor, MalaysiaBackground:  Mental health literacy is the beliefs and knowledge about mental health issues  and their remedies.",Non-OADS,/arxiv_data1/oa_pdf/d6/db/ndt-12-2807.PMC5096745.pdf
"Mental health problems can affect one out of every four people during their  lives, by altering functioning, behavior, and thinking patterns.2 Attitudes and beliefs about mental illness are shaped by personal knowledge about  mental illness, knowing and interacting with someone living with mental illness, Correspondence: Tahir Mehmood Khan School of Pharmacy, Monash University  Malaysia, Sunway City, Selangor, Malaysia Tel +60 3 5514 4418 Fax +60 3 5514 6364 email tahir.mehmood@monash.ed u Journal name: Neuropsychiatric Disease and Treatment Article Designation: Review Y ear: 2016 Volume: 12 Running head verso: Choudhry et al Running head recto: Beliefs and perception about mental health issues DOI: http://dx.doi.org/10.2147/NDT.S111543",Non-OADS,/arxiv_data1/oa_pdf/d6/db/ndt-12-2807.PMC5096745.pdf
"Available from: http://psychology.about.com/od/psychology101/u/ psychology-theories.ht m. Accessed August 11, 2016.",Non-OADS,/arxiv_data1/oa_pdf/d6/db/ndt-12-2807.PMC5096745.pdf
Available from: http://brainblogger.com/2006/03/19/bps- theories-on-health-behaviors /.,Non-OADS,/arxiv_data1/oa_pdf/d6/db/ndt-12-2807.PMC5096745.pdf
"Available from: http://userpage.fu-berlin.de/ ~schuez/ folien/Sutton.pd f. Accessed August 11, 2016.",Non-OADS,/arxiv_data1/oa_pdf/d6/db/ndt-12-2807.PMC5096745.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/d6/db/ndt-12-2807.PMC5096745.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d6/db/ndt-12-2807.PMC5096745.pdf
"Available from: http://sites.tufts.edu/jha/ files/2011/04/a080.pd f. Accessed November 11, 2015.",OADS,/arxiv_data1/oa_pdf/d6/db/ndt-12-2807.PMC5096745.pdf
Available  from: https://www.sciencedaily.com/releases/2013/04/130425103200.,Non-OADS,/arxiv_data1/oa_pdf/d6/db/ndt-12-2807.PMC5096745.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/76/87/dddt-10-3529.PMC5096746.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3529–3543Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3529Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11829 7 Synthesis, anti-inflammatory, analgesic,  cOX1/2-inhibitory activity, and molecular  docking studies of hybrid pyrazole analogues Md Jahangir alam1 Ozair alam1 suroor ahmad Khan1 Mohd Javed naim1 Mohammad islamuddin2 girdhar singh Deora3 1Department of Pharmaceutical  chemistry, Faculty of Pharmacy,   2Parasite immunology laboratory,   Department of Biotechnology, Faculty  of science, Jamia hamdard, new Delhi,   3institute of life sciences, University  of hyderabad, hyderabad, indiaAbstract:  This article reports on the design, synthesis, and pharmacological activity of a new  series of hybrid pyrazole analogues: 5a–5u.",Non-OADS,/arxiv_data1/oa_pdf/76/87/dddt-10-3529.PMC5096746.pdf
"Keywords:  anti-inflammatory activity, analgesic activity, selective COX2 inhibition, TNF α  inhibition, molecular docking studies, pyrazole Introduction Nonsteroidal anti-inflammatory drugs (NSAIDs) are the most widely used therapeutic  agents for the management of pain and inflammation.1 NSAIDs exert their  pharmacological action by inhibiting COX enzymes, which catalyses the conversion  of arachidonic acid to prostaglandins, prostacyclins, and thromboxanes.2 Two differ - ent isoforms of COX exist (COX1 [constitutive] and COX2 [inducible]), which are  assumed to play a vital role in producing pathological and physiological prostaglandins,  respectively.3 Currently used NSAIDs employ their anti-inflammatory action mostly  by inhibition of both isoforms of COX.4–6 However, absence of selectivity and their  long-term clinical use leads to various adverse effects, such as gastric ulceration,  gastrointestinal bleeding, cardiovascular toxicity, and nephrotoxicity, which are mainly  associated with most of the reported nonselective NSAIDs, due to their inhibition of  COX1-mediated physiological prostaglandins.7–9 Similarly, NF κB also plays a key role  by activating the inflammatory response and releasing proinflammatory cytokines and  enzymes, such as TNF α, IL-1β, COX2, and iNOS.10,11 Improper regulation of NF κB correspondence: Ozair alam Department of Pharmaceutical  chemistry, room no 209, Faculty of  Pharmacy, Jamia hamdard, hamdard  nagar, near Batra hospital, new Delhi,  Delhi 110062, india Tel +91 11 2605 9681 Fax +91 11 2605 9666 email dr.ozairalam@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Alam et al Running head recto: Hybrid pyrazole analogues DOI: http://dx.doi.org/10.2147/DDDT.S118297",Non-OADS,/arxiv_data1/oa_pdf/76/87/dddt-10-3529.PMC5096746.pdf
"For this study, the crystal structures  of COX1 and COX2 enzyme complexes with a cocrystal  (http://www.pdb.or g) were selected as the protein target used  for the docking study.",OADS,/arxiv_data1/oa_pdf/76/87/dddt-10-3529.PMC5096746.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/76/87/dddt-10-3529.PMC5096746.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/76/87/dddt-10-3529.PMC5096746.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ce/bf/opth-10-2157.PMC5096747.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2157–2163Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2157Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10476 1analysis of the association between the LUM  rs3759223 variant and high myopia in a Japanese  population shintaro Okui1 akira Meguro1 Masaki Takeuchi1,2 Takahiro Yamane1 eiichi Okada3 Yasuhito iijima4 nobuhisa Mizuki1 1Department of Ophthalmology  and Visual science, Y okohama City  University graduate school of  Medicine, Y okohama, Kanagawa,   Japan; 2inflammatory Disease section,   national human genome research  institute, national institutes of health,   Bethesda, MD, Usa; 3Okada eye Clinic,   Y okohama, Kanagawa, Japan; 4aoto eye  Clinic, Y okohama, Kanagawa, JapanPurpose:  Many studies have investigated the relationship of the lumican gene ( LUM ) rs3759223  variant with the risk of high myopia, but the results have been inconsistent and inconclusive.",Non-OADS,/arxiv_data1/oa_pdf/ce/bf/opth-10-2157.PMC5096747.pdf
"The etiology of myopia remains uncertain, but it is thought that certain environ - mental factors, such as near work (reading, studying, and computer use), can trigger the  symptoms of myopia in individuals with a particular genetic background.3–6 Familial  linkage studies have reported 19 genetic loci for myopia to date (MYP1–MYP19),7,8  and recent genome-wide association studies have identified many important candidate  loci/genes that are implicated in myopia, refractive error, and/or AL elongation in  several ethnic populations.9–12Correspondence: akira Meguro Department of Ophthalmology and  Visual science, Yokohama City University  graduate school of Medicine, 3-9  Fukuura, Kanazawa-ku, Yokohama,  Kanagawa 236-0004, Japan Tel +81 45 787 2683 Fax +81 45 781 9755 email akmeguro@yokohama-cu.ac.j p Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Okui et al Running head recto: LUM  rs3759223 and high myopia DOI: http://dx.doi.org/10.2147/OPTH.S104761",Non-OADS,/arxiv_data1/oa_pdf/ce/bf/opth-10-2157.PMC5096747.pdf
"statistical analysis The SNP & Variation Suite 8.4.0 software (Golden Helix,  Inc., Bozeman, MT, USA, http://www.goldenhelix.co m) was  used to test for Hardy–Weinberg equilibrium (HWE) and to  perform allelic and genotypic association analyses.",OADS,/arxiv_data1/oa_pdf/ce/bf/opth-10-2157.PMC5096747.pdf
"The possibility of  publication bias was assessed by Egger’s regression test  using the CMA v3 software (Biostat, Englewood, NJ, USA,  https://www.meta-analysis.com/index.ph p).",OADS,/arxiv_data1/oa_pdf/ce/bf/opth-10-2157.PMC5096747.pdf
"Clinical Ophthalmology 2016:10submit your manuscript | www.dovepress.co m Dove press Dove press 2162Okui et al Table 5  genotype and allele frequencies of the LUM rs3759223 variant in East Asian populations (Phase 3) of the 1000 Genomes  Projecta Population Genotype   frequency, n (%)Allele  frequency, % TT CT CC T C Chinese Dai in Xishuangbanna, People’s Republic of China (CDX), n =93 41 (44.1) 42 (45.2) 10 (10.8) 66.7 33.3 Han Chinese in Beijing, People’s Republic of China (CHB), n =103 57 (55.3) 39 (37.9) 7 (6.8) 74.3 25.7 Southern Han Chinese, People’s Republic of China (CHS), n =105 50 (47.6) 45 (42.9) 10 (9.5) 69.0 31.0 Japanese in Tokyo, Japan (JPT), n =104 68 (65.4) 30 (28.8) 6 (5.8) 79.8 20.2 Kinh in ho Chi Minh City, Vietnam (KhV), n =99 48 (48.5) 46 (46.5) 5 (5.1) 71.7 28.3 Note:  aData reprinted with permission from Macmillan Publishers Ltd: Nature29 copyright 2015. available from: http://www.1000genomes.org / observed in this study.",Non-OADS,/arxiv_data1/oa_pdf/ce/bf/opth-10-2157.PMC5096747.pdf
Available from: http://www.1000genomes.org/.,OADS,/arxiv_data1/oa_pdf/ce/bf/opth-10-2157.PMC5096747.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/ce/bf/opth-10-2157.PMC5096747.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ce/bf/opth-10-2157.PMC5096747.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5f/61/opth-10-2165.PMC5096748.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2165–2170Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2165Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11565 6 amaurosis fugax: risk factors and prevalence  of significant carotid stenosis Pia Kvickström1 Bertil lindblom2,3 göran Bergström4,5 Madeleine Zetterberg2,3 1Department of Ophthalmology,   skaraborg hospital, skövde,   2Department of Clinical  neuroscience/Ophthalmology,   institute of neuroscience and  Physiology, The sahlgrenska academy  at University of gothenburg,   3Department of Ophthalmology,   sahlgrenska University hospital,   Mölndal, 4Department of Molecular  and Clinical Medicine, The sahlgrenska  academy at University of gothenburg,   5Department of Clinical Physiology,   sahlgrenska University hospital,   gothenburg, swedenPurpose:  The purpose of this study was to describe clinical characteristics and prevalence of  carotid stenosis in patients with amaurosis fugax (AF).",Non-OADS,/arxiv_data1/oa_pdf/5f/61/opth-10-2165.PMC5096748.pdf
"If the patient has a significant carotid stenosis, he or she may  be eligible for carotid endarterectomy, which is the most effective stroke prevention  method in symptomatic patients.7Correspondence: Madeleine Zetterberg Department of Clinical neuroscience/ Ophthalmology, The sahlgrenska  academy at University of gothenburg,  se-431 80 Mölndal, sweden Tel +46 31 343 32 55 Fax +46 31 41 29 04 email madeleine.zetterberg@gu.s e Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Kvickström et al Running head recto: Amaurosis fugax: risk factors and carotid stenosis DOI: http://dx.doi.org/10.2147/OPTH.S115656",Non-OADS,/arxiv_data1/oa_pdf/5f/61/opth-10-2165.PMC5096748.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/5f/61/opth-10-2165.PMC5096748.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5f/61/opth-10-2165.PMC5096748.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4d/dd/opth-10-2149.PMC5096749.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2149–2155Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2149Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11925 1 Preliminary analysis of the relationship between  serum lutein and zeaxanthin levels and macular  pigment optical density shigeto Fujimura1,2 Kohei Ueda1 Y oko nomura1 Yasuo Yanagi3,4 1Department of Ophthalmology,  University of Tokyo school of  Medicine, T okyo, 2Department of  Ophthalmology, Kanazawa University  school of Medicine, ishikawa, Japan;  3singapore eye research institute,  4Medical retina Department, singapore  national eye Centre, singaporePurpose:  To assess the relationship between combined serum lutein and zeaxanthin (L +Z)  concentration and macular pigment optical density (MPOD), and to investigate the effect of  L+Z+docosahexaenoic acid (DHA) dietary supplementation on the spatial distribution of  MPOD.",Non-OADS,/arxiv_data1/oa_pdf/4d/dd/opth-10-2149.PMC5096749.pdf
"Keywords:  fundus autofluorescence, supplement, spatial distribution Introduction The human eye contains a macular pigment concentrated at the center of the retina,  which is thought to protect the retinal photoreceptors and retinal pigment epithelium  (RPE) from photo-oxidative stress and optimize central vision by pre-receptoral filtra - tion of blue light.1 The macular pigment is composed of hydroxyl carotenoids lutein  (L), zeaxanthin (Z), and meso-zeaxanthin (MZ).2 L and Z are obtained from dietary  intake of certain fruits and vegetables, egg yolks, or supplements,3,4 whereas MZ is  converted from L. This conversion takes place in the retina.5 Docosahexaenoic acid  (DHA) is a phospholipid found within the membranes of the outer segments of the  retinal photoreceptors, and is considered to affect membrane permeability and fluidity,  as well as properties of the lipid phase.6 Dietary supplements containing hydroxyl caro - tenoids showed significantly positive effects on both macular pigment optical density  (MPOD) and visual function, and DHA was found to enhance the augmentation of  MPOD.7–9 Despite evidence that supplementation with L +Z successfully increases both  the L +Z serum concentration and MPOD,10,11 it is still being debated whether there is  an association between MPOD and serum L +Z.12–15 Some observational studies using Correspondence: shigeto Fujimura Kanazawa University, school of Medicine,  Department of Ophthalmology, 13-1  Takara-machi, Kanazawa, ishikawa,  920-8641, Japan Tel +81 76 265 2403 Fax +81 76 222 9660 email shigeto-tky@umin.ac.j p Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Fujimura et al Running head recto: Lutein and zeaxanthin levels and MPOD DOI: http://dx.doi.org/10.2147/OPTH.S119251",Non-OADS,/arxiv_data1/oa_pdf/4d/dd/opth-10-2149.PMC5096749.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/4d/dd/opth-10-2149.PMC5096749.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/dd/opth-10-2149.PMC5096749.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a5/7e/ott-9-6727.PMC5096750.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6727–6732OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6727Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10834 0 effect of VegF-c sirna and endostatin on ring  formation and proliferation of esophageal squamous  cell carcinoma lymphatic endothelial cells Yuping Zheng1–3,* Miaomiao sun4,* Jinyan chen1,2 lulu he1,2 na Zhao1,2 Kuisheng chen1,2 1Pathology Department, The First  affiliated hospital of Zhengzhou  University, 2henan Key laboratory  of T umor Pathology, 3Pathology  Department, The second hospital  of shandong University, Jinan,   4Pathology Department, henan  T umor hospital,  Zhengzhou,   People’s  republic of china *These authors contributed equally  to this workObjective:  To study the effects of vascular endothelial growth factor C small interfering RNA  and endostatin on esophageal squamous cell carcinoma-related ring formation in vitro and  proliferation of lymphatic endothelial cells.",Non-OADS,/arxiv_data1/oa_pdf/a5/7e/ott-9-6727.PMC5096750.pdf
"Down’s syndrome patients seem to be protected from diabetic correspondence: Kuisheng chen Pathology Department, First Affiliated  hospital of Zhengzhou University,  100 Kexue street, gaoxin District,  Zhengzhou 450052, henan, People’s  republic of china Tel +86 371 6778 3111 email kuishengchen2015@sina.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Zheng et al Running head recto: VEGF-C siRNA and endostatin effect on ESCC ring formation and proliferation DOI: http://dx.doi.org/10.2147/OTT.S108340",Non-OADS,/arxiv_data1/oa_pdf/a5/7e/ott-9-6727.PMC5096750.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a5/7e/ott-9-6727.PMC5096750.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a5/7e/ott-9-6727.PMC5096750.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p  and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/1e/c3/clep-8-655.PMC5096751.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Epidemiology 2016:8 655–660 (Thematic series on clinical quality databases in Denmark)Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  655REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S9950 9The Danish Quality Database for Cervical Cancer  Screening Carsten Rygaard Department of Pathology,   Copenhagen University Hospital  Hvidovre, Hvidovre, Denmark Correspondence: Carsten Rygaard   Department of Pathology, Copenhagen  University Hospital Hvidovre, Kettegård  Allé 30, 2650 Hvidovre, Denmark   T el + 45 2329 3633   Email rygaard1@hotmail.co mAim of database:  To monitor and improve the quality of the Danish national cervical cancer  screening program, an annual report is published, including nine quality indicators.",Non-OADS,/arxiv_data1/oa_pdf/1e/c3/clep-8-655.PMC5096751.pdf
"Available from http://www.ancr.n u. Accessed March 16, 1016.13",Non-OADS,/arxiv_data1/oa_pdf/1e/c3/clep-8-655.PMC5096751.pdf
"Available from: http://danskpatologi.dk/doc/ DSPAC_pdf/%C3%85rsrapport%20DKLS%202009_final.pd f. Accessed  January 14, 2016.",OADS,/arxiv_data1/oa_pdf/1e/c3/clep-8-655.PMC5096751.pdf
Available from: https://www.sundhed.dk/content/ cms/80/1880_aarsrapport-2010-livmoderhalskraeftscreening.pdf .,Non-OADS,/arxiv_data1/oa_pdf/1e/c3/clep-8-655.PMC5096751.pdf
"Available from: https://www.sundhed.dk/content/ cms/82/4682_dkls-%C3%A5rsrapport-2011-dfs-270612.pd f. Accessed  January 14, 2016.",Non-OADS,/arxiv_data1/oa_pdf/1e/c3/clep-8-655.PMC5096751.pdf
"Available from: https://www.sundhed.dk/content/cms/82/4682_dkls- %E5rsrapport-2012.pd f. Accessed January 14, 2016.",Non-OADS,/arxiv_data1/oa_pdf/1e/c3/clep-8-655.PMC5096751.pdf
"Available from: https://www.sundhed.dk/content/cms/82/4682_dkls- %C3%A5rsrapport-august_vers3-8_final.pd f. Accessed January 14,  2016.",Non-OADS,/arxiv_data1/oa_pdf/1e/c3/clep-8-655.PMC5096751.pdf
Available from: https://www.sundhed.dk/sundhedsfaglig/kvalitet/ kliniske-kvalitetsdatabaser/screening/livmoderhalskraeftscreening /.,Non-OADS,/arxiv_data1/oa_pdf/1e/c3/clep-8-655.PMC5096751.pdf
Available from: https://sundhedsstyrelsen.dk/da/sundhed/folkesundhed/ screeningsprogrammer/livmoderhalskraeftscreening #.,Non-OADS,/arxiv_data1/oa_pdf/1e/c3/clep-8-655.PMC5096751.pdf
"Available from http://www.ancr.n u.  Accessed March 16, 1016.",Non-OADS,/arxiv_data1/oa_pdf/1e/c3/clep-8-655.PMC5096751.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/1e/c3/clep-8-655.PMC5096751.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/97/c7/dddt-10-3519.PMC5096752.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3519–3528Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3519Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10958 9 Design, development, and characterization of  lipid nanocarriers-based epigallocatechin gallate  delivery system for preventive and therapeutic  supplementation iúri Frias ana rute neves Marina Pinheiro salette reis research Unit on applied Molecular  Biosciences, rede de Química e  Tecnologia, Departamento de  ciências Químicas, Faculdade de  Farmácia, Universidade do Porto,   Porto, PortugalAbstract:  Green tea is manufactured from the leaves of Camellia sinensis  and has been shown  to possess, among other properties, anticancer, antiobesity, antiatherosclerotic, antidiabetic,  antibacterial, and antiviral effects.",Non-OADS,/arxiv_data1/oa_pdf/97/c7/dddt-10-3519.PMC5096752.pdf
"Notwithstanding,  EGCG has an extremely low intestinal absorbance and a high degradation rate in the  gastrointestinal environment.4,5 In fact, the oral bioavailability of EGCG after drinking  tea containing catechins is only approximately 0.1% in humans, with a peak plasma  EGCG concentration of 0.15 μM after consumption of two cups of green tea.1 For  these reasons, the use of natural sources of EGCG in the dietary nutrition seems to be correspondence: Marina Pinheiro UciBiO, reQUiMTe, Departamento  de ciências Químicas, Faculdade de  Farmácia, Universidade do Porto, 228  rua de Jorge Viterbo Ferreira, 4050-313  Porto, Portugal email mpinheiro@ff.up.p t Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Frias et al Running head recto: Lipid nanocarriers-based EGCG design, development, and characterization  DOI: http://dx.doi.org/10.2147/DDDT.S109589",Non-OADS,/arxiv_data1/oa_pdf/97/c7/dddt-10-3519.PMC5096752.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/97/c7/dddt-10-3519.PMC5096752.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/97/c7/dddt-10-3519.PMC5096752.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/0a/33/ceor-8-657.PMC5096753.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/0a/33/ceor-8-657.PMC5096753.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).ClinicoEconomics and Outcomes Research 2016:8 657–666ClinicoEconomics and Outcomes Research Dovepress submit your manuscript | www.dovepress.com Dovepress  657 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEOR.S114921Economic impact of longer battery life of cardiac  resynchronization therapy defibrillators in Sweden Fredrik Gadler1  Yao Ding2  Nathalie Verin3  Martin Bergius4  Jeffrey D Miller5  Gregory M Lenhart5  Mason W Russell5 1Department of Cardiology,   Karolinska University Hospital,   Stockholm, Sweden; 2Truven  Health Analytics, an IBM Company,  Bethesda, MD, USA;  3Boston Scientific  Corporation, Hemel Hempstead,  Hertfordshire, UK;  4Boston Scientific  Nordic AB, Helsingborg, Sweden;   5Truven Health Analytics, an IBM  Company, Cambridge, MA, USAObjective: The objective of this study was to quantify the impact that longer battery life of  cardiac resynchronization therapy defibrillator (CRT -D) devices has on reducing the number  of device replacements and associated costs of these replacements from a Swedish health care  system perspective.",Non-OADS,/arxiv_data1/oa_pdf/0a/33/ceor-8-657.PMC5096753.pdf
"2 The total aggregate cost for patients  with HF in Sweden has been estimated in the range of SEK 5–6 billion.3 Implantable cardioverter defibrillator (ICD) devices, including implantable car - dioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators ( CRT -Ds), have become increasingly important in HF management over the past  several Correspondence: Jeffrey D Miller Truven Health Analytics, an IBM Company, 75 Binney Street, Cambridge, MA 02142, USA   Tel +1 978 760 3886   Email jeffrey.d.miller@truvenhealth.comJournal name: ClinicoEconomics and Outcomes Research Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Gadler et alRunning head recto: Economic impact of longer CRT -D battery life in SwedenDOI: http://dx.doi.org/10.2147/CEOR.S114921",Non-OADS,/arxiv_data1/oa_pdf/0a/33/ceor-8-657.PMC5096753.pdf
"22 These event-free battery survival data  were derived from the graph using Engauge Digitizer 5.1 (SourceForce.net, http://markummitchell.github.io/engauge- digitizer/), which is an open-source digitizing software for converting an image file of graphs into numbers (Table 1).",OADS,/arxiv_data1/oa_pdf/0a/33/ceor-8-657.PMC5096753.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs317/en/.,Non-OADS,/arxiv_data1/oa_pdf/0a/33/ceor-8-657.PMC5096753.pdf
Avail- able from: https://www.pacemakerregistret.se/icdpmr/docbankView.do?id=-er3_cQ----KFLbTVD0FrN7A.,Non-OADS,/arxiv_data1/oa_pdf/0a/33/ceor-8-657.PMC5096753.pdf
Available from: https://www.nice.org.uk/guidance/ta314/documents/arrythmias-icds-heart-failure-cardiac-resynchronisation-fad-document2.,Non-OADS,/arxiv_data1/oa_pdf/0a/33/ceor-8-657.PMC5096753.pdf
Available from: http://www.tlv.se/Upload/English/Guidelines-for-economic-evaluations-LFNAR-2003-2.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0a/33/ceor-8-657.PMC5096753.pdf
"ClinicoEconomics and Outcomes Research 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinicoeconomics-and-outcomes-research-journalClinicoEconomics and Outcomes Research is an international, peer- reviewed open-access journal focusing on health technology assess-ment, pharmacoeconomics and outcomes research in the areas of   diagnosis, medical devices, and clinical, surgical and pharmacological intervention.",Non-OADS,/arxiv_data1/oa_pdf/0a/33/ceor-8-657.PMC5096753.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 666 Gadler et al Supplementary material The probability of first replacement in year n (i.e., Pn with n ranging from 1 to 6 years) was calculated as an incremental  difference in battery failure rates (i.e., Fn - F(n - 1)).",OADS,/arxiv_data1/oa_pdf/0a/33/ceor-8-657.PMC5096753.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/64/3d/jpr-9-877.PMC5096754.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/64/3d/jpr-9-877.PMC5096754.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 877–886Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  877 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S117787Altered homotopic connectivity in postherpetic  neuralgia: a resting state fMRI study Jian Jiang1,* Lili Gu2,* Dan Bao2 Shunda Hong1 Wei He1 Y onming Tan1 Xianjun Zeng1 Honghan Gong1 Daying Zhang2 Fuqing Zhou1 1Department of Radiology,   2Department of Pain, The First  Affiliated Hospital, Nanchang  University, Nanchang, Jiangxi,    People’s Republic of China *These authors contributed equally to  this workObjective: The aim of this study was to explore interhemispheric intrinsic connectivity in  patients with postherpetic neuralgia (PHN).",Non-OADS,/arxiv_data1/oa_pdf/64/3d/jpr-9-877.PMC5096754.pdf
"1,2 PHN can exist with various neuropathic  signs that are associated with irreparable damage to the peripheral nervous system.2–4  Recently, several neuroimaging studies5–9 have explored possible alterations of struc- ture and functions in patients with PHN pain, including anatomical damage in the bilateral insula and superior temporal gyrus; 5 functional aberrant activation involved  in affective responses, sensory discrimination (the thalamus, primary and secondary somatosensory, insula, and anterior cingulated cortices), and emotion; 6,7 increased  functional connectivity of the bilateral putamen;7 and decreased local efficiency of the  putamen.8 Assessment of cerebral blood flow (CBF) in these regions has provided an Correspondence: Fuqing Zhou Department of Radiology, The First Affiliated Hospital, Nanchang University, 17 Yongwaizhen Street, Nanchang 330006, Jiangxi, People’s Republic of ChinaTel +86 791 8869 5132Email fq.chou@yahoo.comJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Jiang et alRunning head recto: Altered homotopic connectivity in postherpetic neuralgiaDOI: http://dx.doi.org/10.2147/JPR.S117787",Non-OADS,/arxiv_data1/oa_pdf/64/3d/jpr-9-877.PMC5096754.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/64/3d/jpr-9-877.PMC5096754.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 886 Jiang et al Supplementary materials Table S1 ROC analysis for differentiating patients from healthy subjects Reduced connectivity values in patients Area under the curve Cut-off point Sensitivity Specificity VMHC values in DLPFC 0.898 0.454a72.2% (13/18) 100% (18/18) VMHC values in PCUN/PCC 0.923 0.698 72.2% (13/18) 100% (18/18) iFC values between left PFC and bilateral MFG 0.883 0.356 72.2% (13/18) 94.4% (17/18) iFC values between left PFC and left MFG 0.824 0.409 77.8% (14/18) 72.2% (13/18) Notes: aUsing this cut-off point, the VMHC value of PFC could correctly classify 13 of 18 patients and 18 of 18 healthy subjects, resulting in a sensitivity of 72.2% and a  specificity of 100%.",Non-OADS,/arxiv_data1/oa_pdf/64/3d/jpr-9-877.PMC5096754.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/d8/a5/ceg-9-337.PMC5096755.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/d8/a5/ceg-9-337.PMC5096755.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical and Experimental Gastroenterology 2016:9 337–343Clinical and Experimental Gastroenterology Dovepress submit your manuscript | www.dovepress.com Dovepress  337 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEG.S114860Comparison of Glasgow-Blatchford score and  full Rockall score systems to predict clinical  outcomes in patients with upper gastrointestinal  bleeding Marjan Mokhtare Vida Bozorgi Shahram Agah Mehdi NikkhahAmirhossein FaghihiAmirhossein Boghratian Neda Shalbaf Abbas KhanlariHamidreza Seifmanesh Colorectal Research Center, Rasoul  Akram Hospital, T ehran, IranBackground: Various risk scoring systems have been recently developed to predict clinical  outcomes in patients with upper gastrointestinal bleeding (UGIB).",Non-OADS,/arxiv_data1/oa_pdf/d8/a5/ceg-9-337.PMC5096755.pdf
"6Correspondence: Marjan Mokhtare   Colorectal Research Center, Rasoul  Akram Hospital, Niayesh St, Shahrara, Tehran 1445613131, IranEmail marjanmokhtare@yahoo.comJournal name: Clinical and Experimental Gastroenterology Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Mokhtare et alRunning head recto: Comparison of Glasgow-Blatchford score and full Rockall scoreDOI: http://dx.doi.org/10.2147/CEG.S114860",Non-OADS,/arxiv_data1/oa_pdf/d8/a5/ceg-9-337.PMC5096755.pdf
"Clinical and Experimental Gastroenterology 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-and-experimental-gastroenterology-journalClinical and Experimental Gastroenterology is an international, peer- reviewed, open access, online journal publishing original research, reports, editorials, reviews and commentaries on all aspects of   gastroenterology in the clinic and laboratory.",Non-OADS,/arxiv_data1/oa_pdf/d8/a5/ceg-9-337.PMC5096755.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 343 Comparison of Glasgow-Blatchford score and full Rockall score,Non-OADS,/arxiv_data1/oa_pdf/d8/a5/ceg-9-337.PMC5096755.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/0f/3e/jpr-9-887.PMC5096756.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/0f/3e/jpr-9-887.PMC5096756.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research 2016:9 887–892Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  887 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S116483Performance, pain, and quality of life on use  of central venous catheter for management  of pericardial effusions in patients undergoing  coronary artery bypass graft surgery Kamran Ghods1 Mohammad Reza Razavi2 Mohammad Forozeshfard3 1Clinical Research Development  Unit (CRDU), Department of  Cardiovascular Surgery, Kowsar Hospital,  2Nursing Care Research  Center, 3Cancer Research Center,   Department of Anesthesiology,  Semnan University of Medical Sciences, Semnan, IranAbstract: Different pericardial catheters have been suggested as an effective alternative method  for drainage of pericardial effusion.",Non-OADS,/arxiv_data1/oa_pdf/0f/3e/jpr-9-887.PMC5096756.pdf
"6, 13 Alley, Abouzar Street, Moalem Square,   Semnan City, Semnan Province 250, IranTel/fax +98 23 3365 4177Email mff45@yahoo.comJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Ghods et alRunning head recto: CVC insertion – an effective method for pericardial effusion after CABGDOI: http://dx.doi.org/10.2147/JPR.S116483",Non-OADS,/arxiv_data1/oa_pdf/0f/3e/jpr-9-887.PMC5096756.pdf
"Journal of Pain Research 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/0f/3e/jpr-9-887.PMC5096756.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 892 Ghods et al Acknowledgment The authors would like to express their gratitude to the staff  of Kosar Hospital under supervision of Semnan University of Medical Sciences for their cooperation.,Non-OADS,/arxiv_data1/oa_pdf/0f/3e/jpr-9-887.PMC5096756.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/01/78/jpr-9-909.PMC5096757.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/01/78/jpr-9-909.PMC5096757.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 909–916Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  909 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S87952Management of moderate to severe chronic low  back pain with buprenorphine buccal film using  novel bioerodible mucoadhesive technology Joseph V Pergolizzi Jr1 Robert B Raffa2,3 Charles Fleischer1 Gianpietro Zampogna1 Robert Taylor Jr1 1NEMA Research, Naples, FL,   2University of Arizona College  of Pharmacy, T ucson, AZ, 3T emple  University School of Pharmacy,   Philadelphia, PA, USAAbstract: With a global prevalence of ~ 9%–12%, low back pain (LBP) is a serious public health  issue, associated with high costs for treatment and lost productivity.",Non-OADS,/arxiv_data1/oa_pdf/01/78/jpr-9-909.PMC5096757.pdf
"1 Global prevalence of LBP is estimated to  be ~9%–12%.1,3,5 The risk of LBP increases with age6 and is most prevalent among  persons between the ages of 40 years and 80 years.1 Most people (24%–80%) who  experience one episode of activity-limiting LBP experience recurrent LBP at 1 year.6Correspondence: Joseph V Pergolizzi 868 106th Ave North, Naples,   FL 34108, USAEmail jpjmd@msn.comJournal name: Journal of Pain Research  Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Pergolizzi et alRunning head recto: Chronic low back pain and BelbucaDOI: http://dx.doi.org/10.2147/JPR.S87952",Non-OADS,/arxiv_data1/oa_pdf/01/78/jpr-9-909.PMC5096757.pdf
Available from: http://www.drugs.com/pro/butrans-patch.html.,Non-OADS,/arxiv_data1/oa_pdf/01/78/jpr-9-909.PMC5096757.pdf
Available from: http://www.empr.com/news/belbuca-now-available-for-managing-severe-chronic-pain/article/478192/.,Non-OADS,/arxiv_data1/oa_pdf/01/78/jpr-9-909.PMC5096757.pdf
Available from: http://www.endo.com/File%20Library/Products/Prescribing%20Informa-tion/BELBUCA_prescribing_information.html.,Non-OADS,/arxiv_data1/oa_pdf/01/78/jpr-9-909.PMC5096757.pdf
Available from: http://app.purdueph-arma.com/xmlpublishing/pi.aspx?id=b.,OADS,/arxiv_data1/oa_pdf/01/78/jpr-9-909.PMC5096757.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/01/78/jpr-9-909.PMC5096757.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 916 Pergolizzi et al 53.,Non-OADS,/arxiv_data1/oa_pdf/01/78/jpr-9-909.PMC5096757.pdf
Available from: http://www.who.int/cancer/palliative/   painladder/en/.,Non-OADS,/arxiv_data1/oa_pdf/01/78/jpr-9-909.PMC5096757.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/40/fb/ott-9-6651.PMC5096758.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6651–6661OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6651Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9635 5 The medicinal fungus Antrodia cinnamomea   regulates Dna repair and enhances the  radiosensitivity of human esophageal cancer cells Yu-Ming liu1–3,* Yu-Kuo liu4,* ling-Wei Wang1,3 Yu-chuen huang5,6 Pin-i huang1,3 T ung-hu Tsai2 Yu-Jen chen2,7 1Department of Oncology, Division  of radiation Oncology, Taipei Veterans  general hospital, 2school of Medicine,   institute of Traditional Medicine,   national Yang Ming University, Taipei,   3school of Medicine, national Yang  Ming University, Taipei, 4Department  of chemical and Material engineering,   chang gung University, Taoyuan city,   5Department of Medical research,   china Medical University hospital,   6school of chinese Medicine, college  of chinese Medicine, china Medical  University, Taichung, 7Department of  radiation Oncology, MacKay Memorial  hospital, new Taipei city, Taiwan *These authors contributed equally  to this workAbstract:  This study investigated the adjunctive effects of Antrodia cinnamomea  mycelial  fermentation broth ( AC-MFB), a Taiwanese medicinal fungus, in enhancing the radiosensi - tivity of esophageal cancer cells.",Non-OADS,/arxiv_data1/oa_pdf/40/fb/ott-9-6651.PMC5096758.pdf
"Antrodia cinnamomea , also known as niu-chang-chih, Taiwanofungus camphorate ,  or Antrodia camphorata , is a medicinal fungus indigenous to Taiwan that grows on  decayed Cinnamomum kanehirai .5,6 A. cinnamomea  has been shown to exhibit anti - cancer properties,7–9 and many studies have attempted to determine its exact bioactive  compounds.10–12 For example, Chen et al has reported that the oral administration of  correspondence: Yu-Jen chen Department of radiation Oncology,  MacKay Memorial hospital, no 45,  Minsheng rd, Tamshui District, new  Taipei city 25160, Taiwan Tel +886 2 543 3535 Fax +886 2 809 6180 email chenmdphd@gmail.co m  Tung-hu Tsai school of Medicine, institute of  Traditional Medicine, national Yang Ming  University, no 155, sec 2, linong street,  Taipei 112, Taiwan email thtsai@ym.edu.t wJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Liu et al Running head recto: Antrodia cinnamomeaand  DNA repair DOI: http://dx.doi.org/10.2147/OTT.S96355",Non-OADS,/arxiv_data1/oa_pdf/40/fb/ott-9-6651.PMC5096758.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/40/fb/ott-9-6651.PMC5096758.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/40/fb/ott-9-6651.PMC5096758.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5c/7b/opth-10-2135.PMC5096759.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2135–2140Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2135Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11674 5 Efficacy of single bevacizumab injection as adjuvant  therapy to laser photocoagulation in macular  edema secondary to branch retinal vein occlusion arief s Kartasasmita siska Takarai astriviani switania sutarya enus Department of Ophthalmology,   Universitas Padjadjaran/Cicendo  national eye hospital, Bandung,   indonesiaBackground:  Macular grid laser photocoagulation remains the standard treatment for macular  edema secondary to branch retinal vein occlusion (BRVO).",Non-OADS,/arxiv_data1/oa_pdf/5c/7b/opth-10-2135.PMC5096759.pdf
"The Branch Vein Occlusion Study reported that the mean increase in visual Correspondence: arief s Kartasasmita Department of Ophthalmology,  Universitas Padjadjaran, Jl Cicendo No 4,  Bandung 40141, indonesia email a.kartasasmita@unpad.ac.i d Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Kartasasmita et al Running head recto: Efficacy of single bevacizumab injection as adjuvant therapy DOI: http://dx.doi.org/10.2147/OPTH.S116745",Non-OADS,/arxiv_data1/oa_pdf/5c/7b/opth-10-2135.PMC5096759.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/5c/7b/opth-10-2135.PMC5096759.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5c/7b/opth-10-2135.PMC5096759.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/79/55/ceg-9-345.PMC5096760.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/79/55/ceg-9-345.PMC5096760.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical and Experimental Gastroenterology 2016:9 345–350Clinical and Experimental Gastroenterology Dovepress submit your manuscript | www.dovepress.com Dovepress  345 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CEG.S99824Necrotizing pancreatitis: challenges and solutions Victoria A Bendersky1 Mohan K Mallipeddi2 Alexander Perez2 Theodore N Pappas2 1School of Medicine, 2Department of  Surgery, Duke University, Durham,   NC, USAAbstract:  Acute pancreatitis is a common disease that can progress to gland necrosis, which  imposes significant risk of morbidity and mortality.",Non-OADS,/arxiv_data1/oa_pdf/79/55/ceg-9-345.PMC5096760.pdf
"Notably, anti-inflammatory cytokines are also Correspondence: Theodore N Pappas Department of Surgery, Duke University, DUMC Box 3479, Durham, NC 27710, USATel +1 919 681 3442Fax +1 919 668 1826Email theodore.pappas@duke.edu  Journal name: Clinical and Experimental Gastroenterology Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: Bendersky et alRunning head recto: Necrotizing pancreatitisDOI: http://dx.doi.org/10.2147/CEG.S99824",Non-OADS,/arxiv_data1/oa_pdf/79/55/ceg-9-345.PMC5096760.pdf
"Clinical and Experimental Gastroenterology 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical and Experimental Gastroenterology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-and-experimental-gastroenterology-journalClinical and Experimental Gastroenterology is an international, peer- reviewed, open access, online journal publishing original research, reports, editorials, reviews and commentaries on all aspects of   gastroenterology in the clinic and laboratory.",Non-OADS,/arxiv_data1/oa_pdf/79/55/ceg-9-345.PMC5096760.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 350 Bendersky et al,Non-OADS,/arxiv_data1/oa_pdf/79/55/ceg-9-345.PMC5096760.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/0d/87/jpr-9-917.PMC5096761.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/0d/87/jpr-9-917.PMC5096761.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 917–924Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  917 ORIGINAL RESEARCH   open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S115847Clinical outcome following DIAM implantation  for symptomatic lumbar internal disk disruption:  a 3-year retrospective analysis Kang Lu1  Po-Chou Liliang1  Hao-Kuang Wang1  Jui-Sheng Chen1  T e-Yuan Chen1  Ruyi Huang2  Han-Jung Chen1,3 1Department of Neurosurgery, E-Da  Hospital, 2Department of Family  Medicine, E-Da Hospital, 3Department  of Neurosurgery, E-Da Cancer  Hospital, College of Medicine, I-Shou University, Kaohsiung, TaiwanBackground/objective: Internal disk disruption (IDD), an early event of lumbar disk degenera- tion, is the most common cause of low back pain.",Non-OADS,/arxiv_data1/oa_pdf/0d/87/jpr-9-917.PMC5096761.pdf
"4,5Correspondence: Kang Lu   Department of Neurosurgery, E-Da  Hospital, College of Medicine, I-Shou University, 1 Yida Road, Yanchau District, Kaohsiung 824, Taiwan   Tel +886 7 615 0011 Ext 2976   Email kanglu.1002@gmail.comJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCH Y ear: 2016V olume: 9Running head verso: Lu et alRunning head recto: DIAM for painful lumbar internal disk disruptionDOI: http://dx.doi.org/10.2147/JPR.S115847",Non-OADS,/arxiv_data1/oa_pdf/0d/87/jpr-9-917.PMC5096761.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/0d/87/jpr-9-917.PMC5096761.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 924 Lu et al 13.,Non-OADS,/arxiv_data1/oa_pdf/0d/87/jpr-9-917.PMC5096761.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/65/cb/ott-9-6719.PMC5096762.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6719–6726OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6719Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11138 2 high expression of muscarinic acetylcholine  receptor 3 predicts poor prognosis in patients  with pancreatic ductal adenocarcinoma lingfu Zhang1 Dianrong Xiu1 Jun Zhan2,3 Xiaokun he3 limei guo4,5 Jilian Wang1 Ming Tao1 Wei Fu1 hongquan Zhang2,3 1Department of general surgery,   Peking University Third hospital,   2Key laboratory of carcinogenesis  and Translational research, Ministry  of education, state Key laboratory  of natural and Biomimetic Drugs,   3laboratory of Molecular cell Biology  and Tumor Biology, Department of  anatomy, histology and embryology,   4Department of Pathology, Peking  University health science center,   5Department of Pathology, Peking  University Third hospital, Beijing,   People’s republic of chinaAims:  Recent studies showed that muscarinic acetylcholine receptor 3 (M3), as a muscarinic  acetylcholine receptor family member that plays an important role in normal physiological  function, is engaged in cancer progression.",Non-OADS,/arxiv_data1/oa_pdf/65/cb/ott-9-6719.PMC5096762.pdf
"The muscarinic acetylcholine receptors (mAChRs) contain a family of five related  G protein-coupled receptors (GPCRs, denoted as M1 to M5 and encoded by the genes  CHRM1  to CHRM5 ), belonging to the α-branch of class A GPCRs.2 The mAChRs  play an important role in human physiology, such as the regulation of heart rate,  smooth muscle contraction, glandular secretion and many central nervous system  fundamental functions.3 Currently, drugs targeting muscarinic receptors are applied  in the treatment of several pathophysiological conditions such as chronic obstructive  pulmonary disease, overactive bladder and Sjögren’s syndrome.3,4 Recent studies have demonstrated that overexpression of muscarinic acetylcholine  receptor 3 (M3) has been correlated with tumor progression and metastasis in certain  human colon cancer, gastric cancer and lung cancer.5–7 However, the role of M3 in correspondence: Dianrong Xiu Department of general surgery,  Peking University Third hospital, #49  huan-yuan north road, Beijing 100191,  People’s republic of china Tel +86 10 8226 7320 email xiudianrong@hotmail.co m  hongquan Zhang laboratory of Molecular cell Biology  and Tumor Biology, Department of  anatomy, histology and embryology,  Peking University health science center,  #38 Xue Yuan road, Beijing 100191,  People’s republic of china Tel +86 10 8280 2424 email hongquan.zhang@bjmu.edu.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Zhang et al Running head recto: Role of M3 in PDAC DOI: http://dx.doi.org/10.2147/OTT.S111382",Non-OADS,/arxiv_data1/oa_pdf/65/cb/ott-9-6719.PMC5096762.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/65/cb/ott-9-6719.PMC5096762.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/65/cb/ott-9-6719.PMC5096762.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/d6/af/cia-11-1539.PMC5096763.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1539–1543Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1539OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S12052 6 A prospective study about the preoperative total  blood loss in older people with hip fracture Jie-Zhou Wu1,2,* Peng-Cheng liu1,* Wei ge1,2 Ming Cai1 1Department of Orthopedics,   shanghai T enth People’s hospital,   T ongji University school of Medicine,   shanghai, 2The First Clinical Medical  College, nanjing Medical University,   nanjing, People’s republic of China *These authors contributed equally  to this workPurpose:  Our study is to confirm that hemoglobin (Hb) level is significantly reduced before  operation in elderly patients with hip fracture and to specify potential amounts of bleeding and  Hb decline in different types of fractures.",Non-OADS,/arxiv_data1/oa_pdf/d6/af/cia-11-1539.PMC5096763.pdf
"Our study is to confirm that Hb level Correspondence: Ming Cai Department of Orthopaedics, shanghai  Tenth People’s hospital, Tongji  University school of Medicine, no 301  Yanchang Middle road, Zhabei, shanghai  200072, People’s republic of China Tel +86 138 614 7208 email orthopedics_dsyy@163.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Wu et al Running head recto: Preoperative TBL in older people with hip fracture DOI: http://dx.doi.org/10.2147/CIA.S120526",Non-OADS,/arxiv_data1/oa_pdf/d6/af/cia-11-1539.PMC5096763.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/d6/af/cia-11-1539.PMC5096763.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/d6/af/cia-11-1539.PMC5096763.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a4/99/ott-9-6763.PMC5096767.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6763–6773OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6763Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11745 3 The association, clinicopathological significance,  and diagnostic value of CDH1  promoter  methylation in head and neck squamous cell  carcinoma: a meta-analysis of 23 studies Zhisen shen1 chongchang Zhou1,2 Jinyun li2 hongxia Deng1 Qun li1 Jian Wang3 1Department of Otorhinolaryngology- head and neck surgery, lihuili  hospital, ningbo University,   2Department of Biochemistry and  Molecular Biology, Medical school of  ningbo University, 3Department of  Otorhinolaryngology- head and neck  surgery, ningbo Yinzhou People’s  hospital, ningbo, Zhejiang, People’s  republic of chinaAbstract:  Epithelial cadherin (encoded by the CDH1  gene) is a tumor suppressor  glycoprotein that plays a role in the invasion and metastasis of human cancers.",Non-OADS,/arxiv_data1/oa_pdf/a4/99/ott-9-6763.PMC5096767.pdf
"There are many unknown mechanisms in the etiology and pathogenesis of HNSCC,  but the role of alcohol consumption and smoking, as well as infection with high-risk  subtypes of human papillomavirus are now known risk factors for HNSCC.11,12 Genetic  and epigenetic factors are also involved in the initiation and progression of HNSCC.13,14  More recently, there has been increasing evidence in the published literature that correspondence: Zhisen shen Department of Otorhinolaryngology- head and neck surgery, lihuili hospital  of ningbo University, 57 Xingning road,  ningbo, Zhejiang 315040, People’s  republic of china Tel +86 574 139 0668 7216 Fax +86 574 8739 2232 email szs7216@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Shen et al Running head recto: CDH1  methylation in head and neck squamous cell carcinoma DOI: http://dx.doi.org/10.2147/OTT.S117453",Non-OADS,/arxiv_data1/oa_pdf/a4/99/ott-9-6763.PMC5096767.pdf
"The publication bias was exhibited by the funnel  plot and assessed by Begg’s linear regression test.35 The Fail  safe number (Nfs) was calculated to estimate the influence  of publication bias to our conclusion by the Meta package  in R (version 3.22, http://www.r-project.org /).",Non-OADS,/arxiv_data1/oa_pdf/a4/99/ott-9-6763.PMC5096767.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a4/99/ott-9-6763.PMC5096767.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a4/99/ott-9-6763.PMC5096767.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/db/db/jpr-9-871.PMC5096768.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/db/db/jpr-9-871.PMC5096768.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 871–875Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  871 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S114959Sedation with a remifentanil infusion to facilitate  rapid awakening and tracheal extubation in an  infant with a potentially compromised airway Jeffrey Naples1,2 Mark W Hall1,2 Joseph D T obias3,4 1Department of Pediatrics, The Ohio  State University, 2Division of Pediatric  Critical Care Medicine, Nationwide  Children’s Hospital, 3Department of  Anesthesiology and Pain Medicine,  Nationwide Children’s Hospital,   4Department of Anesthesiology  and Pain Medicine, The Ohio State University, Columbus, OH, USAAbstract: Sedation is generally required during endotracheal intubation and mechanical   ventilation in infants and children.",Non-OADS,/arxiv_data1/oa_pdf/db/db/jpr-9-871.PMC5096768.pdf
"The ultrashort-acting synthetic opioid, remifentanil, was used to provide sedation and yet allow for rapid awakening without concerns of  Correspondence: Jeffrey C Naples Department of Pediatrics, Nationwide Children’s Hospital, 700 Children’s Drive, Columbus, OH 43205, USATel +1 614 722 3436Email Jeffrey.Naples@nationwidechildrens.orgJournal name: Journal of Pain Research  Article Designation: CASE REPORTY ear: 2016V olume: 9Running head verso: Naples et alRunning head recto: Remifentanil sedation for awakening and tracheal extubation in infantsDOI: http://dx.doi.org/10.2147/JPR.S114959",Non-OADS,/arxiv_data1/oa_pdf/db/db/jpr-9-871.PMC5096768.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/db/db/jpr-9-871.PMC5096768.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 875 Remifentanil sedation for awakening and tracheal extubation in infants  20.,Non-OADS,/arxiv_data1/oa_pdf/db/db/jpr-9-871.PMC5096768.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/08/ac/jpr-9-925.PMC5096769.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/08/ac/jpr-9-925.PMC5096769.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 925–931Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  925 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S115003Pain-related fear and functional recovery in  sciatica: results from a 2-year observational study AJ Haugen1  L Grøvle1  JI Brox2  B Natvig3  M Grotle4 1Department of Rheumatology,   Østfold Hospital Trust, Grålum,   2Department of Physical Medicine  and Rehabilitation, Division for  Neuroscience, Oslo University Hospital,  3Department of General  Practice, Institute of Health and Society, University of Oslo,   4FORMI (Communication Unit for  Musculoskeletal Disorders), Division of Neuroscience, Oslo University Hospital, Oslo, NorwayObjectives : The purpose of this study was to explore the associations between pain-related  fear, pain disability, and self-perceived recovery among patients with sciatica and disk hernia- tion followed up for 2 years.",Non-OADS,/arxiv_data1/oa_pdf/08/ac/jpr-9-925.PMC5096769.pdf
"3 Little attention has been given to what happens to pain-related fear in patients  who recover from pain disability.Correspondence: AJ Haugen   Department of Rheumatology, Sykehuset  Østfold, Postboks 300, 1714 Grålum, Norway   Tel +47 9119 3452 Fax +47 6986 6401 Email annhau@so-hf.noJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Haugen et alRunning head recto: Change of pain-related fearDOI: http://dx.doi.org/10.2147/JPR.S115003",Non-OADS,/arxiv_data1/oa_pdf/08/ac/jpr-9-925.PMC5096769.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/08/ac/jpr-9-925.PMC5096769.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 931 Change of pain-related fear  7.,Non-OADS,/arxiv_data1/oa_pdf/08/ac/jpr-9-925.PMC5096769.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/34/92/ijnrd-9-263.PMC5096770.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/34/92/ijnrd-9-263.PMC5096770.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of Nephrology and Renovascular Disease 2016:9 263–272International Journal of Nephrology and Renovascular Disease Dovepress submit your manuscript | www.dovepress.com Dovepress 263 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJNRD.S121548 Psychosocial predictors of nonadherence to  medical management among patients on  maintenance dialysis Fahad Dakheel Alosaimi1 Mohammed Asiri2 Saleh Alsuwayt2 Tariq Alotaibi2  Mohammed Bin Mugren2  Abdulmalik Almufarrih2 Saad Almodameg2 1Department of Psychiatry, King  Saud University, Riyadh, Saudi Arabia;   2College of Medicine, King Saud  University, Riyadh, Saudi ArabiaBackground: A number of reports suggest a link between depression and nonadherence  to recommended management for end-stage renal disease (ESRD) patients on maintenance  dialysis.",Non-OADS,/arxiv_data1/oa_pdf/34/92/ijnrd-9-263.PMC5096770.pdf
"4Correspondence: Fahad Dakheel Alosaimi Department of Psychiatry, #55 King Saud University Medical City, King Saud University, PO Box 7805, Riyadh 11472, Kingdom of Saudi ArabiaTel +966 1467 1226Fax +966 1467 2571Email dr.fahad.alosaimi@gmail.comJournal name: International Journal of Nephrology and Renovascular Disease Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Alosaimi et alRunning head recto: Psychosocial Factors and Hemodialysis NonadherenceDOI: http://dx.doi.org/10.2147/IJNRD.S121548",Non-OADS,/arxiv_data1/oa_pdf/34/92/ijnrd-9-263.PMC5096770.pdf
Available from: http://www.sjkdt.org/text.asp 2012/23/4/881/98196.,Non-OADS,/arxiv_data1/oa_pdf/34/92/ijnrd-9-263.PMC5096770.pdf
"International Journal of Nephrology and Renovascular Disease 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journalThe International Journal of Nephrology and Renovascular Disease is   an international, peer-reviewed open access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/34/92/ijnrd-9-263.PMC5096770.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published   authors.Dovepress 272 Alosaimi et al,Non-OADS,/arxiv_data1/oa_pdf/34/92/ijnrd-9-263.PMC5096770.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/cf/af/ott-9-6733.PMC5096771.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6733–6739OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6733Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S9982 6 A current perspective on stereotactic body  radiation therapy for pancreatic cancer Julian C Hong Brian G Czito Christopher G willett Manisha Palta Department of Radiation Oncology,   Duke University, Durham, NC, USAAbstract:  Pancreatic cancer is a formidable malignancy with poor outcomes.",Non-OADS,/arxiv_data1/oa_pdf/cf/af/ott-9-6733.PMC5096771.pdf
"Moreover, patients with even limited metastatic disease  burden in this study often died due to progressive local disease.Correspondence: Manisha Palta Department of Radiation Oncology,  Duke University, Box 3085, Durham,  NC 27705, USA Tel +919 668 5640 Fax +919 668 7345 email manisha.palta@duke.ed u Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2016 Volume: 9 Running head verso: Hong et al Running head recto: SBRT for pancreatic cancer DOI: http://dx.doi.org/10.2147/OTT.S99826",Non-OADS,/arxiv_data1/oa_pdf/cf/af/ott-9-6733.PMC5096771.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/cf/af/ott-9-6733.PMC5096771.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/cf/af/ott-9-6733.PMC5096771.pdf
Available from: https://clinicaltrials.gov/ct2/show/ NCT01921751.,Non-OADS,/arxiv_data1/oa_pdf/cf/af/ott-9-6733.PMC5096771.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT02347618.,Non-OADS,/arxiv_data1/oa_pdf/cf/af/ott-9-6733.PMC5096771.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT01357525.,Non-OADS,/arxiv_data1/oa_pdf/cf/af/ott-9-6733.PMC5096771.pdf
Available from: https://clinicaltrials.gov/ ct2/show/NCT01992705.,Non-OADS,/arxiv_data1/oa_pdf/cf/af/ott-9-6733.PMC5096771.pdf
Available from: https://clinicaltrials.gov/ct2/show/ NCT01446458.,Non-OADS,/arxiv_data1/oa_pdf/cf/af/ott-9-6733.PMC5096771.pdf
Available from: https://clinicaltrials.gov/ct2/ show/NCT02318095.,Non-OADS,/arxiv_data1/oa_pdf/cf/af/ott-9-6733.PMC5096771.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/92/e1/ppa-10-2197.PMC5096772.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 2197–2207Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  2197OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11997 3 Association between addressing antiseizure drug  side effects and patient-reported medication  adherence in epilepsy lidia M V r Moura1 Thiago s carneiro1 Andrew J cole1 John hsu2,3 Barbara g Vickrey4 Daniel B hoch1 1Department of n eurology,   2Mongan institute for health  Policy, Department of Medicine,   Massachusetts general hospital,   3Department of health care Policy,   harvard Medical school, Boston, MA,   4Department of neurology, icahn  school of Medicine at Mount sinai,   new Y ork, nY, UsABackground and aim:  Adherence to treatment is a critical component of epilepsy management.",Non-OADS,/arxiv_data1/oa_pdf/92/e1/ppa-10-2197.PMC5096772.pdf
"Many investigators have attempted to capture medication adherence disparities  within epilepsy populations using various acquisition methods.27–30 The most correspondence: lidia M V r Moura Department of neurology, Massachusetts  general hospital, 55 Fruit street, Wang  739D, Boston, MA 02114, UsA Tel +1 617 726 3311 Fax +1 617 726 9250 email lidia.moura@mgh.harvard.ed u Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Moura et al Running head recto: Association between addressing AED side effects and medication adherence DOI: http://dx.doi.org/10.2147/PPA.S119973",Non-OADS,/arxiv_data1/oa_pdf/92/e1/ppa-10-2197.PMC5096772.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/92/e1/ppa-10-2197.PMC5096772.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3d/69/ijn-11-5683.PMC5096773.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 5683–5696International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5683OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11285 7 Biogenesis of silver nanoparticles using endophytic  fungus Pestalotiopsis microspora  and evaluation of  their antioxidant and anticancer activities Vasudeva reddy Netala1 Murali satyanarayana  Bethu2,3 Bobbu Pushpalatha1 Vijaya Bhaskar Baki4 sani aishwarya1 J Venkateswara rao2 Vijaya Tartte5 1Department of Biotechnology, sri  Venkateswara University, Tirupati,   2Biology Division, Indian Institute  of chemical T echnology, hyderabad,   3academy of scientific and Innovative  research, New Delhi, 4Department  of Bioinformatics, 5Department of  Botany, sri Venkateswara University,   Tirupati, IndiaAbstract:  An endophytic fungal strain isolated from the leaves of Gymnema sylvestre  was  identified as Pestalotiopsis microspora  VJ1/VS1 based on nucleotide sequencing of internal  transcribed spacer region (ITS 1-5.8S-ITS 2) of 18S rRNA gene (NCBI accession number  KX213894).",Non-OADS,/arxiv_data1/oa_pdf/3d/69/ijn-11-5683.PMC5096773.pdf
"Owing to their large surface-to-volume ratio,  spatial confinement, surface energy, and reduced imperfections, metallic nanoparticles  especially silver nanoparticles (AgNPs) possess unique physicochemical properties correspondence: Vijaya Tartte Department of Botany, sri Venkateswara  University, Tirupati, andhra Pradesh –  517502, India email tvijayasvu@yahoo.co mJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Netala et al Running head recto: Biogenesis of AgNPs and their antioxidant and anticancer activities DOI: http://dx.doi.org/10.2147/IJN.S112857",Non-OADS,/arxiv_data1/oa_pdf/3d/69/ijn-11-5683.PMC5096773.pdf
Homology search of the  sequences obtained was carried out using BLASTn at NCBI  GenBank ( http://www.ncbi.nlm.nih.go v).,OADS,/arxiv_data1/oa_pdf/3d/69/ijn-11-5683.PMC5096773.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/3d/69/ijn-11-5683.PMC5096773.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3d/69/ijn-11-5683.PMC5096773.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b9/04/cia-11-1551.PMC5096774.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1551–1558Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1551OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S10911 4 response to depression treatment in the Aging  Brain Care Medical home model Michael A laMantia1–4 Anthony J Perkins5,6 sujuan gao2,7 Mary g Austrom8,9 Cathy A Alder10 Dustin D French11,12 Debra K litzelman2,3,13 Ann h Cottingham3 Malaz A Boustani1–3,5 1Indiana University Center for Aging  research, 2regenstrief Institute, Inc.,   3Department of Medicine, Indiana  University school of Medicine,   Indianapolis, In , 4Department of  Medicine, University of Vermont  College of Medicine, Burlington,   VT, 5Indiana University Center for  health Innovation and Implementation  science, 6Indiana Clinical and  Translational sciences Institute,   7Department of Biostatistics, Indiana  University school of Medicine,   8Department of Psychiatry, Indiana  University school of Medicine, 9Indiana  University Alzheimer’s Disease Center,   10eskenazi health, Indianapolis, In ,   11Department of Ophthalmology,   Feinberg school of Medicine,   northwestern University, 12Veterans  Affairs health services research and  Development service, Chicago, Il,   13Indiana University Center for health  services and Outcomes research,   Indianapolis, In , UsAObjective:  To evaluate the effect of the Aging Brain Care (ABC) Medical Home program’s  depression module on patients’ depression severity measurement over time.",Non-OADS,/arxiv_data1/oa_pdf/b9/04/cia-11-1551.PMC5096774.pdf
"However, psychiatrists with specialized training in geriatric mental health to treat  these older adults are in short supply.7 Indeed, the majority of mental health care in the  USA is provided not by mental health professionals but by general medical care provid - ers and is considered inadequate.8 Interventions that support primary care physicians in Correspondence: Michael A laMantia Department of Medicine, robert larner,  MD College of Medicine, University  of Vermont, 89 Beaumont Avenue,  given Courtyard, 4th Floor, Burlington,  VT 05405, UsA Tel +1 802 656 4560 Fax +1 802 656 4576 email michael.lamantia@uvmhealth.or gJournal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: LaMantia et al Running head recto: Depression response in older adults DOI: http://dx.doi.org/10.2147/CIA.S109114",Non-OADS,/arxiv_data1/oa_pdf/b9/04/cia-11-1551.PMC5096774.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/b9/04/cia-11-1551.PMC5096774.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/b9/04/cia-11-1551.PMC5096774.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/23/76/dddt-10-3509.PMC5096775.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3509–3517Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3509Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11445 5 supratherapeutic dose evaluation and effect of  lesinurad on cardiac repolarization: a thorough  QT/QTc study Zancong shen1 Michael gillen2 Kathy Tieu1 Mai nguyen1 erin harmon1 David M Wilson1 Bradley Kerr1 caroline a lee1 1ardea Biosciences, inc., san Diego,   ca, 2astraZeneca lP , gaithersburg,   MD, UsaIntroduction:  Lesinurad is a selective uric acid reabsorption inhibitor approved in the United  States and Europe for treatment of gout in combination with a xanthine oxidase inhibitor.",Non-OADS,/arxiv_data1/oa_pdf/23/76/dddt-10-3509.PMC5096775.pdf
"Gout requires chronic lifestyle management and pharmacological treatment to  maintain effective control of sUA levels.4–6 Given that patients with gout will need correspondence: Zancong shen Translational sciences, ardea Biosciences,  inc., 9390 Towne centre Drive,  san Diego, ca, Usa Tel +1 858 652 6623 email zshen@ardeabio.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Shen et al Running head recto: Lesinurad TQT study DOI: http://dx.doi.org/10.2147/DDDT.S114455",Non-OADS,/arxiv_data1/oa_pdf/23/76/dddt-10-3509.PMC5096775.pdf
"Available from: http://www.ich.org/products/guidelines/ efficacy/article/efficacyguideline s. Accessed April 4, 2016.",Non-OADS,/arxiv_data1/oa_pdf/23/76/dddt-10-3509.PMC5096775.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/23/76/dddt-10-3509.PMC5096775.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/23/76/dddt-10-3509.PMC5096775.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/30/2c/ndt-12-2799.PMC5096776.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2799–2806Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2799OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11812 9 Psychometric properties of the self-rating  organization scale with adult samples T oshinobu Takeda1 Yui Tsuji2 Mizuho ando3 1Department of clinical Psychology,   ryukoku University, Kyoto, 2school of  Psychological science, health sciences  University of hokkaido, sapporo,   3graduate school of comprehensive  human sciences, University  of Tsukuba, Tsukuba, JapanAbstract:  Organization skills are defined broadly to include both materials and temporal  features.",Non-OADS,/arxiv_data1/oa_pdf/30/2c/ndt-12-2799.PMC5096776.pdf
"For example, correspondence: Toshinobu Takeda Department of clinical Psychology,  ryukoku University, 125-1 Daiku-cho,  higashi-hairu Omiya, shimogyo-ku,  Kyoto, Japan Tel +81 415 706 1719 Fax +81 75 343 4302 email t-tak@umin.ac.j p Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Takeda et al Running head recto: Psychometric properties of the self-rating organization scale DOI: http://dx.doi.org/10.2147/NDT.S118129",Non-OADS,/arxiv_data1/oa_pdf/30/2c/ndt-12-2799.PMC5096776.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/30/2c/ndt-12-2799.PMC5096776.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/30/2c/ndt-12-2799.PMC5096776.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/5f/0b/dmso-9-355.PMC5096777.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/5f/0b/dmso-9-355.PMC5096777.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016:9 355–369Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 355 REVIEW open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S109216 Practical combination therapy based on  pathophysiology of type 2 diabetes Philip A Levin MODEL Clinical Research,   Endocrinology, Department of Medicine, Greater Baltimore Medical Center, Baltimore, MD, USAAbstract:  Type 2 diabetes is a complex, chronic, and progressive condition that often neces- sitates the use of multiple medications to achieve glycemic goals.",Non-OADS,/arxiv_data1/oa_pdf/5f/0b/dmso-9-355.PMC5096777.pdf
"6 A retrospective cohort study in patients with T2D and glycated hemoglobin Correspondence: Philip A Levin MODEL Clinical Research, Greater Baltimore Medical Center, 6535 N Charles Street, Suite 400 N, Baltimore, MD 21204, USATel +1 410 828 7417Email pal3420@yahoo.comJournal name: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Article Designation: REVIEWY ear: 2016V olume: 9Running head verso: LevinRunning head recto: Combination therapy in type 2 diabetesDOI: http://dx.doi.org/10.2147/DMSO.S109216",Non-OADS,/arxiv_data1/oa_pdf/5f/0b/dmso-9-355.PMC5096777.pdf
Available from: http://www.idf.org/diabetesatlas/5e/the-global-burden.,Non-OADS,/arxiv_data1/oa_pdf/5f/0b/dmso-9-355.PMC5096777.pdf
Available from: http://www.news.sanofi.us/2014-06-14-Sanofi-Reports-Positive-Phase-3-Results-for-Toujeo-insulin-glargine-rDNA-origin-injection-300-U-mL.,Non-OADS,/arxiv_data1/oa_pdf/5f/0b/dmso-9-355.PMC5096777.pdf
Available from: http://professional.diabetes.org/ResourcesForProfessionals.aspx?cid=91777&loc=dorg-statistics.,Non-OADS,/arxiv_data1/oa_pdf/5f/0b/dmso-9-355.PMC5096777.pdf
Available from: http://www.fda.gov/Drugs/DrugSafety/ucm475463.htm.,Non-OADS,/arxiv_data1/oa_pdf/5f/0b/dmso-9-355.PMC5096777.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journal Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to   the rapid publication of the latest laboratory and clinical findings   in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/5f/0b/dmso-9-355.PMC5096777.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 369 Combination therapy in type 2 diabetes  134.,Non-OADS,/arxiv_data1/oa_pdf/5f/0b/dmso-9-355.PMC5096777.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT01897532?term= NCT01897532&rank= 1.,Non-OADS,/arxiv_data1/oa_pdf/5f/0b/dmso-9-355.PMC5096777.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT01730534?term= declare&r ank=2.,Non-OADS,/arxiv_data1/oa_pdf/5f/0b/dmso-9-355.PMC5096777.pdf
Available from: http://www.diabetes.org/newsroom/press-releases/2015/elixa.html?referrer= http://google.diabetes.org/search?site= Diabetes&client =diabetes&entqr= 3&oe= ISO-8859-1&ie= ISO-8859-1&ud= 1&proxys tylesheet =diabetes&output =xml_no_dtd&proxyreload =1&q=ELIXA.,Non-OADS,/arxiv_data1/oa_pdf/5f/0b/dmso-9-355.PMC5096777.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/ef/03/jpr-9-899.PMC5096778.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/ef/03/jpr-9-899.PMC5096778.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 899–907Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  899 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S116968A double-blind, randomized, placebo-controlled  pilot trial to determine the efficacy and safety   of ibudilast, a potential glial attenuator,   in chronic migraine Yuen H Kwok1  James E Swift1  Parisa Gazerani2  Paul Rolan1 1Discipline of Pharmacology,   University of Adelaide, Level 5  Medical School North, South Australia, Australia;  2Department of  Health Science & T echnology, Aalborg University, Aalborg, Denmark Background: Chronic migraine (CM) is problematic, and there are few effective treatments.",Non-OADS,/arxiv_data1/oa_pdf/ef/03/jpr-9-899.PMC5096778.pdf
"5 However, when glia are activated, they become immunoresponsive  and modulate pain by releasing neuroexcitatory signals that can increase neuronal excitability, 6,7 activate neighboring glia, and produce nociceptive mediators (such as Correspondence: Paul Rolan Discipline of Pharmacology, University of Adelaide, Level 5 Medical School North, Frome Road, South Australia, 5005, AustraliaTel +61 405 670 420Email paul.rolan@adelaide.edu.au Journal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Kwok et alRunning head recto: Ibudilast in chronic migraineDOI: http://dx.doi.org/10.2147/JPR.S116968",Non-OADS,/arxiv_data1/oa_pdf/ef/03/jpr-9-899.PMC5096778.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/ef/03/jpr-9-899.PMC5096778.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 907 Ibudilast in chronic migraine 24.,Non-OADS,/arxiv_data1/oa_pdf/ef/03/jpr-9-899.PMC5096778.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/28/84/ott-9-6711.PMC5096779.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6711–6718OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6711Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11475 6 elevated haBP1 protein expression correlates  with progression and poor survival in patients  with gastric cancer hongyu gao1 Qiang Yao1 Xiuwen lan1 sen li1 Junlong Wu2 guangchun Zeng2 Yingwei Xue1 1Department of gastroenterologic  surgery, 2Department of Pathology,   The affiliated T umor hospital, harbin  Medical University, harbin, People’s  republic of chinaBackground:  Hyaluronic acid-binding protein 1 (HABP1/gC1qR/p32) has been recently  implicated in oncogenesis and cancer progression in various malignancies; however, its clinical  role in gastric cancer (GC) is still unclear.",Non-OADS,/arxiv_data1/oa_pdf/28/84/ott-9-6711.PMC5096779.pdf
"Hyaluronic acid-binding protein 1 (HABP1/gC1qR/p32), which is localized in  human chromosome 17p13.3, is expressed ubiquitously in different rat tissues and is  present in eukaryotic species from yeast to humans.6 It was first detected in human correspondence: Yingwei Xue Department of gastroenterologic  Surgery, The Affiliated Tumor Hospital,  harbin Medical University, 150 haping  road, harbin 150081, People’s republic  of china Tel/fax +86 451 8629 8303 email xyw_801@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Gao et al Running head recto: Elevated HABP1 protein expression DOI: http://dx.doi.org/10.2147/OTT.S114756",Non-OADS,/arxiv_data1/oa_pdf/28/84/ott-9-6711.PMC5096779.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/28/84/ott-9-6711.PMC5096779.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/28/84/ott-9-6711.PMC5096779.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/af/15/cia-11-1559.PMC5096780.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1559–1565Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1559OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S11637 6 Behavioral emergency in the elderly: a descriptive  study of patients referred to an Aggression  response T eam in an acute hospital Daniel simpkins1 Carmelle Peisah2,3 Irene Boyatzis1 1Division of rehabilitation and Aged  Care, hornsby Ku-ring-gai hospital,   2school of Psychiatry, University  of new south Wales, 3Discipline  of Psychiatry, University of sydney,   sydney, nsW, AustraliaAim:  The management of severely agitated elderly patients is not easy, and limited guidelines  are available to assist practitioners.",Non-OADS,/arxiv_data1/oa_pdf/af/15/cia-11-1559.PMC5096780.pdf
"Keywords:  aged, aggression, delirium, dementia, antipsychotic agents, benzodiazepines Introduction The management of severely agitated elderly patients in the acute hospital setting  is not easy.1–4 Urgent safety issues for both patient and staff coexist with diagnostic  priorities in a setting not geared to first-line nonpharmacological strategies of meeting  psychosocial and emotional needs of patients.5 The adverse outcomes of cognitively  impaired older people in hospital are well documented and include prolonged length  of stay, increased mortality, polypharmacy, and psychotropic use.6–8 However, agitation among elderly patients in the hospital setting is common, and  needs to be managed given its association with some of these adverse outcomes.9  The most common causes of agitation in the elderly are delirium or behavioral  and psychological symptoms of dementia (BPSD), and less commonly, a primary  psychosis.1,2 Delirium affects an estimated 14%–56% of all hospitalized elderly  patients,10 while an estimated 60% of people with dementia will experience symptoms Correspondence: Daniel simpkins hornsby Ku-ring-gai hospital,  Palmerston road, hornsby,  sydney, nsW 2077, Australia Tel +61 412 712 555 Fax +61 2 9477 9162 email simpkinsdaniel@gmail.co m Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Simpkins et al Running head recto: Behavioral emergency in the elderly DOI: http://dx.doi.org/10.2147/CIA.S116376",Non-OADS,/arxiv_data1/oa_pdf/af/15/cia-11-1559.PMC5096780.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/af/15/cia-11-1559.PMC5096780.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/af/15/cia-11-1559.PMC5096780.pdf
"Available  from: http://www.anzsgm.org/documents/PS13Deliriumstatement  Revision2012.pd f. Accessed November 5, 2015.",Non-OADS,/arxiv_data1/oa_pdf/af/15/cia-11-1559.PMC5096780.pdf
Available from: http://www.cec.health.nsw.gov.au/__data/assets/ pdf_file/0012/258699/sago-12.2013.pdf.,OADS,/arxiv_data1/oa_pdf/af/15/cia-11-1559.PMC5096780.pdf
Available from: https://www.fightdementia.org.au/files/NATIONAL/ documents/Alzheimers-Australia-Numbered-Publication-38.pdf.,Non-OADS,/arxiv_data1/oa_pdf/af/15/cia-11-1559.PMC5096780.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/76/ac/jpr-9-893.PMC5096781.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/76/ac/jpr-9-893.PMC5096781.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Journal of Pain Research  2016:9 893–898Journal of Pain Research Dovepress submit your manuscript | www.dovepress.com Dovepress  893 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S116533Nucleoplasty for treating lumbar disk  degenerative low back pain: an outcome  prediction analysis Po-Chou Liliang1  Kang Lu1  Cheng-Loong Liang1  Ya-Wen Chen2,3  Yu-Duan Tsai1  Yuan-Kun T u4 1Department of Neurosurgery, E-Da  Hospital, 2Department of Nursing,   I-Shou University, 3School of Nursing,   Kaohsiung Medical University,   4Department of Orthopedic Surgery,   E-Da Hospital, I-Shou University,   Kaohsiung, TaiwanPurpose: Nucleoplasty is a minimally invasive technique that is considered efficacious in  alleviating lumbar disk degenerative low back pain (LBP).",Non-OADS,/arxiv_data1/oa_pdf/76/ac/jpr-9-893.PMC5096781.pdf
"8–10Correspondence: Yuan-Kun Tu Department of Orthopedic Surgery, E-Da Hospital, I-Shou University, 1 E-Da Road, Jiau-Shu Tsuen, Yan-Chau Shiang District, Kaohsiung 824, Taiwan   Tel +886 7 615 0011   Fax +886 7 615 0982   Email ed100130@edah.org.twJournal name: Journal of Pain Research  Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Liliang et alRunning head recto: Nucleoplasty for disk degenerative low back painDOI: http://dx.doi.org/10.2147/JPR.S116533",Non-OADS,/arxiv_data1/oa_pdf/76/ac/jpr-9-893.PMC5096781.pdf
"Journal of Pain Research  2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Journal of Pain Research  Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/journal-of-pain-research-journal The Journal of Pain Research is an international, peer reviewed, open  access, online journal that welcomes laboratory and clinical findings   in the fields of pain research and the prevention and management of pain.",Non-OADS,/arxiv_data1/oa_pdf/76/ac/jpr-9-893.PMC5096781.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 898 Liliang et al  22.,Non-OADS,/arxiv_data1/oa_pdf/76/ac/jpr-9-893.PMC5096781.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/49/f0/clep-8-709.PMC5096783.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/49/f0/clep-8-709.PMC5096783.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Danish Urogynaecological Database Ulla Darling Hansen1 Kim Oren Gradel2 Michael Due Larsen2 1Department of Gynaecology and  Obstetrics, Odense University  Hospital, 2Center for Clinical  Epidemiology, Odense University  Hospital, and Research Unit of  Clinical Epidemiology, Institute of  Clinical Research, University of  Southern Denmark, Odense C,   Denmark Correspondence: Ulla Darling Hansen   Department of Gynaecology and  Obstetrics, Odense University Hospital,  Sdr.",Non-OADS,/arxiv_data1/oa_pdf/49/f0/clep-8-709.PMC5096783.pdf
"Available from: http://dugabase.dk/wp_dugabase/wp-content/ uploads/2016/04/ÅRSRAPPORT -Duga_2014-FINAL.pd f. Accessed  April 13, 2016.",Non-OADS,/arxiv_data1/oa_pdf/49/f0/clep-8-709.PMC5096783.pdf
Available from:  http://dugabase.dk /.,Non-OADS,/arxiv_data1/oa_pdf/49/f0/clep-8-709.PMC5096783.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/49/f0/clep-8-709.PMC5096783.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/12/00/ndt-12-2819.PMC5096784.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Neuropsychiatric Disease and Treatment 2016:12 2819–2826Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2819OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S11811 0 Validation of the chinese version of Brief  assessment of cognition in schizophrenia liang-Jen Wang1 Pao-Yen lin2,3 Yu lee2 Yu-chi huang2 su-Ting hsu4 chi-Fa hung2 chih-Ken chen5,6 Yi-chih chen5,6 Ya-ling Wang2 Ming-che Tsai2 1Department of child and adolescent  Psychiatry, Kaohsiung chang gung  Memorial hospital and chang gung  University college of Medicine,   2Department of Psychiatry, Kaohsiung  chang gung Memorial hospital and  chang gung University college of  Medicine, 3institute for Translational  research in Biomedical sciences,   Kaohsiung chang gung Memorial  hospital, 4Department of community  Psychiatry, Kaohsiung Municipal Kai- syuan Psychiatric hospital, Kaohsiung,   5Department of Psychiatry, chang  gung Memorial hospital, Keelung,   6chang gung University college of  Medicine, Taoyuan, Taiwan, republic  of chinaObjective:  A test battery that measures cognitive function impairment in patients with  schizophrenia, the Brief Assessment of Cognition in Schizophrenia (BACS), has been translated  into various languages and validated.",Non-OADS,/arxiv_data1/oa_pdf/12/00/ndt-12-2819.PMC5096784.pdf
"Keywords:  psychometrics, reliability, validity, cognitive function, schizophrenia Introduction Patients with schizophrenia exhibit a wide range of cognitive dysfunctions,1 including  deficits in working memory, verbal and spatial memory, motor and processing speed,  attention, and executive function.2,3 Cognitive impairment determines the level of  patients’ daily function and social-occupational outcome.4,5 Therefore, a cognitive test  battery that can be efficiently and feasibly used to assess cognitive deficits in patients  with schizophrenia is essential for outcome measurement in both clinical settings and  research environments.6,7 The ideal test battery should contain a broad range of cogni - tive dimensions, satisfy reliability and validity criteria, and be repeatable to assess  changes over long-term follow-up periods.8 Numerous neuropsychological testing batteries have been developed to determine  the magnitude of cognitive impairment in patients with schizophrenia.9,10 For example,  the well-known Measurement and Treatment Research to Improve Cognition in  Schizophrenia is used in clinical trials for assessing cognitive function in patients with correspondence: liang-Jen Wang Department of child and adolescent  Psychiatry, Kaohsiung chang gung  Memorial hospital, No 123, Ta-Pei road,  Niao-song District, Kaohsiung city 833,  Taiwan, republic of china Tel +886 7 731 7123 ext 8753 Fax +886 7 732 6817 email wangliangjen@gmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Wang et al Running head recto: Validation of BACS DOI: http://dx.doi.org/10.2147/NDT.S118110",Non-OADS,/arxiv_data1/oa_pdf/12/00/ndt-12-2819.PMC5096784.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/12/00/ndt-12-2819.PMC5096784.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/12/00/ndt-12-2819.PMC5096784.pdf
Available from: http://www.whocc.no/atc_ddd_index /.,OADS,/arxiv_data1/oa_pdf/12/00/ndt-12-2819.PMC5096784.pdf
"41Therefore, we used an in silico approach (RefSeq, http://www.ncbi.nlm.nih.gov/refseq/) to examine the transcriptional start site of the mRNAs whose translation was activated by alcohol.",Non-OADS,/arxiv_data1/oa_pdf/f8/f6/mp201612a.PMC5097030.pdf
The raw data can be found at https://portal.g-node.org/data/.,OADS,/arxiv_data1/oa_pdf/f8/f6/mp201612a.PMC5097030.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)mTORC1-mediated translation of CRMP-2 and alcohol F Liu et al 101 Molecular Psychiatry (2017), 89 –101",Non-OADS,/arxiv_data1/oa_pdf/f8/f6/mp201612a.PMC5097030.pdf
"Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu) OPEN The prognostic signi ﬁcance of trisomy 4 in acute myeloid leukaemia is dependent on age and additional abnormalities Leukemia (2016) 30,2264 –2267; doi:10.1038/leu.2016.200 It is well recognised that cytogenetics is a key prognostic factor in acute myeloid leukaemia (AML)1and that trisomy 4 occurs as a rare chromosomal abnormality ( o1%).1–3The additional chromo- some 4 may be present as a sole abnormality or occur inassociation with other chromosomal changes.",Non-OADS,/arxiv_data1/oa_pdf/97/0d/leu2016200a.PMC5097064.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016 OPEN Concurrent PI3K and NF- κB activation drives B-cell lymphomagenesis Leukemia (2016) 30,2267 –2270; doi:10.1038/leu.2016.204 Aberrant activation of the PI3K and NF- κB pathways occurs frequently in human B-cell lymphomas.1,2Recent studies sug- gested reciprocal molecular interactions between these two pathways in lymphomagenesis.",Non-OADS,/arxiv_data1/oa_pdf/97/0d/leu2016200a.PMC5097064.pdf
"Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu) OPEN Standardization of molecular monitoring for chronic myeloid leukemia in Latin America using locally produced secondary cellular calibrators Leukemia (2016) 30,2258 –2260; doi:10.1038/leu.2016.197 Residual disease in chronic myeloid leukemia (CML) patients undergoing therapy with tyrosine kinase inhibitors (TKIs) is measured by assessing the quantity of transcripts of the BCR- ABL1 fusion gene in peripheral white blood cells.1This analysis is based on reverse-transcription quantitative PCR (RT –qPCR) technology; however, the wide array of methods used worldwide has led to large variation in quantitative BCR-ABL1 measurements, which hamper inter-laboratory comparative studies.2,3It is now recognized that monitoring BCR-ABL1 /control gene ratios on the International Scale (IS) is vital for the management of patients withCML.4Efforts to harmonize procedures to measure BCR-ABL1 fusion transcripts have included important investments in sample exchange programs to derive laboratory-speci ﬁc conversion factors (CF); these efforts showed improvements in inter-laboratory concordance rates, but the process is laborious andlimited due to the lack of a common set of reference samples that can be shared on a global scale.",Non-OADS,/arxiv_data1/oa_pdf/7f/2a/leu2016197a.PMC5097066.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016 Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu) HLA polymorphism and risk of multiple myeloma Leukemia (2016) 30,2260 –2264; doi:10.1038/leu.2016.199 The two- to threefold increased risk of multiple myeloma (MM) within families, and among African Americans vs Whites supporta role of genetic factors in disease development.",Non-OADS,/arxiv_data1/oa_pdf/7f/2a/leu2016197a.PMC5097066.pdf
"RTM28 is a functional3′RTM, which will also be able to correct any other pathogenic mutation (~450) occurring over a 3 ′region of 44 kb of the COL7A1 transcript (http://www.col7.info).",Non-OADS,/arxiv_data1/oa_pdf/63/69/gt201657a.PMC5097067.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016Construction and validation of an RTM B Tockner et al 784 Gene Therapy (2016) 775 –784",Non-OADS,/arxiv_data1/oa_pdf/63/69/gt201657a.PMC5097067.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ © The Author(s) 2016 Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu)Arsenic trioxide combined with proteasome inhibitors in APL S Ganesan et al 2178 Leukemia (2016) 2169 –2178",Non-OADS,/arxiv_data1/oa_pdf/30/35/leu2016227a.PMC5097069.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information accompanies this paper on the Leukemia website (http://www.nature.com/leu)The proteome of proteasome inhibitor-resistant myeloma GP Soriano et al 2207 © 2016 Macmillan Publishers Limited, part of Springer Nature.",Non-OADS,/arxiv_data1/oa_pdf/b5/ce/leu2016102a.PMC5097071.pdf
"This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 3.0  Unported License .© 2016 The authors http://www.edmcasereports.com  Published by Bioscientifica LtdHypoglycemia and   adrenal carcinomaK R Marchetti and others Refractory hypoglycemia in a patient with  functional adrenal cortical carcinoma Katia Regina Marchetti1, Maria Adelaide Albergaria Pereira2, Arnaldo Lichtenstein1  and Edison Ferreira Paiva1 1Department of General Medicine, and 2Department of Endocrinology, Clinics Hospital,   University of Sao Paulo School of Medicine, Sao Paulo, SP, BrazilID: 16-0101; November 2016 DOI: 10.1530/EDM-16-010110.1530/EDM-16-0101ID: 15-0028; XXX 2016 Correspondence  should be addressed  to E F Paiva  Email  paiva.edison@gmail.com Summary Adrenacarcinomas are rare, and hypoglycemic syndrome resulting from the secretion of insulin-like growth factor II  (IGF-II)  by these tumors have been described infrequently.",Non-OADS,/arxiv_data1/oa_pdf/06/3e/edmcr-2016-160101.PMC5097138.pdf
"K R Marchetti and others Hypoglycemia and   adrenal carcinomaID: 16-0101; November 2016 DOI: 10.1530/EDM-16-0101 http://www.edmcasereports.com  2Case presentation A 21-year-old black woman had presented 8 months prior  to the described events with bloating, weakness, lack  of appetite, nausea, weight loss, dyspnea and edema of  the lower limbs.",Non-OADS,/arxiv_data1/oa_pdf/06/3e/edmcr-2016-160101.PMC5097138.pdf
"K R Marchetti and othersID: 16-0101; November 2016 DOI: 10.1530/EDM-16-0101 Hypoglycemia and   adrenal carcinoma http://www.edmcasereports.com  3Treatment During hospitalization, the patient experienced frequent  hypoglycemic episodes and exhibited difficult-to-control  hypokalemia despite the intravenous administration of  potassium and hypertonic glucose.",Non-OADS,/arxiv_data1/oa_pdf/06/3e/edmcr-2016-160101.PMC5097138.pdf
"K R Marchetti and others Hypoglycemia and   adrenal carcinomaID: 16-0101; November 2016 DOI: 10.1530/EDM-16-0101 http://www.edmcasereports.com  4is treated with glucocorticoids ( 8) or with glucagon  (9), somatostatin analogs and hGH ( 9).",Non-OADS,/arxiv_data1/oa_pdf/06/3e/edmcr-2016-160101.PMC5097138.pdf
"This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 3.0  Unported License .© 2016 The authors http://www.edmcasereports.com  Published by Bioscientifica LtdPuumala hantavirus and  polyendocrinopathyM Tarvainen and others Autoimmune polyendocrinopathy and  hypophysitis after Puumala hantavirus  infection Marlene Tarvainen1, Satu Mäkelä1,2, Jukka Mustonen1,2 and Pia Jaatinen1,2,3 1School of Medicine, University of Tampere, Tampere, Finland, 2Department of Internal Medicine,  Tampere University Hospital, Tampere, Finland, and 3Division of Internal Medicine, Seinäjoki Central  Hospital, Seinäjoki, Finland Summary Puumala hantavirus (PUUV) infection causes nephropathia epidemica (NE), a relatively mild form of haemorrhagic fever with  renal syndrome (HFRS).",Non-OADS,/arxiv_data1/oa_pdf/8b/33/edmcr-2016-160084.PMC5097139.pdf
"M Tarvainen and others Puumala hantavirus and  polyendocrinopathy ID: 16-0084; November 2016 DOI: 10.1530/EDM-16-0084 http://www.edmcasereports.com  2typical features of NE are increased capillary permeability,  renal involvement and thrombocytopenia, the latter  rarely causing serious haemorrhages ( 1).",Non-OADS,/arxiv_data1/oa_pdf/8b/33/edmcr-2016-160084.PMC5097139.pdf
"M Tarvainen and others  ID: 16-0084; November 2016 DOI: 10.1530/EDM-16-0084 Puumala hantavirus and  polyendocrinopathy http://www.edmcasereports.com  3Case presentation A 25-year-old previously healthy woman presented  with fever of 39°C, oliguria and lower back pain.",Non-OADS,/arxiv_data1/oa_pdf/8b/33/edmcr-2016-160084.PMC5097139.pdf
M Tarvainen and others Puumala hantavirus and  polyendocrinopathy ID: 16-0084; November 2016 DOI: 10.1530/EDM-16-0084 http://www.edmcasereports.com  4Table 3 Summary of previous case reports on HRFS-related panhypopituitarism.,Non-OADS,/arxiv_data1/oa_pdf/8b/33/edmcr-2016-160084.PMC5097139.pdf
"M Tarvainen and others  ID: 16-0084; November 2016 DOI: 10.1530/EDM-16-0084 Puumala hantavirus and  polyendocrinopathy http://www.edmcasereports.com  5and brain MRI findings, hypophysitis was suspected and  further etiological investigations were scheduled.",Non-OADS,/arxiv_data1/oa_pdf/8b/33/edmcr-2016-160084.PMC5097139.pdf
"M Tarvainen and others Puumala hantavirus and  polyendocrinopathy ID: 16-0084; November 2016 DOI: 10.1530/EDM-16-0084 http://www.edmcasereports.com  6from Germany found hypogonadotrophic hypogonadism,  the most frequent hormonal defect in primary  hypophysitis ( 13).",OADS,/arxiv_data1/oa_pdf/8b/33/edmcr-2016-160084.PMC5097139.pdf
"M Tarvainen and others  ID: 16-0084; November 2016 DOI: 10.1530/EDM-16-0084 Puumala hantavirus and  polyendocrinopathy http://www.edmcasereports.com  7Fimlab Laboratories, Tampere University Hospital for arranging the  autoantibody tests.",Non-OADS,/arxiv_data1/oa_pdf/8b/33/edmcr-2016-160084.PMC5097139.pdf
"© 2016 The authors http://www.edmcasereports.com  Published by Bioscientifica LtdNivolumab-induced   adrenal failureH Trainer and others Hyponatraemia secondary to   nivolumab-induced primary adrenal failure Harris Trainer2, Paul Hulse1, Claire E Higham2, Peter Trainer2 and Paul Lorigan3 Departments of 1Radiology, 2Endocrinology, and 3Medical Oncology, The Christie NHS Foundation Trust, University  of Manchester, Manchester Academic Health Science Centre, Manchester, UK Summary Checkpoint inhibitors, such as ipilimumab and pembrolizumab, have transformed the prognosis for patients with  advanced malignant melanoma and squamous non-small-cell lung cancer, and their use will only expand as experience is  gained in a variety of other malignancies, for instance, renal and lymphoma.",Non-OADS,/arxiv_data1/oa_pdf/0d/88/edmcr-2016-160108.PMC5097140.pdf
"H Trainer and others Nivolumab-induced   adrenal failureID: 16-0108; November 2016 DOI: 10.1530/EDM- 16-0108 http://www.edmcasereports.com  2monoclonal antibodies that block human programmed  death receptor-1 ligand (PD-L1) found on many cancer  cells, attaching to the human programmed death  receptor-1 (PD-1) found on the surface of activated T  cells.",Non-OADS,/arxiv_data1/oa_pdf/0d/88/edmcr-2016-160108.PMC5097140.pdf
"H Trainer and others  ID: 16-0108; November 2016 DOI: 10.1530/EDM- 16-0108 Nivolumab-induced   adrenal failure http://www.edmcasereports.com  3and 19.8 nmol/L/h respectively, with a corresponding  aldosterone of <100 pmol/L indicative of primary  adrenal insufficiency.",Non-OADS,/arxiv_data1/oa_pdf/0d/88/edmcr-2016-160108.PMC5097140.pdf
"H Trainer and others Nivolumab-induced   adrenal failureID: 16-0108; November 2016 DOI: 10.1530/EDM- 16-0108 http://www.edmcasereports.com  4In conclusion, much remains to be understood  about the mechanism and risk factors predisposing to  endocrinopathy with checkpoint inhibitor therapy.",Non-OADS,/arxiv_data1/oa_pdf/0d/88/edmcr-2016-160108.PMC5097140.pdf
"This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 3.0  Unported License .© 2016 The authors http://www.edmcasereports.com  Published by Bioscientifica LtdMoyamoya syndrome and  Graves’ diseaseJ Choi and others Fatal outcome in a Hispanic woman with  moyamoya syndrome and Graves’ disease Julian Choi1, Perin Suthakar2 and Farbod Farmand1  Departments of 1Internal Medicine and 2Neurology, Arrowhead Regional Medical Center, Colton, California, USA Summary We describe the case of a young Hispanic female who presented with thyrotoxicosis with seizures and ischemic stroke.",Non-OADS,/arxiv_data1/oa_pdf/03/b7/edmcr-2016-160045.PMC5097141.pdf
J Choi and others Moyamoya syndrome and  Graves’ diseaseID: 16-0045; November 2016 DOI: 10.1530/EDM-16-0045http://www.edmcasereports.com  2patients are classified as having moyamoya syndrome  (MMS).,Non-OADS,/arxiv_data1/oa_pdf/03/b7/edmcr-2016-160045.PMC5097141.pdf
J Choi and others ID: 16-0045; November 2016 DOI: 10.1530/EDM-16-0045Moyamoya syndrome and  Graves’ diseasehttp://www.edmcasereports.com  3was performed for bilateral encephalomyosynangiosis  with no intraoperative complications.,Non-OADS,/arxiv_data1/oa_pdf/03/b7/edmcr-2016-160045.PMC5097141.pdf
J Choi and others Moyamoya syndrome and  Graves’ diseaseID: 16-0045; November 2016 DOI: 10.1530/EDM-16-0045http://www.edmcasereports.com  4homocysteine and methylmalonic acid levels.,OADS,/arxiv_data1/oa_pdf/03/b7/edmcr-2016-160045.PMC5097141.pdf
"J Choi and others ID: 16-0045; November 2016 DOI: 10.1530/EDM-16-0045Moyamoya syndrome and  Graves’ diseasehttp://www.edmcasereports.com  5Author contribution statement Julian Choi, provided substantial contributions to conception   and design, acquisition of data or analysis and interpretation  of data.",OADS,/arxiv_data1/oa_pdf/03/b7/edmcr-2016-160045.PMC5097141.pdf
"DOI: 10.1530/EC-16-0050 http://www.endocrineconnections.org © 2016 The authors Published by Bioscientifica Ltd53–60 TCF7L2  and severe  hypoglycaemiaP L Kristensen et al.Research Open Access5 6 53:5Endocrine Connections This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.Impact of the TCF7L2  genotype   on risk of hypoglycaemia and  glucagon secretion during  hypoglycaemia Peter L Kristensen1, Ulrik Pedersen-Bjergaard1,2, Rikke Due-Andersen1,3,  Thomas Høi-Hansen1,4, Lise Grimmeshave1,5, Valeriya Lyssenko6,7, Leif Groop7,8,   Jens J Holst2,9, Allan A Vaag2,10 and Birger Thorsteinsson1,2 1Department of Cardiology, Nephrology and Endocrinology, Nordsjællands Hospital, Hillerød, Denmark 2Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark 3Lægerne på Ellemarksvej, Køge, Denmark 4Department of Cardiology, Herlev-Gentofte University Hospital, Herlev, Denmark 5Novo Nordisk A/S, Søborg, Denmark 6Steno Diabetes Center, Gentofte, Denmark 7Lund University Diabetes Centre, Skåne University Hospital, Malmø, Sweden 8Finnish Institute for Molecular Medicine (FIMM), Helsinki University, Helsinki, Finland 9Department of Biomedical Sciences, NNF Center for Basic Metabolic Research, The Panum Institute,   Copenhagen, Denmark 10Department of Endocrinology, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark Abstract Introduction : In healthy carriers of the T allele of the transcription factor 7-like 2  (TCF7L2 ), fasting plasma glucagon concentrations are lower compared with those  with the C allele.",Non-OADS,/arxiv_data1/oa_pdf/cc/7e/ec-5-53.PMC5097143.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-16-0050 http://www.endocrineconnections.org © 2016 The authors Published by Bioscientifica Ltd Research P L Kristensen et al.,Non-OADS,/arxiv_data1/oa_pdf/cc/7e/ec-5-53.PMC5097143.pdf
DOI: 10.1530/EC-16-0050 http://www.endocrineconnections.org © 2016 The authors Published by Bioscientifica LtdThis work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.,Non-OADS,/arxiv_data1/oa_pdf/cc/7e/ec-5-53.PMC5097143.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-16-0050 http://www.endocrineconnections.org © 2016 The authors Published by Bioscientifica Ltd Research P L Kristensen et al.,Non-OADS,/arxiv_data1/oa_pdf/cc/7e/ec-5-53.PMC5097143.pdf
DOI: 10.1530/EC-16-0050 http://www.endocrineconnections.org © 2016 The authors Published by Bioscientifica LtdThis work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.,Non-OADS,/arxiv_data1/oa_pdf/cc/7e/ec-5-53.PMC5097143.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-16-0050 http://www.endocrineconnections.org © 2016 The authors Published by Bioscientifica Ltd Research P L Kristensen et al.,Non-OADS,/arxiv_data1/oa_pdf/cc/7e/ec-5-53.PMC5097143.pdf
DOI: 10.1530/EC-16-0050 http://www.endocrineconnections.org © 2016 The authors Published by Bioscientifica LtdThis work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.,Non-OADS,/arxiv_data1/oa_pdf/cc/7e/ec-5-53.PMC5097143.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial 4.0 International  License.DOI: 10.1530/EC-16-0050 http://www.endocrineconnections.org © 2016 The authors Published by Bioscientifica Ltd Research P L Kristensen et al.,Non-OADS,/arxiv_data1/oa_pdf/cc/7e/ec-5-53.PMC5097143.pdf
"DOI: 10.1530/EC-16-0051 http://www.endocrineconnections.org © 2016 The authors Published by Bioscientifica LtdThis work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 4.0  International License .44–52 Bromocriptine and   insulin sensitivityL Bahler et al.Research Open Access5 6 44:5Endocrine ConnectionsAbstract Bromocriptine is a glucose-lowering drug, which was shown to be effective in obese  subjects with insulin resistance.",Non-OADS,/arxiv_data1/oa_pdf/e2/e2/ec-5-44.PMC5097144.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 4.0  International License .DOI: 10.1530/EC-16-0051 http://www.endocrineconnections.org © 2016 The authors Published by Bioscientifica Ltd5 6 Research L Bahler et al.,Non-OADS,/arxiv_data1/oa_pdf/e2/e2/ec-5-44.PMC5097144.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 4.0  International License .DOI: 10.1530/EC-16-0051 http://www.endocrineconnections.org © 2016 The authors Published by Bioscientifica Ltd Research L Bahler et al.,Non-OADS,/arxiv_data1/oa_pdf/e2/e2/ec-5-44.PMC5097144.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 4.0  International License .DOI: 10.1530/EC-16-0051 http://www.endocrineconnections.org © 2016 The authors Published by Bioscientifica Ltd Research L Bahler et al.,Non-OADS,/arxiv_data1/oa_pdf/e2/e2/ec-5-44.PMC5097144.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 4.0  International License .DOI: 10.1530/EC-16-0051 http://www.endocrineconnections.org © 2016 The authors Published by Bioscientifica Ltd Research L Bahler et al.,Non-OADS,/arxiv_data1/oa_pdf/e2/e2/ec-5-44.PMC5097144.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 4.0  International License .DOI: 10.1530/EC-16-0051 http://www.endocrineconnections.org © 2016 The authors Published by Bioscientifica Ltd Research L Bahler et al.,Non-OADS,/arxiv_data1/oa_pdf/e2/e2/ec-5-44.PMC5097144.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 4.0  International License .DOI: 10.1530/EC-16-0051 http://www.endocrineconnections.org © 2016 The authors Published by Bioscientifica Ltd Research L Bahler et al.,Non-OADS,/arxiv_data1/oa_pdf/e2/e2/ec-5-44.PMC5097144.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 4.0  International License .DOI: 10.1530/EC-16-0051 http://www.endocrineconnections.org © 2016 The authors Published by Bioscientifica Ltd Research L Bahler et al.,Non-OADS,/arxiv_data1/oa_pdf/e2/e2/ec-5-44.PMC5097144.pdf
This work is licensed under a Creative Commons  Attribution-NonCommercial-NoDerivs 4.0  International License .DOI: 10.1530/EC-16-0051 http://www.endocrineconnections.org © 2016 The authors Published by Bioscientifica Ltd Research L Bahler et al.,Non-OADS,/arxiv_data1/oa_pdf/e2/e2/ec-5-44.PMC5097144.pdf
"© 2016 The authors http://www.edmcasereports.com  Published by Bioscientifica LtdTolvaptan in paediatric SIADH R H Willemsen and others Tolvaptan use during hyperhydration in  paediatric intracranial lymphoma with SIADH Ruben H Willemsen1, Violeta Delgado-Carballar1, Daniela Elleri1, Ajay Thankamony1,  G A Amos Burke2, James C Nicholson2 and David B Dunger1 1Department of Paediatric Endocrinology, University of Cambridge, Cambridge, UK and 2Department of  Paediatric Haematology and Oncology, Addenbrooke’s Hospital, Cambridge University Hospitals NHS  Foundation Trust, Cambridge, UKID: 16-0066; November 2016 DOI: 10.1530/EDM-16-006610.1530/EDM-16-0066ID: 15-0028; XXX 2016 Correspondence  should be addressed  to R H Willemsen  Email  rw490@medschl.cam.ac.uk Summary An 11-year-old boy developed severe syndrome of inappropriate antidiuretic hormone secretion (SIADH) after  diagnosis of an intracranial B-cell lymphoma.",Non-OADS,/arxiv_data1/oa_pdf/44/49/edmcr-2016-160066.PMC5097145.pdf
"R H Willemsen and others Tolvaptan in paediatric SIADH ID: 16-0066; November 2016 DOI: 10.1530/EDM-16-0066 http://www.edmcasereports.com  2Vaptans compete with AVP at the receptor-binding site,  thus promoting the excretion of free water ( 3).",Non-OADS,/arxiv_data1/oa_pdf/44/49/edmcr-2016-160066.PMC5097145.pdf
"R H Willemsen and others  ID: 16-0066; November 2016 DOI: 10.1530/EDM-16-0066Tolvaptan in paediatric SIADH http://www.edmcasereports.com  3As the rash appeared whilst he was also receiving  chemotherapy, it was unclear whether this was related  to tolvaptan.",Non-OADS,/arxiv_data1/oa_pdf/44/49/edmcr-2016-160066.PMC5097145.pdf
R H Willemsen and others Tolvaptan in paediatric SIADH ID: 16-0066; November 2016 DOI: 10.1530/EDM-16-0066 http://www.edmcasereports.com  4be accompanied by frequent monitoring of sodium levels  and urinary output.,Non-OADS,/arxiv_data1/oa_pdf/44/49/edmcr-2016-160066.PMC5097145.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/97/d5/hepatmon-16-09-40357.PMC5097177.pdf
Available from: http://www.who.int/ mediacentre/factsheets/fs164_apr2014/en /.,Non-OADS,/arxiv_data1/oa_pdf/97/d5/hepatmon-16-09-40357.PMC5097177.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fa/81/hepatmon-16-09-41054.PMC5097178.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cd/a2/hepatmon-16-09-41077.PMC5097339.pdf
Available from: http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/human/003768/ WC500172848.pdf .,Non-OADS,/arxiv_data1/oa_pdf/cd/a2/hepatmon-16-09-41077.PMC5097339.pdf
Available from: http://packageinserts.bms.com/pi/pi_ daklinza.pdf .,Non-OADS,/arxiv_data1/oa_pdf/cd/a2/hepatmon-16-09-41077.PMC5097339.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/58/55/ijpbs-10-02-4462.PMC5097340.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/96/ijpbs-10-02-2423.PMC5097343.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/33/57/ijpbs-10-03-1887.PMC5097344.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/ca/ijpbs-10-02-3458.PMC5097345.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/13/f1/ijpbs-10-03-4544.PMC5097447.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/86/b4/ijpbs-10-03-5047.PMC5097448.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d5/fb/ijpbs-10-03-2603.PMC5097449.pdf
Available from: http://www.healthquality.va.gov/Post_ Traumatic_Stress_Disorder_PTSD.asp .,Non-OADS,/arxiv_data1/oa_pdf/d5/fb/ijpbs-10-03-2603.PMC5097449.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/be/ff/ijpbs-10-03-2445.PMC5097451.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6f/f9/ijpbs-10-03-1699.PMC5097452.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0d/ef/nihms815150.PMC5097673.pdf
"In addition, they  This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ) Correspondence:  Address to Walter A. Rocca, MD, MPH, Division of Epidemiology, Department of Health Sciences Research,  Mayo Clinic, 200 First St SW, Rochester, MN 55905 (Rocca@mayo.edu).",Non-OADS,/arxiv_data1/oa_pdf/2c/2b/nihms811650.PMC5097693.pdf
SUPPLEMENTAL ONLINE MATERIAL Supplemental material can be found online at http://www.mayoclinicproceedings.org .,Non-OADS,/arxiv_data1/oa_pdf/2c/2b/nihms811650.PMC5097693.pdf
"Women who underwent bilateral oophorectomy were less  educated, were more frequently white, had higher body mass index, and had smoked more  pack-years of cigarettes than referent women at the time of bilateral oophorectomy (or index  date; Supplemental Table 1, available online at http://www.mayoclinicproceedings.org ).",Non-OADS,/arxiv_data1/oa_pdf/2c/2b/nihms811650.PMC5097693.pdf
"Supplemental Figure 2 (available  online at http://www.mayoclinicproceedings.org ) illustrates our overall mechanistic  hypothesis linking premature estrogen loss caused by the oophorectomy to the accelerated  accumulation of multimorbidity used as a clinical proxy measure for accelerated  aging.12,15,16 Some conditions may be affected by estrogen loss more severely or earlier in  life than others.",Non-OADS,/arxiv_data1/oa_pdf/2c/2b/nihms811650.PMC5097693.pdf
http://dx.doi.org/10.1093/ gerona/glw032 .,OADS,/arxiv_data1/oa_pdf/2c/2b/nihms811650.PMC5097693.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d9/93/ijpbs-10-03-1865.PMC5097822.pdf
Available from: http://www.dsm5.org/ ProposedRevisions/Pages/proposedrevision.aspx?rid=424# .,Non-OADS,/arxiv_data1/oa_pdf/d9/93/ijpbs-10-03-1865.PMC5097822.pdf
Available from: http://handouts.aacrao.org/am07/ﬁnished/ F0345p_S_Kamyab.pdf .,Non-OADS,/arxiv_data1/oa_pdf/d9/93/ijpbs-10-03-1865.PMC5097822.pdf
Available from: http://www.khorasannews.com/News.aspx?,Non-OADS,/arxiv_data1/oa_pdf/d9/93/ijpbs-10-03-1865.PMC5097822.pdf
Available from: http://koodakan.akairan.com/koodak/raftari1/ 23488.html .,Non-OADS,/arxiv_data1/oa_pdf/d9/93/ijpbs-10-03-1865.PMC5097822.pdf
Available from: http://www.aral.com.au/resources/grounded.html .,Non-OADS,/arxiv_data1/oa_pdf/d9/93/ijpbs-10-03-1865.PMC5097822.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/28/ijpbs-10-03-3813.PMC5097827.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/28/47/ijpbs-10-03-5268.PMC5097828.pdf
Available from: http://www.sleepfoundation.org/article/sleep-america-polls/2011- communications-technology-use-and-sleep .,Non-OADS,/arxiv_data1/oa_pdf/28/47/ijpbs-10-03-5268.PMC5097828.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/91/34/ijpbs-10-03-5392.PMC5097829.pdf
Available from: http://www.worldpopulationreview.com/countries/ Kuwait-population .,Non-OADS,/arxiv_data1/oa_pdf/91/34/ijpbs-10-03-5392.PMC5097829.pdf
Available from: http://www.countryeconomy.com/demography/ population/Qatar .,Non-OADS,/arxiv_data1/oa_pdf/91/34/ijpbs-10-03-5392.PMC5097829.pdf
Available from: http://www.indexmundi.com/bahrain/ demographics_proﬁle.html .,Non-OADS,/arxiv_data1/oa_pdf/91/34/ijpbs-10-03-5392.PMC5097829.pdf
Available from: http://www.unaids.org/sites/ default/ﬁles/country/documents//KWT_narrative_report_2014.,OADS,/arxiv_data1/oa_pdf/91/34/ijpbs-10-03-5392.PMC5097829.pdf
Available from: http://www.unaids.,Non-OADS,/arxiv_data1/oa_pdf/91/34/ijpbs-10-03-5392.PMC5097829.pdf
Available from: http://www.unaids.org/sites/ default/ﬁles/country/documents//BHR_narrative_report_2014.pdf .,Non-OADS,/arxiv_data1/oa_pdf/91/34/ijpbs-10-03-5392.PMC5097829.pdf
Available from: http://www.unaids.,Non-OADS,/arxiv_data1/oa_pdf/91/34/ijpbs-10-03-5392.PMC5097829.pdf
Available from: http://www.menahra.org/images/ pdf/Menahra.pdf .,Non-OADS,/arxiv_data1/oa_pdf/91/34/ijpbs-10-03-5392.PMC5097829.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/e9/ijpbs-10-03-3894.PMC5097830.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/52/ijpbs-10-03-681.PMC5097832.pdf
Available at: http://www.aftab.ir/glossaries/instance/book/138095 /.,Non-OADS,/arxiv_data1/oa_pdf/17/52/ijpbs-10-03-681.PMC5097832.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1d/48/ijpbs-10-03-2298.PMC5097834.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0a/4f/ijpbs-10-03-7988.PMC5097836.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4a/07/ijpbs-10-03-5644.PMC5097852.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/63/f6/aapm-06-03-26749.PMC5097854.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1f/29/aapm-06-03-35340.PMC5097855.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b6/f0/asjsm-07-03-30172.PMC5097858.pdf
Avail- able from: http://earthquake.usgs.gov/earthquakes/eventpage/ us20002926 general_summary .,OADS,/arxiv_data1/oa_pdf/b6/f0/asjsm-07-03-30172.PMC5097858.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/de/e2/asjsm-07-03-30599.PMC5097860.pdf
http://dx.doi.org/10.1016/j.ajhg.2016.09.010 .,OADS,/arxiv_data1/oa_pdf/f3/a6/main.PMC5097945.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f3/a6/main.PMC5097945.pdf
Supplemental Data Supplemental Data include seven ﬁgures and two tables and can be found with this article online at http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f3/a6/main.PMC5097945.pdf
"Received: August 5, 2016 Accepted: September 19, 2016 Published: October 20, 2016 Web Resources 3D Slicer, https://www.slicer.org/ 1000 Genomes, http://www.internationalgenome.org/ CADD, http://cadd.gs.washington.edu/ dbSNP, http://www.ncbi.nlm.nih.gov/projects/SNP/ Developmental Brain ADC Atlas Creation from Clinical Images, http://www.nmr.mgh.harvard.edu/~you2/publications/ BabyAtlasing_OHBM14.pdf DRAMMS Image Registration Software, https://www.cbica.upenn.",Non-OADS,/arxiv_data1/oa_pdf/f3/a6/main.PMC5097945.pdf
"edu/sbia/software/dramms/ ExAC Browser, http://exac.broadinstitute.org/ GenBank, http://www.ncbi.nlm.nih.gov/genbank/ IRECS, http://irecs.bioinf.mpi-inf.mpg.de/ MutationTaster, http://www.mutationtaster.org/ NHLBI Exome Sequencing Project (ESP) Exome Variant Server, http://evs.gs.washington.edu/EVS/ OMIM, http://www.omim.org/ PolyPhen-2, http://genetics.bwh.harvard.edu/pph2/ PyMOL, http://www.pymol.org RCSB Protein Data Bank, http://www.rcsb.org/pdb/home/ home.do RefSeq, http://www.ncbi.nlm.nih.gov/RefSeq SIFT, http://sift.bii.a-star.edu.sg/ SWISS-MODEL, http://swissmodel.expasy.org/ UCSC Genome Browser, http://genome.ucsc.edu UCSC Genome Browser: Downloads, http://hgdownload.cse.ucsc.",Non-OADS,/arxiv_data1/oa_pdf/f3/a6/main.PMC5097945.pdf
We report a surgical multi-layer technique of pelvic reconstruction using a combination of pedicled omental ﬂap and HADM ﬁlled with Contents lists available at ScienceDirect Gynecologic Oncology Reports journal homepage: www.elsevier.com/locate/gynor http://dx.doi.org/10.1016/j.gore.2016.10.006 2352-5789/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/34/88/main.PMC5097956.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/34/88/main.PMC5097956.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Keywords: Parkinson's diseaseDeep brain stimulation Subthalamic nucleus Basal gangliaT2 relaxometry 1.,Non-OADS,/arxiv_data1/oa_pdf/5c/13/main.PMC5097958.pdf
http://dx.doi.org/10.1016/j.nicl.2016.09.0192213-1582/© 2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/5c/13/main.PMC5097958.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5c/13/main.PMC5097958.pdf
"Salamon's Neuroanatomy and Neurovasculature Web-Atlas Resource, 2013, available online at http://www.radnet.ucla.edu/sections/DINR/index.htm .",OADS,/arxiv_data1/oa_pdf/5c/13/main.PMC5097958.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/c0/69/main.PMC5097960.pdf
He  over  next http://dx.doi.org/10.1016/j.ijscr.2016.10.032 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/c0/69/main.PMC5097960.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fb/2f/main.PMC5097961.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.10.045 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/fb/2f/main.PMC5097961.pdf
This  is  an  open  access  article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f5/dc/main.PMC5097962.pdf
http://dx.doi.org/10.1016/j.ijscr.2016.10.052 2210-2612/© 2016  Published  by  Elsevier  Ltd  on  behalf  of  IJS  Publishing  Group  Ltd.,Non-OADS,/arxiv_data1/oa_pdf/f5/dc/main.PMC5097962.pdf
This  is  an  open access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d8/5c/main.PMC5097963.pdf
An  exploratory  laparo- tomy  was  performed  and  revealed  a  jejunal  hematoma  30  cm  from http://dx.doi.org/10.1016/j.ijscr.2016.10.055 2210-2612/© 2016  The  Authors.,Non-OADS,/arxiv_data1/oa_pdf/d8/5c/main.PMC5097963.pdf
"The two year bioassay is not necessary for evaluation of carcinogenic potential.Received: 7 May 2016, Accepted: 9 May 2016 Published online in J-STAGE: 23 May 2016 *Corresponding author: SM Cohen (e-mail: scohen@unmc.edu) Presented in part at the Annual Meeting of the Japanese Society of  Toxicologic Pathology, January 29, 2016, Kagawa, Japan ©2016 The Japanese Society of Toxicologic PathologyThis is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/e9/83/tox-29-215.PMC5097964.pdf
"Animals and housing condition Seventy-seven male Crl:CD(SD) rats (6 weeks old,  specific pathogen free) were purchased from Charles River Laboratories Japan, Inc. (Shiga, Japan), and housed individ -Received: 4 March 2016, Accepted: 2 May 2016 Published online in J-STAGE: 3 June 2016 *Corresponding author: K Ogata  (e-mail: ogatak2@sc.sumitomo-chem.co.jp) ©2016 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/e9/83/tox-29-215.PMC5097964.pdf
"Target gene prediction for miR-547* For prediction of the target genes for miR-547*, the  TargetScan Human software (http://www.targetscan.org/) Table 1.",OADS,/arxiv_data1/oa_pdf/e9/83/tox-29-215.PMC5097964.pdf
"In  contrast, the consumption of fruits and vegetables has been Received: 21 May 2016, Accepted: 1 June 2016 Published online in J-STAGE: 4 July 2016 *Corresponding author: Y-M Cho (e-mail: ymcho@nihs.go.jp) #Present: Department of Food Science, Korea Christian University,  Kkachisan-ro 24-gil, Gangseo-gu 47, Seoul 07661, Republic of Korea ©2016 The Japanese Society of Toxicologic PathologyThis is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/e9/83/tox-29-215.PMC5097964.pdf
"2013, http://globocan.iarc.fr./Pag - es/fact_sheets_cancer.aspx.",Non-OADS,/arxiv_data1/oa_pdf/e9/83/tox-29-215.PMC5097964.pdf
2005. http://www.fda.gov/downloads/Drugs/guidancecomplianceregulatoryin - formation/Guidances/UCM078932.pdf.,Non-OADS,/arxiv_data1/oa_pdf/e9/83/tox-29-215.PMC5097964.pdf
"However, it is un - known whether Qu can inhibit Cd-induced autophagy in the Received: 15 April 2016, Accepted: 4 July 2016 Published online in J-STAGE: 18 August 2016 *Corresponding author: H Cai (e-mail: caialon@163.com) ©2016 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/e9/83/tox-29-215.PMC5097964.pdf
"Milnacipran, a serotonin–noradrenaline reuptake inhibitor, Received: 25 April 2016, Accepted: 22 July 2016 Published online in J-STAGE: 21 September 2016 *Corresponding author: B Xu (jxchp2000@tom.com) ©2016 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/e9/83/tox-29-215.PMC5097964.pdf
"These slides were subsequently rinsed with TBS plus Tween 20, treated for 30 min at room temperature with biotinylated secondary  Received: 27 February 2016, Accepted: 2 May 2016 Published online in J-STAGE: 27 May 2016 *Corresponding author: K Ozaki  (e-mail: ozaki@pharm.setsunan.ac.jp) ©2016 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/e9/83/tox-29-215.PMC5097964.pdf
"Briefly, after the pretreatments and incubation with primary antibodies, the sections were immunohistochemically stained by the poly - mer immunocomplex method using Histofine Simple Stain Mouse MAX PO (Rat) (Nichirei, Tokyo, Japan) for CD45R/ Received: 18 March 2016, Accepted: 30 May 2016 Published online in J-STAGE: 18 June 2016 *Corresponding author: T Sano (e-mail: tomoya.sano@takeda.com) ©2016 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/e9/83/tox-29-215.PMC5097964.pdf
"Some of the remaining test material was observed in the abdominal  Received: 25 March 2016, Accepted: 5 July 2016 Published online in J-STAGE: 4 August 2016 *Corresponding author: Y Sakamoto  (e-mail: you.sakamoto@teijin.co.jp) ©2016 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/e9/83/tox-29-215.PMC5097964.pdf
"In the lamina propria mucosae, in addition to neoplastic cell proliferation, formation of small clumps of bone tissue was prominent  Received: 8 July 2016, Accepted: 15 July 2016 Published online in J-STAGE: 1 August 2016 *Corresponding author: R Ando (e-mail: ando-ryo@bozo.co.jp) ©2016 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/e9/83/tox-29-215.PMC5097964.pdf
"November 2014, from National Toxicology Program website: https://ntp.niehs.nih.gov/ntp/historical_controls/ ntp2000_2014/histcont2014mice_all_routes_508.pdf.",Non-OADS,/arxiv_data1/oa_pdf/e9/83/tox-29-215.PMC5097964.pdf
"The animals were single-housed in plastic cages on softwood chip bed -Received: 11 March 2016, Accepted: 2 May 2016 Published online in J-STAGE: 28 May 2016 *Corresponding author: S Furukawa  (e-mail: furukawa@nissanchem.co.jp) ©2016 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/e9/83/tox-29-215.PMC5097964.pdf
"Animals and housing condition Seventy-seven male Crl:CD(SD) rats (6 weeks old,  specific pathogen free) were purchased from Charles River Laboratories Japan, Inc. (Shiga, Japan), and housed individ -Received: 4 March 2016, Accepted: 2 May 2016 Published online in J-STAGE: 3 June 2016 *Corresponding author: K Ogata  (e-mail: ogatak2@sc.sumitomo-chem.co.jp) ©2016 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/5a/40/tox-29-229.PMC5097965.pdf
"Target gene prediction for miR-547* For prediction of the target genes for miR-547*, the  TargetScan Human software (http://www.targetscan.org/) Table 1.",OADS,/arxiv_data1/oa_pdf/5a/40/tox-29-229.PMC5097965.pdf
"In  contrast, the consumption of fruits and vegetables has been Received: 21 May 2016, Accepted: 1 June 2016 Published online in J-STAGE: 4 July 2016 *Corresponding author: Y-M Cho (e-mail: ymcho@nihs.go.jp) #Present: Department of Food Science, Korea Christian University,  Kkachisan-ro 24-gil, Gangseo-gu 47, Seoul 07661, Republic of Korea ©2016 The Japanese Society of Toxicologic PathologyThis is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/62/19/tox-29-237.PMC5097966.pdf
"2013, http://globocan.iarc.fr./Pag - es/fact_sheets_cancer.aspx.",Non-OADS,/arxiv_data1/oa_pdf/62/19/tox-29-237.PMC5097966.pdf
2005. http://www.fda.gov/downloads/Drugs/guidancecomplianceregulatoryin - formation/Guidances/UCM078932.pdf.,Non-OADS,/arxiv_data1/oa_pdf/62/19/tox-29-237.PMC5097966.pdf
"However, it is un - known whether Qu can inhibit Cd-induced autophagy in the Received: 15 April 2016, Accepted: 4 July 2016 Published online in J-STAGE: 18 August 2016 *Corresponding author: H Cai (e-mail: caialon@163.com) ©2016 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/34/7e/tox-29-247.PMC5097967.pdf
"Milnacipran, a serotonin–noradrenaline reuptake inhibitor, Received: 25 April 2016, Accepted: 22 July 2016 Published online in J-STAGE: 21 September 2016 *Corresponding author: B Xu (jxchp2000@tom.com) ©2016 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/2b/b2/tox-29-253.PMC5097968.pdf
"These slides were subsequently rinsed with TBS plus Tween 20, treated for 30 min at room temperature with biotinylated secondary  Received: 27 February 2016, Accepted: 2 May 2016 Published online in J-STAGE: 27 May 2016 *Corresponding author: K Ozaki  (e-mail: ozaki@pharm.setsunan.ac.jp) ©2016 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/0d/df/tox-29-261.PMC5097969.pdf
"Briefly, after the pretreatments and incubation with primary antibodies, the sections were immunohistochemically stained by the poly - mer immunocomplex method using Histofine Simple Stain Mouse MAX PO (Rat) (Nichirei, Tokyo, Japan) for CD45R/ Received: 18 March 2016, Accepted: 30 May 2016 Published online in J-STAGE: 18 June 2016 *Corresponding author: T Sano (e-mail: tomoya.sano@takeda.com) ©2016 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/85/31/tox-29-265.PMC5097970.pdf
"Some of the remaining test material was observed in the abdominal  Received: 25 March 2016, Accepted: 5 July 2016 Published online in J-STAGE: 4 August 2016 *Corresponding author: Y Sakamoto  (e-mail: you.sakamoto@teijin.co.jp) ©2016 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/14/20/tox-29-269.PMC5097971.pdf
"In the lamina propria mucosae, in addition to neoplastic cell proliferation, formation of small clumps of bone tissue was prominent  Received: 8 July 2016, Accepted: 15 July 2016 Published online in J-STAGE: 1 August 2016 *Corresponding author: R Ando (e-mail: ando-ryo@bozo.co.jp) ©2016 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/3b/19/tox-29-275.PMC5097972.pdf
"November 2014, from National Toxicology Program website: https://ntp.niehs.nih.gov/ntp/historical_controls/ ntp2000_2014/histcont2014mice_all_routes_508.pdf.",Non-OADS,/arxiv_data1/oa_pdf/3b/19/tox-29-275.PMC5097972.pdf
"The animals were single-housed in plastic cages on softwood chip bed -Received: 11 March 2016, Accepted: 2 May 2016 Published online in J-STAGE: 28 May 2016 *Corresponding author: S Furukawa  (e-mail: furukawa@nissanchem.co.jp) ©2016 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/4.0/>.",Non-OADS,/arxiv_data1/oa_pdf/09/21/tox-29-279.PMC5097973.pdf
Low http://dx.doi.org/10.1016/j.redox.2016.10.007 Received 20 September 2016; Received in revised form 15 October 2016; Accepted 18 October 2016⁎Corresponding authors.,OADS,/arxiv_data1/oa_pdf/06/ab/main.PMC5097975.pdf
This is an open access article under the  CC BY-NC-ND license (http://creativecommons.org/licenses/by/4.0/).Available online 20 October 2016 crossmark,Non-OADS,/arxiv_data1/oa_pdf/06/ab/main.PMC5097975.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.redox.2016.10.007 .,OADS,/arxiv_data1/oa_pdf/06/ab/main.PMC5097975.pdf
1936-5233/16http://dx.doi.org/10.1016/j.tranon.2016.09.009,OADS,/arxiv_data1/oa_pdf/a9/e2/main.PMC5097976.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/75/asjsm-07-03-31778.PMC5098050.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e8/71/asjsm-07-03-33125.PMC5098051.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/30/21/asjsm-07-03-30720.PMC5098066.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d1/a7/asjsm-07-03-33850.PMC5098111.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/83/6c/asjsm-07-03-35289.PMC5098113.pdf
"Hermens HJ, Freriks B. Seniam Available from: http://seniam.org .",Non-OADS,/arxiv_data1/oa_pdf/83/6c/asjsm-07-03-35289.PMC5098113.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/df/d3/asjsm-07-03-33528.PMC5098124.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercialuse, distribution, and reproduction in any medium, provided the original author(s) and the source are creditedSTEM CELLS AND DEVELOPMENT Volume 25, Number 21, 2016 Mary Ann Liebert, Inc. DOI: 10.1089/scd.2016.0169 1652",Non-OADS,/arxiv_data1/oa_pdf/54/0a/scd.2016.0169.PMC5098131.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/06/e6/asjsm-07-03-35287.PMC5098135.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/42/e2/asjsm-07-03-35201.PMC5098160.pdf
"Mudahka F, Herrera C, Farooq A. Ramadan and football Avail- able from: http://www.aspetar.com/journal/viewarticle.aspx?id= 59.VzbwwYR94dV .",Non-OADS,/arxiv_data1/oa_pdf/42/e2/asjsm-07-03-35201.PMC5098160.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b3/83/asjsm-07-03-35308.PMC5098207.pdf
Available from: http://seniam.org /.,Non-OADS,/arxiv_data1/oa_pdf/b3/83/asjsm-07-03-35308.PMC5098207.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b1/bc/asjsm-07-03-35018.PMC5098234.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0c/6f/asjsm-07-03-38633.PMC5098272.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ec/67/aapm-06-04-35458.PMC5098290.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/66/f7/aapm-06-04-32602.PMC5098388.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/74/d7/aapm-06-04-38507.PMC5098390.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/11/ab/aapm-06-04-38886.PMC5098393.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/bf/68/ccid-9-393.PMC5098409.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/bf/68/ccid-9-393.PMC5098409.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical, Cosmetic and Investigational Dermatology 2016:9 393–403Clinical, Cosmetic and Investigational Dermatology Dovepress submit your manuscript | www.dovepress.com Dovepress 393 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S114471 Water-soluble egg membrane enhances the  immunoactivating properties of an Aloe vera-based  extract of Nerium oleander  leaves Kathleen F Benson1 Robert A Newman2,3 Gitte S Jensen1 1NIS Labs, Klamath Falls, OR,   2Department of Experimental  Therapeutics, University of T exas MD  Anderson Cancer Center, Houston,   3Nerium Biotechnology Inc,    San Antonio, TX, USAObjective: To evaluate a blend of two natural ingredients on immune parameters relevant for  their current topical use and potential support of microcirculation in skin tissue.",Non-OADS,/arxiv_data1/oa_pdf/bf/68/ccid-9-393.PMC5098409.pdf
"4,5 In addition to acute skin injury or that due to disease, the formation of facial  wrinkles and tissue aging has also been linked to changes in skin biochemistry Correspondence: Robert A Newman 112 Whale Rock Lane, Surry, ME 04684, USATel +1 713 857 8921Email newmanscientificconsulting@gmail.comJournal name: Clinical, Cosmetic and Investigational Dermatology Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Benson et alRunning head recto: Immunoactivation by N. oleander and egg membraneDOI: http://dx.doi.org/10.2147/CCID.S114471 Video abstract Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/bf/68/ccid-9-393.PMC5098409.pdf
Or use: http://youtu.be/B2D17SuWInY,Non-OADS,/arxiv_data1/oa_pdf/bf/68/ccid-9-393.PMC5098409.pdf
"Clinical, Cosmetic and Investigational Dermatology 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journal Clinical, Cosmetic and Investigational Dermatology is an interna- tional, peer-reviewed, open access, online journal that focuses on   the latest clinical and experimental research in all aspects of skin   disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/bf/68/ccid-9-393.PMC5098409.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authorsDovepress 403 Immunoactivation by N. oleander and egg membrane 44.,Non-OADS,/arxiv_data1/oa_pdf/bf/68/ccid-9-393.PMC5098409.pdf
"The NNRdata were provided by the NOAA/OAR/ ESRL PSD, Boulder, Colorado, USA, and are available at http://www.esrl.noaa.gov/psd/.",OADS,/arxiv_data1/oa_pdf/74/45/JGRD-121-4404.PMC5098412.pdf
ERA-Interim data used in thisstudy are stored at the ECMWF data server (http://data-portal.ecmwf.int/ data/d/interim_mnth/).,OADS,/arxiv_data1/oa_pdf/74/45/JGRD-121-4404.PMC5098412.pdf
"The MERRA canbe obtained from the Goddard EarthSciences Data and Information Services Center, Greenbelt, Maryland, from their website at http://disc.sci.gsfc.nasa.gov/mdisc.",OADS,/arxiv_data1/oa_pdf/74/45/JGRD-121-4404.PMC5098412.pdf
The CERES data used in thisstudy are stored at the Atmospheric Science Data Center at NASA Langley (https://eosweb.larc.nasa.gov).,OADS,/arxiv_data1/oa_pdf/74/45/JGRD-121-4404.PMC5098412.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/3e/aapm-06-04-38334.PMC5098413.pdf
Available from: http://www.icudelirium.org/docs/SAS.pdf .,Non-OADS,/arxiv_data1/oa_pdf/db/3e/aapm-06-04-38334.PMC5098413.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/ff/0b/ccide-8-121.PMC5098416.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/ff/0b/ccide-8-121.PMC5098416.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).",Non-OADS,/arxiv_data1/oa_pdf/ff/0b/ccide-8-121.PMC5098416.pdf
"3–6 With the increased demand  for orthodontic treatment, free health services need a quantifiable method of assigning  Correspondence: Asma M Al-Jobair Department of Pediatric Dentistry and Orthodontics, College of Dentistry, King Saud University, 60169, Riyadh 11545, Saudi ArabiaEmail aaljobair@ksu.edu.saJournal name:  Clinical, Cosmetic and Investigational Dentistry Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Al-Jobair et alRunning head recto: Orthodontic treatment need among young SaudisDOI: http://dx.doi.org/10.2147/CCIDE.S116353",Non-OADS,/arxiv_data1/oa_pdf/ff/0b/ccide-8-121.PMC5098416.pdf
"Available from: http://health.costhelper.com/braces.html,2009.",Non-OADS,/arxiv_data1/oa_pdf/ff/0b/ccide-8-121.PMC5098416.pdf
" Clinical, Cosmetic and Investigational Dentistry 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress  Clinical, Cosmetic and Investigational Dentistry Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-cosmetic-and-investigational-dentistry-journalClinical, Cosmetic and Investigational Dentistry is an international,   peer-reviewed, open access, online journal focusing on the latest clini- cal and experimental research in dentistry with specific emphasis on cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/ff/0b/ccide-8-121.PMC5098416.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/ff/0b/ccide-8-121.PMC5098416.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/9f/aapm-06-04-37428.PMC5098426.pdf
"Published with license by Taylor & Francis Group, LLC © 2016 Cilian AG This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
"8, 1498 –1511 http://dx.doi.org/10.1080/19420862.2016.1228504",Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
ORCID Anna-Janina Behrens http://orcid.org/0000-0002-4270-6744 Sonja Mader http://orcid.org/0000-0002-5393-1015 David J. Harvey http://orcid.org/0000-0003-0544-771X Kai U. Cormann http://orcid.org/0000-0003-0772-6456 Daniel Schinor http://orcid.org/0000-0003-2708-9853 Marcus W.W. Hartmann http://orcid.org/0000-0002-4395-693X References 1.,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
Curr Biol 2005; 15: R317-8; PMID:15886083; http://dx.doi.org/10.1016/j.cub.2005.04.039 2.,OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
Bioessays 1994; 16:367-72; PMID:8024545; http://dx.doi.org/10.1002/bies.950160512 3.,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
Appl Microbiol Biotechnol 1992; 37:576-9; http://dx.doi.org/10.1007/BF00240728 4.,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
Nucleic Acids Res 2006; 34:D500-3; PMID:16381920; http://dx.doi.org/10.1093/nar/gkj054 6.,OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
PLoS Biol 2006; 4:e286; PMID:16933976; http://dx.doi.org/10.1371/journal.pbio.0040286 7.,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
BMC Microbiol 2007; 7:12; PMID:17328820; http://dx.doi.org/10.1186/1471-2180-7-12 9.,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
BMC Biotechnol 2006; 6:21; PMID:16549005; http://dx.doi.org/10.1186/1472-6750-6-21 10.,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
PLoS One 2014; 9:e87198; PMID:24489871; http://dx.doi.org/10.1371/journal.pone.0087198 13.,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
BMC Biotechnol 2011; 11:11; PMID:21281462; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
BMC Biotechnol 2006; 6:19; PMID:16542419; http://dx.doi.org/10.1186/1472-6750-6-19 15.,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
Curr Opin Immunol 1997; 9:121-25; PMID:9039776; http://dx.doi.org/10.1016/S0952-7915(97)80168-9 17.,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
Mol Immunol 2000; 37:697-706; PMID:11275255; http://dx.doi.org/10.1016/S0161-5890(00)00105-X 18.,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
Crit Rev Biochem Mol Biol 1997; 32:1-100;PMID:9063619; http://dx.doi.org/10.3109/10409239709085144 19.,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
J Am Chem Soc 2012; 134:17554-63; PMID:23025485; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
Science 2014; 343:1235681; PMID:24385630; http://dx.doi.org/10.1126/science.1235681 21.,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
J Am Chem Soc 2011; 133:18975- 91; PMID:22004528; http://dx.doi.org/10.1021/ja208390n 23.,OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
"Yu M, Brown D, Reed C, Chung S, Lutman J, Stefanich E, Wong A, Stephan JP, Bayer R. Production, characterization, and pharmacoki-netic properties of antibodies with N-linked mannose-5 glycans.mAbs 2012; 4:475-487; PMID:22699308; http://dx.doi.org/10.4161/ mabs.20737 24.",OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
Glycobiology 2007; 17:104-18;PMID:17012310; http://dx.doi.org/10.1093/glycob/cwl057 25.,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
mAbs 2012; 4:419-425; PMID:22699226;http://dx.doi.org/10.4161/mabs.20996 26.,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
mAbs 2012; 4:294-309; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
mAbs 2011; 3:453-60; PMID:22048694; http://dx.doi.org/10.4161/mabs.3.5.16891 28.,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
mAbs 2015; 7:1-13; PMID:25484055; http://dx.doi.org/10.4161/19420862.2015.988944 29.,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
J Chromatogr A 2008; 1211:80-89;PMID:18945431; http://dx.doi.org/10.1016/j.chroma.2008.09.103 30.,OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
Biotechnol Bioeng 2004; 87:614-22; PMID:15352059; http://dx.doi.org/10.1002/bit.20151 31.,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
Nat Biotechnol 1999; 17:176-80; PMID:10052355; http://dx.doi.org/10.1038/6179 32.,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
mAbs 2011; 3:289-98;PMID:21487242; http://dx.doi.org/10.4161/mabs.3.3.15532 33.,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
J Eukaryot Microbiol 1999; 46:239-47; PMID:10377985; http://dx.doi.org/10.1111/j.1550-7408.1999.tb05120.x 34.,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
Cell Biol Int 1999; 23:551-60; PMID:10704239; http://dx.doi.org/10.1006/cbir.1999.0419 35.,OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
Blood 2002; 99:1314-19;PMID:11830481; http://dx.doi.org/10.1182/blood.V99.4.1314 36.,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
Oncogene 2003; 22:7359-68;PMID:14576843; http://dx.doi.org/10.1038/sj.onc.1206939 37.,OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
Glycobiology 2011; 21:1087-96; PMID:21470983; http://dx.doi.org/10.1093/glycob/cwr047 38.,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
Blood 2002; 99:754-8; PMID:11806974; http://dx.doi.org/ 10.1182/blood.V99.3.754 39.,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
mAbs 2012; 4:310-318; PMID:22531445; http://dx.doi.org/10.4161/mabs.,OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
Glycoconj J 1988; 5:397-409; http://dx.doi.org/10.1007/BF01049915 42.,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
Rapid Commun Mass Spectrom 1995; 9:1031-34; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
Rapid Commun Mass Spectrom 2004; 18:2401-14; PMID:15386629; http://dx.doi.org/10.1002/rcm.1641 44.,OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
Structural and quantitative analysis of N-linked glycans by matrix-assisted laser desorption ionization and negative ion nanospray mass spectrometry.Anal Biochem 2008; 376:44-60; PMID:18294950; http://dx.doi.org/10.1016/j.ab.2008.01.025 46.,OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
Acta Cryst F 2011; 67:785-9; PMID:21795794; http://dx.doi.org/10.1107/S1744309111017672 47.,OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
Anal Biochem 1989; 180:195-204; PMID:2510544; http://dx.doi.org/10.1016/0003-2697(89)90115-2 48.,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
2006; 34 (Database issue):D500-3; PMID:16381920; http://dx.doi.org/ 10.1093/nar/gkj054 49.,OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
mAbs 2015; 7:9-14; PMID:25529996; http://dx.doi.org/10.4161/19420862.2015.989042 50.,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
Front Immunol 2013; 4:217; PMID:23908655; http://dx.doi.org/10.3389/ ﬁmmu.2013.00217 52.,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
Pharmaceut Bioproc 2013; 1:71-87;http://dx.doi.org/10.4155/pbp.13.8 53.,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
Biotechnol Bio- eng 2008; 100(6):1132-43; PMID:18553400; http://dx.doi.org/10.1002/bit.21855 54.,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
Bio- technol Prog 2005; 21:11-6; PMID:15903235; http://dx.doi.org/ 10.1021/bp040016j 55.,OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
Elec- trophoresis 2008; 29:3612-20; PMID:18803223; http://dx.doi.org/ 10.1002/elps.200700958 57.,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
2013; 190(8):4315-23; PMID:23509345; http://dx.doi.org/10.4049/ jimmunol.1200501 58.,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
2012; 420(1-2):1-7; PMID:22484364; http://dx.doi.org/10.1016/j.jmb.2012.04.002 59.,OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
2006; 43(8):1183-93; PMID:16102830; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
The Golgi apparatus of Tetrahymena thermophila .J Eukaryot Microbiol 1993; 40:10-3; PMID:8457796; http://dx.doi.org/ 10.1111/j.1550-7408.1993.tb04874.x 62.,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
Glycobiology 2009; 19:936-49; PMID:19494347; http://dx.doi.org/10.1093/glycob/cwp079 64.,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
MAbs 2013; 5:501-11; PMID:23563583; http://dx.doi.org/10.4161/mabs.23942 65.,OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
Exp Cell Res 1987; 170:259-68; PMID:2954837; http://dx.doi.org/10.1016/0014-4827(87)90304-1 66.,OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
J Mol Biol 2003; 325:979-989; PMID:12527303; http://dx.doi.org/10.1016/S0022-2836(02)01250-0 67.,OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
J Mol Biol 2009; 387:1061-66; PMID:19236877; http://dx.doi.org/10.1016/j.jmb.2009.02.033 68.,OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
Glycobiology 2011; 21:949-59; PMID:21421994; http://dx.doi.org/10.1093/glycob/cwr027 69.,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
Methods Cell Biol 2000; 62:485- 500; PMID:10503213; http://dx.doi.org/10.1016/S0091-679X(08)61552-6 71.,OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
Nature 1970; 227:680-5; PMID: 5432063; http://dx.doi.org/10.1038/227680a0 72.,OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
JImmunol Methods 2014; 408:24-34; PMID:24810583; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
J Proteome Res 2009; 8:681-7; PMID:19099509; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
Proteomics 2009; 9:3796- 3801; PMID:19670245; http://dx.doi.org/10.1002/pmic.200-900096 76.,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
EMBO J 1997; 16:4302-10; PMID:9250674; http://dx.doi.org/10.1093/emboj/16.14.4302MABS 1511,Non-OADS,/arxiv_data1/oa_pdf/3a/7f/kmab-08-08-1228504.PMC5098438.pdf
"8, 1612 –1619 http://dx.doi.org/10.1080/19420862.2016.1229722",Non-OADS,/arxiv_data1/oa_pdf/a5/ce/kmab-08-08-1229722.PMC5098440.pdf
"ORCID Montserrat Carrasco-Triguero http://orcid.org/0000-0002-2805-1008 References 1. van Hal SJ, Jensen SO, Vaska VL, Espedido BA, Paterson DL, Gosbell IB.",Non-OADS,/arxiv_data1/oa_pdf/a5/ce/kmab-08-08-1229722.PMC5098440.pdf
ClinMicrobiol Rev 2012; 25:362-86; PMID:22491776; http://dx.doi.org/ 10.1128/CMR.05022-11 2.,Non-OADS,/arxiv_data1/oa_pdf/a5/ce/kmab-08-08-1229722.PMC5098440.pdf
J Clin Invest 2009; 119:2464-74;PMID:19729844; http://dx.doi.org/10.1172/JCI38226 3.,Non-OADS,/arxiv_data1/oa_pdf/a5/ce/kmab-08-08-1229722.PMC5098440.pdf
Clin Infect Dis 2014; 58:1515-22; PMID:24762631; http://dx.doi.org/10.1093/cid/ciu135 4.,Non-OADS,/arxiv_data1/oa_pdf/a5/ce/kmab-08-08-1229722.PMC5098440.pdf
Nat Rev Microbiol 2011; 9:215-22; PMID:21297670; http://dx.doi.org/10.1038/nrmicro2508 5.,OADS,/arxiv_data1/oa_pdf/a5/ce/kmab-08-08-1229722.PMC5098440.pdf
Nature 2015; PMID:26536114; http://dx.doi.org/10.1038/nature16057 6.,OADS,/arxiv_data1/oa_pdf/a5/ce/kmab-08-08-1229722.PMC5098440.pdf
Nat Biotechnol 2012; 30:184-9; PMID:22267010; http://dx.doi.org/10.1038/nbt.2108 8.,OADS,/arxiv_data1/oa_pdf/a5/ce/kmab-08-08-1229722.PMC5098440.pdf
Bioanalysis 2013; 5:201-26; PMID:23330562; http://dx.doi.org/10.4155/bio.12.299 9.,Non-OADS,/arxiv_data1/oa_pdf/a5/ce/kmab-08-08-1229722.PMC5098440.pdf
Bioanalysis 2013;5:997-1006; PMID:23641692; http://dx.doi.org/10.4155/bio.13.38 10.,Non-OADS,/arxiv_data1/oa_pdf/a5/ce/kmab-08-08-1229722.PMC5098440.pdf
Expert Opin Drug Metab Toxicol 2012; 8:141-60;PMID:22248267; http://dx.doi.org/10.1517/17425255.2012.643868 11.,Non-OADS,/arxiv_data1/oa_pdf/a5/ce/kmab-08-08-1229722.PMC5098440.pdf
MAbs 2011; 3:61-6; PMID:20962582; http://dx.doi.org/10.4161/mabs.3.1.13799 12.,Non-OADS,/arxiv_data1/oa_pdf/a5/ce/kmab-08-08-1229722.PMC5098440.pdf
Nat Biotechnol 2008; 26:925-32; PMID:18641636; http://dx.doi.org/ 10.1038/nbt.1480 13.,Non-OADS,/arxiv_data1/oa_pdf/a5/ce/kmab-08-08-1229722.PMC5098440.pdf
"Wang W, Lu P, Fang Y, Hamuro L, Pittman T, Carr B, Hochman J, Prueksaritanont T. Monoclonal antibodies with identical Fc sequences can bind to FcRn differentially with pharmacokinetic consequences.Drug Metab Dispos 2011; 39:1469-77; PMID:21610128; http://dx.doi.org/10.1124/dmd.111.039453 15.",Non-OADS,/arxiv_data1/oa_pdf/a5/ce/kmab-08-08-1229722.PMC5098440.pdf
PharmRes 2015; 32:1884-93; PMID:25446772; http://dx.doi.org/10.1007/ s11095-014-1582-1 16.http://www.lymepa.org/Antibiotics_spreadsheet_2004-1215.pdf 17.,Non-OADS,/arxiv_data1/oa_pdf/a5/ce/kmab-08-08-1229722.PMC5098440.pdf
Int J Antimicrob Agents 2009; 33:564-8;PMID:19233622; http://dx.doi.org/10.1016/j.ijantimicag.2008.12.010MABS 1619,OADS,/arxiv_data1/oa_pdf/a5/ce/kmab-08-08-1229722.PMC5098440.pdf
"**Present address: NGM Biopharmaceuticals, South San Francisco, CA 94080, USA Published with license by Taylor & Francis Group, LLC © Yiyuan Yin, Guanghui Han, Jianhui Zhou, Michael Dillon, Luke McCarty, Lou Gavino, Diego Ellerm an, Christoph Spiess, Wendy Sandoval, and Paul J. Carter This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/16/5b/kmab-08-08-1232217.PMC5098441.pdf
"8, 1467 –1476 http://dx.doi.org/10.1080/19420862.2016.1232217",Non-OADS,/arxiv_data1/oa_pdf/16/5b/kmab-08-08-1232217.PMC5098441.pdf
ORCID Yiyuan Yin http://orcid.org/0000-0003-1077-810X Guanghui Han http://orcid.org/0000-0002-9893-9168 Lou Gavino http://orcid.org/0000-0003-0398-7595 Diego Ellerman http://orcid.org/0000-0002-3056-3600 Paul J. Carter http://orcid.org/0000-0001-7854-062X References 1.,Non-OADS,/arxiv_data1/oa_pdf/16/5b/kmab-08-08-1232217.PMC5098441.pdf
Drug Discov Today 2015; 20:838-47; PMID:25728220; http://dx.doi.org/10.1016/j.drudis.2015.02.008 2.,OADS,/arxiv_data1/oa_pdf/16/5b/kmab-08-08-1232217.PMC5098441.pdf
Mol Immunol 2015; 67:95-106; PMID:25637431; http://dx.doi.org/10.1016/j.molimm.2015.01.003 3.,Non-OADS,/arxiv_data1/oa_pdf/16/5b/kmab-08-08-1232217.PMC5098441.pdf
Curr Opin Immunol 2016; 40:vii-xiii; PMID:27083411; http://dx.doi.org/10.1016/j.coi.2016.04.001 4.,OADS,/arxiv_data1/oa_pdf/16/5b/kmab-08-08-1232217.PMC5098441.pdf
Trends Biotechnol 2013; 31:621-32; PMID:24094861; http://dx.doi.org/10.1016/j.tibtech.2013.08.007 5.,OADS,/arxiv_data1/oa_pdf/16/5b/kmab-08-08-1232217.PMC5098441.pdf
J Immunol Methods 2001; 248:7-15; PMID:11223065; http://dx.doi.org/10.1016/S0022-1759(00)00339-2 6.,Non-OADS,/arxiv_data1/oa_pdf/16/5b/kmab-08-08-1232217.PMC5098441.pdf
MAbs 2012; 4:653-63; PMID:22925968; http://dx.doi.org/10.4161/mabs.21379 7.,Non-OADS,/arxiv_data1/oa_pdf/16/5b/kmab-08-08-1232217.PMC5098441.pdf
J Mol Biol 1997; 270:26-35; PMID:9231898; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/16/5b/kmab-08-08-1232217.PMC5098441.pdf
ProteinEng 1996; 9:617-21; PMID:8844834; http://dx.doi.org/10.1093/ protein/9.7.6179.,OADS,/arxiv_data1/oa_pdf/16/5b/kmab-08-08-1232217.PMC5098441.pdf
J Mol Biol 2012; 420:204-19; PMID:22543237; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/16/5b/kmab-08-08-1232217.PMC5098441.pdf
J Biol Chem 2010; 285:19637-46; PMID:20400508; http://dx.doi.org/10.1074/jbc.M110.117382 11.,OADS,/arxiv_data1/oa_pdf/16/5b/kmab-08-08-1232217.PMC5098441.pdf
MAbs 2011; 3:546-57; PMID:22123055;http://dx.doi.org/10.4161/mabs.3.6.18123 12.,Non-OADS,/arxiv_data1/oa_pdf/16/5b/kmab-08-08-1232217.PMC5098441.pdf
MAbs 2013; 5:646-54; PMID:23924797; http://dx.doi.org/10.4161/mabs.25632 13.,Non-OADS,/arxiv_data1/oa_pdf/16/5b/kmab-08-08-1232217.PMC5098441.pdf
Nat Biotechnol 1998; 16:677-81; PMID:9661204; http://dx.doi.org/10.1038/nbt0798-677 14.,Non-OADS,/arxiv_data1/oa_pdf/16/5b/kmab-08-08-1232217.PMC5098441.pdf
PLoS One 2013; 8:e57479; PMID:23468998; http://dx.doi.org/10.1371/journal.pone.0057479 15.,Non-OADS,/arxiv_data1/oa_pdf/16/5b/kmab-08-08-1232217.PMC5098441.pdf
Nat Biotechnol 2013; 31:753-8; PMID: 23831709; http://dx.doi.org/10.1038/nbt.2621 16.,OADS,/arxiv_data1/oa_pdf/16/5b/kmab-08-08-1232217.PMC5098441.pdf
Nat Biotechnol 2014; 32:191-8; PMID:24463572; http://dx.doi.org/ 10.1038/nbt.2797 17.,OADS,/arxiv_data1/oa_pdf/16/5b/kmab-08-08-1232217.PMC5098441.pdf
MAbs 2015; 7:377-89; PMID:25621507; http://dx.doi.org/10.1080/19420862.2015.1007816 1 8 .,Non-OADS,/arxiv_data1/oa_pdf/16/5b/kmab-08-08-1232217.PMC5098441.pdf
J Biol Chem 2015; 290:7535-62; PMID:25583986; http://dx.doi.org/10.1074/jbc.M114.620260 19.,OADS,/arxiv_data1/oa_pdf/16/5b/kmab-08-08-1232217.PMC5098441.pdf
J Chromatogr B Analyt Technol Biomed Life Sci 2016; pii: S1570-0232(16)30193-3; PMID:27108304;http://dx.doi.org/10.1016/j.jchromb.2016.03.044 21.,OADS,/arxiv_data1/oa_pdf/16/5b/kmab-08-08-1232217.PMC5098441.pdf
MAbs 2016; 8:331-9; PMID:26655595; http://dx.doi.org/10.1080/19420862.2015.1122150 22.,OADS,/arxiv_data1/oa_pdf/16/5b/kmab-08-08-1232217.PMC5098441.pdf
Anal Chem 2014; 86:10674-83; PMID:25270580; http://dx.doi.org/10.1021/ac502593nMABS 1475,Non-OADS,/arxiv_data1/oa_pdf/16/5b/kmab-08-08-1232217.PMC5098441.pdf
Mabs 2013; 5:711-22; PMID:23884083; http://dx.doi.org/10.4161/mabs.25488 24.,Non-OADS,/arxiv_data1/oa_pdf/16/5b/kmab-08-08-1232217.PMC5098441.pdf
MAbs 2016; 8:49-55; PMID:26496506; http://dx.doi.org/ 10.1080/19420862.2015.1111498 25.,OADS,/arxiv_data1/oa_pdf/16/5b/kmab-08-08-1232217.PMC5098441.pdf
Angew Chem Int Ed Engl 2012; 51:12992-6; PMID:23172610; http://dx.doi.org/10.1002/anie.201206745 26.,OADS,/arxiv_data1/oa_pdf/16/5b/kmab-08-08-1232217.PMC5098441.pdf
Anal Chem 2012; 84:7227-32; PMID:22882109; http://dx.doi.org/10.1021/ac301611d 27.,Non-OADS,/arxiv_data1/oa_pdf/16/5b/kmab-08-08-1232217.PMC5098441.pdf
MAbs 2014; 6:197-203; PMID:24351421; http://dx.doi.org/10.4161/mabs.27126 29.,Non-OADS,/arxiv_data1/oa_pdf/16/5b/kmab-08-08-1232217.PMC5098441.pdf
Proc Natl Acad Sci U S A 1992; 89:4285-9; PMID:1350088; http://dx.doi.org/10.1073/ pnas.89.10.4285 30.,OADS,/arxiv_data1/oa_pdf/16/5b/kmab-08-08-1232217.PMC5098441.pdf
Biotechnol Bioeng 2008; 100:1132-43; PMID:18553400; http://dx.doi.org/10.1002/ bit.21855 32.,Non-OADS,/arxiv_data1/oa_pdf/16/5b/kmab-08-08-1232217.PMC5098441.pdf
Nat Rev Immunol 2010; 10:345-52; PMID:20414207; http://dx.doi.org/10.1038/nri2747 33.,Non-OADS,/arxiv_data1/oa_pdf/16/5b/kmab-08-08-1232217.PMC5098441.pdf
Cancer Cell 2016; 29:117-29; PMID:26766593; http://dx.doi.org/ 10.1016/j.ccell.2015.12.008 35.,Non-OADS,/arxiv_data1/oa_pdf/16/5b/kmab-08-08-1232217.PMC5098441.pdf
Sci Transl Med 2015; 7:287ra70; PMID:25972002; http://dx.doi.org/10.1126/scitranslmed.aaa4802 36.,Non-OADS,/arxiv_data1/oa_pdf/16/5b/kmab-08-08-1232217.PMC5098441.pdf
PLoS One 2013; 8:e68755;PMID:23874750; http://dx.doi.org/10.1371/journal.pone.0068755 38.,Non-OADS,/arxiv_data1/oa_pdf/16/5b/kmab-08-08-1232217.PMC5098441.pdf
Biotechnol Bioeng 2015; 112:1832-42; PMID:25851051; http://dx.doi.org/10.1002/bit.256011476 Y. YIN ET AL.,OADS,/arxiv_data1/oa_pdf/16/5b/kmab-08-08-1232217.PMC5098441.pdf
"8, 1598 –1605 http://dx.doi.org/10.1080/19420862.2016.1226716",Non-OADS,/arxiv_data1/oa_pdf/0f/12/kmab-08-08-1226716.PMC5098442.pdf
A metalloprotei- nase disintegrin that releases tumour-necrosis factor-alpha from cells.Nature 1997; 385:729-33; PMID:9034190; http://dx.doi.org/10.1038/385729a0 3.,Non-OADS,/arxiv_data1/oa_pdf/0f/12/kmab-08-08-1226716.PMC5098442.pdf
Nature 1997; 385:733-6; PMID:9034191; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0f/12/kmab-08-08-1226716.PMC5098442.pdf
J Biol Chem 2002; 277:12838-45; PMID:11823465; http://dx.doi.org/10.1074/jbc.M112050200 5.,OADS,/arxiv_data1/oa_pdf/0f/12/kmab-08-08-1226716.PMC5098442.pdf
J Cell Biol 2004; 164:769-79; PMID:14993236; http://dx.doi.org/10.1083/jcb.200307137 6 .,OADS,/arxiv_data1/oa_pdf/0f/12/kmab-08-08-1226716.PMC5098442.pdf
Exp Opin Drug Discov- ery 2013; 8:157-81; PMID:23231541; http://dx.doi.org/10.1517/17460441.2013.744745 7.,Non-OADS,/arxiv_data1/oa_pdf/0f/12/kmab-08-08-1226716.PMC5098442.pdf
Bioorg Med Chem 2009; 17:444-59;PMID:19095454; http://dx.doi.org/10.1016/j.bmc.2008.11.067 8.,OADS,/arxiv_data1/oa_pdf/0f/12/kmab-08-08-1226716.PMC5098442.pdf
Pro-tein Sci 2008; 17:16-21; PMID:18042673; http://dx.doi.org/10.1110/ps.073287008 11.,OADS,/arxiv_data1/oa_pdf/0f/12/kmab-08-08-1226716.PMC5098442.pdf
J Biol Chem 2008; 283:1501-7; PMID:17991750; http://dx.doi.org/ 10.1074/jbc.M705879200 12.,OADS,/arxiv_data1/oa_pdf/0f/12/kmab-08-08-1226716.PMC5098442.pdf
J Biol Chem 2013; 288:22871-9; PMID:23779109;http://dx.doi.org/10.1074/jbc.M113.462267 14.,OADS,/arxiv_data1/oa_pdf/0f/12/kmab-08-08-1226716.PMC5098442.pdf
Mol Cancer Ther 2015; 14:1637-49; PMID:25948294; http://dx.doi.org/10.1158/1535-7163.MCT-14-1040 15.,Non-OADS,/arxiv_data1/oa_pdf/0f/12/kmab-08-08-1226716.PMC5098442.pdf
J Mol Biol 1996; 263:800-15; PMID:8947577; http://dx.doi.org/ 10.1006/jmbi.1996.0617 16.,Non-OADS,/arxiv_data1/oa_pdf/0f/12/kmab-08-08-1226716.PMC5098442.pdf
Bioorg Med Chem Lett 2008; 18:5809-14; PMID:18835710; http://dx.doi.org/10.1016/j.bmcl.2008.09.045 17.,OADS,/arxiv_data1/oa_pdf/0f/12/kmab-08-08-1226716.PMC5098442.pdf
Bioorg Med Chem 2009; 17:3604-17; PMID:19394232; http://dx.doi.org/10.1016/j.bmc.2009.04.003 18.,OADS,/arxiv_data1/oa_pdf/0f/12/kmab-08-08-1226716.PMC5098442.pdf
J Mol Biol 2008; 381:1307-19; PMID:18638486; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/0f/12/kmab-08-08-1226716.PMC5098442.pdf
Bioorg Med Chem Lett2010; 20:5286-9; PMID:20663669; http://dx.doi.org/10.1016/j.bmcl.,OADS,/arxiv_data1/oa_pdf/0f/12/kmab-08-08-1226716.PMC5098442.pdf
Bioorg MedChem Lett 2011; 21:3172-6; PMID:21458257; http://dx.doi.org/10.1016/j.bmcl.2011.01.002 21.,OADS,/arxiv_data1/oa_pdf/0f/12/kmab-08-08-1226716.PMC5098442.pdf
Protein Eng Des Sel 2014; 27:179-90; PMID:24769623; http://dx.doi.org/10.1093/protein/gzu010 23.,OADS,/arxiv_data1/oa_pdf/0f/12/kmab-08-08-1226716.PMC5098442.pdf
Cell 2005;123:291-304; PMID:16239146; http://dx.doi.org/10.1016/j.cell.2005.08.014 24.,OADS,/arxiv_data1/oa_pdf/0f/12/kmab-08-08-1226716.PMC5098442.pdf
J Biol Chem 2004; 279:24179-88; PMID:15066986; http://dx.doi.org/10.1074/jbc.M312141200 26.,OADS,/arxiv_data1/oa_pdf/0f/12/kmab-08-08-1226716.PMC5098442.pdf
Proteins 2003; 52:80-7; PMID:12784371; http://dx.doi.org/10.1002/prot.10389 27.,OADS,/arxiv_data1/oa_pdf/0f/12/kmab-08-08-1226716.PMC5098442.pdf
J Comput Chem 1983; 4:187-217; http://dx.doi.org/10.1002/jcc.540040211 28.,OADS,/arxiv_data1/oa_pdf/0f/12/kmab-08-08-1226716.PMC5098442.pdf
Proteins 2003; 53:693-707; PMID:14579360;http://dx.doi.org/10.1002/prot.10460 29.,Non-OADS,/arxiv_data1/oa_pdf/0f/12/kmab-08-08-1226716.PMC5098442.pdf
J Mol Biol 1987; 196:901-17; PMID:3681981; http://dx.doi.org/10.1016/0022-2836(87)90412-8 30.,Non-OADS,/arxiv_data1/oa_pdf/0f/12/kmab-08-08-1226716.PMC5098442.pdf
Eur J Med Chem 2016; 111:193-201; PMID:26871660; http://dx.doi.org/ 10.1016/j.ejmech.2016.01.053 32.,OADS,/arxiv_data1/oa_pdf/0f/12/kmab-08-08-1226716.PMC5098442.pdf
J Biol Chem 2009; 284:29077-86; PMID:19692335; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/0f/12/kmab-08-08-1226716.PMC5098442.pdf
"8, 1525 –1535 http://dx.doi.org/10.1080/19420862.2016.1231277",Non-OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
MAbs 2015; 7:1-8; PMID:25484055; http://dx.doi.org/10.4161/19420862.2015.988944 2.,Non-OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
Crit Rev Oncol Hematol 2007;64:226-33; PMID:17716905; http://dx.doi.org/10.1016/j.critrevonc.2007.06.013 3.,Non-OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
J ChromatogrB Biomed Sci Appl 2001; 752:233-45; PMID:11270864; http://dx.doi.org/10.1016/S0378-4347(00)00548-X 5.,OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
"Houde D, Peng Y, Berkowitz SA, Engen JR. Post-translational modi ﬁ- cations differentially affect IgG1 conformation and receptor binding.Mol Cell Proteomics 2010; 9:1716-28; PMID:20103567; http://dx.doi.org/10.1074/mcp.M900540-MCP200 6.",OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
Mol Bio- technol 2008; 39:113-8; PMID:18327554; http://dx.doi.org/10.1007/ s12033-008-9049-4 7.,Non-OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
J Pharm Sci 2008; 97:2426-47;PMID:17828757; http://dx.doi.org/10.1002/jps.21180 8.,Non-OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
Mol Immunol 2009; 46:1878-82; PMID:19269032; http://dx.doi.org/10.1016/j.molimm.2009.02.002 9.,Non-OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
MAbs 2014; 6:327-39; PMID:24441081; http://dx.doi.org/10.4161/mabs.27876 10.,OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
Mol Immunol 2011; 48:860-6; PMID:21256596; http://dx.doi.org/ 10.1016/j.molimm.2010.12.009 11.,Non-OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
J Chromatogr B Analyt Technol Biomed Life Sci 2007; 850:285-94; PMID:17182291; http://dx.doi.org/10.1016/j.jchromb.2006.11.050 12.,OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
Autoim-mun Rev 2008; 7:574-8; PMID:18625447; http://dx.doi.org/10.1016/j.autrev.2008.04.009 13.,OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
"Hensel M, Steurer R, Fichtl J, Elger C, Wedekind F, Petzold A, Schlothauer T, Molhoj M, Reusch D, Bulau P. Identi ﬁcation of potential sites for trypto- phan oxidation in recombinant antibodies using tert-butylhydroperoxideand quantitative LC-MS. PLoS One 2011; 6:e17708; PMID:21390239; http://dx.doi.org/10.1371/journal.pone.0017708 14.",Non-OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
Biochemistry 2008; 47:8665-77; PMID:18652490; http://dx.doi.org/10.1021/bi800806d 15.,Non-OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
J Pharm Sci 2012; 101:4248-57; PMID:22899501; http://dx.doi.org/10.1002/jps.23286 16.,Non-OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
MAbs 2013; 5:576-86; PMID:23765230; http://dx.doi.org/10.4161/mabs.24981 17.,Non-OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
2015 Feb;104 (2):368-77; Epub 2014 Aug 29; PMID: 25175600; http://dx.doi.org/10.1002/jps.24136 18.,Non-OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
"Gaza-Bulseco G, Faldu S, Hurkmans K, Chumsae C, Liu H. Effect of methionine oxidation of a recombinant monoclonal antibody on the binding af ﬁnity to protein A and protein G. J Chromatogr B Analyt Technol Biomed Life Sci 2008; 870:55-62; PMID:18567545; http://dx.doi.org/10.1016/j.jchromb.2008.05.045 19.",OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
Mol Immunol 2008; 45:701-8; PMID:17719636; http://dx.doi.org/10.1016/j.molimm.2007.07.012 20.,Non-OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
MAbs 2014; 6:1229-42; PMID:25517308; http://dx.doi.org/10.4161/mabs.29601 21.,Non-OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
J Chromatogr A 2011; 1218:2091-7; PMID:21145555; http://dx.doi.org/10.1016/j.chroma.2010.10.107 22.,OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
Anal Chem 2007;Apr 1:79:2797-805; Epub 2014 Aug 29; PMID:17319649; http://dx.doi.org/ 10.1021/ac062311j 23.,OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
J Chromatogr BAnalyt Technol Biomed Life Sci 2011; 879:955-60; PMID:21440514; http://dx.doi.org/10.1016/j.jchromb.2011.03.006 24.,OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
Biochemistry 2006; 45:5384-92;PMID:16618128; http://dx.doi.org/10.1021/bi052438n 2 5 .,Non-OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
J Pharm Sci 2013;102:1712-23; PMID:23568760; http://dx.doi.org/10.1002/jps.2352926.,Non-OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
Int J Pharm 2006; 308:46-51; PMID:16316730;http://dx.doi.org/10.1016/j.ijpharm.2005.10.024 27.,OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
Protein Sci 2009; 18:1573-84; PMID:19544580; http://dx.doi.org/10.1002/pro.173 28.,OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
PLoS One 2014; 9:e100736; PMID:24959685; http://dx.doi.org/10.1371/journal.pone.0100736 29.,Non-OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
J Chromatogr B Analyt Technol Biomed Life Sci 2010; 878:777-84; PMID:20153988; http://dx.doi.org/10.1016/j.jchromb.2010.01.036 3 0 .,OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
J Chromatogr A 2007; 1164:153-61; PMID:17640657; http://dx.doi.org/10.1016/j.chroma.2007.06.063 31.,OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
PLoS One 2012; 7:e30295; PMID:22272329; http://dx.doi.org/10.1371/journal.pone.0030295 32.,Non-OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
Biologicals 2009; 37:313-22; PMID:19608432; http://dx.doi.org/ 10.1016/j.biologicals.2009.06.001 33.,OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
An al Biochem 2009; 392:145-54; PMID: 19497295; http://dx.doi.org/10.1016/j.ab.2009.05.043 34.,OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
J Pharm Sci 2009; 98:3509-21; PMID:19475547; http://dx.doi.org/10.1002/jps.21655 35.,Non-OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
J Pharm Sci 2012; 101:895-913; PMID:22083792; http://dx.doi.org/10.1002/jps.22812 36.,Non-OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
J Pharm Sci 1997; 86:1250-5; PMID:9383735; http://dx.doi.org/10.1021/js970143s 37.,Non-OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
Anal Chem 2008; 80:9491-8; PMID:19072263; http://dx.doi.org/10.1021/ac801617u 38.,Non-OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
MAbs 2014; 6:852-8;PMID:24751784; http://dx.doi.org/10.4161/mabs.28693 39.,Non-OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
J Chromatogr A 2013; 1283:89-97; PMID:23428023; http://dx.doi.org/10.1016/j.chroma.2013.01.101 41.,OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
J Chromatogr B Analyt Technol Biomed Life Sci 2010; 878:1973-81; PMID:20554483; http://dx.doi.org/10.1016/j.jchromb.2010.05.0321534 T. DASHIVETS ET AL.,OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
"Terashima I, Koga A, Nagai H. Identi ﬁcation of deamidation and isomerization sites on pharmaceutical recombinant antibody using H(2)(18)O. Anal Biochem 2007; 368:49-60; PMID:17617368; http://dx.doi.org/10.1016/j.ab.2007.05.012 43.",OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
J Chromatogr B Analyt Technol Biomed Life Sci 2014; 965:65-71; PMID:24999246; http://dx.doi.org/10.1016/j.jchromb.2014.06.018 44.,OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
MAbs 2011; 3:243-52; PMID:21406966; http://dx.doi.org/10.4161/mabs.3.3.15234 45.,Non-OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
Anticancer Drugs 2010; 21:907-16; PMID:20847643; http://dx.doi.org/10.1097/CAD.0b013e32833f5d68 46.,Non-OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
MAbs 2016; 8:811-27; PMID:26984378; http://dx.doi.org/10.1080/19420862.2016.1160989 47.,OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
J BiolChem 2014; 289:18693-706; PMID:24841203; http://dx.doi.org/10.1074/jbc.M113.528109 48.,OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
Oncol Rep 2012; 27:867-72; PMID:22200743; http://dx.doi.org/10.3892/or.2011.159749.,Non-OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
Mol Pharm 2013; 10:2642-52; PMID:23641816; http://dx.doi.org/10.1021/ mp400075f 50.,Non-OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
J Pharm Sci 2013; 102:3567-78; PMID:23873630; http://dx.doi.org/10.1002/jps.23669 51.,Non-OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
Protein Sci 2009; 18:424-33; PMID:19165723; http://dx.doi.org/10.1002/pro.45 53.,Non-OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
J Pharm Sci 2008; 97:1414-26; PMID:17721938; http://dx.doi.org/10.1002/jps.21104 54.,Non-OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
Trends Biotechnol 2013; 31:612-20;PMID:23932102; http://dx.doi.org/10.1016/j.tibtech.2013.07.002 55.,OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
J Exp Med 1970; 132:211-50;PMID:5508247; http://dx.doi.org/10.1084/jem.132.2.211 56.,Non-OADS,/arxiv_data1/oa_pdf/77/3c/kmab-08-08-1231277.PMC5098445.pdf
"CONTACT Janice M. Reichert Reichert.BiotechConsulting@gmail.com Published with license by Taylor & Francis Group, LLC © James W. Larrick, Mark R. Alfenito, Jamie K. Scott, Paul W. H. I. Parren, Dennis R. Burton, Andrew R. M. Bradbury, Cynthia A. Lemere, Anne Messer, James S. Huston, Paul J. Carter, Trudi Veldman, Kerry A. Chester, Janine Schuurman, Gregory P. Adams, and Janice M. Reichert This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unre- stricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/94/21/kmab-08-08-1227665.PMC5098447.pdf
"8, 1425 –1434 http://dx.doi.org/10.1080/19420862.2016.1227665",Non-OADS,/arxiv_data1/oa_pdf/94/21/kmab-08-08-1227665.PMC5098447.pdf
"8, 1548 –1560 http://dx.doi.org/10.1080/19420862.2016.1225642",Non-OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
MAbs 2013; 5:801-9; PMID:23924804; http://dx.doi.org/10.4161/mabs.25215 2 .,Non-OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
Cancer Chemother Pharmacol 2014; 74:1047-55; PMID:25212536; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
MAbs 2016; 8:604-16; PMID:26785755; http://dx.doi.org/10.1080/19420862.2015.1130196 4.,OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
"CurrOpin Biotechnol 2014; 30:140-6; PMID:25022603; http://dx.doi.org/10.1016/j.copbio.2014.06.012 5. van Beers MM, Bardor M. Minimizing immunogenicity of biophar- maceuticals by controlling critical quality attributes of proteins.",OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
Bio-technol J 2012; 7:1473-84; PMID:23027660; http://dx.doi.org/10.1002/biot.201200065 6.,OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
J Pharm Sci 2008; 97:2426-47;PMID:17828757; http://dx.doi.org/10.1002/jps.21180 7.,Non-OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
mAbs 2010; 2:500-7; PMID:20671426; http://dx.doi.org/10.4161/mabs.2.5.12897 8.,Non-OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
Biotechnol J 2012; 7:1462-72; PMID:22829536; http://dx.doi.org/ 10.1002/biot.201200078 9.,Non-OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
Mol Cell Proteo- mics 2013; 12:856-65; PMID:23325769; http://dx.doi.org/10.1074/ mcp.R112.026005 10.,Non-OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
Curr Pharm Biotechnol 2008; 9:482-501;PMID:19075687; http://dx.doi.org/10.2174/138920108786786411 11.,Non-OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
Anal Biochem 2007; 364:8-18; PMID:17362871; http://dx.doi.org/10.1016/j.ab.2007.01.023 12.,OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
IUBMB Life 2000; 50:301-7; PMID:11327324; http://dx.doi.org/10.1080/ 15216540051081056 13.,OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
MAbs 2012; 4:17-23; PMID:22327427; http://dx.doi.org/10.4161/mabs.4.1.18347 14.,Non-OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
Anal Biochem 2011; 410:234-43; PMID:21130067; http://dx.doi.org/10.1016/j.ab.2010.11.040 15.,OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
J Chromatogr A 2013; 1319:65-71;PMID:24183595; http://dx.doi.org/10.1016/j.chroma.2013.10.028 16.,OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
J Chromatogr A 2014; 1373:124-30; PMID:25465369; http://dx.doi.org/10.1016/j.chroma.2014.11.021 17.,OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
"Curr Protoc Pr otein Sci; Chapter 19:Unit 19.3 Wiley, 2006; PMID:18429302; http://dx.doi.org/10.1002/0471140864.ps1913s45 18.",Non-OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
FEBS Lett 2014; 588:288-97; PMID:24295643; http://dx.doi.org/10.1016/j.febslet.2013.11.030 19.,OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
Immunol Lett 2014; 160:139-44; PMID:24495619; http://dx.doi.org/10.1016/j.imlet.2014.01.015 20.,Non-OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
Front Immunol 2014; 5:254;PMID:24910634; http://dx.doi.org/10.3389/ ﬁmmu.2014.00254 21.,Non-OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
Front Immunol 2014; 5:520; PMID:25368619; http://dx.doi.org/10.3389/ ﬁmmu.2014.00520 22.,Non-OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
Nat Rev Immunol 2014; 14:94-108; PMID:24445665; http://dx.doi.org/10.1038/nri3582 23.,Non-OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
Adv Drug Deliv Rev 2015; 91:109-24; PMID:25703189; http://dx.doi.org/10.1016/j.addr.2015.02.005 2 4 .,Non-OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
Expert opinion on biological therapy 2008; 8:759-68;PMID:18476787; http://dx.doi.org/10.1517/14712598.8.6.759 25.,Non-OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
Biotechnol J 2007; 2:700-8; PMID:17427997; http://dx.doi.org/10.1002/biot.200600255 26.,Non-OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
ImmunolLett 2006; 106:144-53; PMID:16831470; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
Ann Pharmacother 2013; 47:210-8; PMID:23386066; http://dx.doi.org/ 10.1345/aph.1R353 28.,Non-OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
mAbs 2012; 4:578-85; PMID:22820257; http://dx.doi.org/ 10.4161/mabs.21328 29.,Non-OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
Nat Rev Drug Discov 2011; 10:101-11; PMID:21283105; http://dx.doi.org/ 10.1038/nrd3365 30.,Non-OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
Glycobiology 2007; 17:104-18; PMID:17012310; http://dx.doi.org/10.1093/glycob/cwl057 31.,Non-OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
Control of recombinant mono- clonal antibody effector functions by Fc N-glycan remodeling in vitro.Biotechnol Prog 2005; 21:1644-52; PMID:16321047; http://dx.doi.org/ 10.1021/bp050228w 32.,Non-OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
Mol Cell Proteomics 2010; 9:1716-28; PMID:20103567; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
Protein Sci 2009; 18:247-51; PMID:19177368; http://dx.doi.org/10.1002/pro.19 34.,Non-OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
MAbs 2014; 6:1145- 54; PMID:25517300; http://dx.doi.org/10.4161/mabs.29883 35.,Non-OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
Mol Immunol 2005; 42:1311-9; PMID:15950727; http://dx.doi.org/10.1016/j.molimm.2004.12.018 36.,Non-OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
"Weinheim, Germany: Wiley; 2005; http://dx.doi.org/10.1002/3527603468 37.",Non-OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
Electrophoresis 1997; 18:328- 37; PMID:9150910; http://dx.doi.org/10.1002/elps.1150180306 3 8 .,Non-OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
J Biotechnol 2012; 157:130-9; PMID:22024589; http://dx.doi.org/10.1016/j.jbiotec.2011.09.023 39.,OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
Mol Pharm 2011; 8:286-96; PMID:21138277; http://dx.doi.org/ 10.1021/mp100353a1560 B. HINTERSTEINER ET AL.,OADS,/arxiv_data1/oa_pdf/dc/27/kmab-08-08-1225642.PMC5098448.pdf
"8, 1435 –1436 http://dx.doi.org/10.1080/19420862.2016.1232218",Non-OADS,/arxiv_data1/oa_pdf/3e/8e/kmab-08-08-1232218.PMC5098449.pdf
"References 1. International Conference on Harmonization of Technical Require- ments for Registration of Pharmaceuticals for Human Use, ICH Har-monized Tripartite Guideline, Pharmaceutical Development, Q8 R2Step 4, August 2009 http://www.ich.org/ ﬁleadmin/Public_Web_Site/ ICH_Products/Guidelines/Qualit y/Q8_R1/Step4/Q8_R2_Guideline.",Non-OADS,/arxiv_data1/oa_pdf/3e/8e/kmab-08-08-1232218.PMC5098449.pdf
"pdf 2. International Conference on Harmonization of Technical Require- ments for Registration of Pharmaceuticals for Human Use, ICH Harmonized Tripartite Guideline, Quality Risk Management, Q9 Step4, 9 November 2005 http://www.ich.org/ ﬁleadmin/Public_Web_Site/ ICH_Products/Guidelines/Quality/Q9/Step4/Q9_Guideline.pdf 3. International Conference on Harmonization of Technical Require- ments for Registration of Pharmaceuticals for Human Use, ICH Har-monized Tripartite Guideline, Pharmaceutical Quality, Q10 Step 4, 4June 2008 http://www.ich.org/ ﬁleadmin/Public_Web_Site/ICH_Prod ucts/Guidelines/Quality/Q10/Step4/Q10_Guideline.pdf 4. International Conference on Harmonization of Technical Require- ments for Registration of Pharmaceuticals for Human Use, ICH Harmonized tripartite guideline, development and manufacture of drug substances (chemical entities and biotechnological/biologicalentities), Q11 Step 4, May 2012 http://www.ich.org/ ﬁleadmin/Public_ Web_Site/ICH_Products/Guidelines/Quality/Q11/Q11_Step_4.pdf 5.",Non-OADS,/arxiv_data1/oa_pdf/3e/8e/kmab-08-08-1232218.PMC5098449.pdf
"Emeryville, CA: CASSS, 2009. http://www.casss.org/?page D286 8.",Non-OADS,/arxiv_data1/oa_pdf/3e/8e/kmab-08-08-1232218.PMC5098449.pdf
"Nature Biotechnology, 2009; 27:26-7; PMID:19131992; http://dx.doi.",OADS,/arxiv_data1/oa_pdf/3e/8e/kmab-08-08-1232218.PMC5098449.pdf
Mabs 2015; 7:451-455;PMID:25853461; http://dx.doi.org/10.1080/19420862.2015.1023058 12.,Non-OADS,/arxiv_data1/oa_pdf/3e/8e/kmab-08-08-1232218.PMC5098449.pdf
Food and Drug Administration BLA Market Approval Letter for Gaz- yvahttp://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/125486 Orig1s000Approv.pdf 13.,Non-OADS,/arxiv_data1/oa_pdf/3e/8e/kmab-08-08-1232218.PMC5098449.pdf
Food and Drug Administration BLA Market Approval Letter for Tecentriq http://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/ 761034Orig1s000Approv.pdf 14.,Non-OADS,/arxiv_data1/oa_pdf/3e/8e/kmab-08-08-1232218.PMC5098449.pdf
Biologicals 2016 44:281; http://dx.doi.org/ 10.1016/j.biologicals.2016.06.010 15.,OADS,/arxiv_data1/oa_pdf/3e/8e/kmab-08-08-1232218.PMC5098449.pdf
Biologicals 2016 44:282-290; http://dx.doi.org/10.1016/j.biologicals.2016.07.004 16.,OADS,/arxiv_data1/oa_pdf/3e/8e/kmab-08-08-1232218.PMC5098449.pdf
Biologicals 2016 44:291-305; http://dx.doi.org/ 10.1016/j.biologicals.2016.06.005 17.,OADS,/arxiv_data1/oa_pdf/3e/8e/kmab-08-08-1232218.PMC5098449.pdf
Biologicals 2016 44:306-318; http://dx.doi.org/10.1016/j.biologicals.2016.06.004; PMID:27464992 18.,OADS,/arxiv_data1/oa_pdf/3e/8e/kmab-08-08-1232218.PMC5098449.pdf
Biologicals 2016 44:332-340; PMID:27449920; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/3e/8e/kmab-08-08-1232218.PMC5098449.pdf
Biologicals 2016 44: 341-351; http://dx.doi.org/10.1016/j.biologicals.2016.06.001 21.,OADS,/arxiv_data1/oa_pdf/3e/8e/kmab-08-08-1232218.PMC5098449.pdf
Mabs 2009; 1:443-452; PMID:20065641; http://dx.doi.org/10.4161/mabs.1.5.94481436 B. KELLEY,Non-OADS,/arxiv_data1/oa_pdf/3e/8e/kmab-08-08-1232218.PMC5098449.pdf
"8, 1456 –1466 http://dx.doi.org/10.1080/19420862.2016.1227901",Non-OADS,/arxiv_data1/oa_pdf/e6/ca/kmab-08-08-1227901.PMC5098453.pdf
The Base CaseSuperPro Designer /C210model developed in this study can be downloaded at the following website ( http://ghs.ucdavis.edu/ pmpdownload.shtml ).,OADS,/arxiv_data1/oa_pdf/e6/ca/kmab-08-08-1227901.PMC5098453.pdf
MAbs 2015; 7:9-14; PMID:25529996; http://dx.doi.org/ 10.4161/19420862.2015.989042 2.,Non-OADS,/arxiv_data1/oa_pdf/e6/ca/kmab-08-08-1227901.PMC5098453.pdf
Plant Biotechnol J 2010; 8:529-63;PMID:20132515; http://dx.doi.org/10.1111/j.1467-7652.2009.00494.x 4.,OADS,/arxiv_data1/oa_pdf/e6/ca/kmab-08-08-1227901.PMC5098453.pdf
Curr Pharm Des 2005; 11:2429-37; PMID:16026297; http://dx.doi.org/10.2174/ 1381612054367508 5.,Non-OADS,/arxiv_data1/oa_pdf/e6/ca/kmab-08-08-1227901.PMC5098453.pdf
PLoS One 2010; 5: e15559; PMID:21203523; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/e6/ca/kmab-08-08-1227901.PMC5098453.pdf
Exp Rev Vaccines 2013; 12:211-24; PMID:23414411; http://dx.doi.org/10.1586/erv.12.147 8.,Non-OADS,/arxiv_data1/oa_pdf/e6/ca/kmab-08-08-1227901.PMC5098453.pdf
Nat Biotech 2012; 30:472; http://dx.doi.org/10.1038/nbt0612-472 9.,OADS,/arxiv_data1/oa_pdf/e6/ca/kmab-08-08-1227901.PMC5098453.pdf
Curr Opin Biotechnol 2015; 32:163-70; PMID:25578557; http://dx.doi.org/10.1016/j.copbio.2014.12.008 10.,OADS,/arxiv_data1/oa_pdf/e6/ca/kmab-08-08-1227901.PMC5098453.pdf
Nature 1989; 342:76-8; PMID:2509938; http://dx.doi.org/ 10.1038/342076a0 11.,Non-OADS,/arxiv_data1/oa_pdf/e6/ca/kmab-08-08-1227901.PMC5098453.pdf
Biotechnol Adv 2009; 27:811-32; PMID:19576278; http://dx.doi.org/10.1016/j.biotechadv.2009.06.004 14.,OADS,/arxiv_data1/oa_pdf/e6/ca/kmab-08-08-1227901.PMC5098453.pdf
Annu Rev Phytopathol 2010; 48:45-68;PMID:20337518; http://dx.doi.org/10.1146/annurev-phyto-080508- 081852 15.,Non-OADS,/arxiv_data1/oa_pdf/e6/ca/kmab-08-08-1227901.PMC5098453.pdf
Virology 2010; 405:93-9; PMID:20673747; http://dx.doi.org/10.1016/j.virol.2010.05.016 17.,Non-OADS,/arxiv_data1/oa_pdf/e6/ca/kmab-08-08-1227901.PMC5098453.pdf
Plant Biotechnol J 2015; 13:1180-90; PMID:26387511; http://dx.doi.org/10.1111/pbi.12469 18.,OADS,/arxiv_data1/oa_pdf/e6/ca/kmab-08-08-1227901.PMC5098453.pdf
Biomed Res Int 2014; 2014:256135; PMID:24977145; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e6/ca/kmab-08-08-1227901.PMC5098453.pdf
Appl Bi ochem Biotechnol 2015; 175:841-54; PMID:25344434; http://dx.doi.org/10.1007/s12010-014-1320-5 20.,Non-OADS,/arxiv_data1/oa_pdf/e6/ca/kmab-08-08-1227901.PMC5098453.pdf
Biotechnol Bioeng 2012; 109:2575-88; PMID:22511291; http://dx.doi.org/10.1002/bit.24523 21.,OADS,/arxiv_data1/oa_pdf/e6/ca/kmab-08-08-1227901.PMC5098453.pdf
Adv Drug Delivery Rev 2006; 58:671-85; PMID:16822577; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/e6/ca/kmab-08-08-1227901.PMC5098453.pdf
J Chromatogr B Analyt Technol Biomed Life Sci 2007; 848:8- 18; PMID:16899415; http://dx.doi.org/10.1016/j.jchromb.2006.07.037 23.,OADS,/arxiv_data1/oa_pdf/e6/ca/kmab-08-08-1227901.PMC5098453.pdf
J Biotechnol 2015; 213:3-12; PMID:26014522; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e6/ca/kmab-08-08-1227901.PMC5098453.pdf
"New York, NY: Springer, 2012; http://dx.doi.org/10.1007/978-94-007-2217-0_1125.",Non-OADS,/arxiv_data1/oa_pdf/e6/ca/kmab-08-08-1227901.PMC5098453.pdf
Transgenic Res 2005; 14:237-49;PMID:16145832; http://dx.doi.org/10.1007/s11248-004-8120-6 26.,Non-OADS,/arxiv_data1/oa_pdf/e6/ca/kmab-08-08-1227901.PMC5098453.pdf
J Biotechnol 2004; 113:171-82; PMID:15380655;http://dx.doi.org/10.1016/j.jbiotec.2004.04.036 27.,OADS,/arxiv_data1/oa_pdf/e6/ca/kmab-08-08-1227901.PMC5098453.pdf
J Biotechnol 2015; 213:42-53; PMID:25959171; http://dx.doi.org/10.1016/j.jbiotec.2015.04.020 28.,OADS,/arxiv_data1/oa_pdf/e6/ca/kmab-08-08-1227901.PMC5098453.pdf
Mabs 2009; 1:443-52;PMID:20065641; http://dx.doi.org/10.4161/mabs.1.5.9448 29.,Non-OADS,/arxiv_data1/oa_pdf/e6/ca/kmab-08-08-1227901.PMC5098453.pdf
Bioengineer- ing 2014; 1:154-87; http://dx.doi.org/10.3390/bioengineering1040154 30.,Non-OADS,/arxiv_data1/oa_pdf/e6/ca/kmab-08-08-1227901.PMC5098453.pdf
Nat Rev Genet 2003; 4:794-805; PMID:14526375; http://dx.doi.org/10.1038/nrg1177 31.,Non-OADS,/arxiv_data1/oa_pdf/e6/ca/kmab-08-08-1227901.PMC5098453.pdf
Available at: http://www.escrs.org/endophthalmitis/guidelines/ENGLISH.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c2/d6/ecl-42-366.PMC5098457.pdf
Available at: https://www.uab.edu/medicine/inter - macs/appendices-4-0/appendix-a-4-0.,Non-OADS,/arxiv_data1/oa_pdf/26/c1/mat-62-719.PMC5098459.pdf
"Nonrandomization was due to a delivery delay of the LipiFlow thermal pulsation machine, together with the Lipi- View ocular surface interferometer and standardized force meibo-mian gland evaluator (Details in Supplemental Digital Content 1,http://links.lww.com/ICL/A32).",Non-OADS,/arxiv_data1/oa_pdf/49/a0/ecl-42-339.PMC5098463.pdf
"Inclusion criteria were the following: •At least one of eight dry eye symptoms (Supplemental Digital Content 2, http://links.lww.com/ICL/A33 —questionnaire modi- ﬁed after Schein et al.",Non-OADS,/arxiv_data1/oa_pdf/49/a0/ecl-42-339.PMC5098463.pdf
"28,29) was experienced “often ”or“all the time” •At least one meibomian gland opening with a visible plugging over the eyelid margin30 •No ocular pathology requiring treatment other than eye lubricant and conventional eyelid hygiene within the last month and dur-ing the study •Baseline irritation symptom of more than 0 millimeter as re- ported on the modi ﬁed Symptom Assessment in Dry Eye (SANDE) visual analog scale (Supplemental Digital Content 3, http://links.lww.com/ICL/A34 —in addition to irritation symp- tom, the modi ﬁed version also assessed blurring of vision and light sensitivity 31,32).",Non-OADS,/arxiv_data1/oa_pdf/49/a0/ecl-42-339.PMC5098463.pdf
"35The length of wetting after 5 min was measured from the notch of the strip.30 The meibomian gland morphology was also evaluated using noncontact infrared meibography equipment modi ﬁed from Top- con slit lamp SL-D7 (Topcon Corporation, Tokyo, Japan)32and was graded as healthy, intermediate, or unhealthy based on the amount of glandular loss and glandular characteristics (Supplemen- tal Digital Content 4, http://links.lww.com/ICL/A35 —grading of meibomian gland).32Two trained optometrists graded each image independently, and in the case of a disagreement, a third investi- gator was involved in determining the grade.",Non-OADS,/arxiv_data1/oa_pdf/49/a0/ecl-42-339.PMC5098463.pdf
"The limitations of this study were nonrandomization of inter- ventions, nonblinding of assessors and participants, and lack of meibomian gland secretion evaluation in the control group (Supplemental Digital Content 1, http://links.lww.com/ICL/A32 — describing late delivery of LipiFlow and evaluation equipment).",Non-OADS,/arxiv_data1/oa_pdf/49/a0/ecl-42-339.PMC5098463.pdf
"For variables related to symptom severity, lifestyle factors, and use of concomitant medication, see Suppl ementary Table A, Supplemental Digital Content 1, http://links.lww.com /JCP/A387.Fjukstad et al Journal of Clinical Psychopharmacology Volume 36, Number 6, December 2016 616 www.psychopharmacology.com © 2016 Wolters Kluwer Health, Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/ac/30/jcp-36-615.PMC5098465.pdf
"Demographic and clinical characteristics of the patients are presented in Table 1 and Supplementary Table A, Supplemental Digital Content 1, http://links.lww.com/JCP/A387.",Non-OADS,/arxiv_data1/oa_pdf/ac/30/jcp-36-615.PMC5098465.pdf
"To visualize theresults in absolute terms, the impact of SSRI use related to dose in a 30-year-old woman is presented in Supplementary Figure 1, Supplemental Digital Content 1, http://links.lww.com/JCP/A388.",Non-OADS,/arxiv_data1/oa_pdf/ac/30/jcp-36-615.PMC5098465.pdf
"For details, see “Materials and Methods ”section and Supplementary Table B, Supplemental Digital Content 1, http://links.lww.com/JCP/A387.Journal of Clinical Psychopharmacology Volume 36, Number 6, December 2016 SSRIs and Metabolic Abnormalities © 2016 W olters Kluwer Health, Inc. All rights reserved.",Non-OADS,/arxiv_data1/oa_pdf/ac/30/jcp-36-615.PMC5098465.pdf
http://links.lww.com/JCP/A387) .,Non-OADS,/arxiv_data1/oa_pdf/ac/30/jcp-36-615.PMC5098465.pdf
"Associa- tions between the individual drugs citalopram, escitalopram, and sertraline and the metabolic variables are also presentedin Supplementary Table C, Supp lemental Digital Content 1, http://links.lww.com/JCP/A387.",Non-OADS,/arxiv_data1/oa_pdf/ac/30/jcp-36-615.PMC5098465.pdf
"For details, see “Materials and Methods ”section and Supplementary Table B, Supplemental Digital Content 1, http://links.lww.com/JCP/A387.",Non-OADS,/arxiv_data1/oa_pdf/ac/30/jcp-36-615.PMC5098465.pdf
Available at http://www.whocc.no/atc_ddd_index/.,OADS,/arxiv_data1/oa_pdf/ac/30/jcp-36-615.PMC5098465.pdf
Clinical Trial Registration—URL: http://www.clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/2e/5b/hcg-8-823.PMC5098466.pdf
"Circ Cardiovasc Genet is available at http://circgenetics.ahajournals.org DOI: 10.1161/CIRCGENETICS.115.001129Received February 3, 2015; accepted August 25, 2015.",Non-OADS,/arxiv_data1/oa_pdf/2e/5b/hcg-8-823.PMC5098466.pdf
"*Drs Hopkins and Defesche contributed equally to this work.The Data Supplement is available at http://circgenetics.ahajournals.org/lookup/suppl/doi:10.1161/CIRCGENETICS.115.001129/-/DC1.Correspondence to Paul N. Hopkins, MD, MSPH, Division circoutcomes of Cardiovascular Genetics, University of Utah, 420 Chipeta Way, Room 1160,  Salt Lake City, UT 84108.",Non-OADS,/arxiv_data1/oa_pdf/2e/5b/hcg-8-823.PMC5098466.pdf
Clinical Pharmacology and Biopharmaceutics Review.Available at http://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022264s000clinpharmr.pdf.,Non-OADS,/arxiv_data1/oa_pdf/18/ce/jcp-36-744.PMC5098467.pdf
bhttp://www.smith-nephew.com/professional/products/advanced-wound-management/acticoat/acticoat-absorbent/.,Non-OADS,/arxiv_data1/oa_pdf/fa/a7/wocn-43-598.PMC5098468.pdf
chttp://www.smith-nephew.com/professional/products/advanced-wound-management/allevyn/more-allevyn-options/allevyn-ag-adhesive/.,Non-OADS,/arxiv_data1/oa_pdf/fa/a7/wocn-43-598.PMC5098468.pdf
dhttp://www.advancis.co.uk/products/activonmanukahoney/activon-tulle.,Non-OADS,/arxiv_data1/oa_pdf/fa/a7/wocn-43-598.PMC5098468.pdf
http://www.derbyshiremedicinesmanagement.nhs.uk/clinical_ guidelines.,Non-OADS,/arxiv_data1/oa_pdf/fa/a7/wocn-43-598.PMC5098468.pdf
http://www.worldwidewounds.com/2004/ february/Cooper/Topical-Antimicrobial-Agents.html .,Non-OADS,/arxiv_data1/oa_pdf/fa/a7/wocn-43-598.PMC5098468.pdf
http://www.woundsinternational.com/made-easys/iodine- made-easy .,Non-OADS,/arxiv_data1/oa_pdf/fa/a7/wocn-43-598.PMC5098468.pdf
http://www.merriam-webster.com/dictio   nary/ulcer.,Non-OADS,/arxiv_data1/oa_pdf/78/15/wocn-43-585.PMC5098472.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/14/be/cia-11-1567.PMC5098504.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Interventions in Aging 2016:11 1567–1574Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1567RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S11523 4 Does the use of acetylsalicylic acid have an  influence on our vision?",Non-OADS,/arxiv_data1/oa_pdf/14/be/cia-11-1567.PMC5098504.pdf
"The ASA effect is irreversible, and in Correspondence: Katarzyna Michalska- Małecka Department of Ophthalmology, School of  Medicine in Katowice, Medical University  of Silesia, Ceglana 35, 40-952 Katowice,  Poland Tel +48 600 064 180 email k.michalska.malecka@gmail.co m Journal name: Clinical Interventions in Aging Article Designation: Review Y ear: 2016 Volume: 11 Running head verso: Michalska-Małecka et al Running head recto: AMD and acetylsalicylic acid DOI: http://dx.doi.org/10.2147/CIA.S115234",Non-OADS,/arxiv_data1/oa_pdf/14/be/cia-11-1567.PMC5098504.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/14/be/cia-11-1567.PMC5098504.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/14/be/cia-11-1567.PMC5098504.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f9/dc/clep-8-435.PMC5098505.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/f9/dc/clep-8-435.PMC5098505.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).The Danish Anaesthesia Database Kristian Antonsen1 Charlotte Vallentin  Rosenstock2 Lars Hyldborg Lundstrøm2 1Board of Directors, Copenhagen  University Hospital, Bispebjerg and  Frederiksberg Hospital, Capital Region  of Denmark, Denmark; 2Department  of Anesthesiology, Copenhagen  University Hospital, Nordsjællands  Hospital-Hillerød, Capital Region of  Denmark, Denmark Correspondence: Charlotte Vallentin  Rosenstock   Department of Anesthesiology,  Copenhagen University Hospital,  Nordsjællands Hospital-Hillerød,  Dyrehavevej 29, 3400 Hillerød, Denmark   T el +45 4829 7598   Fax +45 4829 4213   Email charlotte.rosenstock@regionh.d kAim of database:  The aim of the Danish Anaesthesia Database (DAD) is the nationwide  collection of data on all patients undergoing anesthesia.",OADS,/arxiv_data1/oa_pdf/f9/dc/clep-8-435.PMC5098505.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/f9/dc/clep-8-435.PMC5098505.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/54/7b/clep-8-725.PMC5098506.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/54/7b/clep-8-725.PMC5098506.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).The database of the Danish Renal Cancer Group Astrid Christine Petersen1 Mette Søgaard2 Frank Mehnert2 Erik Højkjær Larsen3 Frede Donskov4 Nessn H Azawi5 Bjarne Kromann-Andersen6 1Department of Pathology,   Aalborg University Hospital,   Aalborg, 2Department of Clinical  Epidemiology, Aarhus University  Hospital, Aarhus, 3Department of  Urology, Odense University Hospital,   Odense, 4Department of Oncology,   Aarhus University Hospital, Aarhus,   5Department of Urology, Zealand  University Hospital, Roskilde,   6Department of Urology, Herlev  and Gentofte Hospital, Copenhagen,   Denmark Correspondence: Astrid Christine Petersen   Department of Pathology, Aalborg  University Hospital, Ladegaardsgade 3,  9000 Aalborg, Denmark   T el +45 9766 5278   Fax +45 9766 5320   Email acp@rn.d kAim of the database:  The main purpose of the database of the Danish Renal Cancer Group  (DaRenCaData) is to improve the quality of renal cancer treatment in Denmark and secondarily  to conduct observational research.",OADS,/arxiv_data1/oa_pdf/54/7b/clep-8-725.PMC5098506.pdf
"Available from: http://www.ancr.n u.  Accessed June 19, 2016.",Non-OADS,/arxiv_data1/oa_pdf/54/7b/clep-8-725.PMC5098506.pdf
"Available from: https://sundhedsstyrelsen.dk/da/udgivelser/2005/ kraeftplan-i i. Accessed June 19, 2016.",Non-OADS,/arxiv_data1/oa_pdf/54/7b/clep-8-725.PMC5098506.pdf
"Available  from: http://ducg.dk/databas e. Accessed June 19, 2016.",OADS,/arxiv_data1/oa_pdf/54/7b/clep-8-725.PMC5098506.pdf
"A vailable  from: http://ducg.dk/nyrecancer/aarsrapporte r. Accessed June 19, 2016.",Non-OADS,/arxiv_data1/oa_pdf/54/7b/clep-8-725.PMC5098506.pdf
Available from: http://www.statistik - banken.dk/statbank5a/default.asp?w =1366.,OADS,/arxiv_data1/oa_pdf/54/7b/clep-8-725.PMC5098506.pdf
"Available from: http://www.rkkp.d k. Accessed June  19, 2016.",Non-OADS,/arxiv_data1/oa_pdf/54/7b/clep-8-725.PMC5098506.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/54/7b/clep-8-725.PMC5098506.pdf
The full terms of this license are available at https://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/7c/e6/clep-8-531.PMC5098507.pdf
"com/terms.ph p and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7c/e6/clep-8-531.PMC5098507.pdf
"For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical epidemiology 2016:8 531–535 (Thematic series on clinical quality databases in Denmark) submit your manuscript | www.dovepress.co m Dove press  531 http: //dx.doi.org/10.2147/CLEP .S10067 0The Danish Knee Ligament Reconstruction  Registry Lene Rahr-w agner Martin Lind Department of Orthopaedic Surgery,   Division of Sports Surgery, Aarhus  University Hospital, Aarhus, Denmark Correspondence: Lene Rahr-w agner   Department of Orthopaedic Surgery,  Division of Sports Surgery, Aarhus  University Hospital, Tage-Hansens Gade 2,  8000 Aarhus C, Denmark   T el +45 2639 2926   email lenerahr@dadlnet.d kAbstract:  The Danish Knee Ligament Reconstruction Registry was established in 2005 as  a web-based nationwide clinical database with the purpose of improving the monitoring and  quality of both primary and revision knee ligament reconstructions in Denmark.",Non-OADS,/arxiv_data1/oa_pdf/7c/e6/clep-8-531.PMC5098507.pdf
"All private (n =27) and  public (n=24) hospitals report to this register, and registration is compulsory by legisla - tion ( https://www.retsinformation.dk/Forms/R0710.aspx?id=173197&exp= 1).1 The number of procedures registered in the database each year is ∼2,500 and the  first 9 years, in total, 22,775 procedures have been registered.",Non-OADS,/arxiv_data1/oa_pdf/7c/e6/clep-8-531.PMC5098507.pdf
Available from: https://www.sundhed.,Non-OADS,/arxiv_data1/oa_pdf/7c/e6/clep-8-531.PMC5098507.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/7c/e6/clep-8-531.PMC5098507.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/44/61/clep-8-491.PMC5098508.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).The Danish Head and Neck Cancer database Jens Overgaard1 Aleksandar Jovanovic1 Christian Godballe2,3 Jesper Grau Eriksen3 1Department of Experimental Clinical  Oncology, Aarhus University Hospital,   Aarhus, 2Department of ORL – Head  and Neck Surgery, 3Department  of Oncology, Odense University  Hospital, Odense, Denmark Correspondence: Jens Overgaard   Department of Experimental Clinical  Oncology, Aarhus University Hospital,  Nørrebrogade 44, Building 5, DK-8000  Aarhus C, Denmark   T el +45 7846 2629   Fax +45 8619 7109   Email jens@oncology.au.d kAim of the database:  The Danish Head and Neck Cancer database is a nationwide clinical  quality database that contains prospective data collected since the early 1960s.",OADS,/arxiv_data1/oa_pdf/44/61/clep-8-491.PMC5098508.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/44/61/clep-8-491.PMC5098508.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p and  incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/bd/a2/clep-8-621.PMC5098509.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Epidemiology Clinical Epidemiology 2016:8 621–627 (Thematic series on clinical quality databases in Denmark)Dove press submit your manuscript | www.dovepress.co m Dove press  REviEwopen access to scientific and medical research Open Access Full T ext Article 621 http: //dx.doi.org/10.2147/CLEP .S10264 9The Danish Nephrology Registry James Heaf Department of Medicine, Roskilde  Hospital, University of Copenhagen,   Roskilde, Denmark Correspondence: James Heaf   Department of Medicine, Roskilde  Hospital, Koegevej 7-13, 4000 Roskilde,  Denmark   T el +45 4294 4116   Email heaf@dadlnet.d kAim of database:  The Danish Nephrology Registry’ s (DNR) primary function is to support  the Danish public health authorities’ quality control program for patients with end-stage renal  disease in order to improve patient care.",Non-OADS,/arxiv_data1/oa_pdf/bd/a2/clep-8-621.PMC5098509.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/bd/a2/clep-8-621.PMC5098509.pdf
The full terms of this license are available at https://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/fd/a5/clep-8-475.PMC5098510.pdf
"com/terms.ph p and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/fd/a5/clep-8-475.PMC5098510.pdf
"For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Epidemiology 2016:8 475–478 (Thematic series on clinical quality databases in Denmark)Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  475REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S10029 8The Danish Depression Database Poul videbech1 Anette Deleuran2 1Mental Health Centre Glostrup,   Department of Clinical Medicine,   University of Copenhagen, Glostrup,   2Psychiatric Centre Amager,   Copenhagen S, Denmark Correspondence: Poul videbech   Mental Health Centre Glostrup, Nordre  Ringvej 29 – 67, DK-2600 Glostrup,  Denmark   T el +45 3864 0634   Fax +45 3864 0855   Email videbech@dadlnet.d kAim of database:  The purpose of the Danish Depression Database (DDD) is to monitor and  facilitate the improvement of the quality of the treatment of depression in Denmark.",Non-OADS,/arxiv_data1/oa_pdf/fd/a5/clep-8-475.PMC5098510.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/fd/a5/clep-8-475.PMC5098510.pdf
Available from: http://www.rkkp.dk/in- english /.,Non-OADS,/arxiv_data1/oa_pdf/fd/a5/clep-8-475.PMC5098510.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/c5/c6/clep-8-697.PMC5098511.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/c5/c6/clep-8-697.PMC5098511.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).The Danish Stroke Registry Søren Paaske Johnsen1 Annette Ingeman1,2 Heidi Holmager Hundborg1 Susanne Zielke Schaarup3 Jesper Gyllenborg4 1Department of Clinical Epidemiology,   Aarhus University Hospital, 2Registry  Support Center of Clinical Quality  & Health Informatics (West), The  Danish Clinical Registries, Aarhus,  3Department of Neurology, Bispebjerg  Hospital, Copenhagen, 4Department  of Neurology, Zealand University  Hopital, Roskilde, Denmark Correspondence: Søren Paaske Johnsen   Department of Clinical Epidemiology,  Aarhus University Hospital, Olof Palmes  Allé 43, 8200 Aarhus, Denmark   T el +45 8716 8115   Email spj@clin.au.d kAim of database:  The aim of the Danish Stroke Registry is to monitor and improve the qual - ity of care among all patients with acute stroke and transient ischemic attack (TIA) treated at  Danish hospitals.",Non-OADS,/arxiv_data1/oa_pdf/c5/c6/clep-8-697.PMC5098511.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/c5/c6/clep-8-697.PMC5098511.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/30/ba/clep-8-425.PMC5098512.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/30/ba/clep-8-425.PMC5098512.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Clinical Epidemiology 2016:8 425–427 (Thematic series on clinical quality databases in Denmark)Clinical Epidemiology Dovepress submit your manuscript | www.dovepress.com Dovepress 425 EDITORIAL open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S113265 Danish clinical quality databases – an important  and untapped resource for clinical research Henrik T oft Sørensen1 Lars Pedersen1 Jørgen Jørgensen2 Vera Ehrenstein1 1Department of Clinical Epidemiology,   Aarhus University Hospital, Aarhus,   2Danish Regions, Copenhagen,   DenmarkThe health care systems in many countries are facing several challenges: the aging popu- lation, the need for personalized medicine, evolving treatment modalities,  quality and  safety imperatives, and unsustainable costs, to mention only a few.",Non-OADS,/arxiv_data1/oa_pdf/30/ba/clep-8-425.PMC5098512.pdf
"It is a constellation of three conditions – universal health care, individual linkage, and a long tradition of  longitudinal routine Correspondence: Henrik Toft Sørensen Department of Clinical Epidemiology, Aarhus University Hospital, Olof Palmes Allé 43–45, 8200 Aarhus N, DenmarkTel +45 8716 8215Fax +45 8716 7215Email hts@clin.au.dkJournal name: Clinical Epidemiology Article Designation: EDITORIALY ear: 2016V olume: 8Running head verso:  Sørensen et alRunning head recto: Danish clinical quality databasesDOI: http://dx.doi.org/10.2147/CLEP .S113265",Non-OADS,/arxiv_data1/oa_pdf/30/ba/clep-8-425.PMC5098512.pdf
"Clinical Epidemiology 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Clinical Epidemiology Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/clinical-epidemiology-journalClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica-tion of risk factors and screening procedures to develop optimal pre-ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/30/ba/clep-8-425.PMC5098512.pdf
Available from: http://www.biobankdenmark.dk/.,Non-OADS,/arxiv_data1/oa_pdf/30/ba/clep-8-425.PMC5098512.pdf
Available from: http://www.cancerbiobank.dk/.,Non-OADS,/arxiv_data1/oa_pdf/30/ba/clep-8-425.PMC5098512.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b0/30/clep-8-429.PMC5098513.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Epidemiology 2016:8 429–434 (Thematic series on clinical quality databases in Denmark)Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  429REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S9951 8The Danish Adult Diabetes Registry Marit Eika Jørgensen1,2 Jette K Kristensen3 Gitte Reventlov Husted1 Charlotte Cerqueira4 Peter Rossing1,3,5 1Steno Diabetes Center, Gentofte,   2National institute of Public Health,   University of Southern Denmark,   Odense, 3Aarhus University, Aarhus,   4Registry Support Centre (East) –   Epidemiology and Biostatistics,   Research Centre for Prevention  and Health, Capital Region of  Denmark, 5University of Copenhagen,   Copenhagen, Denmark Correspondence: Peter Rossing   Steno Diabetes Center, Niels Steensens  vej 2, DK 2820 Gentofte, Denmark   T el +45 3075 7310   Email pro@steno.d kAim of the database:  The aim of the Danish Adult Diabetes Registry (DADR) is to provide  data from both the primary health care sector (general practice [GP]) and the secondary sector  (specialized outpatient clinics) to assess the quality of treatment given to patients with diabetes.",Non-OADS,/arxiv_data1/oa_pdf/b0/30/clep-8-429.PMC5098513.pdf
"The final report, including recommendations for improvement, is published  online at https://www.sundhed.d k.8 Use of the database for research The nationwide reporting of unbiased, valid, and standardized  information to the registry makes it attractive for research  purposes.",OADS,/arxiv_data1/oa_pdf/b0/30/clep-8-429.PMC5098513.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/b0/30/clep-8-429.PMC5098513.pdf
Available from: http://vejledninger.dsam.dk/ type2 /.,Non-OADS,/arxiv_data1/oa_pdf/b0/30/clep-8-429.PMC5098513.pdf
"Available from: http://endocrinology.dk/index.php/ nbvhovedmenu/1-diabetes-mellitus/3-type-1-diabetes-mellitu s. Accessed  March 7, 2016.",Non-OADS,/arxiv_data1/oa_pdf/b0/30/clep-8-429.PMC5098513.pdf
Avail - able from: https://www.sundhed.dk/content/cms/87/4687_ kom_%C3%A5rsrapport_diabetes_2014_15_27082015_endelig.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b0/30/clep-8-429.PMC5098513.pdf
Available from: http://dx.doi.org/10.14496/ dia.3104465162.1 6.,Non-OADS,/arxiv_data1/oa_pdf/b0/30/clep-8-429.PMC5098513.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/98/5b/clep-8-573.PMC5098514.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/98/5b/clep-8-573.PMC5098514.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).clinical epidemiology 2016:8 573–576 (Thematic series on clinical quality databases in Denmark) submit your manuscript | www.dovepress.co m Dove press  573 http: //dx.doi.org/10.2147/CLEP .S10196 9The Danish national Database for Obstructive  sleep apnea Poul Jørgen Jennum1 Preben larsen2 charlotte cerqueira3 Thor schmidt4 Philip Tønnesen1 1Department of clinical  neurophysiology, Faculty of health  sciences, Danish center for sleep  Medicine, University of copenhagen,   rigshospitalet, copenhagen, 2section  of respiratory Disease, Medical  Department, Fredericia hospital,   Fredericia, 3registry support  centre ( east) – epidemiology and  Biostatistics, research centre for  Prevention and health, 4registry  support centre ( east) – clinical  Quality improvement and health  informatics, capital region of  Denmark, copenhagen, Denmark correspondence: Poul Jørgen Jennum   Department of clinical neurophysiology,  Faculty of health sciences, Danish center  for sleep Medicine, University of  copenhagen, rigshospitalet, nordre  ringvej 57, DK-2600 glostrup,  copenhagen, Denmark   T el +45 3 863 2512   email poul.joergen.jennum@regionh.d kAim:  The aim of the Danish National Database for Obstructive Sleep Apnea (NDOSA) was  to evaluate the clinical quality (diagnostic, treatment, and management) for obstructive sleep  apnea and obesity hypoventilation syndrome in Denmark using a real-time national database  reporting to the Danish National Patient Registry.",Non-OADS,/arxiv_data1/oa_pdf/98/5b/clep-8-573.PMC5098514.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/98/5b/clep-8-573.PMC5098514.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/02/fb/clep-8-667.PMC5098515.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Epidemiology Clinical Epidemiology 2016:8 667–671 (Thematic series on clinical quality databases in Denmark) Dove press submit your manuscript | www.dovepress.co m Dove press  REviEwopen access to scientific and medical research Open Access Full T ext Article 667 http: //dx.doi.org/10.2147/CLEP .S10091 9The Danish quality database for prehospital  emergency medical services Erika Frischknecht  Christensen1–3 Peter Anthony Berlac4 Henrik Nielsen5 Christian Fynbo  Christiansen5 1Clinical institute, Aalborg University,   2Department of Anesthesiology and  intensive Care, Aalborg University  Hospital, Aalborg, 3Prehospital  Emergency Medical Services, North  Denmark Region, 4Copenhagen  Emergency Medical Services,   Copenhagen, 5Department of Clinical  Epidemiology, Aarhus University  Hospital, Aarhus, Denmark Correspondence: Erika Frischknecht  Christensen   Clinical institute, Aalborg University,  Aalborg Hospital Science and innovation  Center, Søndre Skovvej 15, 9000 Aalborg,  Denmark   T el +45 9766 6337   Email efc@rn.d kAim of database:  The aim of the Danish quality database for prehospital emergency medical  services (QEMS) is to assess, monitor, and improve the quality of prehospital emergency medi - cal service care in the entire prehospital patient pathway.",Non-OADS,/arxiv_data1/oa_pdf/02/fb/clep-8-667.PMC5098515.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/02/fb/clep-8-667.PMC5098515.pdf
Available from: https://www.retsinformation.dk/forms/ R0710.aspx?id =139180&exp =1.,Non-OADS,/arxiv_data1/oa_pdf/02/fb/clep-8-667.PMC5098515.pdf
The full terms of this license are available at https://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/7e/e3/clep-8-649.PMC5098516.pdf
"com/terms.ph p and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7e/e3/clep-8-649.PMC5098516.pdf
"For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical epidemiology 2016:8 649–653 (Thematic series on clinical quality databases in Denmark)submit your manuscript | www.dovepress.co m Dove press  649 http: //dx.doi.org/10.2147/CLEP .S10025 6The Danish Prostate Cancer Database Mary Nguyen-Nielsen1,2 Søren Høyer3 Søren Friis4 Steinbjørn Hansen5 Klaus Brasso6 erik Breth Jakobsen7 Mette Moe8 Heidi Larsson9 Mette Søgaard9 Anne Nakano9,10 Michael Borre1 1Department of Urology, Aarhus  University Hospital, Aarhus, 2Diet,   Genes and environment, Danish  Cancer Society Research Center,   Copenhagen, 3Department of  Pathology, Aarhus University Hospital,   Aarhus, 4Danish Cancer Society  Research Centre, Danish Cancer  Society, Copenhagen, 5Department of  Oncology, Odense University Hospital,   Odense, 6Copenhagen Prostate  Cancer Center and Department of  Urology, Rigshospitalet, University  of Copenhagen, Copenhagen,   7Department of Urology, Næstved  Hospital, Næstved, 8Department of  Oncology, Aalborg University Hospital,   Aalborg, 9Department of Clinical  epidemiology, Aarhus University  Hospital, 10Competence Centre  for Health Quality and informatics  (KCKS-v est), Aarhus, Denmark Correspondence: Mary Nguyen-Nielsen   Department of Urology, Aarhus  University Hospital, Palle Juul-Jensens  Boulevard 99, 8200 Aarhus, Denmark   email maryniel@rm.d kAim of database:  The Danish Prostate Cancer Database (DAPROCA data) is a nationwide  clinical cancer database that has prospectively collected data on patients with incident prostate  cancer in Denmark since February 2010.",Non-OADS,/arxiv_data1/oa_pdf/7e/e3/clep-8-649.PMC5098516.pdf
Updated information on DAP - ROCA data is available at DAPROCA’ s internet homepage:   http://ducg.dk/daproca-prostatacancer /.,OADS,/arxiv_data1/oa_pdf/7e/e3/clep-8-649.PMC5098516.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/7e/e3/clep-8-649.PMC5098516.pdf
"Available from: https://www.sundhed.dk/content/cms/86/15686_ daproca_årsrapport-2014_kommenteret_20150521final.pd f. Accessed  December 23, 2015.",Non-OADS,/arxiv_data1/oa_pdf/7e/e3/clep-8-649.PMC5098516.pdf
Available from: http://dmcg.dk /dmcgdk-benchmarking-consortium/.,OADS,/arxiv_data1/oa_pdf/7e/e3/clep-8-649.PMC5098516.pdf
Available from: http://dmcg.dk /.,Non-OADS,/arxiv_data1/oa_pdf/7e/e3/clep-8-649.PMC5098516.pdf
Available from: http://ducg.dk /.,Non-OADS,/arxiv_data1/oa_pdf/7e/e3/clep-8-649.PMC5098516.pdf
Avail - able from: http://www.rkkp.dk /.,Non-OADS,/arxiv_data1/oa_pdf/7e/e3/clep-8-649.PMC5098516.pdf
Avail - able from: http://info.ambuflex.dk /.,Non-OADS,/arxiv_data1/oa_pdf/7e/e3/clep-8-649.PMC5098516.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/66/88/copd-11-2729.PMC5098517.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 2729–2736International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2729OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11288 2 Prognostic role of D-dimer for in-hospital and  1-year mortality in exacerbations of COPD guoping hu1 Yankui Wu2 Yumin Zhou3 Zelong Wu1 liping Wei1 Yuqun li1 gongY ong Peng3 Weiqiang liang1 Pixin ran3 1Department of respiratory Medicine,   The Third affiliated hospital of  guangzhou Medical University,   guangzhou, guangdong, 2Department  of respiratory Disease of People’s  hospital of guangxi Zhuang  autonomous region, guangxi Zhuang  autonomous region, 3guangzhou  Institute of respiratory Disease, state  Key lab of respiratory Disease, The  First affiliated hospital of guangzhou  Medical University, guangzhou,   guangdong, People’s republic  of ChinaBackground and objective:  Serum D-dimer is elevated in respiratory disease.",Non-OADS,/arxiv_data1/oa_pdf/66/88/copd-11-2729.PMC5098517.pdf
"The most important factors that determine the overall prognosis  of COPD are the frequency and severity of exacerbations;2,3 and AECOPD are often  companied with respiratory failure.1 The blood of most of AECOPD patients is in a  hypercoagulable state for hypoxemia and carbon dioxide retention.4–6 This state causes  the formation of small pulmonary thrombosis and leads to an adverse prognosis.7–9  Some clinical evidence shows that hypercoagulable state and thrombosis in the  pulmonary vessels can alter the clinical course of patients with COPD, especially Correspondence: Pixin ran guangzhou Institute of respiratory  Disease, The First Affiliated Hospital,  guangzhou Medical University,  151 Yanjiang road, guangzhou,  guangdong, 510120, People’s republic  of China Tel +86 20 8134 0482 Fax +86 20 8134 0482 email pxran@gzhmc.edu.c n Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Hu et al Running head recto: D-dimer role in mortality for AECOPD DOI: http://dx.doi.org/10.2147/COPD.S112882",Non-OADS,/arxiv_data1/oa_pdf/66/88/copd-11-2729.PMC5098517.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/66/88/copd-11-2729.PMC5098517.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/66/88/copd-11-2729.PMC5098517.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2f/7c/copd-11-2721.PMC5098518.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 2721–2728International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2721OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11944 8 Dietary vitamin C intake protects against  COPD: the Korea national health and nutrition  examination survey in 2012 hye Jung Park,1 Min Kwang  Byun,1 hyung Jung Kim,1  Jae Yeol Kim,2 Yu-Il Kim,3  Kwang-ha Y oo,4 eun Mi  Chun,5 Ji Ye Jung,6 sang  haak lee,7 Chul Min ahn1 On behalf of the Korean  smoking Cessation study  group 1Department of Internal Medicine,   gangnam severance hospital, Y onsei  University College of Medicine,   2Department of Internal Medicine,   Chung-ang University College  of Medicine, seoul, 3Department  of Internal Medicine, Chonnam  national University hospital,   gwangju, 4Department of Internal  Medicine, Konkuk University school  of Medicine, 5Department of Internal  Medicine, ewha Womans University  school of Medicine, 6Division of  Pulmonology, Department of Internal  Medicine, Institute of Chest Disease,   severance hospital, Y onsei University  College of Medicine, 7Division of  Pulmonology, Critical Care and sleep  Medicine, Department of Internal  Medicine, College of Medicine,   The Catholic University of Korea,   seoul,  KoreaBackground:  Vitamin C, as an antioxidant, has recently been suggested to provide protection  against COPD; however, only few national cohort studies have investigated these effects.",Non-OADS,/arxiv_data1/oa_pdf/2f/7c/copd-11-2721.PMC5098518.pdf
"Vitamin C has symptom-relieving effects on the exacerbation of COPD.6  In addition, it improves pulmonary function in COPD.7,8 Moreover, a recent animal  study has revealed that supplementation with vitamin C not only prevents the develop - ment of COPD but also restores the lung function in COPD subjects.9 The Korea National Health and Nutrition Examination Survey (KNHANES) is  a large-scale survey containing a vast amount of data on demographics, underlying Correspondence: Chul Min ahn Department of Internal Medicine,  gangnam severance hospital, Yonsei  University College of Medicine, 211  eonju-ro gangnam-gu, seoul 135-720,  Korea Tel +82 2 2019 3317 Fax +82 2 3463 3882 email ahn5302@yuhs.a cJournal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Park et al Running head recto: Dietary vitamin C in COPD DOI: http://dx.doi.org/10.2147/COPD.S119448",Non-OADS,/arxiv_data1/oa_pdf/2f/7c/copd-11-2721.PMC5098518.pdf
"We followed guidelines reporting  the sample weight and stratification designated by the KCDC;  this information is available at the KNHANES website  to facilitate obtaining appropriate results, and all the raw  data are open to the public ( https://knhanes.cdc.go.k r).",OADS,/arxiv_data1/oa_pdf/2f/7c/copd-11-2721.PMC5098518.pdf
Available  from: http://goldcopd.org/global-strategy-diagnosis-management- prevention-copd-2016 /.,Non-OADS,/arxiv_data1/oa_pdf/2f/7c/copd-11-2721.PMC5098518.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/2f/7c/copd-11-2721.PMC5098518.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/7c/copd-11-2721.PMC5098518.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/09/0b/copd-11-2711.PMC5098519.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 2711–2720International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2711OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11162 9 The effect of conjugated linoleic acid  supplementation on the nutritional status  of COPD patients hassan ghobadi1 somaieh Matin2 ali nemati3 abbas n aghizadeh-baghi4 1Pulmonary Division, 2Internal  Medicine Department, 3Biochemistry  and nutrition Department, 4Basic  sciences Department, ardabil  University of Medical sciences,   ardabil, IranBackground:  COPD patients are susceptible to anorexia, reduction of caloric intake, weight loss,  and malnutrition.",Non-OADS,/arxiv_data1/oa_pdf/09/0b/copd-11-2711.PMC5098519.pdf
"Keywords:  COPD, CLA, appetite, nutritional status, IL1β Introduction COPD is a common respiratory condition, which occurs with pulmonary and  extrapulmonary complications, accompanied by systemic inflammations and is charac - terized by irreversible airflow limitations.1 It has been predicted that by 2020, it would  be the third most common cause of death and the fifth most common cause of disability  worldwide.2 Smoking and factors such as contamination of the workplace, environ - mental pollution, and genetics are found to be the main causes of this disease.3,4 Extrapulmonary complications that occur in COPD patients are appetite reduction,  decrease of caloric intake, and malnutrition.5 Malnutrition leads to increased risks of Correspondence: somaieh Matin Internal Medicine Department,  ardabil University of Medical  sciences, shahid Jeddi street,  ardabil 5615783143, Iran Tel +98 453 325 1401 Fax +98 453 325 1410 email smh.matin@yahoo.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Ghobadi et al Running head recto: Effect of CLA supplementation on COPD patients  DOI: http://dx.doi.org/10.2147/COPD.S111629",Non-OADS,/arxiv_data1/oa_pdf/09/0b/copd-11-2711.PMC5098519.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/09/0b/copd-11-2711.PMC5098519.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/09/0b/copd-11-2711.PMC5098519.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/dc/fd/dddt-10-3573.PMC5098520.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/dc/fd/dddt-10-3573.PMC5098520.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/dc/fd/dddt-10-3573.PMC5098520.pdf
"The correct Western blot image for Figure 3C is  shown here:Journal name: Drug Design, Development and Therapy Article Designation: Corrigendum Y ear: 2016 Volume: 10 Running head verso: Li et al Running head recto: Mechanism and pharmacological rescue DOI: http://dx.doi.org/10.2147/DDDT.S124104 K(5*N'D N'D N'D $FWLQ&WO %%5%%5)H[ )H[",Non-OADS,/arxiv_data1/oa_pdf/dc/fd/dddt-10-3573.PMC5098520.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/65/3d/dddt-10-3599.PMC5098521.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3599–3609Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3599Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11744 3 The aqueous extract of Brucea javanica  suppresses  cell growth and alleviates tumorigenesis of human  lung cancer cells by targeting mutated epidermal  growth factor receptor seung-hun Kim1,* chun-Yen liu1,* Po-Wei Fan1 chang-heng hsieh1 hsuan-Yuan lin1 Ming-chung lee2 Kang Fang1 1Department of life science, national  Taiwan normal University, Taipei,   2Brion research institute of Taiwan,   new Taipei city, Taiwan *These authors contributed equally  to this workAbstract:  As a practical and safe herbal medicine, the seeds of Brucea javanica (L.) Merr.,  were used to cure patients suffering from infectious diseases such as malaria.",Non-OADS,/arxiv_data1/oa_pdf/65/3d/dddt-10-3599.PMC5098521.pdf
"The ethanol extract from  the fruit has been shown to effectively repress growth of pancreatic cancer cells.4 By  combining with conventional chemotherapy drugs, the emulsion of B. javanica  oil  provided an alternative nontoxic antiproliferative agent in treating patients with lung  adenocarcinoma and advanced gastric cancer.5,6 In addition, the ethyl acetate extract  of the seeds has been shown to heal patients with diseases related to inflammation  and allergy.7 Despite numerous reports on the versatility of the fruit in treating vari - ous types of illness, the effectiveness of aqueous B. javanica (BJ) extract in cancer  therapy is not completely understood.correspondence: Kang Fang Department of life science, national  Taiwan normal University, 88 Ting-chou  rd, sec 4, Taipei 116, Taiwan Tel +886 2 7734 6293 Fax +886 2 2931 2904 email kangfang@ntnu.edu.t w Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Kim et al Running head recto: BJ extracts suppress tumorigenesis of human NSCLC cells DOI: http://dx.doi.org/10.2147/DDDT.S117443",Non-OADS,/arxiv_data1/oa_pdf/65/3d/dddt-10-3599.PMC5098521.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/65/3d/dddt-10-3599.PMC5098521.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/65/3d/dddt-10-3599.PMC5098521.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/87/ee/dddt-10-3323.PMC5098522.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3323–3329Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3323Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S10947 3 The expression of hoxB5 and sPc in neonatal rat  lung after exposure to fluoxetine razieh Taghizadeh1 Zahra Taghipour2 akbar Karimi1 ali shamsizadeh3 Mohammad Mohsen  Taghavi2 Mahdi shariati2 ahmad shabanizadeh2 hamid reza Jafari naveh2 reza Bidaki4 Fariba aminzadeh5 1Department of Biology, Payame noor  University, isfahan, iran; 2Department  of anatomy, rafsanjan University of  Medical sciences, rafsanjan, iran;   3Department of Physiology, rafsanjan  University of Medical sciences,   rafsanjan, iran; 4shahid sadoughi  University of Medical sciences, Yazd,   iran; 5rafsanjan University of Medical  sciences, rafsanjan, iranObjective:  Approximately 10% of pregnant women suffer from pregnancy-associated  depression.",Non-OADS,/arxiv_data1/oa_pdf/87/ee/dddt-10-3323.PMC5098522.pdf
"Women are at increased risk of depression during periods of hormone changes in  various states such as during maturity, pregnancy, and menopause.1 Evidences revealed that depression is a risk factor for both preterm birth and low  birth weight, and hence it is important to cure gestational depression.2 A number of  studies have suggested that selective serotonin reuptake inhibitors (SSRIs) are the  first-line treatment drugs for depression therapy.3 Fluoxetine is an SSRI medication  that is known as an important antidepressant drug for gestational depression which  has been used during the last 2 decades.4 Fluoxetine is able to cross the placenta and  therefore induces some side effects on fetal development, including risk of persistent correspondence: Zahra Taghipour Department of anatomy, rafsanjan  University of Medical sciences,  rafsanjan, iran Tel +98 343 131 5064 email taghipourz@yahoo.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Taghizadeh et al Running head recto: Fluoxetine effects on lung neonatal DOI: http://dx.doi.org/10.2147/DDDT.S109473",Non-OADS,/arxiv_data1/oa_pdf/87/ee/dddt-10-3323.PMC5098522.pdf
"Available from:  https://www.drugs.com/pro/Fluoxetine.htm l. Accessed July 13, 2016.",Non-OADS,/arxiv_data1/oa_pdf/87/ee/dddt-10-3323.PMC5098522.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/87/ee/dddt-10-3323.PMC5098522.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/87/ee/dddt-10-3323.PMC5098522.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4c/c5/copd-11-2737.PMC5098523.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 2737–2740International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2737OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S11125 4 Platelet–lymphocyte ratios: a potential marker  for pulmonary tuberculosis diagnosis in  COPD patients guozhong Chen Chunling Wu Zhiying luo Yiming T eng suping Mao Department of respiratory Medicine,   Yiwu Central hospital, Yiwu, Zhejiang  Province, People’s republic of ChinaBackground:  In recent decades, morbidity and mortality have been found to be significantly  increased in patients with chronic obstructive pulmonary disease (COPD) complicated with  pulmonary tuberculosis (PTB).",Non-OADS,/arxiv_data1/oa_pdf/4c/c5/copd-11-2737.PMC5098523.pdf
"Also, the delayed diagnosis of PTB in COPD patients could contribute  to prevent further disease progression, increase mortality, and transmission of PTB  within the community, which could be an important public health issue.7 Lee et al  suggested that it is necessary to keep a high suspicion and regularly monitor for the  development of PTB in COPD patients.4Correspondence: guozhong Chen Department of respiratory Medicine,  Yiwu Central hospital, no 699 Jiangdong  road, Yiwu City, 322000 Zhejiang  Province, People’s republic of China Tel +86 579 8520 9871 Fax +86 579 8520 9871 email guozhongchen2015@sina.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Chen et al Running head recto: Pulmonary tuberculosis diagnosis by using platelet–lymphocyte ratios DOI: http://dx.doi.org/10.2147/COPD.S111254",Non-OADS,/arxiv_data1/oa_pdf/4c/c5/copd-11-2737.PMC5098523.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/4c/c5/copd-11-2737.PMC5098523.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4c/c5/copd-11-2737.PMC5098523.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/7c/d6/copd-11-2701.PMC5098524.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of COPD 2016:11 2701–2710International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2701OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S10875 8 Efficacy and safety of tiotropium + olodaterol  maintenance treatment in patients with COPD  in the TOnaDO® and OTeMTO® studies:  a subgroup analysis by age Gary T Ferguson1 Jill P Karpel2 emmanuelle Clerisme- Beaty3 lars grönke4 Florian Voß4 roland Buhl5 1Pulmonary Research Institute of  southeast Michigan, Farmington  hills, MI, 2north shore Medical arts  llP , great neck, nY, 3Boehringer  Ingelheim Pharmaceuticals Inc.,   ridgefield, CT, Usa; 4Boehringer  Ingelheim Pharma gmbh & Co. K g,   Ingelheim am rhein, 5Pulmonary  Department, Mainz University  Hospital, Mainz, GermanyBackground:  Increasing age is associated with poor prognosis in patients with COPD.",Non-OADS,/arxiv_data1/oa_pdf/7c/d6/copd-11-2701.PMC5098524.pdf
"Keywords:  FEV1, SGRQ, lung function, TDI, rescue medication Introduction COPD is characterized by persistent, progressive airflow limitation caused by lung  tissue destruction and airway inflammation.1 Age has been shown to be independently  associated with poor prognosis in patients with COPD,1 and the projected aging of  the world population suggests an imminent increase in the global prevalence of older  patients with COPD.2 COPD is often accompanied by comorbidities,3 with 78.4% of patients reporting  more than one chronic condition.4 Older patients with COPD are more likely to have Correspondence: Gary T Ferguson Pulmonary Research Institute of  southeast Michigan, 29255 West 10  Mile road, suite a, Farmington hills,  MI 48336, Usa Tel +1 248 478 6561 Fax +1 248 478 6908 email garytferguson@msn.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Ferguson et al Running head recto: Response to tiotropium + olodaterol by age DOI: http://dx.doi.org/10.2147/COPD.S108758",Non-OADS,/arxiv_data1/oa_pdf/7c/d6/copd-11-2701.PMC5098524.pdf
Available from: http://www.goldcopd.org /.,Non-OADS,/arxiv_data1/oa_pdf/7c/d6/copd-11-2701.PMC5098524.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/7c/d6/copd-11-2701.PMC5098524.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7c/d6/copd-11-2701.PMC5098524.pdf
Available from: http://www.nice.org.uk/guidance/cg101/resources/ chronic-obstructive-pulmonary-disease-in-over-16s-diagnosis-and- management-3510932393158 9.,Non-OADS,/arxiv_data1/oa_pdf/7c/d6/copd-11-2701.PMC5098524.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/21/55/dddt-10-3545.PMC5098525.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3545–3553Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3545Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11876 8 Mimetics of brain-derived neurotrophic factor  loops 1 and 4 are active in a model of ischemic  stroke in rats Tatyana a gudasheva1 Polina Povarnina1 ilya O logvinov2 Tatyana a antipova2 sergey B seredenin3 1Department of Medicinal chemistry,   2Department of neuroprotective  Pharmacology, 3Department of  Pharmacogenetics, VV Zakusov  institute of Pharmacology,   Moscow,  russiaBackground:  Two dimeric dipeptides, bis-(N-monosuccinyl- l-seryl- l-lysine)hexamethy- lenediamide (GSB-106) and bis-(N-monosuccinyl- l-methionyl- l-serine) heptamethylenedi - amide (GSB-214), were designed based on the brain-derived neurotrophic factor (BDNF) loop  4 and loop 1 β-turn sequences, respectively.",Non-OADS,/arxiv_data1/oa_pdf/21/55/dddt-10-3545.PMC5098525.pdf
"BDNF has been reported to reduce  infarct volumes and improve neurological outcomes in rodents subjected to cerebral  ischemia.1–3 Increased BDNF levels after stroke during the acute (hours to days) and  subacute periods (days to weeks) are beneficial for improving lost function.4 The  mechanisms of the neuroprotective capability of BDNF include anti-apoptotic effects,5 correspondence: Tatyana a gudasheva Department of Medicinal chemistry,  VV Zakusov institute of Pharmacology,  Baltiyskaya str 8, 125315 Moscow, russia Tel +7 49 5601 2246 Fax +7 49 9151 1261 email tata-sosnovka@mail.r u Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Gudasheva et al Running head recto: Mimetics of BDNF loops 1 and 4 in model of ischemic stroke in rats DOI: http://dx.doi.org/10.2147/DDDT.S118768",Non-OADS,/arxiv_data1/oa_pdf/21/55/dddt-10-3545.PMC5098525.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/21/55/dddt-10-3545.PMC5098525.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/21/55/dddt-10-3545.PMC5098525.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9d/bc/dddt-10-3555.PMC5098526.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3555–3562Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3555Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11994 4 effects of renal function on pharmacokinetics and  pharmacodynamics of lesinurad in adult volunteers Michael gillen1 shakti Valdez2 Dongmei Zhou2 Bradley Kerr2 caroline a lee2 Zancong shen2 1astraZeneca lP , gaithersburg, MD,   2ardea Biosciences, inc., san Diego,   ca, UsaIntroduction:  Lesinurad is a selective uric acid reabsorption inhibitor approved for the  treatment of gout in combination with a xanthine oxidase inhibitor (XOI) in patients who have  not achieved target serum uric acid (sUA) levels with an XOI alone.",Non-OADS,/arxiv_data1/oa_pdf/9d/bc/dddt-10-3555.PMC5098526.pdf
"The recommendation for long-term management of gout is maintenance of sUA  levels ,6 mg/dL as a minimum and ,5 mg/dL in cases of greater disease severity,  using urate-lowering therapy (ULT).3 Allopurinol and febuxostat are xanthine oxidase  inhibitors (XOIs) that block uric acid production and are recommended as first-line  therapy for patients with gout.3–5 If the sUA target cannot be achieved with an XOI, correspondence: Michael gillen astraZeneca lP, One Medimmune Way,  gaithersburg, MD 20878, Usa Tel +1 302 885 8144 email michael.gillen@astrazeneca.co mJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Gillen et al Running head recto: Effects of renal function on PK and PD of lesinurad DOI: http://dx.doi.org/10.2147/DDDT.S119944",Non-OADS,/arxiv_data1/oa_pdf/9d/bc/dddt-10-3555.PMC5098526.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/9d/bc/dddt-10-3555.PMC5098526.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9d/bc/dddt-10-3555.PMC5098526.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ee/35/dddt-10-3591.PMC5098527.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3591–3597Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3591Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11487 9 Fenretinide inhibits macrophage inflammatory  mediators and controls hypertension in  spontaneously hypertensive rats via the  peroxisome proliferator-activated receptor  gamma pathway ching-han lin,1,* shang-Yu  lee,2,* chun-cheng Zhang,3  Ye-Fong Du,1 hao-chang  hung,1 hung-Tsung Wu,4  horng-Yih Ou1 1Department of internal Medicine,   Division of endocrinology and  Metabolism, national cheng Kung  University hospital, college of  Medicine, national cheng Kung  University, Tainan, 2Department  of internal Medicine, Division of  endocrinology and Metabolism,   chi-Mei Medical center, 3Department  of internal Medicine, Division of  holistic care, chi-Mei Medical  center, 4research center of clinical  Medicine, national cheng Kung  University hospital, Tainan, Taiwan *These authors contributed equally  to this workAbstract:  Fenretinide is a novel anticancer agent reported to exhibit anti-invasive and antimetastatic  activities.",Non-OADS,/arxiv_data1/oa_pdf/ee/35/dddt-10-3591.PMC5098527.pdf
"However, in order to reduce liver toxicity and any other side effects of the  treatment, several analogues have been synthesized, such as fenretinide.1 Fenretinide  induces tumor cell apoptosis by mitochondrial depolarization, caspase-9 activation, and  caspase-3 activation.2 In addition, fenretinide corrects a phospholipid-bound fatty acid  imbalance that impacts the phosphorylation of extracellular signal-regulated kinase  (ERK)1/2 to modulate inflammatory cytokine expression in macrophages.3 A recent  study also demonstrated that fenretinide prevents obesity and hepatic steatosis in high-fat  diet-induced obese mice.4 Furthermore, fenretinide ameliorates insulin resistance through  an increase in the clearance of retinol binding protein-4 in spontaneously hypertensive  rats (SHR).5 Although the role of fenretinide in the improvement of insulin resistance correspondence: horng-Yih Ou Department of internal Medicine,  Division of endocrinology and  Metabolism, national cheng Kung  University hospital, college of Medicine,  national cheng Kung University, 138,  sheng-li road, Tainan 70403, Taiwan Tel +886 6 235 3535 Fax +886 6 302 8130 email wahoryi@mail.ncku.edu.t w  hung-Tsung Wu research center of clinical Medicine,  national cheng Kung University hospital,  national cheng Kung University, 138,  sheng-li road, Tainan 70403, Taiwan Tel +886 6 235 3535 Fax +886 6 275 4243 email wuht0716@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Lin et al Running head recto: Fenretinide inhibits inflammation and controls hypertension DOI: http://dx.doi.org/10.2147/DDDT.S114879",Non-OADS,/arxiv_data1/oa_pdf/ee/35/dddt-10-3591.PMC5098527.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/ee/35/dddt-10-3591.PMC5098527.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ee/35/dddt-10-3591.PMC5098527.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/84/3d/hiv-8-175.PMC5098528.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/84/3d/hiv-8-175.PMC5098528.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).HIV/AIDS - Research and Palliative Care Dovepress submit your manuscript | www.dovepress.com Dovepress 175 ReVIew open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HIV.S56158Profile of once-daily darunavir/cobicistat fixed- dose combination for the treatment of HIV/AIDS Jordi Navarro  Adrian Curran Infectious Diseases Department,   Hospital Universitari Vall d’Hebron,   Universitat Autònoma de Barcelona,  Barcelona, SpainAbstract:  Efficacy is the main objective of antiretroviral treatment and adherence is one of  the cornerstones to achieve it.",Non-OADS,/arxiv_data1/oa_pdf/84/3d/hiv-8-175.PMC5098528.pdf
"This pharmacokinetic enhance-ment affects not only antiretroviral drugs such as PIs or elvitegravir, but also all other comedications metabolized through CYP that the patient might be receiving, Correspondence: Adrian Curran;  Jordi Navarro   Infectious Diseases Department, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Passeig Vall d’Hebron 119–129, 08035 Barcelona, Spain Tel +34 93 274 6090Fax +34 93 489 4091Email acurran@vhebron.net; jnavarro@vhebron.netJournal name: HIV/AIDS - Research and Palliative Care Article Designation: REVIEWY ear: 2016V olume: 8Running head verso: Navarro and CurranRunning head recto: Darunavir/cobicistat fixed-dose combinationDOI: http://dx.doi.org/10.2147/HIV .S56158",Non-OADS,/arxiv_data1/oa_pdf/84/3d/hiv-8-175.PMC5098528.pdf
Available from: http://www.ema.europa.eu/docs/en_GB/ document_library/EPAR_-_Product_Information/human/002819/WC500178953.pdf .,Non-OADS,/arxiv_data1/oa_pdf/84/3d/hiv-8-175.PMC5098528.pdf
Available from: http://aidsinfo.nih.gov/contentfiles/lvguidelines/AdultandAdo-lescentGL.pdf.,Non-OADS,/arxiv_data1/oa_pdf/84/3d/hiv-8-175.PMC5098528.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/84/3d/hiv-8-175.PMC5098528.pdf
Available from: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/84/3d/hiv-8-175.PMC5098528.pdf
"HIV/AIDS - Research and Palliative Care 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress HIV/AIDS - Research and Palliative Care Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/hivaids---research-and-palliative-care-journalHIV/AIDS - Research and Palliative Care is an international, peer- reviewed open access journal focusing on advances in research in HIV , its clinical progression and management options including antiviral treatment, palliative care and public healthcare policies to control viral spread.",Non-OADS,/arxiv_data1/oa_pdf/84/3d/hiv-8-175.PMC5098528.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 182 Navarro and Curran  29.,Non-OADS,/arxiv_data1/oa_pdf/84/3d/hiv-8-175.PMC5098528.pdf
Available from:  http://www.hiv-druginteractions.org.,Non-OADS,/arxiv_data1/oa_pdf/84/3d/hiv-8-175.PMC5098528.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/a0/d5/hmer-8-105.PMC5098529.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/a0/d5/hmer-8-105.PMC5098529.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Hepatic Medicine: Evidence and Research 2016:8 105–113Hepatic Medicine: Evidence and Research Dovepress submit your manuscript | www.dovepress.com Dovepress  105 REviEw open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/HMER.S79243Defibrotide in the treatment of hepatic   veno-occlusive disease Alessandro Fulgenzi Maria Elena Ferrero Department of Biomedical Sciences  for Health, University of Milan,  Milan,  ItalyAbstract:  Hepatic veno-occlusive disease (VOD), also known as sinusoidal obstruction syn- drome (SOS), represents the most frequent complication in patients in early phase following  hematopoietic stem-cell transplantation (HSCT).",Non-OADS,/arxiv_data1/oa_pdf/a0/d5/hmer-8-105.PMC5098529.pdf
"14 Some drugs that cause bone marrow suppression, which are responsible for  SOS development, have recently been described: 6-mercaptopurine, 6-thioguanine, actinomycin D, azathioprine, busulfan, cytosine arabinoside, cyclophosphamide, Correspondence: Maria Elena Ferrero Department of Biomedical Sciences for Health, University of Milan, via Mangiagalli 31, 20133 Milan, ItalyTel +39 2 5031 5333Fax +39 2 5031 5338Email mariaelena.ferrero@unimi.itJournal name: Hepatic Medicine: Evidence and Research Article Designation: ReviewY ear: 2016V olume: 8Running head verso: Fulgenzi and FerreroRunning head recto: Defibrotide and hepatic veno-occlusive diseaseDOI: http://dx.doi.org/10.2147/HMER.S79243",Non-OADS,/arxiv_data1/oa_pdf/a0/d5/hmer-8-105.PMC5098529.pdf
"Hepatic Medicine: Evidence and Research 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Hepatic Medicine: Evidence and Research Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/hepatic-medicine-evidence-and-research-journalHepatic Medicine: Evidence and Research is an international, peer- reviewed, open access journal covering all aspects of adult and pediatric hepatology in the clinic and laboratory including the following topics: Pathology, pathophysiology of hepatic disease; Investigation and treat-ment of hepatic disease; Pharmacology of drugs used for the treatment of hepatic disease.",Non-OADS,/arxiv_data1/oa_pdf/a0/d5/hmer-8-105.PMC5098529.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 113 Defibrotide and hepatic veno-occlusive disease  46.,Non-OADS,/arxiv_data1/oa_pdf/a0/d5/hmer-8-105.PMC5098529.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/44/5f/dmso-9-371.PMC5098530.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/44/5f/dmso-9-371.PMC5098530.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016:9 371–380Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dovepress submit your manuscript | www.dovepress.com Dovepress 371 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S120101 Trends in medication use in patients with type 2  diabetes mellitus: a long-term view of real-world  treatment between 2000 and 2015 Victoria Higgins   James Piercy   Adam Roughley   Gary Milligan   Andrea Leith   James Siddall   Mike Benford Adelphi Real World, Macclesfield, UKBackground: Despite the availability of a variety of treatments, many patients with type 2  diabetes mellitus (T2DM) are not achieving glucose control.",Non-OADS,/arxiv_data1/oa_pdf/44/5f/dmso-9-371.PMC5098530.pdf
"Current guidelines from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) recommend a personalized approach to glycemic control rather than a universal goal for all patients; an HbA 1c level of 7%  is often used as a cutoff point.1,2 Despite  comprehensive treatment guidelines and the Correspondence: Victoria Higgins   Adelphi Real World, Adelphi Mill,  Grimshaw Lane, Bollington, Macclesfield, Cheshire SK10 5JB, UK   Tel +44 1625 57 7361   Fax +44 1625 57 5853   Email victoria.higgins@adelphigroup.comJournal name: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Higgins et alRunning head recto: Trends in medication use in patients with type 2 diabetes mellitusDOI: http://dx.doi.org/10.2147/DMSO.S120101",Non-OADS,/arxiv_data1/oa_pdf/44/5f/dmso-9-371.PMC5098530.pdf
Available from: https://www.nice.org.uk/guidance/ng28.,Non-OADS,/arxiv_data1/oa_pdf/44/5f/dmso-9-371.PMC5098530.pdf
Available from: http://www.hscic.gov.uk/catalogue/PUB14970/nati-diab-audi-12-13-care-proc-rep.pdf.,Non-OADS,/arxiv_data1/oa_pdf/44/5f/dmso-9-371.PMC5098530.pdf
Available from: http://www.hhs.gov/sites/default/files/privacysummary.pdf.,Non-OADS,/arxiv_data1/oa_pdf/44/5f/dmso-9-371.PMC5098530.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journal Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to   the rapid publication of the latest laboratory and clinical findings   in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/44/5f/dmso-9-371.PMC5098530.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 380 Higgins et al  8.,Non-OADS,/arxiv_data1/oa_pdf/44/5f/dmso-9-371.PMC5098530.pdf
Available from: http://www.ephmra.org/code-of-conduct/2/A-Purpose-Scope-and-Sources.,Non-OADS,/arxiv_data1/oa_pdf/44/5f/dmso-9-371.PMC5098530.pdf
Available from: https://www.healthit.gov/sites/default/files/hitech_act_excerpt_from_arra_with_index.pdf.,OADS,/arxiv_data1/oa_pdf/44/5f/dmso-9-371.PMC5098530.pdf
Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm109026.htm.,Non-OADS,/arxiv_data1/oa_pdf/44/5f/dmso-9-371.PMC5098530.pdf
Available from: http://www.nehi.net/writable/publication_files/file/rwe_issue_brief_final.pdf.,Non-OADS,/arxiv_data1/oa_pdf/44/5f/dmso-9-371.PMC5098530.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c2/98/dddt-10-3563.PMC5098531.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3563–3572Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3563Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S11921 4 evaluating the cytotoxic effects of the water  extracts of four anticancer herbs against human  malignant melanoma cells Binbing ling1,2 Deborah Michell Meena Kishore sakharkar1 Jian Yang1 1Drug Discovery and Development  research group, college of  Pharmacy and nutrition, University  of saskatchewan, saskatoon, sK,   2Department of Biomedical and  Molecular sciences, Queen’s  University, cancer Biology & genetics  Division, Queen’s cancer research  institute, Kingston, On , canadaAbstract:  Malignant melanoma (MM) is the most dangerous type of skin cancer, killing more  than 1,100 people each year in Canada.",Non-OADS,/arxiv_data1/oa_pdf/c2/98/dddt-10-3563.PMC5098531.pdf
"The  5-year relative survival rate is higher than 90% for early diagnosed MM patients  (stages IA and IB); however, prognosis is extremely poor for deeper ( .4 cm) and  metastatic MM partially due to resistance development toward chemotherapy drugs.3  Thus, many advanced or recurrent MM patients seek complementary and alternative  medicines, expecting to achieve better therapeutic efficacy, reduced chemotherapy- related side effects, and/or a boost to the immune system.4–6correspondence: Jian Yang Drug Discovery and Development  research group, college of  Pharmacy and nutrition, University  of saskatchewan, 110 science Place,  saskatoon, sK s7n 5c9, canada Tel +1 306 966 6361 Fax +1 306 966 6377 email jian.yang@usask.c a Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Ling et al Running head recto: Cytotoxic effects of the water extracts of four anticancer herbs DOI: http://dx.doi.org/10.2147/DDDT.S119214",Non-OADS,/arxiv_data1/oa_pdf/c2/98/dddt-10-3563.PMC5098531.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/c2/98/dddt-10-3563.PMC5098531.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c2/98/dddt-10-3563.PMC5098531.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/74/90/dddt-10-3575.PMC5098533.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Drug Design, Development and Therapy 2016:10 3575–3590Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3575Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S11811 6 endoperoxide antimalarials: development, structural  diversity and pharmacodynamic aspects with  reference to 1,2,4-trioxane-based structural scaffold Mithun Rudrapal Dipak Chetia Department of Pharmaceutical  Sciences, Dibrugarh University,   Dibrugarh, indiaAbstract:  Malaria disease continues to be a major health problem worldwide due to the  emergence of multidrug-resistant strains of Plasmodium falciparum .",Non-OADS,/arxiv_data1/oa_pdf/74/90/dddt-10-3575.PMC5098533.pdf
"Among these five organisms,   P. falciparum  is the most widespread and pernicious species which causes poten - tially fatal malaria such as cerebral malaria and most of the malaria-related deaths  worldwide.2–4 In patients with severe and complicated malaria caused by P. falciparum ,  the mortality rate accounts for 20%–50% when left untreated.1 P. falciparum  also  produces a varying degree of resistance against a majority of existing antimalarial Correspondence: Mithun Rudrapal Department of Pharmaceutical Sciences,  Dibrugarh University, Dibrugarh 786 004,  Assam, india Tel +91 373 237 0254 Fax +91 373 237 0323 email rs_rudrapal@yahoo.co.i n Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Rudrapal and Chetia Running head recto: Endoperoxide antimalarials DOI: http://dx.doi.org/10.2147/DDDT.S118116",Non-OADS,/arxiv_data1/oa_pdf/74/90/dddt-10-3575.PMC5098533.pdf
Available from: https://clinicaltrials.gov/ct2/show/NCT0245330 8.,Non-OADS,/arxiv_data1/oa_pdf/74/90/dddt-10-3575.PMC5098533.pdf
Available from: http://www.mmv.org/sites/default/ files/uploads/docs/publications /.,Non-OADS,/arxiv_data1/oa_pdf/74/90/dddt-10-3575.PMC5098533.pdf
Available from: http://www.mmv.org/ research-development/project-year-award/mmv-project-year-award- 2006.,Non-OADS,/arxiv_data1/oa_pdf/74/90/dddt-10-3575.PMC5098533.pdf
Available from: http://www.mmv.org/newsroom/ publications/annual-report-201 5.,Non-OADS,/arxiv_data1/oa_pdf/74/90/dddt-10-3575.PMC5098533.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/74/90/dddt-10-3575.PMC5098533.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/74/90/dddt-10-3575.PMC5098533.pdf
"Key Words:  Marine drug development, Cytostatics, Analgetics, Antiviral, AntihyperlipidemicAbstractInvited Review Biomol  Ther 24(6), 561-571 (2016) *Corresponding Author E-mail: lindequi@uni-greifswald.de Tel: +49-3834-864868, Fax: +49-3834-864885Received  Aug 11, 2016  Revised  Oct 4, 2016  Accepted  Oct 5, 2016 Published Online  Nov 1, 2016 Copyright © 2016 The Korean Society of Applied Pharmacologyhttps://doi.org/10.4062/biomolther.2016.181 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5f/ca/bt-24-561.PMC5098534.pdf
562 https://doi.org/10.4062/biomolther.2016.181(antiinflammatory pseudopterosins from the coral Pseudop - terogorgia elisabethae etc.),Non-OADS,/arxiv_data1/oa_pdf/5f/ca/bt-24-561.PMC5098534.pdf
"The World Register of Marine Spe- cies (2016, http://www.marinespecies.org/) counts currently  about 240,000 known species.",OADS,/arxiv_data1/oa_pdf/5f/ca/bt-24-561.PMC5098534.pdf
"In the frame of the worldwide research project Census of marine life (c2010,  http://www.coml.org/) numerous new species have been de- tected.",OADS,/arxiv_data1/oa_pdf/5f/ca/bt-24-561.PMC5098534.pdf
564 https://doi.org/10.4062/biomolther.2016.181alogue cytosine arabinoside cytarabine (e.g.,Non-OADS,/arxiv_data1/oa_pdf/5f/ca/bt-24-561.PMC5098534.pdf
566 https://doi.org/10.4062/biomolther.2016.181tigations of sponge nucleosides as possible drugs in the 1950s  (see above).,Non-OADS,/arxiv_data1/oa_pdf/5f/ca/bt-24-561.PMC5098534.pdf
"568 https://doi.org/10.4062/biomolther.2016.181lar proteins have possibly the function to act as light driven  electron transfer (Bogdanov et al., 2009).",OADS,/arxiv_data1/oa_pdf/5f/ca/bt-24-561.PMC5098534.pdf
Available from: http://www.coml.org/.,Non-OADS,/arxiv_data1/oa_pdf/5f/ca/bt-24-561.PMC5098534.pdf
570 https://doi.org/10.4062/biomolther.2016.181Molecular and cellular mechanisms of okadaic acid (OKA)-induced  neurotoxicity: a novel tool of Alzheimer’s disease therapeutic ap-plication.,Non-OADS,/arxiv_data1/oa_pdf/5f/ca/bt-24-561.PMC5098534.pdf
[cited 2016 Aug 01] Available from: http://marinepharmacology.midwestern.edu/clinPipeline.htm/.,OADS,/arxiv_data1/oa_pdf/5f/ca/bt-24-561.PMC5098534.pdf
Available from: http://www.marinespe - cies.org/.,Non-OADS,/arxiv_data1/oa_pdf/5f/ca/bt-24-561.PMC5098534.pdf
"Key Words:  3-deoxysappanchalcone, Human hair follicle dermal papilla cells, WNT/β-catenin, STAT3, STAT6, C57BL/6 miceAbstractOriginal Article Biomol  Ther 24(6), 572-580 (2016) *Corresponding Author E-mail: bychoi@seowon.ac.kr Tel: +82-43-299-8470, Fax: +82-43-299-8411Received  Aug 16, 2016  Revised  Sep 14, 2016  Accepted  Sep 22, 2016 Published Online  Nov 1, 2016 Copyright © 2016 The Korean Society of Applied Pharmacologyhttp://dx.doi.org/10.4062/biomolther.2016.183 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/61/61/bt-24-572.PMC5098535.pdf
"574 http://dx.doi.org/10.4062/biomolther.2016.183pedance, which is displayed as cell index (CI) values, was  used to provide quantitative information about the biological  status of cells, including cell number, viability, and morphol - ogy.",OADS,/arxiv_data1/oa_pdf/61/61/bt-24-572.PMC5098535.pdf
"576 http://dx.doi.org/10.4062/biomolther.2016.183RESUL TS The effects of 3-DSC on hair follicle dermal papilla cell  growth Since 3-DSC has been reported to elicit the activation of  cell survival pathways (Kim et al., 2014), we examined the  effects of 3-DSC on growth of HDPCs.",OADS,/arxiv_data1/oa_pdf/61/61/bt-24-572.PMC5098535.pdf
"578 http://dx.doi.org/10.4062/biomolther.2016.183der to determine whether the inhibitory effects of 3-DSC on  STAT6 phosphorylation can be ascribed to the attenuation of  the STAT6 transcriptional response, we analyzed the effects  of 3-DSC on IL-4 receptor site-mediated reporter gene ex- pression using a stably transfected HEK293 cell line that ex- presses the IL-4R site-TKluc/STAT6 regulated luciferase gene after treatment with IL-4 (Fig.",Non-OADS,/arxiv_data1/oa_pdf/61/61/bt-24-572.PMC5098535.pdf
"580 http://dx.doi.org/10.4062/biomolther.2016.183Huelsken, J., Vogel, R., Erdmann, B., Cotsarelis, G. and Birchmeier,  W. (2001) β-Catenin controls hair follicle morphogenesis and stem  cell differentiation in the skin.",Non-OADS,/arxiv_data1/oa_pdf/61/61/bt-24-572.PMC5098535.pdf
"Key Words:  Lonchocarpine, Astrocytes, Antioxidant enzymes, AMPK, MAPK, Nrf2/ARE signaling AbstractOriginal Article Biomol  Ther 24(6), 581-588 (2016) *Corresponding Author E-mail: hskimp@ewha.ac.kr Tel: +82-2-2650-5823, Fax: +82-2-2653-8891Received  Jun 28, 2016  Revised  Aug 29, 2016  Accepted  Sep 8, 2016 Published Online  Nov 1, 2016 Copyright © 2016 The Korean Society of Applied Pharmacologyhttps://doi.org/10.4062/biomolther.2016.141 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/50/bd/bt-24-581.PMC5098536.pdf
582 https://doi.org/10.4062/biomolther.2016.141nents of Abrus precatorius .,Non-OADS,/arxiv_data1/oa_pdf/50/bd/bt-24-581.PMC5098536.pdf
584 https://doi.org/10.4062/biomolther.2016.141oligonucleotides containing the ARE consensus sequences  (Santa Cruz) were end-labeled with [γ-32P]ATP.,OADS,/arxiv_data1/oa_pdf/50/bd/bt-24-581.PMC5098536.pdf
"586 https://doi.org/10.4062/biomolther.2016.141DISCUSSION In the present study, we demonstrated that lonchocarpine  inhibited ROS production in H 2O2-treated rat primary astro- cytes.",Non-OADS,/arxiv_data1/oa_pdf/50/bd/bt-24-581.PMC5098536.pdf
588 https://doi.org/10.4062/biomolther.2016.141Rev.,Non-OADS,/arxiv_data1/oa_pdf/50/bd/bt-24-581.PMC5098536.pdf
"The above mentioned pathways  *Corresponding Author E-mail: kimsj@khu.ac.kr Tel: +82-2-961-0868, Fax: +82-2-960-0867Received  Feb 14, 2016  Revised  Mar 23, 2016  Accepted  Mar 29, 2016 Published Online  Nov 1, 2016https://doi.org/10.4062/biomolther.2016.030 Copyright © 2016 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/97/5c/bt-24-589.PMC5098537.pdf
"590 https://doi.org/10.4062/biomolther.2016.030are activated after the activation of intrinsic tyrosine kinase  associated with IRs, but how signaling progresses remains  poorly understood (Cheatham and Kahn, 1995).",Non-OADS,/arxiv_data1/oa_pdf/97/5c/bt-24-589.PMC5098537.pdf
592 https://doi.org/10.4062/biomolther.2016.030DISCUSSION Insulin treatment activates the insulin receptor tyrosine ki- nase initiated by phosphorylation of insulin receptor substrate  and followed by the association of SH2 containing proteins  including PI3K.,Non-OADS,/arxiv_data1/oa_pdf/97/5c/bt-24-589.PMC5098537.pdf
"594 https://doi.org/10.4062/biomolther.2016.030ity to stimulate phosphorylation of Akt, ERK levels and inhib - in-βE in the UMR-106 cells.",Non-OADS,/arxiv_data1/oa_pdf/97/5c/bt-24-589.PMC5098537.pdf
"Key Words:  Pyrrole, Chalcone, Anti-inflammatory activity, Macrophages, NF-κBAbstract Copyright  © 2016 The Korean Society of Applied Pharmacology*Corresponding Authors E-mail: tawkim@kangwon.ac.kr (Kim TW), jaecho@skku.edu (Cho JY) Tel: +82-33-250-8515 (Kim TW), +82-31-290-7868 (Cho JY)Fax: +82-33-250-8510 (Kim TW), +82-31-290-7870 (Cho JY)Received  Feb 11, 2016  Revised  Apr 2, 2016  Accepted  Apr 21, 2016 Published Online  Nov 1, 2016https://doi.org/10.4062/biomolther.2016.027 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/de/60/bt-24-595.PMC5098538.pdf
"596 https://doi.org/10.4062/biomolther.2016.027(DAMPs) such as heat-shock proteins, DNA, RNA, and high- mobility group box-1 (HMGB-1), which are largely connected  to sepsis (Rittirsch et al., 2008).",Non-OADS,/arxiv_data1/oa_pdf/de/60/bt-24-595.PMC5098538.pdf
598 https://doi.org/10.4062/biomolther.2016.027concentrations (0 to 100 mM) prior to LPS stimulation.,Non-OADS,/arxiv_data1/oa_pdf/de/60/bt-24-595.PMC5098538.pdf
600 https://doi.org/10.4062/biomolther.2016.027strategy with TAK1 gene.,OADS,/arxiv_data1/oa_pdf/de/60/bt-24-595.PMC5098538.pdf
"602 https://doi.org/10.4062/biomolther.2016.027molecular and in vivo pharmacological studies, the drug value  of our chalcone pyrrole-derivative compound may be further  examined in the future.",Non-OADS,/arxiv_data1/oa_pdf/de/60/bt-24-595.PMC5098538.pdf
"MATERIALS AND METHODS Reagents, antibodies and cell culture Purified α-mangostin was directly provided from Dr. Young- *Corresponding Author E-mail: keum03@dongguk.edu Tel: +82-31-961-5215, Fax: +82-31-961-5206  †The first two authors contributed equally to this work.Received  Feb 11, 2016  Revised  Apr 6, 2016  Accepted  Apr 7, 2016 Published Online  Nov 1, 2016https://doi.org/10.4062/biomolther.2016.028 Copyright © 2016 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fe/d5/bt-24-604.PMC5098539.pdf
"606 https://doi.org/10.4062/biomolther.2016.028Immunofluorescence against 8-hydroxyguanosine (8-OH-G)    and 4-hydroxynonenal (4-HNE) In order to measure the changes of 8-hydroxyguanosine  (8-OH-G) and 4-hydroxynonal (4-HNE) levels, SNUC5 and  SNUC5/5-FUR cells grown on a slice glass were permeabi - lized by 4% paraformaldehyde.",OADS,/arxiv_data1/oa_pdf/fe/d5/bt-24-604.PMC5098539.pdf
608 https://doi.org/10.4062/biomolther.2016.028Treatment of α-mangostin provides direct oxidative   damages on SNUC5 and SNUC5/5-FU cells  We next suspected that the growth-inhibitory mechanism  of α-mangostin could be ascribed to the disruption of genomic  integrity.,Non-OADS,/arxiv_data1/oa_pdf/fe/d5/bt-24-604.PMC5098539.pdf
"Bacterial activation of macro-phages has been reported to cause a wide range of pro-in - flammatory responses including secretion of pro-inflammatory mediators, expression of adhesion molecules and coagulation  factors, phagocytosis, and cytoskeletal rearrangement (Sweet  *Corresponding Author E-mail: wchun@kangwon.ac.kr Tel: +82-33-250-8853, Fax: +82-33-255-8809Received  Feb 5, 2016  Revised  Mar 4, 2016  Accepted  Mar 29, 2016 Published Online  Nov 1, 2016https://doi.org/10.4062/biomolther.2016.026 Copyright © 2016 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a3/43/bt-24-610.PMC5098540.pdf
612 https://doi.org/10.4062/biomolther.2016.026the extracellular secretion of NO and PGE 2 were examined  in LPS-challenged RAW264.7 macrophages.,OADS,/arxiv_data1/oa_pdf/a3/43/bt-24-610.PMC5098540.pdf
"614 https://doi.org/10.4062/biomolther.2016.026(Sweet and Hume, 1996) and that many of the downstream  targets of MAPK pathways are transcription factors, which  regulate various genes encoding inflammatory mediators  (Zhang et al., 2006; Lee et al., 2009; Zhang et al., 2011).",OADS,/arxiv_data1/oa_pdf/a3/43/bt-24-610.PMC5098540.pdf
"In addition, baicalein reduces oxidative stress-induced DNA  *Corresponding Author E-mail: jinwonh@jejunu.ac.kr Tel: +82-64-754-3838, Fax: +82-64-702-2687Received  Feb 1, 2016  Revised  Mar 18, 2016  Accepted  Mar 24, 2016 Published Online  Nov 1, 2016https://doi.org/10.4062/biomolther.2016.022 Copyright © 2016 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/69/eb/bt-24-616.PMC5098541.pdf
618 https://doi.org/10.4062/biomolther.2016.022labile damage.,Non-OADS,/arxiv_data1/oa_pdf/69/eb/bt-24-616.PMC5098541.pdf
620 https://doi.org/10.4062/biomolther.2016.022cells with baicalein reduced the fluorescence intensity (Fig.,Non-OADS,/arxiv_data1/oa_pdf/69/eb/bt-24-616.PMC5098541.pdf
"622 https://doi.org/10.4062/biomolther.2016.022Lee, I. K., Kang, K. A., Zhang, R., Kim, B. J., Kang, S. S. and Hyun,  J. W. (2011) Mitochondria protection of baicalein against oxidative  damage via induction of manganese superoxide dismutase.",OADS,/arxiv_data1/oa_pdf/69/eb/bt-24-616.PMC5098541.pdf
"Key Words:  LS-1, SNU-C5, Apoptosis, Wnt/β-catenin pathway, TGF-β pathwayAbstractOriginal Article Biomol  Ther 24(6), 623-629 (2016) *Corresponding Author E-mail: pharmkhk@jejunu.ac.kr Tel: +82-64-754-3846, Fax: +82-64-702-2687Received  Feb 1, 2016  Revised  May 4, 2016  Accepted  May 12, 2016 Published Online  Nov 1, 2016https://doi.org/10.4062/biomolther.2016.023 Copyright © 2016 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/65/eb/bt-24-623.PMC5098542.pdf
624 https://doi.org/10.4062/biomolther.2016.023the TGF βRI.,Non-OADS,/arxiv_data1/oa_pdf/65/eb/bt-24-623.PMC5098542.pdf
626 https://doi.org/10.4062/biomolther.2016.023cell death by LS-1 could result from induction of apoptosis.,Non-OADS,/arxiv_data1/oa_pdf/65/eb/bt-24-623.PMC5098542.pdf
"628 https://doi.org/10.4062/biomolther.2016.023cause of inactived-GSK-3 β did not degrade the β-catenin, the  β-catenin acts as a transcription factor in nucleus (Akiyama,  2000).",Non-OADS,/arxiv_data1/oa_pdf/65/eb/bt-24-623.PMC5098542.pdf
"Another key enzyme involved in the inflammatory process is  *Corresponding Author E-mail: ypjang@khu.ac.kr Tel: +82-2-961-9421, Fax: +82-2-966-3885Received  Jan 27, 2016  Revised  Mar 2, 2016  Accepted  Mar 24, 2016 Published Online  Nov 1, 2016https://doi.org/10.4062/biomolther.2016.019 Copyright © 2016 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2f/0a/bt-24-630.PMC5098543.pdf
"632 https://doi.org/10.4062/biomolther.2016.019lent Technologies 1200 series HPLC (Santa Clara, CA, USA)  coupled to a Waters Quattro MicroTM atmospheric pressure  ionization (API) mass spectrometer equipped with an ESI in- terface.",Non-OADS,/arxiv_data1/oa_pdf/2f/0a/bt-24-630.PMC5098543.pdf
"634 https://doi.org/10.4062/biomolther.2016.019were elucidated by comparing their physicochemical data in- cluding UV/Vis spectra, MS and MS/MS data, and 1H-NMR  spectra with those previously described in the literature (Su- zuki et al., 2003; Xie et al., 2003; Erel et al., 2011).",OADS,/arxiv_data1/oa_pdf/2f/0a/bt-24-630.PMC5098543.pdf
636 https://doi.org/10.4062/biomolther.2016.019Griess reagent.,OADS,/arxiv_data1/oa_pdf/2f/0a/bt-24-630.PMC5098543.pdf
"Therefore, we investigated  the effect of DW2007 on Th cell differentiation in mice with  *Corresponding Author E-mail: dhkim@khu.ac.kr Tel: +82-2-961-0374, Fax: +82-2-966-3885 †The first two authors contributed equally to this work.Received  Jan 27, 2016  Revised  Feb 18, 2016  Accepted  Mar 24, 2016 Published Online  Nov 1, 2016https://doi.org/10.4062/biomolther.2016.018 Copyright © 2016 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/04/51/bt-24-638.PMC5098544.pdf
"640 https://doi.org/10.4062/biomolther.2016.018immunization, arthritis incidence, disease severity, paw thick- ness, and body weight were determined.",OADS,/arxiv_data1/oa_pdf/04/51/bt-24-638.PMC5098544.pdf
"642 https://doi.org/10.4062/biomolther.2016.018corporation: activation of DNA polymerase at 95°C for 5 min  and 38 cycles of amplification at 95°C for 10 s and at 60°C for  30 s. The normalized expression of the assayed genes, with  respect to β-actin, was computed for all samples by using the  Microsoft Excel data spreadsheet.",OADS,/arxiv_data1/oa_pdf/04/51/bt-24-638.PMC5098544.pdf
"644 https://doi.org/10.4062/biomolther.2016.018Biomol  Ther 24(6), 638-649 (2016)  Fig.",Non-OADS,/arxiv_data1/oa_pdf/04/51/bt-24-638.PMC5098544.pdf
646 https://doi.org/10.4062/biomolther.2016.018pressed Treg cell differentiation and Foxp3 and IL-10 expres- sion (Fig.,Non-OADS,/arxiv_data1/oa_pdf/04/51/bt-24-638.PMC5098544.pdf
648 https://doi.org/10.4062/biomolther.2016.018in both mice and increased Treg cell differentiation.,Non-OADS,/arxiv_data1/oa_pdf/04/51/bt-24-638.PMC5098544.pdf
"Key Words:  Ecklonia stolonifera, Hepatoprotective effect, Fatty liver, PPAR-alpha, SREBP-1, EthanolAbstractOriginal Article Biomol  Ther 24(6), 650-658 (2016) *Corresponding Author E-mail: sychoung@khu.ac.kr Tel: +82-2-961-0372, Fax: +82-2-961-0372Received  Aug 9, 2016  Revised  Sep 28, 2016  Accepted  Sep 29, 2016 Published Online  Nov 1, 2016 Copyright © 2016 The Korean Society of Applied Pharmacologyhttps://doi.org/10.4062/biomolther.2016.176 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9b/1b/bt-24-650.PMC5098545.pdf
652 https://doi.org/10.4062/biomolther.2016.176formic acid (0.1%) (solvent A) and acetonitrile acidified with  formic acid (0.1%) (solvent B).,Non-OADS,/arxiv_data1/oa_pdf/9b/1b/bt-24-650.PMC5098545.pdf
"654 https://doi.org/10.4062/biomolther.2016.176solutions of eckol, dieckol, and phlorofucofuroeckol A, each  diluted to an appropriate concentration (Fig.",Non-OADS,/arxiv_data1/oa_pdf/9b/1b/bt-24-650.PMC5098545.pdf
"656 https://doi.org/10.4062/biomolther.2016.176cially, ES at concentrations of 100 and 200 mg/kg was more  effective in inhibiting the lipid accumulation than did silymarin.",Non-OADS,/arxiv_data1/oa_pdf/9b/1b/bt-24-650.PMC5098545.pdf
"658 https://doi.org/10.4062/biomolther.2016.176Shield, K. D., Rylett, M., Gmel, G., Gmel, G., Kehoe-Chan, T. A. and  Rehm, J.",OADS,/arxiv_data1/oa_pdf/9b/1b/bt-24-650.PMC5098545.pdf
"Many researchers have reported strong antioxidant ef- *Corresponding Author E-mail: jungom@hwpharm.com Tel: +82-33-260-0500, Fax: +82-33-260-0507 †The first two authors contributed equally to this work.Received  Jan 29, 2016  Revised  Apr 7, 2016  Accepted  May 3, 2016 Published Online  Nov 1, 2016https://doi.org/10.4062/biomolther.2016.021 Copyright © 2016 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens- es/by-nc/4.0/) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b7/fb/bt-24-659.PMC5098546.pdf
"660 https://doi.org/10.4062/biomolther.2016.021fects and various physiological activities of Lindera obtusiloba   leaf extracts (Hong et al., 2013a; Hong et al., 2013b; Hong,  2013).",OADS,/arxiv_data1/oa_pdf/b7/fb/bt-24-659.PMC5098546.pdf
"662 https://doi.org/10.4062/biomolther.2016.021is quickly converted to TXB2, the stable metabolite of TXA2.",Non-OADS,/arxiv_data1/oa_pdf/b7/fb/bt-24-659.PMC5098546.pdf
"664 https://doi.org/10.4062/biomolther.2016.021Fuentes, E., Alarcón, M., Fuentes, M., Carrasco, G. and Palomo, I.",OADS,/arxiv_data1/oa_pdf/b7/fb/bt-24-659.PMC5098546.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4a/ec/tcrm-12-1609.PMC5098547.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Therapeutics and Clinical Risk Management 2016:12 1609–1613Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1609ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S11240 0 Patent ductus arteriosus with persistent  pulmonary artery hypertension after  transcatheter closure Jianqi Feng1,2 Xiangqing Kong1 Yanhui sheng1 Rong Yang1 1Department of Cardiology, the  First affiliated hospital of nanjing  Medical University, nanjing, Jiangsu,   2Department of Cardiology, the  second affiliated hospital of XuZhou  Medical University, XuZhou, Jiangsu,   People’s Republic of ChinaObjectives:  To observe the change in pulmonary artery systolic pressure (PASP) of patients with  persistent pulmonary arterial hypertension (PAH) after patent ductus arteriosus (PDA) occlusion.",Non-OADS,/arxiv_data1/oa_pdf/4a/ec/tcrm-12-1609.PMC5098547.pdf
"Pulmonary hypertension maintained after occlusion.Correspondence: Xiangqing Kong Department of Cardiology, the First  Affiliated Hospital of Nanjing Medical  University, nanjing, Jiangsu 210000,  People’s Republic of China Tel +86 139 5161 0265 email xiangqingkong1@sina.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2016 Volume: 12 Running head verso: Feng et al Running head recto: PDA with persistent PAH after TCC  DOI: http://dx.doi.org/10.2147/TCRM.S112400",Non-OADS,/arxiv_data1/oa_pdf/4a/ec/tcrm-12-1609.PMC5098547.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/4a/ec/tcrm-12-1609.PMC5098547.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4a/ec/tcrm-12-1609.PMC5098547.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/6a/6b/ppa-10-2255.PMC5098548.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 2255–2260Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  2255OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11642 4 The Universal Patient centeredness Questionnaire:  scaling approaches to reduce positive skew Oyvind Bjertnaes hilde hestad iversen Andrew M garratt Unit for Patient-reported Quality,   norwegian institute of Public health,   Oslo, norwayPurpose:  Surveys of patients’ experiences typically show results that are indicative of positive  experiences.",Non-OADS,/arxiv_data1/oa_pdf/6a/6b/ppa-10-2255.PMC5098548.pdf
"A common feature of patient-based instruments  evaluating health care services is a skew toward positive evaluations,1,2 which has  also been observed in service user evaluations in other sectors.3 The reasons for this  positivity tendency are complex and multifaceted, and it involves a range of cultural,  methodological, and relational factors.3–5 Positive skew casts doubt over the validity correspondence: Oyvind Bjertnaes Unit for Patient-reported Quality,  norwegian institute of Public  health, Postbox 4404 nydalen,  0403 Oslo, norway Tel +47 91 17 60 45 email oyvindandresen.bjertnaes@fhi.n o Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Bjertnaes et al Running head recto: The UPC-Q DOI: http://dx.doi.org/10.2147/PPA.S116424",Non-OADS,/arxiv_data1/oa_pdf/6a/6b/ppa-10-2255.PMC5098548.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/6a/6b/ppa-10-2255.PMC5098548.pdf
©2016TheAuthor(s).PublishedbyElsevierInc.ThisisanopenaccessarticleundertheCCBY-NC-ND license( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/13/c7/main.PMC5098550.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc- nd/4.0/).,Non-OADS,/arxiv_data1/oa_pdf/13/c7/main.PMC5098550.pdf
http://dx.doi.org/10.1016/j.jcte.2016.06.002Journal of Clinical & Translational Endocrinology 5 (2016) 21–25 Contents lists available at ScienceDirect Journal of Clinical & Translational Endocrinology journal homepage: www.elsevier.com/locate/jcte,Non-OADS,/arxiv_data1/oa_pdf/13/c7/main.PMC5098550.pdf
A fulllistof participatingREGARDSinvestigatorsandinstitutionscan be found at http://www.regardsstudy.org .,Non-OADS,/arxiv_data1/oa_pdf/13/c7/main.PMC5098550.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/bf/3c/ppa-10-2239.PMC5098562.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 2239–2254Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  2239OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S10800 6 communication during counseling sessions  about inhaled corticosteroids at the community  pharmacy Jeanine A Driesenaar1 Peter A gM De smet2,3 rolf van hulten4,5 litje hu1 sandra van Dulmen1,6,7 1niVel, netherlands institute for  health services research, Utrecht,   the netherlands; 2Department  of clinical Pharmacy, radboud  University Medical center, nijmegen,   the netherlands; 3iQ healthcare,   radboud University Medical center,   nijmegen, the netherlands; 4Division  of Pharmacoepidemiology and  clinical Pharmacology, Utrecht  University, Utrecht, the netherlands;   5Department of Pharmacotherapy  and Pharmaceutical care,   University of groningen, groningen,   the n etherlands; 6Department of  Primary and community care,   radboud University Medical center,   nijmegen, the netherlands; 7Faculty of  health sciences, University college of  southeast norway, Drammen, norwayBackground:  Pharmaceutical care is one of the major tasks of pharmacists, which aims to  improve patient outcomes.",Non-OADS,/arxiv_data1/oa_pdf/bf/3c/ppa-10-2239.PMC5098562.pdf
"Several pharmaceutical care programs and activities have been developed to correspondence: Jeanine A Driesenaar niVel, netherlands institute for health  services research, PO Box 1568,  3500 Bn Utrecht, the netherlands Tel +31 30 272 9707 email j.driesenaar@nivel.n l Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Driesenaar et al Running head recto: Communication during counseling sessions DOI: http://dx.doi.org/10.2147/PPA.S108006",Non-OADS,/arxiv_data1/oa_pdf/bf/3c/ppa-10-2239.PMC5098562.pdf
"Available from: http://www.longalliantie.nl/publicatie s.  Accessed February 2, 2012.",Non-OADS,/arxiv_data1/oa_pdf/bf/3c/ppa-10-2239.PMC5098562.pdf
"Available  from: http://www.knmp.nl/patientenzorg/aandoening-en-preventie/ astma-copd/knmp-richtlijn-cop d. Accessed March 1, 2012.",Non-OADS,/arxiv_data1/oa_pdf/bf/3c/ppa-10-2239.PMC5098562.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/bf/3c/ppa-10-2239.PMC5098562.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/b1/00/ppa-10-2217.PMC5098563.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 2217–2228Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  2217OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11777 4 examining patient preferences in the treatment  of rheumatoid arthritis using a discrete-choice  approach rieke Alten1 Klaus Krüger2 Julian rellecke3 Julia schiffner-rohe4 Olaf Behmer5 guido schiffhorst3 hans-Dieter nolting3 1schlosspark-Klinik, charité,   University Medicine Berlin,   2Praxiszentrum st Bonifatius,   Munich, 3iges institut gmbh, 4Pfizer  Deutschland gmbh, 5Pfizer Pharma  gmbh, Berlin, germanyBackground:  Biological disease-modifying antirheumatic drugs (bDMARDs) used in  second-line treatment of rheumatoid arthritis (RA) are administered parenterally.",Non-OADS,/arxiv_data1/oa_pdf/b1/00/ppa-10-2217.PMC5098563.pdf
"Keywords:  rheumatoid arthritis, disease-modifying antirheumatic drugs, patient preferences,  discrete-choice experiment, best–worst scaling Introduction Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease associated  with multisystemic manifestations, characterized by persistent inflammatory synovitis  of peripheral joints in symmetric distribution, which causes cartilage damage and  bone erosion.1 In addition, RA patients display a variety of other clinical features, correspondence: rieke Alten schlosspark-Klinik, Universitätsmedizin  charité, 2 heubnerweg, Berlin 14059,  germany Tel +49 30 3264 1325 email rieke.alten@schlosspark-klinik.d e Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Alten et al Running head recto: Patient preferences in rheumatoid arthritis DOI: http://dx.doi.org/10.2147/PPA.S117774",Non-OADS,/arxiv_data1/oa_pdf/b1/00/ppa-10-2217.PMC5098563.pdf
"Available from: http://www.eumusc.net/myUploadData/files/ Musculoskeletal %20Health%20in%20Europe%20Report%20v5.pd f.  Accessed November 19, 2015.",Non-OADS,/arxiv_data1/oa_pdf/b1/00/ppa-10-2217.PMC5098563.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/b1/00/ppa-10-2217.PMC5098563.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/2b/12/ppa-10-2229.PMC5098564.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Patient Preference and Adherence 2016:10 2229–2237Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  2229OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S11924 3 Factors influencing access to education, decision  making, and receipt of preferred dialysis modality  in unplanned dialysis start patients Anna Machowska1 Mark Dominik Alscher2 Satyanarayana Reddy Vanga3 Michael Koch4 Michael Aarup5 Abdul rashid Qureshi1 Bengt Lindholm1 Peter A rutherford6 1Division of renal Medicine and  Baxter Novum, Department of  Clinical Science, Intervention, and  T echnology, Karolinska Institutet,   Stockholm, Sweden; 2Division of  Nephrology, Department of Internal  Medicine, Robert-Bosch-Krankenhaus,   Stuttgart, Germany; 3Department of  Renal Medicine, University Hospital  of North Staffordshire, Stoke-on- Trent, Staffordshire, UK; 4center  of Nephrology, Nephrologisches  Zentrum, Mettmann, Germany;   5Department of Nephrology, Odense  University Hospital, Odense,   Denmark; 6Baxter Healthcare SA,   Zurich, SwitzerlandObjectives:  Unplanned dialysis start (UPS) leads to worse clinical outcomes than planned  start, and only a minority of patients ever receive education on this topic and are able to make  a modality choice, particularly for home dialysis.",Non-OADS,/arxiv_data1/oa_pdf/2b/12/ppa-10-2229.PMC5098564.pdf
"Keywords:  chronic kidney disease, dialysis, patient education, unplanned dialysis start, decision- making process Introduction The prevalence of chronic kidney disease (CKD) has reached epidemic proportions, with  10%–12% of the population and 50% of elderly showing signs of kidney dysfunction.1 A  proportion of CKD patients progressively lose kidney function until dialysis is required correspondence: Anna Machowska Division of renal Medicine and Baxter  Novum, Department of Clinical  Science, Intervention, and Technology,  Karolinska Institutet, M99, Karolinska  University Hospital, Huddinge, SE-141  86 Stockholm, Sweden email anna.machowska@ki.s e Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Machowska et al Running head recto: Education of unplanned dialysis start patients DOI: http://dx.doi.org/10.2147/PPA.S119243",Non-OADS,/arxiv_data1/oa_pdf/2b/12/ppa-10-2229.PMC5098564.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/2b/12/ppa-10-2229.PMC5098564.pdf
"Available from: http://www.yodda.leeds.ac.uk/ Survey/Introductio n. Accessed September 26, 2016.",Non-OADS,/arxiv_data1/oa_pdf/2b/12/ppa-10-2229.PMC5098564.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/9f/a2/ott-9-6801.PMC5098565.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6801–6808OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6801Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11411 3 association of TiMP-2-418g/c and TiMP-2- 303g/a with gastric cancer: a meta-analysis Yan Yang Yuqi Xiong Jing li changping Wu Jingting Jiang Department of Tumor Biological  Treatment, The Third affiliated  hospital, soochow University,   changzhou, Jiangsu, People’s  republic of chinaBackground:  According to the relevant reports, TIMP-2 polymorphism might be associated  with the susceptibility to gastric cancer.",Non-OADS,/arxiv_data1/oa_pdf/9f/a2/ott-9-6801.PMC5098565.pdf
"Currently,  the relationship between single nucleotide polymorphisms (SNPs) and gastric cancer  remains unclear, but it may help to explain the genetic susceptibility of patients with  risk of gastric cancer.correspondence: changping Wu;   Jingting Jiang Department of Tumor Biological  Treatment, The Third Affiliated Hospital  of soochow University, 185 Juqian street,  changzhou 213003, Jiangsu, People’s  republic of china email wcpjjt@163.co m;   jiangjingting@suda.edu.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Y ang et al Running head recto: Association of TIMP-2-418G/C and TIMP-2-303G/A with gastric cancer DOI: http://dx.doi.org/10.2147/OTT.S114113",Non-OADS,/arxiv_data1/oa_pdf/9f/a2/ott-9-6801.PMC5098565.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/9f/a2/ott-9-6801.PMC5098565.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9f/a2/ott-9-6801.PMC5098565.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ae/a3/ott-9-6809.PMC5098566.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6809–6817OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6809Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11200 3 Differentiation between adrenal adenomas and  nonadenomas using dynamic contrast-enhanced  computed tomography Xifu Wang1 Kangan li1 haoran sun2 Jinglong Zhao1 linfeng Zheng1 Zhuoli Zhang3 renju Bai2 guixiang Zhang1 1Department of radiology, shanghai  general hospital, shanghai Jiao Tong  University, shanghai, 2Department of  radiology, Tianjin Medical University  general hospital, Tianjin, People’s  republic of china; 3Department  of radiology, Feinberg school of  Medicine, northwestern University,   chicago, il, UsaAbstract:  This study was performed to evaluate the findings including the time density curve  (TD curve), the relative percentage of enhancement washout (Washr) and the absolute percentage  of enhancement washout (Washa) at dynamic contrast-enhanced computed tomography  (DCE-CT) in 70 patients with 79 adrenal masses (including 44 adenomas and 35 nonadenomas)  confirmed histopathologically and/or clinically.",Non-OADS,/arxiv_data1/oa_pdf/ae/a3/ott-9-6809.PMC5098566.pdf
"correspondence: renju Bai Department of radiology, Tianjin Medical  University general hospital, 154 anshan  road, heping District, Tianjin 300052,  People’s republic of china Tel +86 22 6036 2911 Fax +86 22 2721 9052 email cjr.bairenju@vip.163.co m  guixiang Zhang Department of radiology, shanghai general  hospital, shanghai Jiao Tong University,  100 haining road, hongkou District,  shanghai 200080, People’s republic  of china Tel +86 21 6324 0090 ext 4166 Fax +86 21 6324 0825 email guixiangzhang@sina.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Wang et al Running head recto: Differentiation of adrenal masses using DCE-CT DOI: http://dx.doi.org/10.2147/OTT.S112003",Non-OADS,/arxiv_data1/oa_pdf/ae/a3/ott-9-6809.PMC5098566.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ae/a3/ott-9-6809.PMC5098566.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/a3/ott-9-6809.PMC5098566.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/01/3f/ott-9-6741.PMC5098585.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6741–6749OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6741Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11597 4 Positive expression of KiF20a indicates poor  prognosis of glioma patients Jia Duan* Wei huang* haiping shi Department of neurosurgery, suining  central hospital, suining, sichuan,   People’s republic of china *These authors contributed equally  to this workAbstract:  Glioma patients have a poor overall survival; however, patients can show distinct  clinical outcomes due to the high heterogeneity of the tumor, which may be indicated by  certain clinicobiological parameters.",Non-OADS,/arxiv_data1/oa_pdf/01/3f/ott-9-6741.PMC5098585.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/01/3f/ott-9-6741.PMC5098585.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/01/3f/ott-9-6741.PMC5098585.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/3c/b0/ott-9-6785.PMC5098586.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6785–6794OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6785Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S10652 8 antineoplastic-related cardiotoxicity,  morphofunctional aspects in a murine model:  contribution of the new tool 2D-speckle tracking carmela coppola1 gennaro riccio1 antonio Barbieri2 Maria gaia Monti3 giovanna Piscopo1 Domenica rea2 claudio arra2 carlo Maurea1 claudia De lorenzo4,5 nicola Maurea1 1Division of cardiology, istituto  nazionale per lo studio e la cura  dei T umori “Fondazione g. Pascale”,   irccs, naples, italy; 2animal Facility  Unit, Department of experimental  Oncology, istituto nazionale per  lo studio e la cura dei Tumori  “Fondazione g. Pascale”, irccs,   naples, italy; 3Department of  Translational Medical sciences,   University Federico ii, naples, italy;   4Department of Molecular Medicine  and Medical Biotechnology, University  Federico ii, naples, italy; 5ceinge  Biotecnologie avanzate, naples, italyObjective:  Considering that global left ventricular systolic radial strain is a sensitive technique  for the early detection of left ventricular dysfunction due to antineoplastics and the analysis  of segmental myocardial contractility, we evaluated this technique for early detection of  trastuzumab-related cardiotoxicity by comparing it with cardiac structural damage.",Non-OADS,/arxiv_data1/oa_pdf/3c/b0/ott-9-6785.PMC5098586.pdf
"Two main  pathways have been proposed; first, doxorubicin induces cardiotoxicity by reactive oxygen  species formation;4 second, doxorubicin-top2 β complex in cardiomyocytes plays a key role  to induce changes in mitochondrial membrane potential, function, and morphology.5correspondence: nicola Maurea Division of cardiology, istituto nazionale  per lo studio e la cura dei Tumori  “Fondazione g. Pascale”, irccs, 80131  naples, italy  Tel +39 081 590 3519 Fax +39 081 590 3829 email n.maurea@istitutotumori.na.i t Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Coppola et al Running head recto: Antineoplastic-related cardiotoxicity: morphofunctional aspects DOI: http://dx.doi.org/10.2147/OTT.S106528",Non-OADS,/arxiv_data1/oa_pdf/3c/b0/ott-9-6785.PMC5098586.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/3c/b0/ott-9-6785.PMC5098586.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3c/b0/ott-9-6785.PMC5098586.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/4a/f0/ott-9-6775.PMC5098587.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6775–6783OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6775Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11055 8 cervical nodal necrosis is an independent  survival predictor in nasopharyngeal carcinoma:  an observational cohort study Yangkun luo1 Jing ren2 Peng Zhou2 Yang gao3 guangquan Yang1 Jinyi lang1 1Department of radiation Oncology,   2Department of radiology, sichuan  cancer hospital, chengdu,   3Department of radiation Oncology,   Zigong no 4 People’s hospital of  sichuan Province, Zigong, sichuan,   People’s republic of chinaPurpose:  Most nasopharyngeal carcinoma (NPC) patients present with locoregionally advanced  disease at the time of diagnosis; however, there is a lack of consensus on specific prognostic  factors potentially improving overall survival, especially in late-stage disease.",Non-OADS,/arxiv_data1/oa_pdf/4a/f0/ott-9-6775.PMC5098587.pdf
"NPC presents with a variation of nonspecific symptoms  including trismus, pain, otitis media, nasal regurgitation, hearing loss, and cranial nerve  pulses,1 which when added to the anatomical complexity of the nasopharynx confound  and delay diagnosis; therefore, most patients with NPC have locally advanced disease  and up to 85% have regional node metastasis at the time of diagnosis.2,3 This underscores  the need for improving diagnostic methods for early detection of NPC.correspondence: Jinyi lang #55, section 4, renmin south road,  chengdu 610041, sichuan Province,  People’s republic of china Tel/fax +86 28 8542 0692 email langjy610@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Luo et al Running head recto: CNN is an independent survival predictor in NPC DOI: http://dx.doi.org/10.2147/OTT.S110558",Non-OADS,/arxiv_data1/oa_pdf/4a/f0/ott-9-6775.PMC5098587.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/4a/f0/ott-9-6775.PMC5098587.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4a/f0/ott-9-6775.PMC5098587.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/80/2a/ott-9-6631.PMC5098588.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).OncoTargets and Therapy 2016:9 6631–6640OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  6631Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S11437 0 Mll1 promotes cervical carcinoma cell  tumorigenesis and metastasis through  interaction with β-catenin rong Qiang1,2 na cai2 Xiaobin Wang2 lin Wang2 Ke cui2 Xiang Wang1 Xu li1 1center for Translational Medicine,   The First affiliated hospital of Xi’an  Jiaotong University, 2Medical heredity  research center, northwest Women’s  and children’s hospital, shaanxi,   People’s republic of chinaAbstract:  MLL protein genes encode a family of crucial transcription factors that play a key  role in multiple cancer development.",Non-OADS,/arxiv_data1/oa_pdf/80/2a/ott-9-6631.PMC5098588.pdf
"A previous study indicated that Wnt signaling pathway works as  a promoter in epithelial–mesenchymal transition and invasion/metastasis in breast correspondence: Xu li center for Translational Medicine,  The First Affiliated Hospital of Xi’an  Jiaotong University, 277 West Yanta  road, Xi’an 710061, shaanxi, People’s  republic of china Tel +86 29 8532 4630 email xulijiayou1314@yeah.ne t Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2016 Volume: 9 Running head verso: Qiang et al Running head recto: MLL1 promotes cervical carcinoma cell tumorigenesis and metastasis DOI: http://dx.doi.org/10.2147/OTT.S114370",Non-OADS,/arxiv_data1/oa_pdf/80/2a/ott-9-6631.PMC5098588.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/80/2a/ott-9-6631.PMC5098588.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/80/2a/ott-9-6631.PMC5098588.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/56/3f/ijcp-09-04-5810.PMC5098589.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a9/17/ijcp-09-04-4099.PMC5098590.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/eb/83/opth-10-2213.PMC5098591.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2213–2221Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2213Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S12234 5 T opography-modified refraction (TMR):  adjustment of treated cylinder amount and axis to  the topography versus standard clinical refraction  in myopic topography-guided lasiK anastasios John  Kanellopoulos1,2 1laserVision Clinical and research  institute, athens, greece;   2Department of Ophthalmology, NYU  Medical School, New Y ork, NY, USAPurpose:  To evaluate the safety, efficacy, and contralateral eye comparison of topography-guided  myopic LASIK with two different refraction treatment strategies.",Non-OADS,/arxiv_data1/oa_pdf/eb/83/opth-10-2213.PMC5098591.pdf
"Keywords:  TMR, topography-modified refraction, myopic LASIK, femtosecond laser,  FS200, EX500 excimer laser, long-term stability, regression, astigmatism correction, post-LASIK  refraction Introduction Laser vision correction has been established over the last 2 decades as a safe and  effective intervention, with Laser-assisted in situ keratomileusis (LASIK) being one  of the main techniques practiced globally.1,2 Femtosecond laser-assisted LASIK has become a popularized modification  over the last decade and over the standard LASIK technique utilizing mechanical  microkeratomes.3,4Correspondence: anastasios John  Kanellopoulos laserVision Clinical and research  institute, 17 Tsocha street,  athens 11521, greece Tel +30 210 747 2777 Fax +30 210 747 2789 email ajk@brilliantvision.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Kanellopoulos Running head recto: Comparison of topography cylinder adjustment in LASIK vs standard refraction DOI: http://dx.doi.org/10.2147/OPTH.S122345",Non-OADS,/arxiv_data1/oa_pdf/eb/83/opth-10-2213.PMC5098591.pdf
"Available from:  http://www.accessdata.fda.gov/cdrh_docs/pdf2/P020050S012b.pd f.  Accessed August 27, 2016.",OADS,/arxiv_data1/oa_pdf/eb/83/opth-10-2213.PMC5098591.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/eb/83/opth-10-2213.PMC5098591.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/83/opth-10-2213.PMC5098591.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/18/39/opth-10-2205.PMC5098592.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2205–2212Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2205Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10677 0 a new endocapsular open ring for prevention of  anterior and posterior capsule opacification ioannis g Pallikaris nela r stojanovic harilaos s ginis institute of Vision and Optics,   Department of Medicine, University  of Crete, heraklion, Crete, greecePurpose:  The aim of this study is to demonstrate the functionality of a new design of a thick  endocapsular open ring for prevention of anterior capsule opacification (ACO) and posterior  capsule opacification (PCO).",Non-OADS,/arxiv_data1/oa_pdf/18/39/opth-10-2205.PMC5098592.pdf
"Correspondence: ioannis g Pallikaris institute of Vision and Optics,  Department of Medicine, University of  Crete, 71003 heraklion, Crete, greece email pallikar@med.uoc.g r Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Pallikaris et al Running head recto: A new endocapsular open ring for capsule opacification prevention DOI: http://dx.doi.org/10.2147/OPTH.S106770",Non-OADS,/arxiv_data1/oa_pdf/18/39/opth-10-2205.PMC5098592.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/18/39/opth-10-2205.PMC5098592.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/18/39/opth-10-2205.PMC5098592.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/36/f5/opth-10-2141.PMC5098593.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2141–2147Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2141Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S12041 4 Clinical outcomes with toric intraocular lenses  planned using an optical low coherence  reflectometry ocular biometer with a new  toric calculator Kjell g gundersen1 richard Potvin2 1iFocus Øyeklinikk as, haugesund,   norway; 2science in Vision, akron,   nY, UsaPurpose:  To prospectively evaluate postoperative clinical outcomes with implantation of toric  intraocular lenses (IOLs) using preoperative keratometry from an optical low coherence reflec - tometry (OLCR) ocular biometer (Lenstar® LS900) and the built-in Barrett toric calculator.",Non-OADS,/arxiv_data1/oa_pdf/36/f5/opth-10-2141.PMC5098593.pdf
"Keywords:  Lenstar, keratometry, cataract surgery, astigmatism, cylinder, toric IOL Introduction Toric intraocular lenses (IOLs) are arguably one of the most successful methods to  reduce astigmatism at the time of cataract surgery.1 However, residual astigmatism  after toric IOL implantation remains a concern, with 36.5% of eyes not within 25%  of their target astigmatism correction and 35.2% having uncorrected distance visual  acuity worse than 20/25.1,2 In otherwise healthy and uncomplicated cataract surgeries,  one of the most important causes for unexpected residual astigmatism postoperatively  is believed to be inaccurate preoperative keratometry measurements.2 Some commonly Correspondence: Kjell g gundersen iFocus Øyeklinikk as, sørhauggaten 111,  haugesund 5527, norway Tel +47 5 280 8900 email kg@ifocus.n o Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Gundersen and Potvin Running head recto: Lenstar LS900 biometer and Barrett toric calculator: clinical results DOI: http://dx.doi.org/10.2147/OPTH.S120414 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/36/f5/opth-10-2141.PMC5098593.pdf
Or use: http://youtu.be/4SMNzyi4z2 AVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/36/f5/opth-10-2141.PMC5098593.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/36/f5/opth-10-2141.PMC5098593.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/36/f5/opth-10-2141.PMC5098593.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/8e/29/opth-10-2179.PMC5098594.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2179–2185Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2179Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11987 2 incidence of and risk factors for chloroquine  and hydroxychloroquine retinopathy in Thai  rheumatologic patients nuanpan Tangtavorn Y osanan Y ospaiboon Tanapat ratanapakorn suthasinee sinawat Thuss sanguansak Chavakij Bhoomibunchoo Wipada laovirojjanakul KKU eye Center, Department of  Ophthalmology, Faculty of Medicine,   Khon Kaen University, Khon Kaen,   ThailandObjective:  To study the incidences of and risk factors for chloroquine (CQ) and  hydroxychloroquine (HCQ) retinopathy in Thai rheumatologic patients.",Non-OADS,/arxiv_data1/oa_pdf/8e/29/opth-10-2179.PMC5098594.pdf
"This damage is incurable and  may progress even after the drugs are discontinued.2 An ophthalmologic screening Correspondence: Yosanan Yospaiboon KKU eye Center, Department of  Ophthalmology, Faculty of Medicine,  Khon Kaen University, 123 Mitraparb  highway, Khon Kaen 40002, Thailand Tel +66 43 348 383 email yosanan@kku.ac.t h Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Tangtavorn et al Running head recto: Chloroquine and hydroxychloroquine retinopathy DOI: http://dx.doi.org/10.2147/OPTH.S119872",Non-OADS,/arxiv_data1/oa_pdf/8e/29/opth-10-2179.PMC5098594.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/8e/29/opth-10-2179.PMC5098594.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8e/29/opth-10-2179.PMC5098594.pdf
Available  from: http://www.geoba.se /  15.,Non-OADS,/arxiv_data1/oa_pdf/8e/29/opth-10-2179.PMC5098594.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/03/e4/opth-10-2199.PMC5098595.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2199–2203Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2199Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11975 5 Vector analysis investigation of toric intraocular  lens with no deviation from the intended axis atsushi Kawahara1,2 Y oshinori Takayanagi1 1Takayanagi Clinic, Kushiro, 2sapporo  Kato eye Clinic, sapporo, hokkaido,   JapanAim:  The aim of this research was to evaluate vector analysis after implantation of toric  intraocular lenses (IOLs) without deviation from the intended axis.",Non-OADS,/arxiv_data1/oa_pdf/03/e4/opth-10-2199.PMC5098595.pdf
"Accordingly, the  implantation of toric IOLs has become a routine method for correcting postcataract  extraction astigmatic refractive error to increase uncorrected distance visual acuity.4 The  principle underlying the treatment rests on the assumption that the significant source  of astigmatic refractive error, following removal of the crystalline lens, is the anterior  surface of the cornea and that the cylinder power of the toric IOL, chosen using the  toric calculator, will match the astigmatism correction requirement of the individual  eye if the postoperative IOL meridian placement of the lens corresponds exactly to  that planned.5 The purpose of this retrospective study was to evaluate vector analysis Correspondence: atsushi Kawahara Takayanagi Clinic, 1-3-5, Minamiodori,  Kushiro, hokkaido 085-0841, Japan Tel +81 154 43 0211 Fax +81 154 43 0210 email atsusi-k@coral.plala.or.j p Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Kawahara and Takayanagi Running head recto: Toric IOL without deviation DOI: http://dx.doi.org/10.2147/OPTH.S119755",Non-OADS,/arxiv_data1/oa_pdf/03/e4/opth-10-2199.PMC5098595.pdf
"The cylinder power and IOL placement  meridian were chosen using the online Alcon Acrysof Toric  Calculator ( http://www.acrysoftoriccalculator.com /), which  provides expected postoperative refraction values.",Non-OADS,/arxiv_data1/oa_pdf/03/e4/opth-10-2199.PMC5098595.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/03/e4/opth-10-2199.PMC5098595.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/03/e4/opth-10-2199.PMC5098595.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/21/66/opth-10-2187.PMC5098596.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2187–2190Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2187Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S12019 7 Leber’s hereditary optic neuropathy is multiorgan  not mono-organ Josef Finsterer1 Sinda Zarrouk-Mahjoub2 1Krankenanstalt Rudolfstiftung, vienna,   Austria; 2Genomics Platform, Pasteur  institute of T unis, T unisiaAbstract:  Leber’s hereditary optic neuropathy (LHON) is a maternally inherited mitochondrial  disorder with bilateral loss of central vision primarily due to mitochondrial DNA (mtDNA)  mutations in subunits of complex I in the respiratory chain (primary LHON mutations), while  other mtDNA mutations can also be causative.",Non-OADS,/arxiv_data1/oa_pdf/21/66/opth-10-2187.PMC5098596.pdf
"Methods Data for this review were identified by searching MEDLINE, Current Contents,  EMBASE, Web of Science, Web of Knowledge, LILACS, SCOPUS, and Google  Scholar for references of relevant articles using the search terms “central nervous Correspondence: Josef Finsterer Krankenanstalt Rudolfstiftung,  Postfach 20, 1180 vienna, Austria Tel +43 1 71165 92085 Fax +43 1 478 1711 email fifigs1@yahoo.d e Journal name: Clinical Ophthalmology Article Designation: Review Y ear: 2016 Volume: 10 Running head verso: Finsterer and Zarrouk-Mahjoub Running head recto: LHON is multiorgan DOI: http://dx.doi.org/10.2147/OPTH.S120197",OADS,/arxiv_data1/oa_pdf/21/66/opth-10-2187.PMC5098596.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/21/66/opth-10-2187.PMC5098596.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/21/66/opth-10-2187.PMC5098596.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/e9/3d/opth-10-2191.PMC5098597.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2191–2198Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2191Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S11579 8 six-month visual outcomes for the correction  of presbyopia using a small-aperture corneal  inlay: single-site experience Majid Moshirfar1,2 Tyler s Quist3 David F skanchy4 ryan T Wallace5 steven h linn1 Phillip C hoopes Jr1 1hoopes, Durrie, rivera research  Center, hoopes Vision, Draper,   2Department of Ophthalmology and  Visual sciences, John a Moran eye  Center, University of Utah school of  Medicine, salt lake City, 3University  of Utah school of Medicine, salt  lake City, UT, 4Mcgovern Medical  school, The University of Texas  health science Center at houston,   TX, 5Brigham Y oung University, Provo,   UT, UsaObjective:  The objective of this study was to describe 6-month postoperative efficacy and  safety outcomes after monocular KAMRA corneal inlay implantation in emmetropic pres - byopic patients.",Non-OADS,/arxiv_data1/oa_pdf/e9/3d/opth-10-2191.PMC5098597.pdf
"The KAMRA corneal inlay (AcuFocus, Inc., Irvine, CA, USA) was approved Correspondence: Majid Moshirfar hDr research Center, hoopes Vision,  11820 s state street, suite #200,   Draper, UT 84020, Usa Tel +1 801 568 0200 Fax +1 801 563 0200 email cornea2020@me.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Moshirfar et al Running head recto: Visual outcomes at 6 months for small-aperture corneal inlay DOI: http://dx.doi.org/10.2147/OPTH.S115798",Non-OADS,/arxiv_data1/oa_pdf/e9/3d/opth-10-2191.PMC5098597.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/e9/3d/opth-10-2191.PMC5098597.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e9/3d/opth-10-2191.PMC5098597.pdf
"Available from: http://www.accessdata.fda.gov/ cdrh_docs/pdf12/P120023d.pd f. Accessed June 13, 2016.",OADS,/arxiv_data1/oa_pdf/e9/3d/opth-10-2191.PMC5098597.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ad/87/main.PMC5098599.pdf
Contents lists available at ScienceDirect Neurobiology of Stress journal homepage: http://www.journals.elsevier .com/neurobiology-of-stress/ http://dx.doi.org/10.1016/j.ynstr.2016.02.003 2352-2895/ ©2016 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/87/main.PMC5098599.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Neurobiology of Stress 4 (2016) 55 e61,Non-OADS,/arxiv_data1/oa_pdf/ad/87/main.PMC5098599.pdf
"Sample The ALSPAC birth cohort comprises 14,062 live births from pregnant women resident in county Avon, a geographically de ﬁned region in southwest of England, with expected dates of delivery between April 1991 and December 1992 ( http://www.bristol.ac.uk/ alspac/ )(Boyd et al., 2013; Fraser et al., 2013 ).",OADS,/arxiv_data1/oa_pdf/ad/87/main.PMC5098599.pdf
http://dx.doi.org/10.1007/ s00213-015-3975-1 .,Non-OADS,/arxiv_data1/oa_pdf/ad/87/main.PMC5098599.pdf
"The full terms of this license are available at https://www.dovepress.com/ terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a1/b4/clep-8-691.PMC5098605.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical epidemiology 2016:8 691–695 (Thematic series on clinical quality databases in Denmark)submit your manuscript | www.dovepress.co m Dove press  691 http: //dx.doi.org/10.2147/CLEP .S9948 8The Danish Schizophrenia Registry Lone Baandrup1 Charlotte Cerqueira2 Lea Haller3 Lene Korshøj3 inge voldsgaard4 Merete Nordentoft5 1Centre for Neuropsychiatric  Schizophrenia Research (CNSR)  and Centre for Clinical intervention  and Neuropsychiatric Schizophrenia  Research (C iNS), Mental Health  Centre Glostrup, Copenhagen  University Hospital, Glostrup,   2Registry Support Centre ( east) –  epidemiology and Biostatistics,   Research Centre for Prevention and  Health, Capital Region of Denmark,   Copenhagen, 3The Danish Clinical  Registries, Registry Support Centre  for Health Quality and informatics  (KCKS-w est), Aarhus, 4Psychosis  ward, Section P, Aarhus University  Hospital, Risskov, 5Mental Health  Centre Copenhagen, Mental Health  Services in the Capital Region of  Denmark, University of Copenhagen,   Copenhagen, Denmark Correspondence: Lone Baandrup   Centre for Neuropsychiatric  Schizophrenia Research (CNSR) and  Centre for Clinical intervention and  Neuropsychiatric Schizophrenia Research  (CiNS), Mental Health Centre Glostrup,  Copenhagen University Hospital, Nordre  Ringvej 21-67, DK-2600 Glostrup,  Denmark   T el +45 3027 0879   email lone.baandrup@regionh.d kAim of database:  To systematically monitor and improve the quality of treatment and care  of patients with schizophrenia in Denmark.",Non-OADS,/arxiv_data1/oa_pdf/a1/b4/clep-8-691.PMC5098605.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/a1/b4/clep-8-691.PMC5098605.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/95/c6/opth-10-2171.PMC5098680.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).Clinical Ophthalmology 2016:10 2171–2177Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2171Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S10599 2 effect of cataract surgery on subfoveal choroidal  and ganglion cell complex thicknesses measured  by enhanced depth imaging optical coherence  tomography erkan Celik Burcin Cakır elif Betul T urkoglu Emine Dog ˘an gursoy alagoz sakarya University Medical education  and research hospital, sakarya, T urkeyPurpose:  We aimed to evaluate the effect of cataract surgery on subfoveal choroidal thickness  (CT) and ganglion cell complex (GCC) thickness, as measured by enhanced depth imaging- optical coherence tomography (OCT).",Non-OADS,/arxiv_data1/oa_pdf/95/c6/opth-10-2171.PMC5098680.pdf
"Computerized algorithms can be used on the  high-resolution images obtained by modern OCT devices in order to identify and  measure the thicknesses of discrete retinal layers, including the retinal nerve fiber  layer (RNFL), macular ganglion cell complex (GCC), and choroid.2,3Correspondence: erkan Celik sakarya University Medical education  and research hospital, sakarya 54000,  Turkey Tel +90 532 660 56 57 email drerkancelik@gmail.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2016 Volume: 10 Running head verso: Celik et al Running head recto: Effect of cataract surgery on subfoveal choroidal and GCC thicknesses DOI: http://dx.doi.org/10.2147/OPTH.S105992",Non-OADS,/arxiv_data1/oa_pdf/95/c6/opth-10-2171.PMC5098680.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/95/c6/opth-10-2171.PMC5098680.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/95/c6/opth-10-2171.PMC5098680.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/5f/5f/oarrr-8-093.PMC5098681.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/5f/5f/oarrr-8-093.PMC5098681.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Rheumatology: Research and Reviews 2016:8 93–95Open Access Rheumatology: Research and Reviews Dovepress submit your manuscript | www.dovepress.com Dovepress 93 METHODOLOGY open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OARRR.S116036 Polymyalgia rheumatica and cancer risk: the  importance of the diagnostic set Ciro Manzo1  Maria Natale2 1Department of Geriatric and Internal  Medicine, 2Geriatric Rheumatologic  Outpatient Clinic, Hospital “Mariano  Lauro,” Sant’Agnello, Naples, ItalyAbstract: In the last few years, the relationship between polymyalgia rheumatica (PMR) and can- cer has been considered with very different conclusions.",Non-OADS,/arxiv_data1/oa_pdf/5f/5f/oarrr-8-093.PMC5098681.pdf
"Keywords: polymyalgia rheumatica, cancer risk, paraneoplastic phenomenon, methodology Introduction Polymyalgia rheumatica (PMR) represents the most frequent inflammatory rheumatic  disease in the elderly.1,2 In patients with PMR, the association of some constitutional signs  (fatigue, general malaise, fever, anorexia, or hyporexia) with highly elevated  inflammatory Correspondence: Ciro Manzo Hospital “Mariano Lauro”, viale dei Pini 1, Sant’Agnello 80065, Naples, ItalyTel +39 08 1533 1465   Email cirmanzo@libero.itJournal name: Open Access Rheumatology: Research and Reviews Article Designation: METHODOLOGYY ear: 2016V olume: 8Running head verso: Manzo and NataleRunning head recto: PMR and cancer riskDOI: http://dx.doi.org/10.2147/OARRR.S116036",Non-OADS,/arxiv_data1/oa_pdf/5f/5f/oarrr-8-093.PMC5098681.pdf
"Open Access Rheumatology: Research and Reviews 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Rheumatology: Research and Reviews Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/open-access-rheumatology-research-and-reviews-journalOpen Access Rheumatology: Research and Reviews is an international, peer- reviewed, open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of clinical and experimental rheuma-tology in the clinic and laboratory including the following topics: Pathology, pathophysiology of rheumatological diseases; Investigation, treatment and management of rheumatological diseases; Clinical trials and novel pharmacologi-cal approaches for the treatment of rheumatological disorders.",Non-OADS,/arxiv_data1/oa_pdf/5f/5f/oarrr-8-093.PMC5098681.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 95 PMR and cancer risk This time increases in the territories where the cooperation  between general practitioners and rheumatologists is poor and the waiting lists are long.,Non-OADS,/arxiv_data1/oa_pdf/5f/5f/oarrr-8-093.PMC5098681.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/82/18/oarrr-8-103.PMC5098683.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/82/18/oarrr-8-103.PMC5098683.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Rheumatology: Research and Reviews 2016:8 103–113Open Access Rheumatology: Research and Reviews Dovepress submit your manuscript | www.dovepress.com Dovepress 103 ORiginAl ReseARch open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OARRR.S93516 Anxiety and depression in patients with  osteoarthritis: impact and management challenges Anirudh sharma1  Prtha Kudesia2  Qian shi2  Rajiv gandhi2 1Division of genetics and  Development, Krembil Research  institute, 2Division of Orthopaedic  surgery, T oronto Western hospital,   T oronto, On , canadaBackground: Anxiety and depression are common psychological comorbidities that impact  the quality of life (QoL) of patients.",Non-OADS,/arxiv_data1/oa_pdf/82/18/oarrr-8-103.PMC5098683.pdf
"6,7 Anxiety is defined as the presence of “fear or nervousness about  what might happen”.8 When this fear produces behavioral and physiological changes,  the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-V) correspondence: Rajiv gandhi Division of Orthopaedic surgery, Toronto Western hospital, University of Toronto, Toronto, On M5T 2s8, canada   Tel +1 416 603 5642   email rajiv.gandhi@uhn.caJournal name: Open Access Rheumatology: Research and Reviews Article Designation: ORIgIn AL RESEARCh Y ear: 2016V olume: 8Running head verso: Sharma et alRunning head recto: Psychological challenges in OA managementDOI: http://dx.doi.org/10.2147/OARRR.S93516",Non-OADS,/arxiv_data1/oa_pdf/82/18/oarrr-8-103.PMC5098683.pdf
"The national Institute for health and Care Excellence (nICE) has outlined recom-mendations regarding holistic assessment of patients with OA ( https://www.nice.org.uk/guidance/cg177), which serves  as an excellent starting point and it is highly recommended that physicians consult this document.",Non-OADS,/arxiv_data1/oa_pdf/82/18/oarrr-8-103.PMC5098683.pdf
Available from: http://www.merriam-webster.com/.,Non-OADS,/arxiv_data1/oa_pdf/82/18/oarrr-8-103.PMC5098683.pdf
"Open Access Rheumatology: Research and Reviews 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Rheumatology: Research and Reviews Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/open-access-rheumatology-research-and-reviews-journalOpen Access Rheumatology: Research and Reviews is an international, peer- reviewed, open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of clinical and experimental rheuma-tology in the clinic and laboratory including the following topics: Pathology, pathophysiology of rheumatological diseases; Investigation, treatment and management of rheumatological diseases; Clinical trials and novel pharmacologi-cal approaches for the treatment of rheumatological disorders.",Non-OADS,/arxiv_data1/oa_pdf/82/18/oarrr-8-103.PMC5098683.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 113 Psychological challenges in OA management  51.,Non-OADS,/arxiv_data1/oa_pdf/82/18/oarrr-8-103.PMC5098683.pdf
Reprints and permissions:   http://www.sagepub.co.uk/journalsPermissions.navMULTIPLE SCLEROSIS MSJJOURNAL http://msj.sagepub.com 1719Introduction Multiple sclerosis (MS) is the most common disa-bling neurological disease of young adults.,Non-OADS,/arxiv_data1/oa_pdf/18/52/10.1177_1352458516667568.PMC5098693.pdf
"Multiple Sclerosis Journal 22(13) 1720 http://msj.sagepub.comdegree of clinical improvement, including Expanded  Disability Status Scale (EDSS) reductions in 22%.11  Biotin is a cofactor for four essential carboxylases: acetyl-CoA carboxylase (expressed in oligodendro-cytes) generates malonyl-CoA, the building block for fatty acid synthesis, whereas pyruvate carboxylase, 3-methylcrotonyl-CoA carboxylase and propionyl-CoA carboxylase (expressed in neurons) produce intermediates for the tricarboxylic acid cycle.",Non-OADS,/arxiv_data1/oa_pdf/18/52/10.1177_1352458516667568.PMC5098693.pdf
"http://msj.sagepub.com 1721global impression of change scored by the clinician  (clinician-assessed Clinical Global Impression Scale (CGI)) and patient (subject-assessed Clinical Global Impression Scale (SGI)) at month 12; and mean changes from randomisation in the 12-item Multiple Sclerosis Walking Scale (MSWS), Short Form 36 Health Survey (SF-36) subscores, TW25, modified Fatigue Impact Scale (MFIS), nine-hole peg test (9-HPT) and Kurtzke EDSS functional subscores.",Non-OADS,/arxiv_data1/oa_pdf/18/52/10.1177_1352458516667568.PMC5098693.pdf
Multiple Sclerosis Journal 22(13) 1722 http://msj.sagepub.comprimary endpoint compared with none in the placebo  arm (n = 42; p = 0.009).,Non-OADS,/arxiv_data1/oa_pdf/18/52/10.1177_1352458516667568.PMC5098693.pdf
http://msj.sagepub.com 1723and disease history did not influence the proportion of  patients achieving the primary endpoint.,Non-OADS,/arxiv_data1/oa_pdf/18/52/10.1177_1352458516667568.PMC5098693.pdf
"Multiple Sclerosis Journal 22(13) 1724 http://msj.sagepub.comIn patients who remained on MD1003, mean EDSS  was relatively stable over 24 months (+0.04 ± 0.62).",Non-OADS,/arxiv_data1/oa_pdf/18/52/10.1177_1352458516667568.PMC5098693.pdf
http://msj.sagepub.com 1725 Table 3.,Non-OADS,/arxiv_data1/oa_pdf/18/52/10.1177_1352458516667568.PMC5098693.pdf
"Multiple Sclerosis Journal 22(13) 1726 http://msj.sagepub.com(values truncated at 180 seconds) progressed at a  lower rate in the MD1003 group (from 1.0% at month  0 to 6.4% at month 12), than in the placebo group (from 2.0% at month 0 to 19.0% at month 12; p = 0.07).",Non-OADS,/arxiv_data1/oa_pdf/18/52/10.1177_1352458516667568.PMC5098693.pdf
http://msj.sagepub.com 1727Safety The incidence and distribution of AEs during the pla-cebo-controlled phase were similar between arms (Table 4 and Table S2).,OADS,/arxiv_data1/oa_pdf/18/52/10.1177_1352458516667568.PMC5098693.pdf
Multiple Sclerosis Journal 22(13) 1728 http://msj.sagepub.comTable 4.,Non-OADS,/arxiv_data1/oa_pdf/18/52/10.1177_1352458516667568.PMC5098693.pdf
http://msj.sagepub.com 1729treated with an anxiolytic.,Non-OADS,/arxiv_data1/oa_pdf/18/52/10.1177_1352458516667568.PMC5098693.pdf
"Multiple Sclerosis Journal 22(13) 1730 http://msj.sagepub.comBiogen Idec, Novartis and Genzyme; grants from  Merck Serono; grants, personal fees and non-financial support from Teva Pharmaceuticals; and grants and non-financial support from Bayer, outside the submit-ted work.",Non-OADS,/arxiv_data1/oa_pdf/18/52/10.1177_1352458516667568.PMC5098693.pdf
http://msj.sagepub.com 1731 21.,Non-OADS,/arxiv_data1/oa_pdf/18/52/10.1177_1352458516667568.PMC5098693.pdf
Visit SAGE journals online  http://msj.sagepub.com  SAGE journals,Non-OADS,/arxiv_data1/oa_pdf/18/52/10.1177_1352458516667568.PMC5098693.pdf
http://answers.hhs.gov/ohrp/categories/1569.,Non-OADS,/arxiv_data1/oa_pdf/58/6a/10.1177_1062860615606801.PMC5098699.pdf
Available at: http://citeseerx.ist.psu.edu/ Figure 20.,Non-OADS,/arxiv_data1/oa_pdf/4c/cc/10.1177_1059712316664017.PMC5098700.pdf
Available at: http://psycnet.apa.org/psycinfo/ 2003-88051-000 (accessed 19 August 2016).,Non-OADS,/arxiv_data1/oa_pdf/4c/cc/10.1177_1059712316664017.PMC5098700.pdf
Available at: http://www.jmlr.org/proceed- ings/papers/v15/glorot11a.html (accessed 19 August 2016).,Non-OADS,/arxiv_data1/oa_pdf/4c/cc/10.1177_1059712316664017.PMC5098700.pdf
Available at: https://scholar.google.de/scholar?,Non-OADS,/arxiv_data1/oa_pdf/4c/cc/10.1177_1059712316664017.PMC5098700.pdf
"Available at: https://scholar.google.de/ scholar?cluster=18130383993448916657&hl=de&as_sdt =0,5 (accessed 19 August 2016).",Non-OADS,/arxiv_data1/oa_pdf/4c/cc/10.1177_1059712316664017.PMC5098700.pdf
Available at: mhttp://journal.frontiersin.org/article/10.3389/fnhum.2013.00810/full (accessed 19 August 2016).,Non-OADS,/arxiv_data1/oa_pdf/4c/cc/10.1177_1059712316664017.PMC5098700.pdf
Available at: https://scholar.google.de/scholar?q=Children%E2%80%99s+emotions+and+moods%3A+Develop-+mental+theory+and+measurement&btnG=&hl=de&as_sdt=0%2C5 (accessed 19 August 2016).,Non-OADS,/arxiv_data1/oa_pdf/4c/cc/10.1177_1059712316664017.PMC5098700.pdf
Available at: http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.302.7795 (accessed 19 August 2016).,Non-OADS,/arxiv_data1/oa_pdf/4c/cc/10.1177_1059712316664017.PMC5098700.pdf
"Available at: https://scholar.google.de/scholar?start=0&hl=de&as_sdt=0,5&cluster=14924728719521477429 (accessed 19 August 2016).",Non-OADS,/arxiv_data1/oa_pdf/4c/cc/10.1177_1059712316664017.PMC5098700.pdf
Available at: http://link.sprin-ger.com/chapter/10.1007/978- 3-319-10590-1_53 (accessed 19 August 2016).,Non-OADS,/arxiv_data1/oa_pdf/4c/cc/10.1177_1059712316664017.PMC5098700.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by/4.0/.,Non-OADS,/arxiv_data1/oa_pdf/f3/9d/oarrr-8-077.PMC5098718.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/f3/9d/oarrr-8-077.PMC5098718.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/f3/9d/oarrr-8-077.PMC5098718.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Rheumatology: Research and Reviews 2016:8 77–80Open Access Rheumatology: Research and Reviews Dovepress submit your manuscript | www.dovepress.com Dovepress 77 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OARRR.S110560 The onset of rheumatoid arthritis following  trauma Arthur E Brawer Noopur Goel Department of Medicine, Monmouth  Medical Center, Long Branch, NJ, USABackground: Rheumatoid arthritis (RA) is known to have many predisposing factors.",Non-OADS,/arxiv_data1/oa_pdf/f3/9d/oarrr-8-077.PMC5098718.pdf
"We report on 60 cases where RA was initiated by a wide variety of physical injuries, Correspondence: Arthur E Brawer Division of Rheumatology, Department of Medicine, Monmouth Medical Center, 300 Second Avenue, Long Branch, NJ 07740, USATel +1 732 870 3133Fax +1 732 222 0824Email arthurbrawer@optimum.netJournal name: Open Access Rheumatology: Research and Reviews Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 8Running head verso: Brawer and GoelRunning head recto: Trauma and rheumatoid arthritisDOI: http://dx.doi.org/10.2147/OARRR.S110560",Non-OADS,/arxiv_data1/oa_pdf/f3/9d/oarrr-8-077.PMC5098718.pdf
"Open Access Rheumatology: Research and Reviews 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Rheumatology: Research and Reviews Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/open-access-rheumatology-research-and-reviews-journalOpen Access Rheumatology Research and Reviews is an international, peer- reviewed, open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of clinical and experimental rheuma-tology in the clinic and laboratory including the following topics: Pathology, pathophysiology of rheumatological diseases; Investigation, treatment and management of rheumatological diseases; Clinical trials and novel pharmacologi-cal approaches for the treatment of rheumatological disorders.",Non-OADS,/arxiv_data1/oa_pdf/f3/9d/oarrr-8-077.PMC5098718.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 80 Brawer and Goel,Non-OADS,/arxiv_data1/oa_pdf/f3/9d/oarrr-8-077.PMC5098718.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/62/ad/oarrr-8-081.PMC5098719.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/62/ad/oarrr-8-081.PMC5098719.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Rheumatology: Research and Reviews 2016:8 81–91Open Access Rheumatology: Research and Reviews Dovepress submit your manuscript | www.dovepress.com Dovepress 81 Review open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OARRR.S112829 Potential serum and urine biomarkers in patients  with lupus nephritis and the unsolved problems Song-Chou Hsieh1 Chang-Y ouh Tsai2 Chia-Li Yu3 1Department of internal Medicine,   National Taiwan University Hospital,   National Taiwan University College of Medicine,  2Section of Allergy,   immunology & Rheumatology,  Taipei veterans General Hospital,   3Department of internal Medicine,   institute of Molecular Medicine,  National Taiwan University College of Medicine, Taipei, TaiwanAbstract:  Lupus nephritis (LN) is one of the most frequent and serious complications in the  patients with systemic lupus erythematosus.",Non-OADS,/arxiv_data1/oa_pdf/62/ad/oarrr-8-081.PMC5098719.pdf
"3,4 However, these clinical parameters lack enough  sensitivity and Correspondence: Chia-Li Yu Department of internal Medicine, institute of Molecular Medicine, National Taiwan University College of Medicine, #7 Chung-Shan South Road, Taipei 10002, TaiwanFax +886 2 2395 7801email chialiyu@ntu.edu.twJournal name: Open Access Rheumatology: Research and Reviews Article Designation: ReviewY ear: 2016V olume: 8Running head verso: Hsieh et alRunning head recto: Urine biomarkers in LNDOI: http://dx.doi.org/10.2147/OARRR.S112829",Non-OADS,/arxiv_data1/oa_pdf/62/ad/oarrr-8-081.PMC5098719.pdf
"Open Access Rheumatology: Research and Reviews 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Rheumatology: Research and Reviews Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/open-access-rheumatology-research-and-reviews-journalOpen Access Rheumatology: Research and Reviews is an international, peer- reviewed, open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of clinical and experimental rheuma-tology in the clinic and laboratory including the following topics: Pathology, pathophysiology of rheumatological diseases; Investigation, treatment and management of rheumatological diseases; Clinical trials and novel pharmacologi-cal approaches for the treatment of rheumatological disorders.",Non-OADS,/arxiv_data1/oa_pdf/62/ad/oarrr-8-081.PMC5098719.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 91 Urine biomarkers in LN 124.,Non-OADS,/arxiv_data1/oa_pdf/62/ad/oarrr-8-081.PMC5098719.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/63/bb/oarrr-8-073.PMC5098720.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/63/bb/oarrr-8-073.PMC5098720.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).Open Access Rheumatology: Research and Reviews 2016:8 73–75Open Access Rheumatology: Research and Reviews Dovepress submit your manuscript | www.dovepress.com Dovepress 73 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OARRR.S105338 Wissler–Fanconi syndrome and related diagnoses:  a case report Mustafa Q Albustani1 Robert F Howard2 1Section of Medicine/Pediatrics, The  University of Oklahoma College of  Medicine, T ulsa, OK, USA; 2Division of  Rheumatology, Utica Park Clinic, T ulsa,  OK, USAIntroduction: Wissler–Fanconi syndrome is a rare rheumatic syndrome that was first described during  the 1940s in Europe.",Non-OADS,/arxiv_data1/oa_pdf/63/bb/oarrr-8-073.PMC5098720.pdf
"Under the more general descriptive umbrella of Wissler–Fanconi syndrome, our patient also fulfils the Modified Jones criteria for acute rheumatic fever, and the 2010 ACR/ Correspondence: Mustafa Q Albustani Section of Medicine/Pediatrics, The University of Oklahoma College of Medicine, 4502 East 41st Street Tulsa, OK 74135-2512, USATel +1 918 660 3395Fax +1 918 660 3444Email Mustafa-albustani@ouhsc.eduJournal name: Open Access Rheumatology: Research and Reviews Article Designation: CASE REPORTY ear: 2016V olume: 8Running head verso: Albustani and HowardRunning head recto: Wissler–Fanconi syndrome and related diagnosesDOI: http://dx.doi.org/10.2147/OARRR.S105338",Non-OADS,/arxiv_data1/oa_pdf/63/bb/oarrr-8-073.PMC5098720.pdf
"Open Access Rheumatology: Research and Reviews 2016:8submit your manuscript | www.dovepress.com Dovepress Dovepress Open Access Rheumatology: Research and Reviews Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/open-access-rheumatology-research-and-reviews-journalOpen Access Rheumatology Research and Reviews is an international, peer- reviewed, open access journal publishing original research, reports, editorials, reviews and commentaries on all aspects of clinical and experimental rheuma-tology in the clinic and laboratory including the following topics: Pathology, pathophysiology of rheumatological diseases; Investigation, treatment and management of rheumatological diseases; Clinical trials and novel pharmacologi-cal approaches for the treatment of rheumatological disorders.",Non-OADS,/arxiv_data1/oa_pdf/63/bb/oarrr-8-073.PMC5098720.pdf
"Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 75 Wissler–Fanconi syndrome and related diagnoses for adult onset Still’ s disease, there was no sore throat, and  rheumatoid factor was positive).",Non-OADS,/arxiv_data1/oa_pdf/63/bb/oarrr-8-073.PMC5098720.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/cf/93/oarrr-8-061.PMC5098721.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",OADS,/arxiv_data1/oa_pdf/cf/93/oarrr-8-061.PMC5098721.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).The family journey-to-diagnosis with systemic  juvenile idiopathic arthritis: a cross-sectional study  of the changing social media presence Renee F Modica1 Kathleen Graham Lomax2 Pamela Batzel3 Leah Shapardanis3 Kimberly Compton Katzer3 Melissa E Elder1 1Division of Pediatric  Rheumatology,   Immunology and Infectious Diseases,   University of Florida, Gainesville,   FL, USA; 2Immunology and  Dermatology Medical Affairs, Novartis  Pharmaceuticals Corporation, East  Hanover, USA; 3Treato, Princeton, NJ,   USA Correspondence: Renee F Modica   Division of Pediatric Rheumatology,  Immunology and Infectious Diseases,  University of Florida, 1600 SW  Archer Road, HD-405 Gainesville,  FL 32610-0296, USA   T el +1 352 294 5252   Email modicar@peds.ufl.ed uBackground:  Children with systemic juvenile idiopathic arthritis (SJIA) often encounter a  delay between symptom onset and disease diagnosis, partly due to the broad differential of fever  and lack of symptom recognition by providers.",Non-OADS,/arxiv_data1/oa_pdf/cf/93/oarrr-8-061.PMC5098721.pdf
"Open Access Rheumatology Research and Reviews Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-rheumatology-research-and-reviews-journa lOpen Access Rheumatology Research and Reviews is an international,  peer-reviewed, open access journal, publishing all aspects of clinical  and experimental rheumatology in the clinic and laboratory including  the following topics: Pathology, pathophysiology of rheumatological  diseases; Investigation, treatment and management of rheumatological diseases; Clinical trials and novel pharmacological approaches for the  treatment of rheumatological disorders.",Non-OADS,/arxiv_data1/oa_pdf/cf/93/oarrr-8-061.PMC5098721.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cf/93/oarrr-8-061.PMC5098721.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License ( http://creativecommons.org/licenses/by-nc/3.0/ ), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ad/a6/kbim-06-01-1231276.PMC5098722.pdf
"1, e1231276 (12 pages)http://dx.doi.org/10.1080/21592535.2016.1231276",Non-OADS,/arxiv_data1/oa_pdf/ad/a6/kbim-06-01-1231276.PMC5098722.pdf
"ORCID Gregory De Crescenzo http://orcid.org/0000-0002-6280- 1570 References [1] Cummings BJ, Uchida N, Tamaki SJ, Salazar DL, Hoosh- mand M, Summers R, Gage FH, Anderson AJ.",Non-OADS,/arxiv_data1/oa_pdf/ad/a6/kbim-06-01-1231276.PMC5098722.pdf
"Cell Transplant 2008; 17:1115-23; PMID:19181206;http://dx.doi.org/10.3727/096368908787236585 [3] Parr AM, Kulbatski I, Zahir T, Wang X, Yue C, Keating A, Tator CH.",OADS,/arxiv_data1/oa_pdf/ad/a6/kbim-06-01-1231276.PMC5098722.pdf
Neuroscience 2008;155:760-70; PMID:18588947; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ad/a6/kbim-06-01-1231276.PMC5098722.pdf
"Bio-materials 2007; 28:3517-29; PMID:17482256; http://dx.doi.org/10.1016/j.biomaterials.2007.04.022 [5] Tropepe V, Sibilia M, Ciruna BG, Rossant J, Wagner EF, van der Kooy D. Distinct Neural Stem Cells proliferate in response to EGF and FGF in the developing mouse telen- cephalon.",OADS,/arxiv_data1/oa_pdf/ad/a6/kbim-06-01-1231276.PMC5098722.pdf
"Dev Biol 1999; 208:166-88; PMID:10075850; http://dx.doi.org/10.1006/dbio.1998.9192 [6] Karimi-Abdolrezaee S, Eftekharpour E, Wang J, Mors- head CM, Fehlings MG.",OADS,/arxiv_data1/oa_pdf/ad/a6/kbim-06-01-1231276.PMC5098722.pdf
"Stem Cell Rev 2014; 10:251- 68; PMID:24415130; http://dx.doi.org/10.1007/s12015-013-9484-x [8] Guo X, Zahir T, Mothe A, Shoichet MS, Morshead CM, Katayama Y, Tator CH.",OADS,/arxiv_data1/oa_pdf/ad/a6/kbim-06-01-1231276.PMC5098722.pdf
"Cell Transplant2012; 21:1177-97; PMID:22236767; http://dx.doi.org/10.3727/096368911X612503 [9] Subramanian A, Krishnan UM, Sethuraman S. Develop- ment of biomaterial scaffold for nerve tissue engineering: Biomaterial mediated neural regeneration.",Non-OADS,/arxiv_data1/oa_pdf/ad/a6/kbim-06-01-1231276.PMC5098722.pdf
"J Biomed Sci2009; 16:108; PMID:19939265; http://dx.doi.org/10.1186/ 1423-0127-16-108 [10] Tayalia P, Mooney DJ.",OADS,/arxiv_data1/oa_pdf/ad/a6/kbim-06-01-1231276.PMC5098722.pdf
"Adv Mater 2009; 21:3269-85; PMID:20882497; http://dx.doi.org/10.1002/adma.200900241 [11] Peppas NA, Hilt JZ, Khademhosseini A, Langer R. Hydro- gels in biology and medicine: From molecular principles to bionanotechnology.",OADS,/arxiv_data1/oa_pdf/ad/a6/kbim-06-01-1231276.PMC5098722.pdf
"Acta Biomater2011; 7:1634-43; PMID:21130187; http://dx.doi.org/10.1016/j.actbio.2010.11.039 [13] Wang Y, Wei YT, Zu ZH, Ju RK, Guo MY, Wang XM, Xu QY, Cui FZ.",OADS,/arxiv_data1/oa_pdf/ad/a6/kbim-06-01-1231276.PMC5098722.pdf
"Pharm Res 2011; 28:1406-14;PMID:21537876; http://dx.doi.org/10.1007/s11095-011-0452-3 [14] Yang F, Murugan R, Wang S, Ramakrishna S. Electro- spinning of nano/micro scale poly(L-lactic acid) alignedﬁbers and their potential in neural tissue engineering.",OADS,/arxiv_data1/oa_pdf/ad/a6/kbim-06-01-1231276.PMC5098722.pdf
"J Biomater Sci Polym Ed 2004; 15:1483-97; PMID:15696794; http://dx.doi.org/10.1163/1568562042459733 [16] Pham QP, Sharma U, Mikos AG.",OADS,/arxiv_data1/oa_pdf/ad/a6/kbim-06-01-1231276.PMC5098722.pdf
"Tissue Eng 2006; 12:1197-211; PMID:16771634; http://dx.doi.org/10.1089/ten.2006.12.1197 [17] Xu CY, Inai R, Kotaki M, Ramakrishna S. Aligned biode- gradable nano ﬁbrous structure: a potential scaffold for blood vessel engineering.",OADS,/arxiv_data1/oa_pdf/ad/a6/kbim-06-01-1231276.PMC5098722.pdf
"Biomaterials 2004; 25:877-86;PMID:14609676; http://dx.doi.org/10.1016/S0142-9612(03)00593-3 [18] Fadeev AY, McCarthy TJ.",OADS,/arxiv_data1/oa_pdf/ad/a6/kbim-06-01-1231276.PMC5098722.pdf
"Langmuir 1998; 14:5586-93; http://dx.doi.org/10.1021/la980512f [19] Yang P, Zhang X, Yang B, Zhao H, Chen J, Yang W. Facile preparation of a patterned, aminated polymer surface byUV-light-induces surface aminolysis.",Non-OADS,/arxiv_data1/oa_pdf/ad/a6/kbim-06-01-1231276.PMC5098722.pdf
"Adv Funct Mater2005; 15:1415-25; http://dx.doi.org/10.1002/adfm.2004- 00335 [20] Dimitrievska S, Maire M, Diaz-Quijada GA, Robitaille L, Ajji A, Yahia L, Moreno M, Merhi Y, Bureau MN.",Non-OADS,/arxiv_data1/oa_pdf/ad/a6/kbim-06-01-1231276.PMC5098722.pdf
"Macromol Biosci 2011; 11:493-502; PMID:21259437; http://dx.doi.org/10.1002/mabi.201000390 [21] Noel S, Liberelle B, Yogi A, Moreno MJ, Bureau MN, Robitaille L, De Crescenzo G. A non-damaging chemical amination protocol for poly(ethylene terephthalate) -BIOMATTER e1231276-11",Non-OADS,/arxiv_data1/oa_pdf/ad/a6/kbim-06-01-1231276.PMC5098722.pdf
"J Mater Chem B 2013; 1:230-8; http://dx.doi.org/10.1039/C2TB00082B [22] Noel S, Liberelle B, Robitaille L, De Crescenzo G. Quanti ﬁca- tion of primary amine groups available for subsequent bio-functionalization of polymer surfaces.",Non-OADS,/arxiv_data1/oa_pdf/ad/a6/kbim-06-01-1231276.PMC5098722.pdf
"Bioconjugate Chem2011; 22:1690-9; http://dx.doi.org/10.1021/bc200259c [23] Ahlfors JE, Elayoubi R. Methods for Reprogramming Cells and Uses Thereof.",OADS,/arxiv_data1/oa_pdf/ad/a6/kbim-06-01-1231276.PMC5098722.pdf
"Polymer 1988; 29:2229-34; http://dx.doi.org/10.1016/0032-3861(88)90116-4 [25] Ishiyama C, Higo Y.",OADS,/arxiv_data1/oa_pdf/ad/a6/kbim-06-01-1231276.PMC5098722.pdf
"J Polym Sci, PartB: Polym Phys 2002; 40:460-5; http://dx.doi.org/10.1002/ polb.10107 [26] Shen J, Chen CC, Sauer JA.",OADS,/arxiv_data1/oa_pdf/ad/a6/kbim-06-01-1231276.PMC5098722.pdf
"Polymer 1985; 26:511-8;http://dx.doi.org/10.1016/0032-3861(85)90150-8 [27] Lequoy P, Liberelle B, De Crescenzo G, Lerouge S. Additive beneﬁts of chondroitin sulfate and oriented tethered epi- dermal growth factor for vascular smooth muscle cell sur- vival.",Non-OADS,/arxiv_data1/oa_pdf/ad/a6/kbim-06-01-1231276.PMC5098722.pdf
"Macromol Biosci 2014; 14:720-30; PMID:24469944; http://dx.doi.org/10.1002/mabi.201300443 [28] Liberelle B, Boucher C, Chen JK, Jolicoeur M, Durocher Y, De Crescenzo G. Impact of Epidermal Growth FactorTethering Strategy on Cellular Response.",OADS,/arxiv_data1/oa_pdf/ad/a6/kbim-06-01-1231276.PMC5098722.pdf
"BioconjugateChem 2010; 21:2257-66; http://dx.doi.org/10.1021/bc1002604 [29] Cooke MJ, Wang Y, Morshead CM, Shoichet MS. Con- trolled epi-cortical delivery of epidermal growth factor for the stimulation of endogenous neural stem cell prolif-eration in stroke-injured brain.",OADS,/arxiv_data1/oa_pdf/ad/a6/kbim-06-01-1231276.PMC5098722.pdf
"Biomaterials 2011;32:5688-97; PMID:21550655; http://dx.doi.org/10.1016/j.biomaterials.2011.04.032 [30] Jeon O, Alsberg E. Regulation of stem cell fate in a three- dimensional micropatterned dual-crosslinked hydrogelsystem.",OADS,/arxiv_data1/oa_pdf/ad/a6/kbim-06-01-1231276.PMC5098722.pdf
"Cell-cell signaling by direct contact increases cell proliferation via a PI3K-dependent signal.FEBS Lett 2002; 514:238-42; PMID:11943158; http://dx.doi.org/10.1016/S0014-5793(02)02370-0[32] Liu WF, Nelson CM, Pirone DM, Chen CS.",OADS,/arxiv_data1/oa_pdf/ad/a6/kbim-06-01-1231276.PMC5098722.pdf
"J Cell Biol2006; 173:431-41; PMID:16682529; http://dx.doi.org/10.1083/jcb.200510087 [33] Johnson WE, Eisenstein SM, Roberts S. Cell cluster for- mation in degenerate lumbar intervertebral discs is asso-ciated with increased disc cell proliferation.",Non-OADS,/arxiv_data1/oa_pdf/ad/a6/kbim-06-01-1231276.PMC5098722.pdf
"J Colloid Interf Sci 1985; 104:28-39; http://dx.doi.org/10.1016/0021-9797(85)90006-2 [35] Lee JH, Khang G, Lee JW, Lee HB.",OADS,/arxiv_data1/oa_pdf/ad/a6/kbim-06-01-1231276.PMC5098722.pdf
"J Colloid Interface Sci 1998; 205:323-30; PMID: 9735195; http://dx.doi.org/10.1006/jcis.1998.5688 [36] van Wachem PB, Beugeling T, Feijen J, Bantjes A, Detmers JP, van Aken WG.",OADS,/arxiv_data1/oa_pdf/ad/a6/kbim-06-01-1231276.PMC5098722.pdf
"Interaction of cultured human endothe-lial cells with polymeric surfaces of different wettabilities.Biomaterials 1985; 6:403-8; PMID:4084642; http://dx.doi.org/10.1016/0142-9612(85)90101-2 [37] van Wachem PB, Hogt AH, Beugeling T, Feijen J, Bantjes A, Detmers JP, van Aken WG.",OADS,/arxiv_data1/oa_pdf/ad/a6/kbim-06-01-1231276.PMC5098722.pdf
"Biomaterials1987; 8:323-8; PMID:3676418; http://dx.doi.org/10.1016/0142-9612(87)90001-9 [38] Ma ZW, Mao ZW, Gao CY.",OADS,/arxiv_data1/oa_pdf/ad/a6/kbim-06-01-1231276.PMC5098722.pdf
"J Biomed Mater Res A 2004; 69a:436-43; http://dx.doi.org/10.1002/jbm.a.30007 [40] Chen G, Kawazoe N, Tateishi T. Effects of ECM proteins and cationic polymers on the adhesion and proliferationof rat islet cells.",OADS,/arxiv_data1/oa_pdf/ad/a6/kbim-06-01-1231276.PMC5098722.pdf
J Appl Polym Sci 2009; 112:3754-63; http://dx.doi.org/10.1002/app.29800e1231276-12 T. HADDAD ET AL.,OADS,/arxiv_data1/oa_pdf/ad/a6/kbim-06-01-1231276.PMC5098722.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/02/f7/ijpbs-10-03-3604.PMC5098723.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/ca/ed/ijgm-9-393.PMC5098745.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/ca/ed/ijgm-9-393.PMC5098745.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of General Medicine 2016:9 393–399International Journal of General Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 393 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S118422Treatment of bleeding in acquired hemophilia A  with the proper administration of recombinant  activated factor VII: single-center study of 7 cases Makoto Saito1 Minoru Kanaya1 Koh Izumiyama1 Akio Mori1 Tatsuro Irie1 Masanori Tanaka1 Masanobu Morioka1 Masahiro Ieko2 1Department of Internal Medicine  and Hematology, Aiiku Hospital, Japan;   2Department of Internal Medicine,   Health Sciences University of  Hokkaido, JapanAbstract:  Recombinant activated factor VII (rFVIIa) is the bypassing agent used in the first-line  hemostatic therapy for acquired hemophilia A (AHA); however, the occurrence of thrombotic  complications in rFVIIa-treated AHA patients was recently reported to be 2.9–6.5%.",Non-OADS,/arxiv_data1/oa_pdf/ca/ed/ijgm-9-393.PMC5098745.pdf
"4–6 Especially,  rFVIIa is the most frequently used,7,8 suggesting its high efficacy (more than 80%).9,10 It is  administered according to the administration dose and method for congenital hemophilia A patients possessing inhibitors (bolus administrations of 90 μg/kg every 2–3 hours until Correspondence: Makoto Saito Department of Internal Medicine and Hematology, Aiiku Hospital,Minami4 Nishi25 Chuo-ku, Sapporo 064–0804, JapanTel +81 11 563 2211Fax +81 11 522 1691Email ikyoku@aiiku-hp.or.jpJournal name: International Journal of General Medicine Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Saito et alRunning head recto: Treatment in AHA with recombinant activated factor VIIDOI: http://dx.doi.org/10.2147/IJGM.S118422",Non-OADS,/arxiv_data1/oa_pdf/ca/ed/ijgm-9-393.PMC5098745.pdf
"International Journal of General Medicine 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of General Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-general-medicine-journalThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat-ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/ca/ed/ijgm-9-393.PMC5098745.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 399 Treatment in AHA with recombinant activated factor VII,Non-OADS,/arxiv_data1/oa_pdf/ca/ed/ijgm-9-393.PMC5098745.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/eb/7a/ijn-11-5505.PMC5098746.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 5505–5518International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5505OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11542 8 cD20 monoclonal antibody targeted nanoscale  drug delivery system for doxorubicin  chemotherapy: an in vitro study of cell lysis  of cD20-positive raji cells shuang Jiang,1,2,* Xiaobo  Wang,2,* Zhiran Zhang,2 lan  sun,3 Yunzhu Pu,3 hongjuan  Yao,3 Jingcao li,3 Yan liu,3  Yingge Zhang,3 Weijing  Zhang1,4 1Department of l ymphoma,   affiliated hospital of the Military  Medical academy of sciences,   Beijing, 2Department of Pharmacy,   210th hospital of the People’s  liberation army, Dalian, 3Key  laboratory of Nanopharmacology  and Nanotoxicology, Institute of  Pharmacology and T oxicology,   academy of Military Medical sciences,   4Department of lymphoma, Beijing  shijitan hospital of capital Medical  University, Beijing, People’s republic  of china *These authors contributed equally  to this work Abstract:  A monoclonal antibody targeted nanoscale drug delivery system (NDDS) for che - motherapy was evaluated in CD20-positive Raji cells in vitro.",Non-OADS,/arxiv_data1/oa_pdf/eb/7a/ijn-11-5505.PMC5098746.pdf
"B-cell NHL is the most common type of NHL, accounting for 85% of cases in  People’s Republic of China.1 Patients with high-grade, B-cell NHL may require treatment  with high-dose chemotherapy and immunotherapy using monoclonal antibodies.2 New  treatments for high-grade B-cell NHL now include liposomal doxorubicin (DOX),3 the  anti-CD20 monoclonal antibody Rituximab,4 the CD20 monoclonal antibody-conjugated  isotope Zevalin,5 and proteasome inhibitors including bortezomib,6 which have improved correspondence: Yingge Zhang Institute of Pharmacology and Toxicology,  academy of Military Medical sciences,  room 2255, North Building, 27 Taiping  road, haidian District, Beijing 100850,  People’s republic of china Tel +86 10 6693 0654 Fax +86 10 6821 1656 email zhangyg58@126.co m  Weijing Zhang Department of Lymphoma, Affiliated  hospital of the Military Medical academy  of sciences, 8th street east, Fengtai  District, Beijing 100071, People’s  republic of china Tel +86 10 6392 6950 email zhangwj3072@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Jiang et al Running head recto: CD20 monoclonal antibody targeted NDDS DOI: http://dx.doi.org/10.2147/IJN.S115428",Non-OADS,/arxiv_data1/oa_pdf/eb/7a/ijn-11-5505.PMC5098746.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/eb/7a/ijn-11-5505.PMC5098746.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/7a/ijn-11-5505.PMC5098746.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/e2/b5/ijgm-9-383.PMC5098747.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/e2/b5/ijgm-9-383.PMC5098747.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Journal of General Medicine 2016:9 383–391International Journal of General Medicine Dovepress submit your manuscript | www.dovepress.com Dovepress 383 ORIGINAL RESEARCH open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S114188Incidence of clinical symptoms during   long-duration orbital spaceflight Brian Crucian1 Adriana Babiak-Vazquez2 Smith Johnston1 Duane L Pierson1 C Mark Ott1 Clarence Sams1 1Biomedical Research and  Environmental Sciences Division,   NASA-Johnson Space Center,   2Epidemiology/Lifetime Surveillance  of Astronaut Health, KBR-Wyle,  Houston, TX, USABackground: The environment of spaceflight may elevate an astronaut’ s clinical risk for specific  diseases.",Non-OADS,/arxiv_data1/oa_pdf/e2/b5/ijgm-9-383.PMC5098747.pdf
"23 Recent data  collected on board the Space Shuttle and International Space Station (ISS) confirms that human immune dysregulation is indeed an in-flight phenomenon, and not merely Correspondence: Brian Crucian NASA Johnson Space Center, 2101 NASA Parkway, Houston, TX, 77058, USATel +1 281 483 7061Email brian.crucian-1@nasa.govJournal name: International Journal of General Medicine Article Designation: ORIGINAL RESEARCHY ear: 2016V olume: 9Running head verso: Crucian et alRunning head recto: Incidence of clinical symptoms during long-duration spaceflightDOI: http://dx.doi.org/10.2147/IJGM.S114188",Non-OADS,/arxiv_data1/oa_pdf/e2/b5/ijgm-9-383.PMC5098747.pdf
"International Journal of General Medicine 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Journal of General Medicine Publish your work in this journal Submit your manuscript here: https://www.dovepress.com/international-journal-of-general-medicine-journalThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat-ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/e2/b5/ijgm-9-383.PMC5098747.pdf
Visit http://www.dovepress.com/testimonials.php to read real quotes from published authors.Dovepress 391 Incidence of clinical symptoms during long-duration spaceflight  5.,Non-OADS,/arxiv_data1/oa_pdf/e2/b5/ijgm-9-383.PMC5098747.pdf
Available from: http://www.nasa.gov/audience/foreducators/mathandscience/research/Prob_IMM_detail.html.,Non-OADS,/arxiv_data1/oa_pdf/e2/b5/ijgm-9-383.PMC5098747.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/a0/7f/ijn-11-5709.PMC5098748.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 5709–5727International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5709OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10776 7 salvianolic acid B protects against myocardial  damage caused by nanocarrier TiO2; and synergistic  anti-breast carcinoma effect with curcumin via  codelivery system of folic acid-targeted and  polyethylene glycol-modified TiO2 nanoparticles lingling Ding1–3 Jiawei li1,2 rui huang1,2 Zhidong liu1,2 chunhua li1–3 shaozi Yao1,2 Jinyan Wang1,2 Dongli Qi1,2 Nan li1,2 Jiaxin Pi1,2 1Tianjin state Key laboratory of  Modern chinese Medicine, Institute  of Traditional chinese Medicine,   Tianjin University of Traditional  chinese Medicine, 2engineering  research center of Modern chinese  Medicine Discovery and Preparation  Technique, Tianjin University of  Traditional chinese Medicine, 3Tianjin  International Joint academy of  Biomedicine, Tianjin, People’s republic  of chinaAbstract:  Targeted delivery by the folate ligand is an effective way to enhance an anti-breast  carcinoma effect, due to its high affinity for the folate receptor, which is overexpressed in many  tumor cells.",Non-OADS,/arxiv_data1/oa_pdf/a0/7f/ijn-11-5709.PMC5098748.pdf
"With the development of nanotechnology, nanodrug- delivery systems have emerged as a promising strategy to accomplish this requirement,  and can be delivered and accumulated at their targeted sites by either passive or active  targeting mechanisms.3 Additionally, synergy therapy, the simultaneous use of two or  more drugs as a “one–two punch”, has generated much interest, due to its effectiveness  in cancer treatments.4 Therefore, designing novel nanocarriers is beneficial toward  achieving preferable antitumor effects.correspondence: Zhidong liu; Jiawei li Tianjin state Key laboratory of Modern  chinese Medicine, Institute of Traditional  chinese Medicine, Tianjin University  of Traditional chinese Medicine,  88 Yuquan road, Nankai, Tianjin 300193,  People’s republic of china Tel +86 22 5959 6153 email lonerliuzd@163.co m;  lijiawei1981@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Ding et al Running head recto: FA-PEG-TiO2 NPs loaded with curcumin and salvianolic acid B DOI: http://dx.doi.org/10.2147/IJN.S107767",Non-OADS,/arxiv_data1/oa_pdf/a0/7f/ijn-11-5709.PMC5098748.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/a0/7f/ijn-11-5709.PMC5098748.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/7f/ijn-11-5709.PMC5098748.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/11/20/ijwh-8-633.PMC5098751.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2016:8 633–645International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  633RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S8931 7 Prevention of preterm delivery: current challenges  and future prospects Maud D van Zijl1 Bouchra Koullali1 Ben WJ Mol2 eva Pajkrt1 Martijn A Oudijk1 1Department of Obstetrics and  Gynaecology, Academic Medical  Center, Amsterdam, the Netherlands;   2The Robinson Research Institute,   School for Reproductive Health and  Pediatrics, University of Adelaide,   Adelaide, SA, AustraliaAbstract:  Preterm birth (PTB), defined as delivery at ,37 weeks of gestation, is the most  important cause of neonatal morbidity and mortality.",Non-OADS,/arxiv_data1/oa_pdf/11/20/ijwh-8-633.PMC5098751.pdf
"These  costs were significantly higher in the extreme premature group.9Correspondence: Martijn A Oudijk Department of Obstetrics and  Gynaecology, Academic Medical Center,  Meibergdreef 9, 1105 AZ Amsterdam,  the Netherlands Tel +31 20 566 7204 email m.a.oudijk@amc.n l Journal name: International Journal of Women’s Health Article Designation: Review Y ear: 2016 Volume: 8 Running head verso: van Zijl et al Running head recto: Prevention of preterm delivery DOI: http://dx.doi.org/10.2147/IJWH.S89317",Non-OADS,/arxiv_data1/oa_pdf/11/20/ijwh-8-633.PMC5098751.pdf
"Available from: http://www.studies- obsgyn.nl/trus t. Accessed March 20, 2016.",Non-OADS,/arxiv_data1/oa_pdf/11/20/ijwh-8-633.PMC5098751.pdf
"Available from: http://www.nvog.nl//Sites/Files/0000004608_ IVF_cijfers_2014_per_kliniek[1][1].pd f. Accessed March 1, 2016.",OADS,/arxiv_data1/oa_pdf/11/20/ijwh-8-633.PMC5098751.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/11/20/ijwh-8-633.PMC5098751.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/11/20/ijwh-8-633.PMC5098751.pdf
"Available from: http://www.studies-obsgyn.nl/P C.  Accessed February 23, 2016.",Non-OADS,/arxiv_data1/oa_pdf/11/20/ijwh-8-633.PMC5098751.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/ed/00/ijn-11-5743.PMC5098752.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 5743–5755International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5743OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11367 4 antibacterial abilities and biocompatibilities  of Ti–ag alloys with nanotubular coatings Xingwang liu,1 ang Tian,2  Junhua Y ou,3 hangzhou Zhang,4  lin Wu,5 Xizhuang Bai,1  Zeming lei,1 Xiaoguo shi,2  Xiangxin Xue,2 hanning Wang4 1Department of Orthopedics, The  People’s hospital of china Medical  University, 2liaoning Provincial Universities  Key laboratory of Boron resource  ecological Utilization Technology and Boron  Materials, Northeastern University, 3school  of Materials science and engineering,   shenyang University of T echnology,   4Department of sports Medicine and Joint  surgery, The First affiliated hospital of  china Medical University, 5Department of  Prosthodontics, school of stomatology,   china Medical University, shenyang,   People’s republic of chinaPurpose:  To endow implants with both short- and long-term antibacterial activities without  impairing their biocompatibility, novel Ti–Ag alloy substrates with different proportions of Ag  (1, 2, and 4 wt% Ag) were generated with nanotubular coverings (TiAg-NT).",Non-OADS,/arxiv_data1/oa_pdf/ed/00/ijn-11-5743.PMC5098752.pdf
"The  most urgent problem faced by orthopedists when using surgically implanted devices is  implant-related infection (IRI), which can result in serious complications, such as the need for  complex revision procedures, as well as poor prognosis, patient suffering, and even death.1  Biofilms that are irreversibly attached to device surfaces are the main cause of refractory  IRI.2 The best method for managing IRI is to prevent bacteria from adhering to implant  devices and ensure that any adhered bacteria are killed within the initial stage of implant  placement.3 The use of antibiotic-laden bone cement as a local drug delivery system has  shown some promise,4 but the short-lived antibacterial effects caused by the burst release  of antibiotics in the initial phase and the bacterial resistance resulting from continuous low- dose antibiotic release in the following phase are difficult limitations to overcome.5correspondence: Xizhuang Bai Department of Orthopedics, The People’s  hospital of china Medical University, 33 Wenyi  road, shenhe District, shenyang 110016,  People’s republic of china Tel +86 24 135 0490 0218 Fax +86 24 2401 6595 email doctor_baixizhuang@163.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Liu et al Running head recto: Antibacterial abilities of Ti–Ag alloy nanotubes DOI: http://dx.doi.org/10.2147/IJN.S113674 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/ed/00/ijn-11-5743.PMC5098752.pdf
Or use: http://youtu.be/c_kGlPCTO6 8Video abstract,Non-OADS,/arxiv_data1/oa_pdf/ed/00/ijn-11-5743.PMC5098752.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/ed/00/ijn-11-5743.PMC5098752.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ed/00/ijn-11-5743.PMC5098752.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/c4/9e/ijn-11-5757.PMC5098753.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 5757–5770International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5757OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S11856 8 Nanomicelles loaded with doxorubicin and  curcumin for alleviating multidrug resistance  in lung cancer Yue gu1,* Jing li2,* Yang li1 lei song1 Dan li1 liping Peng1 Ying Wan3 shucheng hua1 1Department of respiratory and  critical care Medicine, the First  affiliated hospital of Jilin University,   changchun, Jilin, 2hubei Province  Key laboratory on cardiovascular,   cerebrovascular, and Metabolic  Disorders, hubei University of  science and T echnology, Xianning,   3college of life sciences and  T echnology, huazhong University of  science and T echnology, Wuhan, hubei,   People’s republic of china *These authors contributed equally  to this workPurpose:  A new type of polymeric micelle (PM) was assembled using a polyethylene  glycol (PEG)-linked (PEGylated) amphiphilic copolymer and d-tocopheryl PEG1000 succinate  (TPGS1000).",Non-OADS,/arxiv_data1/oa_pdf/c4/9e/ijn-11-5757.PMC5098753.pdf
"The  second one is the main cause of the failure of chemotherapy.1,2 To enhance the thera - peutic efficacy of chemotherapeutic agents involved in MDR-related cancer therapies, correspondence: Ying Wan college of life sciences and Technology,  huazhong University of science and  Technology, Wuhan, hubei 430074,  People’s republic of china Tel +86 27 8779 2147 Fax +86 27 8779 2234 email ying_wan@hust.edu.c n shucheng hua Department of respiratory and critical  Care Medicine, the First Affiliated  hospital of Jilin University, changchun,  Jilin 130021, People’s republic of china Tel +86 431 8565 4528 Fax +86 431 8878 2442 email shuchenghua@aliyun.co m Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Gu et al Running head recto: Doxorubicin/curcumin-loaded nanomicelles for alleviating MDR in cancer DOI: http://dx.doi.org/10.2147/IJN.S118568",Non-OADS,/arxiv_data1/oa_pdf/c4/9e/ijn-11-5757.PMC5098753.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/c4/9e/ijn-11-5757.PMC5098753.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/9e/ijn-11-5757.PMC5098753.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/71/e0/ijn-11-5729.PMC5098754.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Nanomedicine 2016:11 5729–5742International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  5729OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S10900 1 T oll-like receptor 3-induced immune response by  poly( d,l-lactide-co-glycolide) nanoparticles for  dendritic cell-based cancer immunotherapy hee Dong han1,* Yeongseon Byeon1,* Tae heung Kang1 In Duk Jung1 Jeong-Won lee2 Byung cheol shin3 Y oung Joo lee4 anil K sood5–7 Yeong-Min Park1 1Department of Immunology, school  of Medicine, Konkuk University,   chungwondaero, chungju-si,   chungcheongbuk-Do, 2Department of  Obstetrics and gynecology, samsung  Medical center, sungkyunkwan  University school of Medicine, seoul,   3Bio/Drug Discovery Division, Korea  research Institute of chemical  T echnology, Yuseong-gu, Daejeon,   4Department of Bioscience and  Biotechnology, sejong University,   Kwang-Jin-gu, seoul, south Korea;   5Department of gynecologic  Oncology and reproductive Medicine,   6Department of cancer Biology,   7center for rNa Interference and  Non-coding rNa, The University  of Texas MD anderson cancer  center, TX, Usa *These authors contributed equally  to this workAbstract:  Dendritic cells (DCs) are potent professional antigen-presenting cells that are capable  of initiating a primary immune response and activating T cells, and they play a pivotal role  in the immune responses of the host to cancer.",Non-OADS,/arxiv_data1/oa_pdf/71/e0/ijn-11-5729.PMC5098754.pdf
"Recent  studies have shown that antigen-loaded NPs increase DC maturation, enhancing antigen  cross-presentation in DCs and inducing cytotoxic T cell responses.7 As DCs require high antigen uptake, various nanomaterials have been developed  with specific physicochemical properties and are currently under extensive investigation correspondence: Yeong-Min Park Department of Immunology, school  of Medicine, Konkuk University,  268 chungwondaero, chungju-si,  chungcheongbuk-Do 380-701,  south Korea Tel +82 2 2049 6330 Fax +82 2 2049 6192 email immun3023@kku.ac.k r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2016 Volume: 11 Running head verso: Han et al Running head recto: Dendritic cell-based cancer immunotherapy DOI: http://dx.doi.org/10.2147/IJN.S109001",Non-OADS,/arxiv_data1/oa_pdf/71/e0/ijn-11-5729.PMC5098754.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/71/e0/ijn-11-5729.PMC5098754.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/71/e0/ijn-11-5729.PMC5098754.pdf
"The full terms of this license are available at https://www.dovepress.com/terms.ph p   and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0 /).",Non-OADS,/arxiv_data1/oa_pdf/5f/f6/ijwh-8-647.PMC5098756.pdf
"For permission  for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.ph p).International Journal of Women’s Health 2016:8 647–650International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  647OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S11923 2 Postpartum hemorrhage: incidence, risk factors,  and outcomes in a low-resource setting solwayo ngwenya1–3 1Department of Obstetrics and  gynaecology, Mpilo central Hospital,   Bulawayo, Zimbabwe; 2royal Women’s  clinic, Bulawayo, Zimbabwe; 3Medical  school, national University of science  and T echnology, Matabeleland,   ZimbabweBackground:  Primary postpartum hemorrhage (PPH) is defined as blood loss from the geni - tal tract of 500 mL or more following a normal vaginal delivery (NVD) or 1,000 mL or more  following a cesarean section within 24 hours of birth.",Non-OADS,/arxiv_data1/oa_pdf/5f/f6/ijwh-8-647.PMC5098756.pdf
"Keywords:  causes, uterotonics, avoidable deaths, maternal outcomes, low-resource settingscorrespondence: solwayo ngwenya Mpilo central Hospital, Vera road,  Mzilikazi, Bulawayo, Zimbabwe email drsolngwe@yahoo.co.u k Journal name: International Journal of Women’s Health Article Designation: Original Research Y ear: 2016 Volume: 8 Running head verso: Ngwenya Running head recto: Postpartum hemorrhage DOI: http://dx.doi.org/10.2147/IJWH.S119232",Non-OADS,/arxiv_data1/oa_pdf/5f/f6/ijwh-8-647.PMC5098756.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/5f/f6/ijwh-8-647.PMC5098756.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5f/f6/ijwh-8-647.PMC5098756.pdf
The full terms of this license are available at https://www.dovepress.com/terms.,Non-OADS,/arxiv_data1/oa_pdf/ec/44/imcrj-9-341.PMC5098757.pdf
"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/).",OADS,/arxiv_data1/oa_pdf/ec/44/imcrj-9-341.PMC5098757.pdf
"For  permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).International Medical Case Reports Journal 2016:9 341–345International Medical Case Reports Journal Dovepress submit your manuscript | www.dovepress.com Dovepress 341 CASE REPORT open access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IMCRJ.S118139Virtual surgical planning and 3D printing  in prosthetic orbital reconstruction with  percutaneous implants: a technical case report Yu-Hui Huang1,2 Rosemary Seelaus1,2 Linping Zhao1,2 Pravin K Patel1,2 Mimis Cohen1,2 1The Craniofacial Center, Department  of Surgery, Division of Plastic &  Reconstructive Surgery, University of Illinois Hospital & Health Sciences System,  2University of Illinois College  of Medicine at Chicago, Chicago,    IL, USAAbstract:  Osseointegrated titanium implants to the cranial skeleton for retention of facial  prostheses have proven to be a reliable replacement for adhesive systems.",Non-OADS,/arxiv_data1/oa_pdf/ec/44/imcrj-9-341.PMC5098757.pdf
"10,11Correspondence: Rosemary Seelaus Craniofacial Center, Department of Surgery, Division of Plastic and Reconstructive Surgery, University of Illinois Hospital & Health Sciences System, 811 South Paulina Street, Chicago, IL 60612-7314, USATel +1 312 996 7546Fax +1 312 413 1157Email rseelaus@gmail.comJournal name: International Medical Case Reports Journal Article Designation: CASE REPORTY ear: 2016V olume: 9Running head verso: Huang et alRunning head recto: VSP and 3D printing in prosthetic orbital reconstructionDOI: http://dx.doi.org/10.2147/IMCRJ.S118139",Non-OADS,/arxiv_data1/oa_pdf/ec/44/imcrj-9-341.PMC5098757.pdf
"International Medical Case Reports Journal 2016:9submit your manuscript | www.dovepress.com Dovepress Dovepress International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  https://www.dovepress.com/international-medical-case-reports-journal-journalThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/ec/44/imcrj-9-341.PMC5098757.pdf
